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ABSTRACT 
 
CHRISTOPHER MICHAEL WELCH:  Rho GTPase Dynamics in the Regulation of 
Cellular Signaling and Migration 
(Under the direction of Dr. Klaus M. Hahn) 
 
Cell migration is critical to the development and maintenance of higher 
organisms, and is required for the patterning of the nervous system, for the development 
of organs, and for responses to wounds or sites of inflammation.  Because cell migration 
is so widely utilized, it must be very tightly controlled, as is apparent when the process 
goes awry, such as in cancer cell metastasis or chronic inflammation.  
Growth factors and other cues mediate the activation of a variety of pathways that 
induce cell migration.  Despite these many pathways, a family of proteins called Rho 
GTPases are universally engaged to cause changes in the cellular cytoskeleton, leading to 
cell migration.  Because Rho GTPases are so critical to cell migration, yet can be used to 
mediate many different types of cellular responses, they must be precisely controlled.  In 
most cases, it is the timing and placement of Rho GTPase activity that defines cellular 
behaviors in response to specific signals.  However, tools to investigate the 
spatiotemporal dynamics of Rho GTPase activity in live cells have only recently been 
developed.  I this work, I characterize the spatial and temporal dynamics of the Rho 
GTPases in cell migration through the development of sensors for Rho GTPase activity 
for live cell imaging.  I establish the spatial and temporal dynamics of RhoA, Rac1, and 
 iv
Cdc42 at the leading edge of migrating cells, and the role of RhoG in its ability to 
precisely position and activate Rac1 at the leading edge of cells.  This work provides the 
first thorough characterization of the roles of these GTPases at the leading edge relative 
to one another and the mechanisms by which they are regulated.  This work also 
demonstrates preliminary studies on the roles of these GTPases during leukocyte 
transendothelial migration.   
It is critical to gain an understanding of the mechanisms  by which cells control 
cell migration via the Rho GTPases.    Aberrant signaling through the GTPases leads to a 
variety of disease processes.  Thus, a better understanding of normal Rho GTPase 
signaling will provide a framework for understanding how cell migration goes awry and 
how it can be potentially treated.   
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CHAPTER ONE:  INTRODUCTION 
 
1.1  Introduction to Cell Migration 
A Historical Perspective: 
Cell migration is clearly critical to most physiological and pathological 
organismal processes, playing necessary roles in embryogenesis, neural cell migration 
and brain cortical development, inflammatory responses, wound healing, and cancer cell 
metastasis.  While we understand this clearly today, this knowledge has been long in 
development.   
Since the invention of the microscope in the early 17th century, scientists have 
been able to examine the world of living organisms in more detail, in particular the world 
of the very small living things that had theretofore gone unnoticed by the naked human 
eye.  A bewildering variety of new structures and particles were seen by early luminaries 
such as Hooke, Leeuwenhoek, Kircher, and Swammerdam, with Hooke being the first to 
use the term “cell” as he visualized the cell walls of the components of cork.  These early 
experiments also noted the movement of cells within their samples, as Leeuwenhoek saw 
and described motility in bacteria and spermatozoa (Ford 1995).  However, it was almost 
200 years later that “cell theory,” or the idea that all living things are composed of cells 
as a fundamental unit, was proposed by Schleiden (Schleiden 1838) and Schwann 
(Schwann 1839).  In addition, the cell was also recognized as the fundamental unit of 
disease processes, as stated in Virchow’s works on cellular pathology (Mazzarello 1999), 
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which became the standard for the approach to disease pathology until molecular 
pathology was developed in the following century.  In parallel with these studies, the 
microscope was also improved and advanced, with achromatic lenses in the 1800s 
pushing the field forward and allowing better visualization of cellular structures at higher 
magnification.  However, further technological advances were needed to study the 
movements and migration of metazoan cells.  In the late 1800s, Ernst Abbe and Carl 
Zeiss developed several technologies that enabled progress in visualizing thin, low-
contrast objects: apochromatic lenses, the Abbe condenser for oblique and darkfield 
imaging, and a new theory of image formation in microscopy (Dunn and Jones 2004).  
Among the first observations of metazoan cell migration was that by Ilya Metchnikoff, 
who studied motile cells in transparent starfish larvae.  By the introduction of small 
thorns into the larvae to see if the cells would defend against intruders, he observed the 
accumulation of cells around the sites of injury, single-handedly discovering leukocyte 
chemotaxis and engulfment (Tauber 2003).  However, it was not until Ross Harrison, in 
1907, plated frog neural tissue explants in clotted lymph and observed cells migrating out 
of the tissues, that it was confirmed with certainty that cells from tissues could move, and 
that cells from tissues could be cultured (Harrison 1907). Further developments in 
photography and interference contrast microscopy all enhanced scientists’ abilities to 
visualize and record such cellular movements.   
 What still remained to be identified were the molecular components of the cellular 
machinery.  Through development of antibodies for cytoskeletal components, scientists 
were able to identify the structure and location of actin and tubulin in fixed cells 
(Lazarides and Weber 1974) but these cells were not moving.  In the late 1970s, D. 
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Lansing Taylor and Yu-Li Wang revived the use of the microscope by injecting 
fluorescently labeled actin into live cells and visualizing its dynamics (Taylor and Wang 
1978).  With the advent of the laser-scanning confocal microscope (Amos and White 
2003) and the cloning and expression of green fluorescent protein (GFP) (Prasher et al. 
1992), the usefulness of fluorescent microscopy massively expanded, and scientists were 
then able to tag multiple components of cellular machinery and observe their dynamics in 
both space and time as cells moved or were perturbed.   
In parallel, the methodological barriers to studying cell migration were being 
overcome as well, with scientists developing methods for visualizing chemotaxis, 
mechanical forces, and signaling pathways.  As research on the GFP molecule has 
advanced, the field of cell migration has been provided with a myriad of tools to allow 
for visualization of protein localization, protein dynamics, protein activity, diffusion of 
molecules at steady-state, and lifetimes of expressed proteins (Newman et al. 2011).  
Similar work has also provided novel tools that allow for the ability to tune and activate 
proteins by light in living cells (Levskaya et al. 2009; Wu et al. 2009), enabling specific 
manipulation of protein activity in time and space to study how cellular behaviors are 
then changed.  Lastly, with new microscopy techniques, such as total internal reflection 
microscopy (TIRF) (Lanni et al. 1985), fluorescence correlation spectroscopy (FCS) 
(Schwille et al. 1999), and multiphoton fluorescence microscopy (also known as two-
photon fluorescence microscopy) (Zipfel et al. 2003), scientists can now examine cellular 
dynamics from a variety of angles at a variety of time-scales and depths, even permitting 
imaging of protein dynamics in large living organisms such as mice (Condeelis and 
Segall 2003).  With these tools, cell biology seems poised to better understand the 
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complexity of the amazing integrative signal processing device that is the cellular 
cytoskeleton, with all its myriad components.  However, much work remains to be done 
and hopefully the work presented here will unravel just a very small part of this 
complexity. 
The Role of Cell Migration in Development, Homeostasis, and Disease: 
In nearly all organisms, cell migration is critical for development and normal 
homeostatic function.  The ways in which organisms guide neuronal development, target 
immune cells appropriately for their development, guide neural crest cells to their wide 
range of physical locations during development, respond to wounds, or respond to 
infections all involve precise regulation of cell migration (Franz et al. 2002).  A wide 
array of research has probed the various areas of development in which cell migration is 
crucial.  For example, due to the ability to visualize and perturb many proteins involved 
in cell migration, studies of development in Drosophila melanogaster have provided 
great insight into how cell migration is controlled through the observation of defects.  
The process of migration in development has been broken down into a number of 
questions.  What causes cells to initiate their movement?  How do they move?  How are 
cells guided?  How do cells know when to stop migrating?  In Drosophila border cells, it 
has been shown that local paracrine signaling helps define which cells will migrate 
(Silver and Montell 2001), and then ecdysone, a hormone, specifies the timing of their 
migration (McDonald et al. 2003), and as the cells migrate, they are guided to the 
appropriate sites by ligands for the epidermal growth factor (EGF) and platelet-derived 
growth factor/vascular endothelial growth factor (PDGF/VEGF) receptors (Duchek et al. 
2001).  Each of these pathways leads to engagement of the machinery required for 
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alteration of the actin cytoskeleton, including the Rho guanosine triphosphatases 
(GTPases), and in particular Rac1 in Drosophila (Bianco et al. 2007).   
Similarly, the role of migration in the targeting of immune cells to sites of 
infection for homeostatic maintenance has been intensively studied.  In response to 
inflammation, endothelial cells upregulate the expression of a number of chemokines and 
adhesion molecules.  As leukocytes flow by in the bloodstream, engagement of the 
selectins on the surface of the endothelium causes the leukocytes to slow down (Kansas 
1996), whereupon they can be stimulated by chemokines on the surface of the 
endothelium (Middleton et al. 1997), telling the leukocytes to “activate.”  Once activated, 
the leukocyte can engage other upregulated receptors on the endothelium and come to a 
full stop (Kinashi 2005), whereupon the leukocyte will engage its machinery to 
reorganize the actin cytoskeleton and transmigrate into tissues to the site of infection 
(Springer 1995; Ley et al. 2007).  Thus, cell migration is absolutely critical to these 
normal processes of development and homeostasis. 
If cell migration becomes dysregulated, a number of disorders and diseases may 
result, depending on the cell type and location affected.  Cell migration must be 
exquisitely controlled, not just by the migrating cell itself, but also in the ways that 
tissues surrounding the migrating cells interact with them.  Aberrant migration is a 
hallmark of cancer cell metastasis, inflammatory disease, neuronal developmental 
disorders, and many other diseases, whether as a cause or a consequence of the disease.  
For example, in cancer cell metastasis, cells must disseminate from the primary tumor, 
invade into those local tissues, invade into the lymphatic or vascular system, extravasate 
from those systems, and colonize distant tissues, all of which require cell migration 
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behaviors (Bos et al. 2009).  To accomplish these movements, cancer cells take on highly 
migratory and invasive capabilities due to changes in gene expression and function, often 
through the epithelial-to-mesenchymal transition (Yilmaz and Christofori 2009).  Once 
these capabilities are acquired, cells can migrate by a number of different paradigms, 
including amoeboid, mesenchymal, and collective migration modes, all of which require 
reorganization of the actin cytoskeleton and force generation to move through tissues 
(Nurnberg et al. 2011).  Many studies have been targeted at understanding and inhibiting 
the changes that occur that drive cancer cell migration, but due to the plasticity of cancer 
cells, attempts to inhibit cell migratory pathways have often failed because cells simply 
engage other available signaling pathways to continue cell migration (Sanz-Moreno et al. 
2008), though there have been some promising studies (Shan et al. 2005). 
A lack of cell migration in tissues can also lead to significant impairments and 
disease.  Perhaps one of the richest fields for the study of disorders due to aberrant cell 
migration is neuronal development.  A number of proteins and signaling pathways have 
been identified that when disrupted lead to defective cell migration and defective 
patterning of the brain.  To achieve proper structuring and patterning of the brain, 
neuronal cells must divide (Valiente and Marin 2010), develop a leading process, move 
along radial glial cells to their proper position, stop their migratory program, and polarize 
appropriately for the formation of cell-cell contacts.  Mutations have been discovered that 
impact nearly every stage of this process.  For example, proteins regulating cell polarity 
and centrosome progression have been found to be defective in lissencephaly, with the 
classical Lis1 protein and dynein both being required for centrosome progression and 
nucleokinesis.  Similarly, doublecortin (DCX), when lost, leads to aberrant dynamics of 
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microtubules which are normally utilized by the Lis1 protein to regulate nucleokinesis 
and centrosome positioning (Grabham et al. 2007; Sapir et al. 2008).  Recent studies have 
also identified mutations in both the  and  tubulin genes that cause a variety of 
neuronal disorders in humans (Jaglin et al. 2009).  Cell migration also appears to play a 
role in some more complicated disorders, such as Alzheimer’s disease and schizophrenia, 
where the disease causative factors are still unclear.  In these diseases, it has been shown 
that genes encoding Neuregulin-1, a growth factor, and Disc-1,which regulates dynein 
function, both contribute to the development of these diseases through the dysregulation 
of neuronal cell positioning, especially later in life.  However, these findings have largely 
been ignored from a clinical standpoint (Flames et al. 2004; Kamiya et al. 2005; Duan et 
al. 2007).  Thus, gaining an understanding of the molecular mechanisms that contribute to 
the proper cell migration, and of the mechanisms that are engaged when this process goes 
awry, is essential for the development of therapeutics targeted to either enhance or 
suppress the signaling pathways that control cell migration. 
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1.2  Overview of Signaling Pathways Involved in Regulating Cell Migration 
 Cell migration has long been a visually-oriented field of study.  It is upon this 
backdrop that the signaling pathways that regulate cell migration have been investigated.  
However, before the development of probes for visually studying protein activity in 
living cells, biochemical methods and fixed-cell observations have been the preferred 
techniques for the investigation of the signaling pathways leading to cell migration.   
The individual players in the signaling processes that regulate cell migration have 
been and are being discovered rather rapidly, and how they regulate cell migration is only 
slightly behind.  However, the understanding of the integrative and combinatorial 
functions of the cytoskeleton as a complete signaling network are only starting to be 
understood, though it is clear that cell migration is a coordinated process in both time and 
space.  The space needed to cover all the signaling pathways studied and their relevance 
for cell migration would be prohibitive, and many excellent review articles are available 
that cover the field exceptionally well (Lauffenburger and Horwitz 1996; Ridley et al. 
2003; Burridge and Wennerberg 2004; Yilmaz and Christofori 2009; Nurnberg et al. 
2011).  Thus, what will be covered here is a more broad-scale view of cell migration 
signaling that will eventually focus on the role of the Rho GTPases in cell migration, as 
these molecules are at the core of the work contained within this dissertation. 
 
Rho GTPases as Coordinators of Cell Migration:   
 The Ras superfamily of small (21–25 kDa) GTPases is subdivided into five 
branches, namely Rho, Ras, Rab, Ran, and Arf. To date, 20 members of Rho family 
GTPases (Figure 1.1) and 36 Ras family members are known (Wennerberg et al. 2005). 
 9
The best characterized of the Rho GTPases are RhoA, Rac1, and Cdc42.  However, it 
should be noted that unique roles have been identified, some cell-type specific, for the 
other GTPases as well, and the cell migratory behaviors discussed above are not solely 
the domain of RhoA, Rac1, and Cdc42.   
These GTPases cycle between an active GTP-bound and an inactive GDP-bound 
state, acting as molecular switches in a variety of signalling pathways regulating many 
diverse cellular processes. When converted to the active, GTP-bound state, the GTPases 
develop high affinity for downstream effectors via conformational changes in switch I 
and switch II, and this process is tightly controlled.  Inactivation to the GDP-loaded state 
is tightly controlled as well, since GTPases have low intrinsic hydrolytic activity.  The 
molecules involved in this process of GTP-loading and hydrolysis to GDP are guanine 
exchange factors (GEFs), GTPase activating proteins (GAPs), and guanine dissociation 
inhibitors (GDIs).  GEFs catalyze the exchange of GTP for GDP, leading to activation of 
the GTPase.  GAPs enhance the intrinsic hydrolytic rate of the GTPase, inactivating the 
GTPase.  Lastly, GDIs sequester the GTPase, binding to the prenyl moiety on the C-
terminus and stabilizing the GDP-bound state.  Regulation of the GTPases is very 
context-dependent and varies from cell-line to cell-line depending on the composition of 
regulatory molecules present.  However, these GTPase molecules are often defined as the 
master regulatory molecules of cell migration, serving as integration nodes for cellular 
signaling pathways to effect coordinated changes in the cellular cytoskeleton leading to 
cell migration (Burridge and Wennerberg 2004). 
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Signaling Pathways Leading to Cellular Morphological Polarization: 
Traditionally, cell migration has been broken down into a series of physical 
events, each utilizing distinct signaling pathways: cellular polarization, lamellipodial 
protrusion, establishment of cell-substrate contacts, contractility and force generation, 
and release of rearward attachments (Lauffenburger and Horwitz 1996; Ridley et al. 
2003).  Figure 1.2 summarizes these steps and the critical signaling molecules in each 
step.  The first event in this process is the response of the cell to some form of polarized 
extracellular cue, such as chemokines or growth factors, but also including extracellular 
matrix proteins, mechanical force, and electrical gradients.  These signals cause 
morphological polarization of the cell, which is required for directional extension of 
actin-rich lamellipodial structures via the activity of actin-polymerizing proteins 
discussed shortly.  These cues (both intracellular and extracellular) activate many 
downstream pathways leading to cell polarization, but most converge on the master 
regulator of polarity, Cdc42.  Activation of Cdc42 recruits the Par3/Par6/aPKC complex 
and serves as a central regulatory node for crosstalk between Rac1, RhoA, and Cdc42 
(Etienne-Manneville and Hall 2003), for centrosome reorientation, for microtubule 
stabilization, and for membrane trafficking to the leading edge for the maintenance of 
polarity (Etienne-Manneville and Hall 2002; Rodriguez et al. 2003).  Cdc42 activation 
leads to recruitment of the GEF Pix to the leading edge for activation of Rac1 (Koh et 
al. 2001), while simultaneously activating Rac1 via Tiam-1 recruitment to the 
Par3/Par6/aPKC complex, in addition to stabilizing microtubules at the leading edge via 
the same complex (Nishimura et al. 2005; Pegtel et al. 2007).  Cdc42 not only facilitates 
actin polymerization for lamellipodial protrusion via Rac1, but also stabilizes 
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microtubule “highways” such that molecules needed for further signaling at the leading 
edge are added and replenished, maintaining a signaling polarity (Osmani et al. 2010).  
This leading edge activation of Cdc42 (Li et al. 2003) and Rac1 (Kraynov et al. 2000) 
also appears to be important for antagonizing RhoA activity at the leading edge, leading 
to activation of RhoA at the rear of cells to further polarize the cell and to define the 
leading and retracting edges of the cell required for efficient cell migration (Xu et al. 
2003).  In contrast, if RhoA is activated at the leading edge, which has been described in 
numerous studies (Pertz et al. 2006; Ridley 2006; Machacek et al. 2009; Tkachenko et al. 
2011), Rho kinase (ROCK) can then phosphorylate Par3, leading to the disruption of 
Cdc42 effects through Par3 and Rac1 recruitment to the edge (Nakayama et al. 2008; 
Simoes Sde et al. 2010), thus antagonizing Cdc42 and Rac1 activities.  Thus, these are 
but several of the many mechanisms which can lead to polarization of the cell during 
motility (Burridge and Wennerberg 2004). 
 
Signaling Pathways Regulating Lamellipodium Formation: 
Once polarity is generated, lamellipodia must be extended and stabilized by the 
eventual formation of new cellular contacts.  At the leading edge, phospholipid signaling 
pathways appear to play a significant role in the extension of lamellipodia by converging 
on the Rho GTPases and defining, critically, where the GTPases are active, particularly 
Rac1 (Welch et al. 2003).  In chemotaxis, it has been shown that by their non-overlapping 
distributions, PI3K (phosphatidylinositol-3 kinase) can generate PtdIns(3,4,5)P3 (PIP3) at 
the edge in response to extracellular cues, while PTEN at non-leading-edge locations 
tends to degrade PIP3 into PtdIns(4,5)P2 (PIP2) to create a gradient of PIP3 which can 
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activate Rac1 and a subsequent positive feedback loop that stimulates massive 
polymerization of actin and lamellipodial extension (Devreotes and Janetopoulos 2003; 
Huang et al. 2003; Merlot and Firtel 2003).  Additionally, it has been shown that 
phospholipase A2 (PLA2), phospholipase C (PLC), and phospholipase D (PLD) all 
contribute to the modulation of this gradient and the activation of parallel pathways 
(Kolsch et al. 2008), such as the inhibition of cofilin (Edwards et al. 1999), which 
enhance Rac1 activity and actin polymerization downstream of extracellular cues .  These 
parallel pathways also seem to be critical for the direction-finding component of cell 
migration, suppressing lateral lamellipodia, while the PI3K pathway predominantly 
affects the velocity of the migration (Wessels et al. 2007).  Additionally, a myriad of 
feedback amplification pathways are present for both Rac1 and Cdc42 (Sasaki et al. 
2007)in this process such that even extremely shallow chemoattractant gradients can be 
amplified into very strong signals that cause directed cell migration (Andrew and Insall 
2007).  Ultimately, lamellipodial protrusion is generated when Rac1 and Cdc42 bind to 
WASP homology domain containing proteins such as N-WASP and WAVE which 
subsequently activate Arp2/3, which directly polymerizes actin (Ridley et al. 2003; 
Burridge and Wennerberg 2004).  Further, Cdc42 is also well known for generating 
another protrusive structure, filopodia, via interaction with an additional actin nucleating 
protein, mDia2, and these structures may even extend from lamellipodia and serve 
sensory functions during protrusion (Mellor 2009; Lee et al. 2010b).  Rac1 and Cdc42 
both can bind and activate the PAK kinases which phosphorylate and activate LIM kinase 
(Bokoch et al. 1998), which in turn phosphorylates and inactivates cofilin, which 
normally severs actin filaments, permitting actin filament growth (Wang et al. 2007).  
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RhoA at the leading edge can also polymerize actin, which was a surprising finding, even 
though biochemical and colocalization data both show that RhoA can bind and activate 
mDia (Lammers et al. 2008) at the leading edge to nucleate and polymerize actin 
(Kurokawa and Matsuda 2005; Pertz et al. 2006; Machacek et al. 2009; Tkachenko et al. 
2011).    Collectively, these signaling pathways lead to the extension and stabilization of 
actin-rich lamellipodia. 
 
Signaling Pathways Involved in the Stabilization of Extended Lamellipodia: 
Once a lamellipodium is extended, it needs to form new contacts with the 
substrate to stabilize the extension.  At this step, perhaps more than others, integrins play 
a large role.  Integrins serve as links or tethers between the extracellular matrix and 
cellular components, and are activated by inside-out cellular signaling which permits 
them to attach to extracellular substrates.  Their binding, clustering, and conformational 
changes lead to a variety of intracellular signals, including formation and strengthening 
of focal adhesions, cytoskeletal changes through the Rho GTPases, and alterations in cell 
polarity (Hood and Cheresh 2002; Geiger et al. 2009).  Where these integrins interact 
with the extracellular matrix, molecular complexes called focal complexes and focal 
adhesions often form .  These structures, in many cell types, appear to require the 
GTPases to form, with Rac1 and Cdc42 stabilizing the formation of smaller focal 
complexes (Ridley et al. 2003), while RhoA activity and actomyosin contractility are 
required for the larger focal adhesions to develop (Chrzanowska-Wodnicka and Burridge 
1996; Worthylake et al. 2001).  These focal adhesions are extremely dense with signaling 
proteins, which enter and exit at varying times during the development of the adhesions.  
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Over 180 proteins have been identified within these complexes (Zaidel-Bar et al. 2007), 
and a thorough review of adhesion signaling is well beyond the scope of this 
introduction.  Very recent work using superresolution microscopy has also shown that the 
proteins present in adhesions are very precisely stratified to either anchor other signaling 
proteins or transduce signals further within the cell (Kanchanawong et al. 2010).  Suffice 
to say that these adhesions serve as anchor points for the cell for generation tractional 
forces for movement, and for mechanosensation by the cell.  At this point in the 
migration cycle, the cell has stretched and extended a lamellipodium which has become 
anchored, through which it can sense adhesion via mechanical forces exerted on these 
new adhesive contacts.   
 
Signaling Pathways Involved with Retraction of the Cell Tail with Body Translocation: 
How force is generated underlies the final stage of cell migration: the cell rear 
retraction event.  First, adhesion attachment sites have to be severed, and this is mediated 
by pathways involving FAK, Src, intracellular Ca2+, and various proteases including 
calpain (Hendey et al. 1992; Lee et al. 1999; Glading et al. 2002).  Once these adhesions 
are weakened, the forces exerted on the cell cause detachment of adhesions at the rear of 
the cell to allow retraction of the tail and propulsive forward movement of the cell.  This 
force is generated by the interaction of myosin II with actin filaments anchored at 
adhesion sites (Chung et al. 2001).  Myosin is a motor protein whose activation causes 
increased tension generation on the actin filaments to which it is adhered.  It in turn is 
activated by a number of mechanisms, perhaps most prominently by RhoA via Rho 
kinase (ROCK), which activates myosin light chain kinase and inactivates the myosin 
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light chain phosphatase to increase myosin activation (Riento et al. 2003).  It is curious to 
note that the severing of adhesion sites at the cellular rear appears to have a stimulatory 
effect on leading edge protrusion, perhaps through generation and transmission of 
hydrostatic pressure, starting the protrusion-adhesion cycle anew (Ridley 2006).  
 
Specific Role of RhoG Signaling in Cell Migration: 
While most of the small GTPase literature has focused on the canonical GTPases 
RhoA, Rac1, and Cdc42, 20 other Rho GTPases have been identified.  One particularly 
interesting GTPase for this work is RhoG.  RhoG is a Rac-family GTPase with 72% 
sequence identity to Rac1, and was identified in a screen looking for early gene 
expression induced during cellular growth by stimulation with growth factors (Vincent et 
al. 1992).  RhoG is a ubiquitously expressed, evolutionarily conserved GTPase, with 
homologs identified in C. elegans, D. melanogaster, M. musculus, and others.  Further, 
RhoG appears to play a critical role in the evolutionarily conserved processes of 
phagocytosis and apoptotic cell clearance via the GEF Trio (deBakker et al. 2004).  
However, its importance in cellular signaling has been debated given that RhoG knockout 
mice display only minor defects in immune cell function and no gross pathological 
changes (Vigorito et al. 2004).   
Further, given its homology to Rac1, many have sought to determine its role in 
other forms of cytoskeletal rearrangement, such as lamellipodial protrusion during cell 
migration.  RhoG is thought to act upstream of both Rac1 and Cdc42 (Gauthier-Rouviere 
et al. 1998; Katoh et al. 2000; Hiramoto et al. 2006; Katoh et al. 2006) and in parallel 
(Wennerberg et al. 2002).  With regard to effectors, it is unclear the variety of effectors 
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that RhoG engages; for example, RhoG does not bind IRSp53, WASP, Por-1, POSH, or 
PAKs (Gauthier-Rouviere et al. 1998; Wennerberg et al. 2002), but does bind MLK3, 
IQGAP, and PLD1, as well as kinectin, and the fragment RhoGIP122 which appears to 
map to a sequence from TRAF3 Interacting protein.  It has also been shown that at least 
in C. elegans axon guidance, RhoG (Mig-2) interacts with WASP (WSP-1), whereas 
Rac1 (CED-10) interacts with WAVE (WVE-1), suggesting an ability to polymerize actin 
via the Arp2/3 complex, but this interaction or the interaction of RhoG with Sra1 has not 
been tested fully in higher organisms (Shakir et al. 2008).  Later studies manipulating 
RhoG and Rac1 in fibroblasts have shown that RhoG is dispensable for cell spreading 
and only contributes to cell migration in the absence of Rac1 (Meller et al. 2008), 
suggesting minimal capacity for RhoG to signal on its own.  In contrast, the key factors 
regulating RhoG activation of Rac1 were identified to be ELMO1 and DOCK180, an 
unconventional Rac1 GEF (Katoh and Negishi 2003), and this pathway was shown to 
play a role in cell migration (Katoh et al. 2006).  Thus, the true downstream effects of 
RhoG still remain poorly understood. 
Similarly, the upstream regulation of RhoG is also poorly defined.  To date, only 
two growth factors have been shown to activate RhoG, EGF (Samson et al. 2010) and 
FGF (Elfenbein et al. 2009), and in a related fashion phosphatidylserine via the BAI-1 
receptor (Park et al. 2007), and ICAM-1 via LFA-1 (van Buul et al. 2007a).  Similarly, 
only a few GEFs have been shown to activate RhoG, among them Trio/Kalirin, Vav2, 
Vav3, SGEF (Ellerbroek et al. 2004), PLEKHG6 (D'Angelo et al. 2007), and Ephexin4 
(Hiramoto-Yamaki et al. 2010).  Among the other regulators of GTPases, to date no GAP 
has been identified for RhoG, but two GDI molecules, GDI-1 and GDI-3, have both been 
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shown to bind to RhoG (Zalcman et al. 1996; Olofsson 1999; Michaelson et al. 2001; 
Brunet et al. 2002; Elfenbein et al. 2009).  Thus, piecing together a coherent picture of 
what RhoG does in cells is a bit difficult.  Based on localization and function studies, 
RhoG appears to be trafficked along microtubules in vesicles, as regulated by its effector 
kinectin, and these vesicles likely contain caveolin-1 (Prieto-Sanchez and Bustelo 2003) 
and Trio (Prosser et al. 2010).  RhoG is also present at the cell membrane where it can be 
activated by extracellular cues via GEFs and subsequently engage ELMO1 and 
DOCK180 to activate Rac1.  Beyond this, functionally, little is known.  Loss of RhoG is 
known to reduce EGF-stimulated macropinocytosis in A431 cells (Samson et al. 2010), to 
block phagocytic engulfment of apoptotic cells (deBakker et al. 2004), to reduce dorsal 
ruffling in some cell types (Wennerberg et al. 2002), and to potentially alter the velocity 
of cell migration (Katoh et al. 2006; Monypenny et al. 2009), or migration in cancer cells 
(Hiramoto-Yamaki et al. 2010).  Given the ability of RhoG to modulate other GTPases 
and potentially affect the actin cytoskeleton in so many ways, it is of importance to better 
understand its functional role in cellular behaviors, particularly in migration where its 
role remains most controversial (Meller et al. 2008).   
 
Conclusion: 
It is important to note, however, that while cells share most aspects of these 
migration behaviors, the actual details may vary dramatically from cell type to cell type 
and from one environment to another.  Fibroblasts clearly migrate in a manner strikingly 
different from leukocytes, and cells migrating in a 3-dimensional culture migrate very 
differently from those migrating on a 2-dimensional culture dish (Wolf and Friedl 2006; 
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Wolf et al. 2009).  Some cells can even modify their modes of migration dramatically in 
response to extrinsic challenges (Sahai and Marshall 2003).  All of these curiosities we 
wish to better understand so that we can better understand how normal and pathological 
cell migration disorders develop and how they can be treated. 
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1.3  Introduction to Growth Factor Signaling and the Regulation of Cytoskeletal 
Dynamics: 
 
A Broader Perspective: 
 To respond to environmental changes, cells must have mechanisms by which they 
can sense those environmental changes and translate them into changes in cellular 
behavior.  Broadly speaking, the ability of cells to respond to extracellular cues is 
conferred by the expression of a variety of receptors that are incorporated into the plasma 
membrane and bridge the extracellular and intracellular environments.  Many classes of 
receptor exist, including G-protein coupled receptors (GPCRs), receptor tyrosine kinases 
(RTKs), cellular adhesion molecules (CAMs), integrins, and many others.  Many of these 
receptors respond to molecules known as growth factors, which were discovered as 
components of serum that caused cellular proliferation.  In addition to their ability to 
cause cellular proliferation, many of these growth factors are also known to cause cell 
migration, or chemotaxis, toward the growth factor.   
Among these extracellular growth factors known to stimulate and regulate cell 
migration is the extracellular ligand epidermal growth factor (EGF).  The fact that a 
number of different therapeutic attempts have been made to target EGF signaling in 
metastatic breast cancer and other diseases indicates the importance of this signaling 
pathway not only in normal physiological development, but in pathological cellular 
responses as well. 
 
EGF Signaling in the Regulation of Cell Migration:  
The EGF signaling pathway is evolutionarily very highly conserved, but attains 
great complexity in higher organisms.  In fact, it is the combinatorial nature of the 
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components of the EGF signaling pathway that determine specific contextual and cellular 
responses to EGF ligands, rather than simple activation of the pathway itself (Figure 1.3).  
EGF binding to EGF receptors promotes hetero- or homodimerization of the four major 
EGF receptors (ErbB1-4), which are receptor tyrosine kinases, and induces 
autophosphorylation of the receptor.  In turn, this autophosphorylation generates docking 
sites on the cytoplasmic tail of the receptor that allow for the binding of adaptor proteins 
and scaffolds.  From this point, many signaling proteins interact with the adaptor 
proteins, initiating downstream signaling cascades dependent on the particular proteins 
recruited to the receptor.  Common to all EGF signaling is the activation of the mitogen-
activated protein kinase (MAPK) pathway, the PI3K/Akt pathway, and the p70S6 kinase 
pathway, which lead to cellular responses such as apoptosis, migration, growth, adhesion, 
and differentiation (Rubin and Yarden 2001; Yarden and Sliwkowski 2001).   
With the early work of Ridley and Hall (Ridley and Hall 1992; Ridley et al. 1992; 
Nobes and Hall 1995; Nobes et al. 1995), it was established that the Rho GTPase family 
could be activated downstream of growth factor signaling, and that led to a number of 
changes in the actin cytoskeleton that were visibly prominent, including membrane 
ruffling and stress fiber formation.  How these morphological changes are mediated has 
been the subject of a large body of work since those seminal studies.  The GTPases can 
all be stimulated downstream of growth factor receptors, including lysophosphatidic acid 
(LPA), bombesin, endothelin-1, vascular endothelial growth factor (VEGF), and EGF 
(Figure 1.4) (Burridge and Wennerberg 2004).  The activation of Cdc42 and Rac1 
downstream of EGF receptor signaling is perhaps most clear.  For both Rac1 and Cdc42, 
the GEF Vav2 is recruited to the receptor and phosphorylated, causing its activation and 
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subsequent activation of both Rac1 and Cdc42 (Liu and Burridge 2000).  Additionally, 
there are many other pathways leading to Rac1 activation downstream of the EGF 
receptor, predominantly mediated by the PI3K pathway (Nobes et al. 1995).  Through 
this pathway, as mentioned above, phosphoinositides are generated, particularly PI3P, at 
the leading edge, leading to recruitment of a variety of Rac1 GEFs including Tiam-1, P-
Rex, and others (Kolsch et al. 2008).  In turn, both Cdc42 and Rac1 can bind to and 
activate PI3K generating a feedback loop that further stimulates the production of leading 
edge phosphoinositides for signaling and actin polymerization.  In addition, RhoA is 
apparently inactivated at first by EGF stimulation, giving further credence to the mutual 
antagonism of Rac1/RhoA (Sander et al. 1999; Nimnual et al. 2003), but is activated at 
later stages, perhaps to assist in productive cell migration by retraction of the trailing 
edge (Burridge and Wennerberg 2004). 
 
EGF Signaling in the Regulation of Macropinocytosis: 
In addition to its effects on cell migration pathways mediated through the Rho 
GTPases, EGF stimulation in many cell lines also engages the Rho GTPases to rearrange 
the actin cytoskeleton for the purposes of macropinocytosis.  Macropinocytosis is a non-
selective fluid-uptake process.  Most cells do not demonstrate constitutive 
macropinocytosis, but rather macropinocytose in response to growth factor signaling, 
such as in fibroblasts which respond potently to both PDGF and EGF (Mellstrom et al. 
1988; West et al. 1989; Anton et al. 2003).  The macropinocytosis process is very similar 
to phagocytosis and requires rearrangement of the actin cytoskeleton on the dorsal 
surface to engulf and enclose extracellular fluid.  Typically, cells form cup-shaped ruffles 
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on the dorsal surface which are actin-based, and eventually the cup closes in a similar 
fashion to phagosome formation (Swanson and Watts 1995).  Because of its dependence 
on actin-based dynamics, a number of actin-regulatory proteins have been identified in 
these structures, including the GTPases Rac1 and Cdc42 (Cox et al. 1997; West et al. 
2000; May and Machesky 2001).  The phosphoinositides again play a role in 
macropinocytosis, particularly in the closure of the macropinosomes (Araki et al. 1996) 
(Swanson JCB 1996).  Further, PI3K in particular appears critically important in growth-
factor induced macropinosomes (Wennstrom et al. 1994; Kotani et al. 1995), functioning 
upstream of Rac1 to regulate the actin cytoskeletal changes needed for cup formation in 
some cell lines, while becoming more important for macropinosome closure in others 
such as A431 cells.  The reasons for these differences remain unclear, but are likely due 
to the different composition of signaling proteins downstream of EGF signaling.  For 
example, it was recently reported that PLEKHG6 is a GEF that binds to ezrin on the 
dorsal surface of cells to mediate dorsal ruffling and in its absence, EGF-induced 
macropinocytosis through membrane ruffling is inhibited (Samson et al. 2010).  Further, 
PLEKHG6 was identified as a specific GEF for RhoG, which can subsequently activate 
Rac1 through the ELMO1/DOCK180 pathway.  How the ezrin/PLEKHG6 complex is 
activated is uncertain, but appears to involve a RhoA-mediated pathway through PI4,5K 
that increases PIP2 concentration and recruits ezrin to the membrane for microvillus 
formation (Hirao et al. 1996; Matsui et al. 1999).  Further, work by Araki et al. (Araki et 
al. 2007) is in line with these observations, demonstrating that PIP2 is elevated first and 
is required for the formation of ruffles, but is rapidly degraded with the formation of 
PIP3, and that this is closely correlated with actin depolymerization and macropinosome 
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closure.  However, signaling through ezrin is complex and may activate a number of 
GTPases, so the full context is not clearly understood.  However, it is clear that the Rho 
GTPases are activated by EGF in the process of growth-factor induced macropinocytosis, 
and much remains to be understood about their spatiotemporal regulation, in particular 
their ability to affect both the formation of macropinocytic cups, and the closure of those 
macropinosomes. 
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1.4  Overview of Fluorescent Biosensors for Protein Activity  
Introduction: 
Dynamic cellular responses and behaviors, such as cell migration described 
above, are encoded by the complex spatial and temporal dynamics of a variety of 
signaling networks.  A major challenge is to delineate the precise spatial and temporal 
behaviors of each of the signaling molecules and second messengers in these networks 
and how they relate to one another in both space and time.  To this end, a large body of 
work has been devoted to observing the formation, localization, activation, and turnover 
of a vast number of these signaling molecules.  Many techniques have been developed to 
observe the activity of these molecules over a large population of cells with biochemistry, 
or single molecules in single cells, both with and without spatial and temporal resolution.  
Recently, fluorescence-based methodologies have become among the most widely used 
methods to monitor these cellular events.  Biosensors, probes designed to detect changes 
in protein or second messenger activity or concentration, have been developed to achieve 
these goals, and they provide the exquisite spatial and temporal resolution needed for 
analysis of signaling pathways within single cells.  However, researchers have long 
sought to observe more than one molecule’s activity in cells at the same time, such that 
correlative analyses can be made more accurately.  As the fluorescent protein and dye 
palette has expanded, new biosensors and imaging technologies have been designed to 
observe multiple protein activities within live cells, known as multiplexing or 
multiparameter imaging.  In tandem with the expansion of the available biosensors, 
analysis of biosensor data has become increasingly complex as well, allowing better 
analysis of signaling pathways from complex imaging data.  In this section, I will 
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highlight the developments that have led to the ability to image signaling activity within 
cells, the development of probes for the study of intracellular signaling, and some of the 
current approaches and challenges to the study of intracellular signaling by imaging.   
 
Development of Fluorescent Proteins and Chemical Dyes: 
Fluorescence as a biophysical phenomenon has been used for many years to 
visualize cellular structures and targets, typically by labeling antibodies with small 
organic dyes, fixing cells or samples of interest, and then adding the antibody which can 
be subsequently visualized via fluorescence.  However, these techniques were highly 
invasive and gave little information about cellular dynamics due to fixation.  Later, dyes 
were developed that could recognize some cellular structures and molecules, such as 
DNA or intracellular ions, in living cells, but these are fewer in number and limited in 
their utility overall.  The true revolution in fluorescence technology came with the 
discovery and development of fluorescent proteins, the first of which were 
phycobiliproteins isolated from cyanobacteria (Oi et al. 1982).  Despite their excellent 
brightness properties, these fluorescent proteins have remained somewhat limited in their 
usefulness given their large size (> 200 kDa) and the need to supply bilin chromophores 
for their functionality.  While discovered earlier, green fluorescent protein (GFP) was not 
cloned until a few years after the phycobiliproteins were used.  Clearly the cloning and 
expression of GFP and its variants has revolutionized the whole of biology (Prasher et al. 
1992; Chalfie et al. 1994), allowing for the visualization of molecules within living cells 
with minimal invasiveness and simplicity of use.  In those early days following the 
cloning and expression of GFP, numerous papers were published simply by tagging a 
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protein with GFP and observing its dynamics and localization.  As years went by, the 
complexity of such studies gradually increased.  In parallel, much work has been devoted 
to improving and expanding the “base” GFP molecule, yielding advances in protein 
folding efficiency, brightness, photostability, monomericity, and spectral diversity 
(Shaner et al. 2004; Shaner et al. 2007; Shaner et al. 2008; Newman et al. 2011).  
Through these advances, the ease of use of fluorescent proteins through either 
transfection of plasmid DNA or transgenic methods for expression has brought them to 
the forefront of imaging studies of protein dynamics.   
 
Biosensors for Monitoring Protein Movement and Translocation: 
One of the first uses of the GFP molecule was to examine protein localization, 
function, or activity simply by labeling the target molecule with a fluorophore, which acts 
as the “affinity reagent,” and monitoring the movement or translocation of the target 
(Newman et al. 2011).  This background information cannot begin to cover all the 
examples of fluorescently tagged proteins used for localization studies, as there are now 
hundreds, if not thousands, of examples, but we provide a few examples of “activity” 
probes using tagged proteins.  For example, the treadmilling of actin and the dynamic 
polymerization/depolymerization of microtubules have been studied extensively by the 
introduction of small quantities of fluorescently-labeled actin or tubulin (< 0.5%) to 
reveal significant information about the structure of the cytoskeleton and its dynamics 
(Waterman-Storer et al. 1998; Watanabe and Mitchison 2002; Danuser and Waterman-
Storer 2006).  Similarly, a variety of proteins and second messengers are known to 
translocate to various cellular compartments, such as GTPases to the plasma membrane 
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in response to growth factors, phosphoinositide-binding proteins to sites of inositide 
production (Akt, ARNO, GRP1, PLC) (Stauffer et al. 1998; Gray et al. 1999; Hirose et al. 
1999; Meili et al. 1999; Oatey et al. 1999; Watton and Downward 1999; Servant et al. 
2000), and transcription factors to the nucleus, such as NF-κB (Nelson et al. 2004), and 
these have been observed through imaging of single fluorophores (O'Rourke et al. 2005).  
Observation of combinations of such probes simultaneously is relatively trivial today 
given the available range of bandpass filters, dichroic mirrors, and spectrally separable 
fluorophores, and has been applied to a variety of high-throughput methodologies for the 
examination of signaling pathways, of which category a particularly elegant study was 
recently published (Taylor et al. 2009).  However, these single protein fluorescent fusions 
can only reveal a limited amount of information when it comes to localization or 
translocation.  In particular, for many enzymes or signaling proteins, simply observing 
localization does not reflect when and where the protein is active, which likely represents 
the truly functional form of the protein.  Thus, sensors that could detect the active form of 
proteins were soon developed via the use of fluorescence resonance energy transfer 
(FRET) principles. 
 
FRET-Based Biosensor Design and Usage: 
In the field of biosensor development, a myriad of sensors for the detection or 
identification of signaling protein or second messenger function, activity, or 
concentration has been generated for use in live-cell imaging.  The majority of these 
probes are based upon Förster Resonance Energy Transfer, or FRET.  These probes are 
particularly advantageous because of their ability to reveal cellular behaviors with a high 
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degree of spatial and temporal resolution.  Probe designs have been extensively covered 
in several excellent review articles (Zhang et al. 2002; Miyawaki 2003; Lalonde et al. 
2005; Tsien 2005; VanEngelenburg and Palmer 2008) and here I will broadly cover 
common designs, methods for their use, and their advantages and disadvantages in 
multiplexing.   
In general, biosensors come in two basic “flavors”: target/substrate-modified 
sensors or endogenous sensors.  Either format contains an “affinity reagent,” which is 
either a sensing or substrate element that is modified or bound upon signaling molecule 
activity/concentration change within the cell, resulting in a change in FRET or associated 
fluorophore intensity/wavelength.  See Figure 1.5 for general biosensor design and 
possible variations.  Here I will discuss several categories of these sensors and their use 
in the evaluation of signaling molecule behaviors or activities within cells. 
The range of available FRET probes has expanded greatly since the first 
demonstrated use of FRET between two fluorescent proteins in an intracellular probe, 
which observed the protease-mediated cleavage of a peptide flanked by BFP (blue 
fluorescent protein) and GFP (green fluorescent protein) (Mitra et al. 1996).  The current 
list is almost too exhaustive to list but general classes of sensors can be defined.  In 
general, there are three categories of probe activity detection methods: activity or ligand-
binding causes 1) FRET between two fluorescent proteins to change, or 2) spectral 
properties of a single fluorophore to change, or 3) translocation of a fluorophore.  
Translocation sensors and single fluorophore sensor designs are typically simpler than the 
FRET-based sensors.  The most common examples of these types of sensors are the 
phosphoinositide binding domains from a number of proteins, such as Akt, ARNO, Grb2, 
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and others (O'Rourke et al. 2005; Newman et al. 2011).  Single fluorophore probes that 
change spectrally have been designed based on a critical understanding of the chemistry 
of the fluorophore itself, often designing the fluorophore to be more sensitive to pH, ions, 
redox status, or even adding domains to the fluorophore that cause the fluorophore to 
change its spectral properties.  In contrast, FRET-based sensors are much more complex, 
usually consisting of multiple domains and flexible linker regions connecting the 
fluorophores to the activity-detecting segment, or “affinity reagent.”  Three basic designs 
of these probes exist, with many variants: the sensors separate two fluorescent proteins 
with 1) a cleavage-sensitive linker, 2) an affinity reagent that undergoes conformational 
change (phosphorylation motif, binding of the molecule of interest, etc.), or 3) an affinity 
reagent in addition to the molecule that binds the affinity reagent on the same molecule or 
on separate molecules (intramolecular versus intermolecular FRET).  These three broad 
classes cover most available FRET probes published to date.  For design variants that fall 
within these classes, see Figure 1.5.  For prototypical examples of these probe designs, 
the different classes of molecules that can be studied with them, and representative 
references, see Table 1.1.   
One additional way these sensors can be modified is to alter their targeting.  In 
many cases, cellular signaling is compartmentalized, and thus it is of interest to better 
understand the signaling within that compartment or region.  To this end, sensors have 
been modified with a number of cellular targeting signals, including, but not limited to 
the K-Ras4b membrane targeting sequence for plasma membrane targeting, an ER lumen 
targeting sequence, nuclear localization sequences, and Golgi lumen targeting sequences 
(VanEngelenburg and Palmer 2008; Palmer et al. 2011).  In a number of cases, by 
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compartmentalizing sensors, multiple sensors can be introduced into cells in different 
compartments to allow visualization of subsets of the protein of interest, or to allow study 
of two proteins simultaneously, which will be discussed in more detail below.   
 
FRET-Based Biosensors for the Rho GTPases: 
Of particular interest to this work, most Rho GTPase FRET probes fall under the 
intramolecular FRET sensor design, wherein the affinity reagent and the molecule of 
interest are both contained within the probe, in addition to the two fluorophores.  Much 
optimization has been undertaken to obtain GTPase probes that change their FRET signal 
when in the active versus inactive states.  In chapter two, I will discuss the design and 
optimization of these probes, as well as new advances in this area generated by the Hahn  
lab. 
 
Selection of Fluorescent Proteins for Optimal FRET: 
In addition to the design of the probe, a key to the development of a sensitive, 
useful FRET sensor is to select fluorophores that are optimal for FRET.  For a suitable 
FRET pair, the following criteria should be met as laid out by Campbell et al. (Campbell 
2009): 1) Spectral overlap, donor quantum yield, and acceptor extinction coefficient 
sufficient to provide a proper Förster radius; 2) minimal direct excitation of the acceptor 
at the wavelength used to excite the donor; 3) sufficient separation of the emission peaks 
for ratiometric imaging with bandpass filters; 4) sufficient quantum yield (φA > 0.5) or in 
FRET-FLIM, an extinction coefficient, εA, greater than 50000 M-1 cm-1; 5) and closely 
matched values for maturation in both donor and acceptor in the case of fluorescent 
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proteins (if the acceptor is slow to mature, FRET will be reduced).  Additionally, 6) each 
FRET pair must be excited using wavelengths that do not excite the other FRET pair, or 
the microscope should be able to collect emission from each pair where the other FRET 
pair does not fluoresce, or the FRET pairs must be targeted to non-overlapping 
subcellular regions.  Finally, 7) longer excitation wavelengths are preferred as they cause 
significantly less photodamage to the cells under study, permitting shorter intervals 
between each image acquisition, and autofluorescence is reduced in the longer 
wavelengths, thus reducing background and enhancing signal-to-noise ratio.   
 When used ratiometrically, these probes consume the greatest amount of spectral 
bandwidth, requiring the use of both the donor and acceptor emission and excitation 
spectra.   Many fluorophores, particularly fluorescent proteins, are problematic in that 
they have broad excitation and emission spectra, are relatively dim compared to dyes, and 
the resultant FRET signal is relatively small.  Thus, only a few fluorophores fit the 
criteria above, with most FRET probes largely developed using the fluorophores CFP and 
YFP, because they meet all the criteria listed above (Tsien and Miyawaki 1998; Campbell 
2009), and can be genetically encoded.  Other pairs, such as BFP/CFP and EGFP/DsRed, 
have also been used for FRET probes (even before CFP/YFP), but each of these pairs has 
significant excitation and emission overlap with the other available pairs, preventing their 
simultaneous use in live cells for ratiometric imaging when the probes are present in the 
same location.  This has prevented the ability of researchers to achieve imaging of 
multiple signaling molecule activities/changes simultaneously. 
The available palette of FRET fluorophores can be broadened if one considers 
dyes in addition to fluorescent proteins.  A number of dyes have been used in the 
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literature to effect FRET, and these have been covered in previous reviews (Berney and 
Danuser 2003; Wallrabe and Periasamy 2005).  In addition to these previously used dyes, 
environmentally-sensitive dyes that change intensity in response to local conformational 
changes may be used to detect protein activity quantitatively when the change is ratioed 
against a non-responding fluorophore such as EGFP (Nalbant et al. 2004).  Dyes are often 
much brighter than fluorescent proteins, though less photostable, and there are a number 
of dyes which extend further into red wavelengths than fluorescent proteins, permitting a 
greater number of ratiometric FRET pairs, which was taken advantage of to 
simultaneously image the activities of both RhoA and Cdc42 GTPases using a CFP/YFP 
FRET pair in addition to an environmentally sensitive long-wavelength dye ratioed 
against Alexa750 (Machacek et al. 2009).  In the case of dyes, there are some limitations.  
First, the probe must be labeled with the dye in an appropriate location that detects the 
activation/change in the molecule of interest.  For some affinity reagents which can be 
labeled on a lysine or the N- or C-termini of the protein to detect target changes, dye-
coupling is easier and more efficient.  However, if the dye is to be coupled to a specific 
position internal to the affinity reagent, alteration of a number of residues to allow 
coupling of the dye and testing of the response may be necessary before generating an 
appropriate construct for experimental use.  Dye use also requires protein purification, 
which is not tractable for all probes.  Further, the protein must then be reintroduced into 
cells at an appropriate level, either by shear-loading, cell-penetrating peptides, endocytic 
uptake, or by microinjection, all of which will perturb cellular dynamics to a degree.  
However, there are methods for labeling proteins within cells, such as the FlAsH/ReAsH 
system, which is dependent upon a tetracysteine motif tagged onto the protein of interest, 
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and a biarsenical dye, which has been previously used for FRET studies (Van 
Engelenburg et al.; Martin et al. 2005).  Such methods for labeling endogenous proteins 
are still few in number, but will likely expand as time goes on and will permit easier use 
of dyes for multiplex imaging studies (Hinner and Johnsson 2010). 
A third fluorescent protein-based intracellular signal detection technique which 
has many useful applications, but does not fall under the realm of FRET, is bimolecular 
fluorescence complementation (BiFC) (Hu et al. 2005; Kerppola 2006; Kerppola 2009; 
Robida and Kerppola 2009).  This technique has the advantage of detecting protein 
interactions similar to FRET, while only using a single fluorescent protein.  However, 
this technique suffers from irreversibility and the necessity of tagging two proteins with 
fragments of the fluorescent protein to be complemented.  Thus, this technique is 
primarily useful for detecting protein interaction, but not the dynamics of these 
interactions.  However, it has been used to effect in multicolour studies (Vidi et al. 2008; 
Kodama and Wada 2009). 
Less useful for many applications, intensiometric changes have been measured for 
FRET or single fluorophore probes.  While such intensiometric changes are helpful in 
assessing relative changes in activity or concentration, they are not truly quantitative and 
make comparisons between cells and between labs difficult, if not impossible and thus we 
will not cover these extensively here.  Campbell et al. (Carlson and Campbell 2009) have 
written an excellent review for examining such uses. 
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Current Approaches and Challenges to Studying Intracellular Signaling by Imaging: 
Progress toward the ability to use two FRET pairs simultaneously and thus detect 
two intracellular signaling activities for correlation studies has been one of the key goals 
of FRET-based biosensor work.  However, this goal has been limited by the lack of 
fluorophores for novel FRET pairs that are genetically encodable, spectrally distinct, 
bright, monomeric, photostable, and do not overlap with the common CFP/YFP pair.  
The development of the red fluorescent protein from Discosoma, DsRed, initially brought 
much hope toward the development of a second FRET pair (Matz et al. 1999), but 
development of red-shifted fluorescent proteins for sensitized FRET emission that meet 
the criteria defined above has been difficult.  Only recently have there been significant 
advances in the improvement of the photostability, brightness, and quantum yield of red-
shifted fluorescent proteins (Ouyang et al.; Shaner et al. 2004; Shaner et al. 2008), though 
the current red-shifted fluorescent proteins are still not as useful for FRET as the 
previously developed FRET pairs, given their poorer photostability and lower quantum 
yield (Ai et al. 2008).  Here we will briefly cover the fluorophores that have been used to 
effect in multiparameter imaging experiments. 
True emission ratiometric multiplex FRET imaging experiments provide the 
greatest quantitative measurements of the spatial and temporal behaviors of the molecules 
of interest and thus are preferable to other techniques.  For a current list of published 
multiplex FRET experiments, see Table 1.2.  We will highlight a few illustrative 
examples here.  In perhaps the most complex multiplex methodology to date, Piljic et al. 
(Piljic and Schultz 2008) performed a series of experiments using two spatially resolved 
CFP/YFP FRET probes with another probe converted to an mOrange/mCherry FRET 
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pair, along with Fura red to sense Ca2+ levels.  They achieved resolution of FRET signal, 
corrected for bleedthrough, despite mCherry being a poor FRET acceptor due to its low 
quantum yield (Wallrabe and Periasamy 2005; Ai et al. 2008).  In that work, the authors 
were able to relate temporally the relationship among Ca2+ changes, PKC and CaMKIIα 
activity, and Annexin A4 assembly down to a temporal resolution of seconds from 
imaging data.  Further, Ouyang et al. (Ouyang et al. 2010) have recently demonstrated 
use of mOrange2/mCherry as a second FRET pair to examine both Src and MMP-MT1 
simultaneously within cells, showing dramatically different spatiotemporal patterns for 
each molecule, with Src activity being fast and dispersed downstream of EGF 
stimulation, whereas MMP-MT1 was slow and predominantly membranous, despite the 
fact that Src activates MMP-MT1.  In contrast to these studies utilizing currently 
available orange and red fluorescent proteins for novel FRET pairs, Ai and others (Ai et 
al. 2008) sought to generate a second FRET pair that would better meet the criteria above 
than mOrange/mCherry combinations and developed an mTeal/YFP and 
mAmetrine/tdTomato combination which they used to image nucleus-targeted and 
nucleus-excluded caspase-3 activity sensors simultaneously within the same cell.  
mAmetrine is a unique fluorophore with a large Stokes shift that allows effective 
separation of the two FRET pairs but suffers from the need to irradiate cells with near-
UV-wavelength light (405 nm).  Otherwise, this unique set of FRET pairs best fits the 
properties laid out above and should be considered for use where cells can tolerate the 
near-UV-wavelength light irradiation.  Additional fluorophores have recently emerged in 
the violet excitation and emission ranges that permit multiplex imaging, but again, these 
suffer from the need to illuminate cells with damaging near-UV light (Niino et al. ; Niino 
 36
et al. 2009; Tomosugi et al. 2009).  A graphical representation of the spectra of 
fluorophores used in known ratiometric multiplex FRET experiments is illustrated in 
Figure 1.6. 
Perhaps the largest and most successful set of multiplexing experiments has been 
performed using a CFP/YFP FRET sensor with a ratiometric Ca2+ sensor such as Fura-2, 
Fura red, or Indo-1 (Violin et al. 2003; Palmer et al. 2004; Landa et al. 2005; Harbeck et 
al. 2006; Newman and Zhang 2008; Wier et al. 2008).  In particular the study by Wier et 
al. examining Ca2+ levels via Fura-2, and a CFP/YFP biosensor for MLCK, performs 
particularly careful experiments addressing spectral crosstalk between the two probes 
while permitting simultaneous imaging of Ca2+ levels and MLCK activity in mouse small 
arteries.  Other groups have suggested that Indo-1 may have less spectral interference 
than Fura-2 (Tay et al. 2007), while recently Fura red was used with a blue-shifted FRET 
sensor for cGMP (Cygnus), and a CFP/YFP sensor for cAMP (Niino et al. 2010).   
Other groups have developed other methods to expand the range of useful FRET 
biosensors.  Several groups have used additional FRET pairs such as CFP/tHcRed or 
mTagRFP/mPlum for fluorescence lifetime imaging (FLIM) (in parallel with 
YFP/tHcRed FLIM or CFP/YFP emission ratiometric imaging) which is highly 
quantitative, but these FLIM-based multiplexing experiments require tradeoffs in 
temporal resolution or spatial resolution, depending on the variable measured, not seen 
with ratiometric imaging.    Homo-FRET can also be used with changes in fluorescent 
polarity being the readout, and this technique only uses a single wavelength, but the 
emantating signals are often very weak.  Additional red-shifted sensors have been used to 
detect Ras activation via TagRFP/mPlum in FLIM (Grant et al. 2008), and T-
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Sapphire/DsRed to detect cGMP (Niino et al. 2009), in addition to a CFP/YFP FRET pair 
in each study. 
 
Appropriate Probe Use and the Potential for Perturbation of Signaling Dynamics: 
As researchers load cells with multiple activity sensors for multiplex imaging, one 
might hypothesize that cellular perturbation might be an even greater concern than simple 
spectral separation of the sensors.  It is difficult to study a system without perturbing said 
system.  However, we believe that the higher the dynamic range of the sensor, the better, 
as it allows lower expression levels of the sensor to visualize the same target changes, 
preventing perturbation of intracellular signaling.  In general, the sensitivity or dynamic 
range of a sensor should be great enough to detect normal, constitutive signaling 
behaviors within the range of cells’ endogenous changes.  As we consider a few cases, 
we can imagine the different ways in which FRET sensors might alter the system they are 
measuring.  When one considers available Ca2+ sensors, introduction of these sensors 
necessitates the binding of some of the cellular Ca2+ to the sensor itself.  As cellular 
concentration of the FRET probe increases, binding of Ca2+ will increase, thus depleting 
the cellular pool of Ca2+ and potentially blunting or altering intracellular signaling 
cascades (Berlin et al. 1994; Helmchen et al. 1996).  Some calcium-sensing probes were 
even shown to significantly affect other proteins in the cell, though modification of the 
sensor to a unimolecular construct abrogated this problem (Miyawaki et al. 1999; 
Miyawaki 2003).  Similarly, substrate sensors, such as phosphorylation sensors, may 
simply sense active kinase within the cell when expressed at low levels, but as one 
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increases the amount of sensor, the sensor may compete with the endogenous substrate 
for phosphorylation, thus blunting or altering intracellular signaling cascades.   
In the case where the enzyme of interest is contained within the sensor, the cell 
may be swamped by the addition of this extra enzymatic activity.  In the case of GTPase 
sensors, where the GTPase itself is present within the sensor, comparison of both 
unimolecular and bimolecular designs is illustrative.  In the case of an intramolecular 
GTPase sensor, it has been shown previously that the sensor is unable to interact 
effectively with downstream effectors (Pertz et al. 2006), but it is still capable of 
interacting with GEFs, GAPs, and GDI.  As one increases the amount of sensor, the 
interaction with these proteins increases, and thus the sensor can behave as a dominant 
negative.  Overexpression of GTPases also depletes the available GDI within cells, thus 
increasing the activity and altering the normal function of many other GTPases dependent 
on GDI1 (Boulter et al. 2010).  In intermolecular GTPase sensors, the same GAP, GEF, 
and GDI interactions occur, along with additional interactions with downstream effectors.  
Overexpression of this sensor type can cause it to behave either as a dominant negative or 
a signal amplifier if allowed to interact with downstream effectors, depending on the 
circumstances.  Massive overexpression of the intermolecular sensor may allow the 
sensor to act on downstream effectors more easily and activate downstream signaling 
pathways.  However, the dynamic range may be as great as 600% due to low FRET in the 
“off” state (Welch and Hahn, unpublished observations) with such intermolecular 
sensors, allowing the expression levels to be titrated much lower than with intramolecular 
sensors while still obtaining usable FRET signal, reducing the possibility of perturbation.  
One commonly used method to determine whether GTPase biosensor expression has 
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perturbed cellular signaling is to monitor for morphological changes or changes in 
migratory behavior (Kraynov et al. 2000) . 
A final consideration in the use of multiple sensors and their potential impacts on 
cellular signaling should discuss where in signaling cascades these probes should be used 
in order to reveal the greatest amount of information.  Several authors (Miyawaki 2003; 
O'Rourke et al. 2005; Schultz et al. 2005) have proposed that sensors should be applied to 
major signaling cassettes, or nodes, where use of a single sensor could reveal the 
behavior of the entire cassette.  Further, they argue that the sensors should be introduced 
into nodes where the sensor will be buffered or hidden by greater amounts of the 
endogenous target, thus preventing significant perturbation of the signaling pathway.  
Indeed, as discussed above with Ca2+ sensors, and with other work on GTPases, 
researchers have addressed how probe expression compares to endogenous molecule 
concentration.  Lastly, if one expresses two sensors that are within the same signaling 
pathway, perturbations may thus be multiplicative, rather than if two sensors in separate 
pathways are used, where the perturbation to a pathway is affected by a single sensor 
rather than two.  Thus, careful consideration should not only be given to selection of the 
available fluorophores for imaging, but also to expression levels and potential impacts on 
cellular signaling.  
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1.5  An Introduction to Leukocyte Transendothelial Migration 
Blood leukocytes play a critical role in immune surveillance and the host response 
to foreign antigens.  This surveillance is rapid and efficient and involves the routine 
trafficking of leukocytes from blood to tissue, to lymph, and back to the blood (Springer 
1994).  In inflammation, an inflammatory stimulus or antigen causes the extravasation of 
leukocytes to the site of the stimulus or antigen.  Extravasation of these leukocytes into 
tissues is the critical process of transendothelial migration (TEM), and excessive TEM is 
seen in a variety of inflammatory disorders, including ischemia-reperfusion injury after 
heart attack, atherosclerosis, and asthma (Jones et al. 2000; Worthylake and Burridge 
2001; Hordijk 2006; Galkina and Ley 2007), among others. 
 
Inflammation and Endothelial Adhesion Molecules in the Pathogenesis of Disease: 
 Many of these disease processes, including atherosclerosis, asthma, rheumatoid 
arthritis, and others, are chronic inflammatory diseases characterized by the formation of 
inflammatory lesions at different sites within the body.  These lesions are comprised of a 
myriad of cells, including numerous inflammatory cells which undergo TEM to reach 
these lesions.  The continued presence of these lesions can lead to vessel occlusion 
causing ischemic damage to the heart (Hansson and Libby 2006), or can cause long-term 
damage to tissues surrounding the lesions. 
 Inflammation is also important in the events that occur after an event such as a 
myocardial infarct caused by an occlusive atherosclerotic plaque, leading to ischemia-
reperfusion injury.  It is thought that a major mechanism by which the heart is damaged 
following an infarct is the intense inflammatory response that occurs after reperfusion of 
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the ischemic tissue.  This inflammation causes additional damage in the area around the 
ischemic heart, resulting in an enlarged lesion.  However, the central tenet in all of these 
issues is the recruitment of leukocytes into the tissues and their continued presence at 
those sites.  Thus, a better understanding of the signals that lead to leukocyte recruitment 
at those sites would offer potential therapeutic mechanisms for preventing these diseases.  
The only issue with this approach is how one targets pathological inflammation without 
causing immunosuppression by blocking the ability of leukocytes to be recruited 
appropriately to sites of infections or other external threats. 
 
Adhesion Molecules and the Initiation of Signaling Events during Leukocyte TEM: 
 In an effort to modulate inflammatory signals and leukocyte recruitment to reduce 
disease burden, TEM has been studied intensively.  In the endothelium of the vasculature, 
tight and adherens junctions restrict the passage of fluid and macromolecules into tissues, 
so to effect inflammation leukocytes must cross this barrier by undergoing TEM.  
Historical models are based on leukocyte TEM occurring at endothelial cell-cell junctions 
with junctional breakdown, termed the paracellular TEM route.  The possibility that 
leukocytes traverse endothelial cells, or the transcellular TEM route, was ignored until 
recently, despite numerous studies (Williamson and Grisham 1961; Faustmann and 
Dermietzel 1985; Raine et al. 1990) showing that the transcellular route contributes 
significantly to TEM.  Even higher frequencies of transcellular TEM are observed in 
vivo, especially in the microvasculature (Wekerle et al. 1991; McMenamin et al. 1992; 
Greenwood et al. 1994; Engelhardt and Wolburg 2004; Yang et al. 2005; Hordijk 2006; 
Nieminen et al. 2006; Carman et al. 2007).   
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 The paradigm of leukocyte TEM signaling divides the process into three steps: 
rolling adhesion, firm adhesion, and TEM, illustrated with its major molecular players in 
Figure 1.7.  In rolling adhesion, selectins on the leukocyte bind weakly to carbohydrate 
ligands on the endothelial surface.  Next, leukocytes encounter endothelial-bound 
chemokines which in turn activate leukocyte integrins, facilitating firm adhesion through 
binding and clustering of the leukocyte integrins 41 and L/M2 to the endothelial 
ligands VCAM-1 (vascular cellular adhesion molecule 1) and ICAM-1 (intracellular 
adhesion molecule 1), respectively (Springer 1994).  This process is facilitated by 
signaling processes within endothelial cells with the endothelium responding in a 
complex fashion to leukocyte adhesion via VCAM-1 and ICAM-1 (van Buul et al. 
2007b).  Interestingly, mouse models predisposed to atherosclerosis demonstrate that 
disruption of endothelial cell adhesion molecule interactions reduces the development of 
atherosclerotic plaques (Lichtman et al. 1996; Lutters et al. 2004; Galkina and Ley 2007).  
ICAM-1 in particular is critical for leukocyte adhesion in TEM, and is upregulated by 
inflammatory stimuli (Ross 1999; Cybulsky et al. 2001).  Blockade of ICAM-1 and 
genetic deficiency both reduce the development of atherosclerotic plaques (Sligh et al. 
1993; Bourdillon et al. 2000; Hansson and Libby 2006) and significantly attenuate 
myocardial necrosis in ischemia reperfusion injury (Entman et al. 1991; Smith et al. 
1991; Jones and Lefer 2000; Jones et al. 2000), in addition to alleviating a number of 
other inflammatory diseases such as Crohn’s disease and multiple sclerosis (Miller et al. 
2003; Sandborn and Yednock 2003; Dalton et al. 2004).   
After adhesion to ICAM-1 or VCAM-1, one mechanism by which the 
endothelium responds is the formation of “transmigratory cups” (TCs), which are actin-
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rich processes that form around the adhered leukocyte (Barreiro et al. 2002; Carman et al. 
2003; Carman and Springer 2004; Millan et al. 2006).  Finally, in the actual process of 
TEM leukocytes migrate across the endothelium by either passing between adjacent ECs 
(paracellular TEM) into the tissues or by crossing through endothelial cells (transcellular 
TEM).  TCs may be involved in guiding leukocyte TEM, as they appear to organize 
leukocyte 2- and 4- containing integrins into linear patterns oriented in the direction of 
TEM, and have been observed to form regardless of the route of TEM taken (Carman et 
al. 2003; Carman and Springer 2004; Dejana 2006).  However, while paracellular TEM 
mechanisms are better understood, the signaling pathways involved in TC formation and 
transcellular TEM, and how the cell decides between the two routes, remain mostly 
unknown.     
 
Endothelial Cell Signaling During TEM: 
 A great deal of work has been done examining leukocyte signaling during TEM 
and in establishing the transmigration paradigm, but it has become apparent that the 
endothelium plays more than a passive role in TEM.  Current knowledge of TEM 
signaling suggests that leukocyte adhesion to the endothelium begins with engagement of 
the selectins which induces the recruitment of a variety of proteins that affect actin, 
including FAK, filamin, -actinin and others (Millan et al. 2006; Ley et al. 2007).  Next, 
the leukocyte binds endothelial ICAM-1 and VCAM-1 via the integrins L/M2 and 41, 
leading to the RhoA-mediated clustering of the receptors and actin stress fiber formation 
(Thompson et al. 2002).  Upon ICAM-1 and VCAM-1 clustering, these molecules are 
incorporated into lipid rafts with other molecules such as tetraspanins from which they 
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form a scaffold to initiate signaling within the endothelial cell (Rohlena et al. 2009).  
Among the pathways activated include phosphoinositide signaling pathways, release of 
intracellular Ca2+, and phosphorylation of actin-binding proteins (Etienne et al. 1998; 
Adamson et al. 1999; Etienne-Manneville et al. 2000).  Ultimately, each signaling 
pathway converges on the Rho GTPases Rac1, RhoG, and RhoA to cause cytoskeletal 
rearrangement in the endothelium in response to the adherent leukocyte.  Interestingly, it 
is from these clustered ICAM-1 patches that dorsal ruffles often form and lead to the 
formation of microvillous cup-like structures that embrace the migrating leukocytes 
within minutes.  ICAM-1 signaling is clearly important in TEM since the cytoplasmic tail 
is required for the formation of these cups and leukocyte TEM (van Buul et al. 2007b; 
van Buul and Hordijk 2009; Fernandez-Borja et al. 2010).  These pathways are 
summarized in Figure 1.8. 
It is at this point in TEM that clarity in cellular behaviors begins to fade.  It is 
clear that in some cases, adherence of the leukocyte and formation of these “cups” causes 
the endothelium to engulf the leukocyte and passage it to the basolateral surface via 
“transcellular” transmigration.  The precise mechanisms leading to this behavior remain 
obscure, but do use the GTPases described above (Barreiro et al. 2002; Carman and 
Springer 2004; Dejana 2006).  In contrast, many leukocytes are known to pass between 
cells, or the “paracellular” transmigration pathway (Springer 1994; Ley et al. 2007).  
Compared to transcellular migration, the signaling pathways involved in paracellular 
transmigration are better characterized.  First, leukocyte adhesion to ICAM-1 and 
VCAM-1 causes the disassembly of tight and adherens junctions between endothelial 
cells (Fernandez-Borja et al. 2010).  It accomplishes this by a RhoA-dependent 
 45
phosphorylation of VE-Cadherin, one of the junctional proteins, leading to junctional 
instability and separation of endothelial cells (Allingham et al. 2007).  VE-Cadherin also 
couples to the actin cytoskeleton, and it is likely that actomyosin contractility via RhoA 
pulls on these contacts to further assist in the separation of the cellular junctions (Saito et 
al. 1998).    In addition, downstream of VCAM-1, Rac1 is activated and binds to the 
NADPH oxidase system to produce reactive oxygen species which indirectly induce 
phosphorylation of components of the adherens and tight junctions, further impairing cell 
junction stability (van Wetering et al. 2002; van Wetering et al. 2003).  This paracellular 
pathway is clearly important, as most leukocytes appear to pass through endothelial 
monolayers by this mechanism (70-100%) (Dejana 2006).  Thus, by investigating these 
signaling pathways further, we hope to identify novel targets for inhibition that may more 
selectively prevent leukocyte recruitment and transendothelial migration at sites of 
pathological inflammation. 
 
Therapeutic Strategies in Inflammatory Diseases: 
 The general paradigm for leukocyte TEM has provided a great wealth of 
information on which molecules are involved at different stages of TEM.  As a result, 
many attempts have been made to selectively block the different steps of TEM to prevent 
disease.  Most of the attempts to generate therapeutics have focused on the first two steps, 
rolling adhesion and firm adhesion.  Some of the first studies focused on rolling adhesion 
as a target to prevent inflammatory cell recruitment, with double knockout mice for P-
selectin and E-selectin having no leukocyte rolling and virtually no recruitment in 
response to an inflammatory insult (Mayadas et al. 1993; Bullard et al. 1996; Frenette et 
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al. 1996).  A commercially available compound, fucoidan, was an excellent blocking 
agent for both selectins, but in systematic assessment of its use, a number of issues were 
raised, chief among them that nearly 95% inhibition of rolling had to be achieved before 
leukocyte adhesion could be affected (Kubes et al. 1995).  Further, some blood vessels 
did not even respond to the fucoidan treatment.  Continued investigations into using 
selectin inhibitors have been performed, but nearly all have been unsuccessful (Harlan 
and Winn 2002).  Curiously though, studies have indicated that the timing of anti-selectin 
therapy may be critical (Staite et al. 1996), demonstrating that for the first two hours after 
an insult, selectins are important for leukocyte recruitment, and treatment works at this 
stage, but after two hours, treatments have no impact (Hwang et al. 2004).   
 Attention has also been turned to the cellular adhesion molecules and their 
associated binding partners, the leukocyte integrins.  One of the first targets was the 
CD18 receptor (Arfors et al. 1987; Harlan and Winn 2002), with many positive studies 
suggesting potential therapeutic effects by blocking it (Doerschuk et al. 1990; Kurose et 
al. 1994; Issekutz et al. 1996).  However, clinical trials with agents designed to target the 
CD18 receptor have largely failed (Kelly et al. 2007), with the exception being 
Efazulimab, which targets the co-receptor CD11a and is used in moderate to severe 
psoriasis (Papp et al. 2001; Jullien et al. 2004).  It is suspected that it may be of value in 
some inflammatory conditions to inhibit CD18, but it has become apparent that 
leukocytes simply bypass the need for CD18 and selectins in adhesion by using 4 
integrins to bind VCAM-1 and subsequently firmly adhere (Alon et al. 1995).  Indeed, 
clinical trials using an antibody against 4 integrin have shown promise against multiple 
sclerosis, Crohn’s disease, and ulcerative colitis (Ghosh 2003; Miller et al. 2003; 
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Sandborn and Yednock 2003; Dalton et al. 2004).  While there is some promise in these 
studies, they suggest that either combinatorial therapy or targeting of new signaling 
molecules will be necessary for the treatment of inflammatory diseases.  Thus, we 
anticipate looking at other targets, starting with those involved in endothelial cell 
signaling, particularly as it pertains to the Rho GTPases. 
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1.6  Figures and Legends 
Figure 1.1: Rho Family of Small GTPases. 
Summary of all known Rho family small GTPases and their phylogenetic relationships. 
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Figure 1.1  
 
 Adapted from Heasman and Ridley, Nat Rev Mol Cell Bio 2008;9:690-701 
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Figure 1.2:  Distinct Steps in the Cell Migration Cycle. 
A depiction of the three major steps in cell migration and associated signaling proteins.  
(A) Cell Polarization: the first step is morphological polarization, mediated largely by 
generation of phosphoinositides at the leading edge, activation of Cdc42, and alteration of 
microtubule/Golgi polarity.   
(B) Cell Protrusion: the second step combines protrusion and adhesion formation, with 
protrusion mediated largely by actin polymerization through Rac1/Cdc42, potentially 
RhoA, and actin regulators, and adhesion also mediated by Rac1/Cdc42, but also via 
integrins and other focal adhesion proteins.   
(C) Tail Retraction: the last step is adhesion disassembly and rear retraction, mediated by 
FAK, actomyosin contractility (RhoA-Myosin II), Ca2+, and proteases.  Each of these 
steps is critical to the cyclical nature of cell migration.  
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Figure 1.2 
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Adapted from A. J. Ridley et al. Science 2003;302:1704-1709. 
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Figure 1.3:  Combinatorial Nature of Growth Factor Signaling Networks. 
(A) A variety of growth factors and ligands are capable of binding to a variety of cell 
surface receptors.  EGF, for example, and its related growth factor ligands such as NRG 
bind to a combination of the dimers of the four EGF receptor tyrosine kinase subtypes, 
initiating a variety of downstream signals.   
(B) The signal-processing layer is activated by particular combinations of the receptor 
homo- and hetero-dimers after ligand binding, and depending on the spatial and temporal 
dynamics of the signals, initiates a variety of cellular signaling cascades, a few of which 
are illustrated here. 
(C) Upon engagement of a variety of cellular signaling cascades, a variety of cellular 
behaviors can be initiated depending on the context of the stimulus, leading to behaviors 
as varied as migration, adhesion, growth, apoptosis, and differentiation.   
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Figure 1.3 
 
Figure adapted from Yarden and Sliwkowski Nat Rev Mol Cell Bio (2001);2(2):127-37. 
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Figure 1.4:  Regulation of Rho GTPases Downstream of Growth Factors. 
Summary of known signaling pathways activated by growth factor signaling that lead to 
regulation of the major Rho GTPases Rac1, RhoA, and Cdc42 for actin cytoskeleton 
rearrangement.  Both stimulatory and inhibitory pathways exist downstream of these 
factors. 
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Figure 1.4 
 
Figure adapted from Burridge and Wennerberg, Cell. 2004;116(2):167-79. 
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Figure 1.5:  Common Designs for Intracellular Signaling Probes. 
Biosensors for intracellular signaling come in a variety of designs, for sensing both (A) 
the regulation of the endogenous protein, and (B) the endogenous protein itself. 
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Figure 1.5  
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Figure 1.6:  Spectra of Fluorophores Used in Ratiometric FRET Multiplex 
Experiments. 
 
Four major “groups” of fluorophores have been utilized to perform ratiometric imaging 
of two FRET probes simultaneously.  These orthogonal FRET pairs are (A) EBFP/ECFP 
and mOrange/mCherry, (B) ECFP/EYFP and mOrange2/mCherry, (C) 
mAmetrine/tdTomato and mTeal/YFP, and (D) T-Sapphire/DsRed and ECFP/EYFP. 
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Figure 1.6 
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Figure 1.7:  Leukocyte Adhesion and Signaling Cascade. 
For leukocytes to respond to sites of inflammation, they must interact with the inflamed 
endothelium to receive the appropriate signals to stop and transmigrate.  The first 
interaction with the endothelium is rolling, mediated largely by selectins.  The leukocyte 
is then activated (integrins, specifically) by chemokines on the surface of the endothelium 
as it rolls across the endothelium, leading to arrest of the leukocyte via integrin-
endothelial cell adhesion molecule interactions.  Additional steps have been described, 
such as tethering and slow rolling mediated by selectins, adhesion strengthening and 
intravascular crawling mediated by a variety of signaling pathways, and paracellular and 
transcellular transmigration mediated by signaling processes in both the leukocyte and 
the endothelium. Key molecules involved in each step are indicated in boxes. 
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Figure 1.7 
 
 
 
Figure adapted from Ley, K et al. Nat Rev Immunol 2007;7(9):678-89. 
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Figure 1.8:  Proximal Signaling Events in the Endothelium Leading to Formation of 
Endothelial Docking Structures Induced Upon Firm Adhesion of Leukocytes via 
ICAM-1. 
 
Overview of signalling events leading to the formation of endothelial docking structures, 
due to firm leukocyte adhesion. Ligation and clustering of ICAM-1 leads to activation of 
GEFs, which activate a subset of Rho GTPases that lead to formation of the docking 
structure via cytoskeletal rearrangement. RhoA appears to be involved in clustering 
ICAM-1and stiffening the cell, whereas RhoG and Rac1 mediate membrane ruffling and 
actin dynamics that lead to formation of the docking structure.  
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Figure 1.8 
 
Figure adapted from Fernandez-Borja M et al. Cardiovasc Res 2010;86(2):202-210. 
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Table 1.1:  Fluorescent Biosensors for Intracellular Signaling Pathways 
A list of available targets for study of intracellular signaling pathways with representative 
biosensor examples for each.  
Reporter For: Types of Sensors: Sensor Examples: References: 
Transcriptional activity Single fluorophore, color-
changing fluorophores 
DsRed-Timer, EGFP-
MODC 
(Li et al. 1998; 
Terskikh et al. 
2000; Bogdanov et 
al. 2009)  
Protein turnover Fluorescent proteins, 
FLASH/ReAsH 
Fluorescent timers, 
FLASH/ReAsH labeled 
proteins  
(Gaietta et al. 
2002; Patterson 
and Lippincott-
Schwartz 2002) 
PI(4,5)P2 Dynamics Localization-based, FRET-
based 
CYPHER, Pippi-
PI(4,5)P2, FP-PHPLC1 
(Violin et al. 2003; 
Varnai and Balla 
2006; Nishioka et 
al. 2008) 
PI(3,4,5)P3 Dynamics Localization-based, FRET-
based 
FP-PHGRP1, FP-PHARNO, 
Fllip 
(Sasaki et al. 2003; 
Varnai and Balla 
2006) 
3’PI Dynamics FRET-based InPAkt (Ananthanarayanan 
et al. 2005) 
Absolute [IP3] FRET-based FIRE-1,-2,-3, IRIS-1 (Tanimura et al. 
2004; Matsu-ura et 
al. 2006; Kapur et 
al. 2007) 
Diacylglycerol Dynamics FRET-based DAGR, DIGDA; 
(PKCII) 
(Violin et al. 2003; 
Nishioka et al. 
2008) 
Phosphatidylserine 
Dynamics 
Localization-based GFP-Lact-C2 (Yeung et al. 2008) 
Phosphatidic Acid 
Dynamics 
FRET-based Pii-DK (based on 
DOCK2) 
(Nishioka et al.) 
Halide Ions Intensity-based, FRET-
based 
YFP(H148Q), 
Clomeleon, Cl-Sensor 
(Jayaraman et al. 
2000; Kuner and 
Augustine 2000; 
Galietta et al. 
2001; Markova et 
al. 2008) 
Intracellular pH Intensity-based, Ratiometric 
single fluorophore, FRET-
based 
EGFP, EYFP, 
SuperEcliptic pHluorin, 
ratiometric pHluorin, 
YFpH 
(Kneen et al. 1998; 
Llopis et al. 1998; 
Miesenböck et al. 
1998; Awaji et al. 
2001) 
Redox Status and Redox 
Species 
Intensity-based, Ratiometric 
single fluorophore 
rxYFPNC, roGFP, 
roGFP 1-iX, HyPer, mt-
cpYFP 
(Ostergaard et al. 
2001; Dooley et al. 
2004; Hanson et al. 
2004; Belousov et 
al. 2006; Cannon 
and Remington 
2006; Wang et al. 
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2008) 
[Ca2+] Intensity-based Camgaroo-2, GCaMP3, 
flash-pericam 
(Griesbeck et al. 
2001; Nagai et al. 
2001; Tian et al. 
2009) 
Absolute [Ca2+] FRET-based Cameleon3, split 
cameleon, D3cpv 
(Miyawaki et al. 
1997; Palmer et al. 
2006) 
Absolute [cAMP] FRET-based ICUE3, PKA-camps, 
PKARII-ECFP/PKACat-
EYFP 
(Zaccolo and 
Pozzan 2002; 
Nikolaev et al. 
2004; Allen et al. 
2006) 
[cGMP] Intensity-based FlincG or  (Nausch et al. 
2008) 
Absolute [cGMP] Ratiometric single 
fluorophore, FRET-based 
Cygnet-2.1, cGi family, 
cGS-DE5 
(Honda et al. 2005; 
Lohse 2006; 
Russwurm et al. 
2007) 
NO FRET-based FRET-MT, Piccell (Pearce et al. 2000; 
Sato et al. 2006) 
Absolute [ATP] FRET-based Ateam-1.03/3.10 (Imamura et al. 
2009) 
[ATP]/[ADP] Ratiometric single 
fluorophore 
Perceval (Imamura et al. 
2009) 
Extracellular [glutamate] FRET-based FLIPE-Y, 
SuperGluSnFR 
(Okumoto et al. 
2005; Hires et al. 
2008) 
Absolute [sugar] FRET-based FLIPglu-Y, FLIPmal-Y, 
FLIPrib-Y 
(Lager et al. 2003; 
Deuschle et al. 
2005) 
Absolute [Zn2+] FRET-based eCALWY, Cys2His2, 
His4 
(Dittmer et al. 
2009; Vinkenborg 
et al. 2009) 
Membrane Potential Intensity-based, FRET-
based 
FlaSh family, Flare, 
VSFP2.3, Mermaid, 
SPARCS 
(Siegel and Isacoff 
1997; Ataka and 
Pieribone 2002; 
Guerrero et al. 
2002; Dimitrov et 
al. 2007; Tsutsui et 
al. 2008) 
Small G-Protein Activity FRET-based Raichu series, FLAIR 
(Rac1), RhoA, Cdc42, 
Ral, Ras, Rap probes 
(Kraynov et al. 
2000b; Mochizuki 
et al. 2001; Chiu et 
al. 2002; Itoh et al. 
2002; Yoshizaki et 
al. 2003; Nalbant 
et al. 2004a; 
Fujioka et al. 2006; 
Pertz et al. 2006b; 
Machacek et al. 
2009) 
Kinase Activity FRET-based Akind (Akt), Miu2 
(ERK), GFP-PDK1-
(Gavet and Pines ; 
Kurokawa et al. 
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RFP (PDK1), DKAR 
(PKD), CKAR (PKC), 
AKAR (PKA), Phocus-
2pp (InsR Kinase), 
Srcus/Src reporter, 
Picchu (RTK), Picchu-Z 
(EGFR), ATOMIC 
(ATM), Aurora B 
kinase, Cyclin-B1, 
Histone H3 
phosphorylation,  
2001; Violin et al. 
2003; Lin and Ting 
2004; Sato and 
Umezawa 2004; 
Schleifenbaum et 
al. 2004; Itoh et al. 
2005; Wang et al. 
2005; Fujioka et al. 
2006; Calleja et al. 
2007; Johnson et 
al. 2007; Kunkel et 
al. 2007; Fuller et 
al. 2008) 
Calcineurin Phosphatase FRET-based CaNAR1 (Newman and 
Zhang 2008) 
O-glycosyl-transferase FRET-based O-GlcNAc Sensor (Mahal 2008) 
Proteases FRET-based Caspase-3, Caspase-3/6, 
MT1-MMP 
Luo Y Nuc Acids 
Res 1998, He L 
Cytometry A 2006, 
Ouyang M JBC 
2008 
Histone Modification FRET-based K9, K27, Histac Yoshida M PNAS 
2009, Singh PB 
Bioessays 2000 
Cell Cycle Progression Intensity-based Fucci series Miyawaki Cell 
2008 
Neutrophic Factor 
[BDNF] 
FRET-based Becell Umezawa Y ACS 
Chem Bio 2008 
Mechanical Force Intensity-based, FRET-
based 
TSMod, stFRET, 
PriSSM 
511, 512, 513, 
Schwartz MA 
Nature 2010, Sachs 
F FEBS 2008, 
Uyeda TQ PNAS 
2008 
Table 1.1 
Table adapted from Newman et al., Chem Rev. 2011 May 11;111(5):3614-66. 
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Table 1.2:  Known Multiplex Imaging Experiments 
A list of known multiplex imaging experiments with the fluorophores and analysis 
techniques used.  
FRET Multiplex 
Experiments 
Reference Fluorophores Used Methods Used for Imaging 
 (Abad et al. 2004; 
Galperin et al. 
2004; He et al. 
2004; He et al. 
2005; Wu et al. 
2006) 
CFP/YFP/mRFP1 Three-color, Ratiometric 
FRET x2 on same probe 
 (Kawai et al. 
2004; Kawai et al. 
2005) 
CFP/DsRed with YFP/DsRed Intensiometric FRET x2 
 (DiPilato et al. 
2004) 
CFP/YFP Spatial separation, 
Ratiometric FRET x2 
 (Brumbaugh et al. 
2006) 
CFP/YFP Ratiometric FRET x2 on 
same probe 
 (Piljic and Schultz 
2008) 
CFP/YFP, mOrange/mCherry, 
Fura Red 
Ratiometric FRET x2, 
Spatial separation, 
Ratiometric FRET x2 + 
Intensiometric FRET + 
Calcium Sensor 
 (Ai et al. 2008)  mTFP1/YFP, 
mAmetrine/tdTomato 
Ratiometric FRET x2 
 (Tomosugi et al. 
2009)  
Sirius/mseCFP, Sapphire/DsRed Ratiometric FRET x2 
 (Niino et al. 2009) mSapphire/RFP 
CFP/YFP 
Single wavelength 
excitation, Ratiometric 
FRET x2 
 (Machacek et al. 
2009)  
CFP/YFP, Dyes: 
Mero87/Alexa750 pair 
Ratiometric FRET + 
Ratiometric dye change 
 (Niino et al. 2010) mTagBFP/sREACh, CFP/YFP, 
Fura Red 
Ratiometric FRET x2 + Ca2+
 (Ouyang et al. 
2010)  
CFP/YFP, mOrange2/mCherry Ratiometric FRET x2 
 (Peyker et al. 
2005)  
FLIM: CFP/tHcRed and 
YFP/tHcRed 
FLIM FRET 
 (Grant et al. 2008) CFP/YFP and FLIM: 
mTagRFP/mPlum 
Ratiometric FRET + FLIM 
FRET 
 (Kwok et al. 2008) FLIM: mRFP/GFP, 
mStrawberry/GFP, 
mRFP/Venus, 
mStrawberry/Venus, and 
mDarkVenus/mGFP 
FLIM FRET 
Table 1.2
  
CHAPTER TWO:  RATIONAL DESIGN AND DEVEOPMENT OF RHO 
GTPASE BIOSENSORS FOR LIVE CELL IMAGING 
 
2.1  Abstract 
 Numerous FRET-based biosensors have been developed for the study of 
intracellular signaling.  One of the classes of intracellular targets whose understanding 
has grown greatly from development of these tools has been the Rho GTPases.  Rho 
GTPase biosensors have largely taken two forms: intramolecular (single-chain) FRET 
sensors and intermolecular (dual-chain) FRET sensors based on CFP/YFP FRET pairs.  
Traditionally, single-chain sensors have been preferred given their ease of use due to 
equimolar expression of donor and acceptor fluorophores, and their assumed inability to 
interact with downstream effectors.  However, these sensors exhibit significant FRET in 
the “off” state and dynamic ranges are not large.  Here we improve upon existing dual-
chain and single-chain sensors, and compare and contrast their sensitivity and dynamic 
ranges, their tendencies to exhibit artefacts, and their ability to perturb downstream 
signaling pathways.   
In addition, we develop new sensors utilizing FRET pairs orthogonal to 
CFP/YFP, and also a new construct design that allows for equimolar expression of dual-
chain sensors from a single plasmid.  Our results indicate that both single-chain and dual-
chain sensors are highly useful depending on the particular experiment, and that through 
the use of new expression and analysis techniques, dual-chain sensors, due to their high 
dynamic range, are the preferred choice for many experiments. 
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2.2  Introduction 
 As discussed in the background materials, the Rho GTPases are biochemical 
switches that bridge the gap between extracellular stimuli and changes in intracellular 
signaling and cellular morphology.  The GTPases couple a variety of extracellular 
receptors to a host of cellular processes, including gene transcription, phagocytosis, cell 
migration, cell-cycle progression, vesicular trafficking, and others.  That these GTPases 
can selectively control so many responses indicates that these molecules are very tightly 
controlled both spatially and temporally.  Thus, to tease apart these different signaling 
pathways, researchers have long sought to examine the activity of these GTPases in 
living cells. 
 
Previous Methods for Assessing Rho GTPase Activity: 
 As molecular switches, Rho GTPases cycle between an “on” and “off” form, 
dictated by their GTP-loading status.  When bound to GTP, Rho GTPases are “on,” and 
when bound to GDP, Rho GTPases are “off.”  Guanine Exchange Factors (GEFs) are 
molecules that catalyze the exchange of GDP for GTP and activate the GTPases, while 
GTPase Activating Proteins (GAPs) catalyze the hydrolysis of GTP to GDP, turning the 
GTPases “off.”  Only when the GTPases are in the “on” state do they interact with 
downstream effectors, and this state of the protein is the one that scientists are interested 
in, as it catalyzes the myriad cellular events controlled by the Rho GTPases.  Accessing 
the activity status of Rho GTPases, however, has been a difficult process over the years.     
Early studies used proxy indicators for Rho GTPase activation, such as the presence of 
stress fibers, as an indicator of RhoA activation.  Biochemical assays were also 
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developed to examine the activation status of the GTPases, first by adding 32Pi-
orthophosphate to cell media, allowing its incorporation into GTP, immunoprecipitating 
the Rho GTPase, and then using thin layer chromatography to separate GDP and GTP 
(Gibbs 1995) as an indicator of Rho GTP loading status.  Next, other researchers 
developed the “pull down” assay whereby the GTPases were immunoprecipitated by the 
use of a GST-fused binding domain that selectively bound the active form of the GTPase 
(Taylor and Shalloway 1996; de Rooij and Bos 1997).   
Slowly, these concepts pushed their way into imaging studies, where fluorescently 
labeled forms of the GTPases were observed for changes in localization (Kranenburg et 
al. 1997; Michaelson et al. 2001).  Others utilized fluorescently tagged versions of the 
binding domains used in the pull down studies as an indicator of where the active forms 
of the GTPases were located (Kim et al. 2000; Cannon et al. 2001; Srinivasan et al. 
2003).  While the biochemical assays showed excellent sensitivity and selectivity, they 
simply averaged what was going on in large populations of cells, in contrast to the ability 
of imaging to identify processes in single cells.  However, the imaging studies were not 
very sensitive or specific.  Thus, FRET-based sensors which were both sensitive and 
specific were developed to examine GTPase activity status in live cells (Kraynov et al. 
2000b; Mochizuki et al. 2001).  Over the course of development of these FRET-based 
sensors, a handful of basic designs have come to the front in terms of usefulness, but each 
sensor type must be used with a full understanding of the caveats of each. 
 
 71
Comparison of Basic Rho GTPase Biosensor Design: 
 The basic sensor designs that have arisen from studies attempting to discern Rho 
GTPase activation by FRET are: 1) intermolecular (dual-chain) and 2) intramolecular 
(single-chain) designs as illustrated in Figure 1.5.  Within the intramolecular class of 
sensors, two basic flavors exist as well, the GTPase-effector fusion and effector domain-
only designs (Itoh et al. 2002; Seth et al. 2003).  These sensor designs have been used for 
a variety of other intracellular targets as well (Miyawaki 2003; Newman et al. 2011) .  
Due to the lack of specificity and sensitivity inherent in the effector domain-only designs, 
these sensors are rarely used today, given the better characteristics of the other sensor 
formats.  Basic differences in these sensor designs unfold in the acquisition and 
processing of the imaging data.  Intermolecular FRET sensors consist of two components 
which often distribute differentially within the cell at different expression levels, so 
bleedthrough correction must be performed to correct for contributions due to localized 
accumulation of one domain or the other.  In contrast, bleedthrough correction has 
typically been ignored for single-chain sensors as both donor and acceptor fluors are 
present in the same place at the same time, reducing these artefacts.  Such differences are 
largely responsible for the differences in their frequency of usage and popularity in 
scientific studies. 
 
Comparison of Usage of Intramolecular and Intermolecular Rho GTPase FRET 
Biosensor Designs: 
 
As mentioned above, intramolecular FRET sensors typically require less intensive 
image acquisition and processing techniques in order to obtain an informative FRET 
signal, and typically generate a fairly large FRET signal due to proximity of the 
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fluorophores.  Further, it has been argued that intramolecular FRET sensors typically 
interact less with other cellular components since it is likely that once the GTPase 
becomes activated, it is immediately bound by the associated binding domain, preventing 
interaction with endogenous effectors and thus perturbing intracellular signaling to a 
smaller degree (at least as demonstrated for the cameleon sensors) (Miyawaki et al. 1999; 
Miyawaki 2003).  These lines of reasoning have largely driven the use of intramolecular 
FRET sensors for the GTPases.   
While there is some evidence that these concerns are true of the intramolecular 
Rho GTPase sensors (Pertz et al. 2006), these sensors could as a result behave as 
dominant negative constructs, sequestering upstream regulators such as GAPs, GEFs, and 
GDI.  Indeed, recent work suggests that overexpression of Rho GTPases alters 
intracellular signaling by a mechanism different than expected: alterations in the 
expression of endogenous GTPases due to derangement of GTPase/GDI ratios in cells 
(Michaelson et al. 2001; Boulter et al. 2010) .  Interestingly, it has been shown recently 
that use of dual-chain and single-chain RhoA FRET sensors produced the same results in 
a thorough quantitative assessment of the role of RhoA activation at the leading edge of 
cells, suggesting that sensor design does not significantly influence the detection of 
GTPase activation dynamics in live cells (Machacek et al. 2009).  Additionally, it is 
known that intermolecular FRET sensors, while requiring more extensive image 
processing, generate larger dynamic ranges due to lower FRET in the off state, perhaps 
permitting their expression at lower levels in cells (Pertz and Hahn 2004; Hodgson et al. 
2008).  This property could be exploited to detect smaller changes in intracellular 
signaling if the intermolecular sensors are used appropriately.   
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Thus, in light of the lack of comparative data on different Rho GTPase sensors 
and sensor designs, our aim was to generate new and improved versions of our Rho 
GTPase sensors utilizing dual-chain and single-chain sensor designs.  Through 
comparison of these designs, we are able to show that sensitivity and dynamic range of 
these GTPase sensors can be improved through several new strategies.  Additionally, we 
show that both dual-chain and single-chain sensors suffer from artefacts that must be 
considered when selecting probes for imaging, that dual-chain sensors are more sensitive 
than single-chain sensors and can be analyzed by different methods compared to single-
chain sensors, that both dual-chain and single-chain sensors perturb cellular signaling at 
high expression levels, that expression levels of dual-chain sensors can be normalized 
through utilization of a novel expression cassette, and that new red-shifted FRET pairs 
can be utilized in these sensors that are orthogonal to the traditional CFP/YFP pair so 
commonly used.  This work thus provides a quantitative comparison of Rho GTPase 
sensor designs and enables researchers to better select and interpret data generated by 
these probes, in addition to providing new sensors for use. 
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2.3  Results 
Comparison of Sensitivity and Cellular Perturbation with Intramolecular and 
Intermolecular GTPase Activity FRET Sensors: 
 
Over the past decade, a variety of FRET-based probes to monitor signaling 
protein activity have emerged, particularly targeting kinase and GTPase activities 
(Newman et al. 2011) (See Table 1.1).  These probes have enabled a much greater 
understanding of the spatial and temporal dynamics of intracellular signaling.  One of the 
more prevalent Rho GTPase probe designs has been the intramolecular, or single-chain, 
design, which contains both donor and acceptor fluorophores, in addition to the affinity 
reagent and often the target GTPase, on the same protein to allow for simple ratiometric 
analysis of activity (Figure 2.1A).  A similar but less frequently used sensor type is the 
“dual-chain” or intermolecular FRET sensor, in which the GTPase is tagged with the 
donor fluorophore and expressed separately from the binding domain, which is tagged 
with the acceptor fluorophore (Figure 2.1B). 
While the construction and validation of these different sensor types can be 
difficult and time-consuming, FRET signal analysis and interpretation for each type of 
sensor is even more critical.  First, a major difference between single-chain and dual-
chain sensors is the quantity of FRET present in the “off” state.  For single-chain sensors, 
since the fluorophores are constrained together within the construct, there is always 
FRET at baseline, regardless of GTPase activity status.  If single- and dual-chain sensors 
are constructed missing the binding domain/recognition motif, single-chain sensors still 
exhibit FRET at baseline, whereas the dual-chain sensor shows no FRET in this case 
(Figure 2.1C).  In using this truncated single-chain construct, fluctuating patterns of 
RhoA are still observed, presumably reflecting stochastic FRET changes due to 
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movements of the fluorophores in space at any point in time within a voxel of cellular 
space, in addition to bleedthrough from the donor fluorophore.  Visually, these signals 
can mislead one into observing changes in FRET that appear “real” due to activation of 
the sensor.  In fact, validation of the RhoA.SC sensor in its truncated state illustrates that 
the probe can still respond to interaction with p50RhoGAP and RhoGDI-1 with changes 
in FRET, though to significantly smaller degree than the wild-type sensor (Figure 
S2.1A).  Quantitation of linescans at the cell edge where it has been previously shown 
that RhoA is activated during protrusion demonstrated that the change in intensity is 
diminished in the RBD truncation mutant (Figure 2.1D).  Thus, when examining small 
changes in FRET or subcellular FRET changes, single-chain sensors can be more prone 
to false-positive signals, resulting in the presumption of activity changes where none 
exist.   
In the converse, dual-chain sensors may have difficulty in showing FRET where 
minimal activity exists due to minimal activation of the endogenous GTPase, making 
these sensors prone to false-negative issues.  For example, in HeLa cells, which have low 
but biochemically detectable RhoA activity, a single-chain sensor for RhoA shows 
significant activity, but a dual-chain sensor fails to detect RhoA activity (Figure S2.1B).  
In contrast, in mouse embryonic fibroblasts, which have higher baseline levels of RhoA 
activity biochemically, both single- and dual-chain FRET sensors detect significant RhoA 
activity (Figure S2.1B).   
Lastly, we note that in some cases, dual-chain sensors can be “shielded” from the 
affinity reagent by interactions with endogenous proteins or subcellular localizations that 
prevent interaction with the fluorescently labeled affinity reagent, as shown in Figure 
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S2.1C.  Thus, choice of sensor and interpretation of the resultant FRET signal will vary 
based on the particular experiment being performed.  The risks and benefits of using each 
sensor design must be considered.   
However, there are methods that can be used to overcome this apparent lack of 
signal for dual-chain sensors.  Since dual-chain sensor exhibit virtually no FRET in the 
“off” state, any FRET signal indicates activity, though not activity per unit molecule as 
the FRET ratio provides.  By analyzing the raw, or total, FRET signal from these sensors, 
conclusions can be made about the total activity present at subcellular locations in the 
cell.  Thus the total FRET observed will reflect a combination of local changes in FRET 
and diminishing amount of target protein available to FRET in the thinner parts of the 
cell.  Analyzing total FRET by linescan analysis and comparing the total FRET signal 
with ratiometric FRET and the donor signal by both widefield and TIRF microscopy 
(Figure 2.1E) demonstrates that the total FRET signal differs from the ratiometric FRET 
signal (Figure 2.1G).  By using total FRET, significant increases in FRET are observed at 
the leading, protrusive edge, in addition to significant amounts of FRET from regions 
associated with endomembranes, both in widefield and TIRF.  By contrast, when using of 
a modified form of the Rac1.DC sensor C-terminus with a K-Ras4b polybasic region and 
CAAX motif which membrane anchors the probe, this same analysis demonstrates that 
the total FRET signal perfectly parallels the FRET ratio.  In addition to demonstrating 
this total FRET is a viable method for measuring FRET signal, especially in cases where 
signal is too low to measure ratiometric FRET, these results also show that Rac1 is 
activated in regions other than the plasma membrane such as the cytosol and 
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endomembranes, consistent with previous reports (Del Pozo et al. 2002; del Pozo et al. 
2004) .   
 
Comparison of Sensitivity and Cellular Perturbation with Intramolecular and 
Intermolecular GTPase Activity FRET Sensors: 
 
One of the greatest challenges in the development of probes for signaling 
molecule activity is to avoid perturbing the system under study.  As others have noted, 
this is difficult, if not impossible (Miyawaki 2003; O'Rourke et al. 2005), but a few 
guiding principles aid us in choosing molecules for study.  For example, central nodes in 
cell signaling pathways that have a sizable buffering capacity are the preferred choice for 
study.  Thus, researchers need probes that have high sensitivity so that expression levels 
can be kept low while still observing subtle changes within the system.  Traditionally, 
single-chain sensors have been favored because they often give high FRET signal 
compared to dual-chain sensors (Figure 2.2A), but the dynamic ranges are often much 
smaller for single-chain sensors due to significant FRET at baseline.  Thus, we attempted 
to determine whether we could detect leading edge activation of RhoA with decreasing 
amounts of single-chain or dual-chain RhoA FRET probe.  Figure 2.2B demonstrates that 
a RhoA dual-chain sensor can be expressed at much lower levels than the single-chain 
sensor and still detect at minimum a twenty percent increase in leading edge activation of 
RhoA, suggesting much greater sensitivity for dual-chain sensors.  This is further 
confirmed in fluorescence lifetime (FLIM) FRET analysis of these probes, which is not 
subject to artifacts due to cellular thickness or uneven distribution of the two 
fluorophores in dual-chain sensors.  By use of FLIM, for a single-chain RhoA sensor the 
low FRET and high FRET states demonstrate FRET efficiencies of 9.4% and 35.4% 
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(2.28 ns to 2.10 ns lifetime shift), respectively, whereas for a dual-chain Rac1 sensor, the 
low and high FRET states demonstrate FRET efficiencies of 1% and 30.6% (2.45 ns to 
2.10 ns lifetime shift), indicating a much greater dynamic range for the dual-chain sensor 
and thus enhanced sensitivity (Figure 2.2C) due to lower FRET in the “off” state.   
Knowing that the dual-chain sensor is more sensitive to cellular signaling 
behaviors, we attempted to determine whether expression of dual-chain and single-chain 
sensors had differential impacts on downstream signaling in cells.  Previous studies have 
implied that single-chain sensors tend to interact with downstream effectors less than 
dual-chains and thus are preferable.  However, it has been shown that overexpression of 
GTPases leads to dysregulation of endogenous GTPases via saturation of the binding 
capacity of RhoGDI (Boulter et al. 2010).  To determine the effects of both dual-chain 
and single-chain RhoA and Rac1 sensors on downstream signaling, we examined the 
levels of cofilin phosphorylation before and after serum stimulation in the presence of 
low or high levels of sensor expression.  Cofilin phosphorylation is influenced by both 
Rac1 and RhoA activity (Wang et al. 2007), allowing us to compare the effects of these 
sensors.  Figure S2.2 shows that at high levels of sensor expression, both dual-chain and 
single-chain RhoA sensors appear to alter downstream signaling through cofilin slightly, 
whereas at low levels, little change in cofilin phosphorylation is observed.  Similar 
effects are observed for both dual-chain and single-chain Rac1 sensors.  Given recent 
reports demonstrating that overexpression of GTPases does not just influence effector 
interactions, but also the pool of available GDI-1 (Boulter et al. 2010), these results are 
not unexpected.  Typical imaging experiments use expression levels more closely 
corresponding to the “low expression” condition for the sensor types used.  Thus, these 
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results demonstrate that dual-chain sensors are more sensitive to changes in cellular 
signaling, and in addition, do not perturb cellular signaling to any greater degree than 
single-chain sensors.  Thus, this argues for use of dual-chain FRET sensors where 
possible. 
 
Comparison of C-terminal Modifications in GTPase Activity FRET Sensors: 
One additional consideration when selecting a sensor for use and interpreting the 
resultant FRET signal is that a number of modifications are used to target the sensors to 
different subcellular regions.  For example, Rho GTPases are often lipid-modified to 
allow for their insertion into the plasma membrane to permit activation by GEFs and 
downstream signaling.  It has been held that GTPases are membrane-bound in the active 
state, but cytostolic in the inactive state due to sequestration by RhoGDI.  To test whether 
regulation of the GTPase cycle by GDI-1 affects apparent activity, we generated sensors 
mutated from the wild-type form by swapping the poly-basic region and CAAX box for 
the K-Ras4b sequence, or by truncating this region entirely (see Figure 2.3A for sequence 
alignment).  As anticipated, truncation of the tail grossly affected both localization and 
activity patterns (Figure 2.3B, bottom panel) for the Rac1.DC sensor.  Without a 
prenylation sequence, Rac1 strongly localizes to the nucleus in addition to the cytosol 
(Michaelson et al. 2008), and activity patterns are dramatically different.  In the tail 
truncation mutant, activation appears to occur only near membranes, suggesting that 
transient diffusion of the GTPase to the membrane may bring it in proximity to GEFs for 
activation, but this activation does not persist past the very leading edge of the cell, in 
contrast to wild-type Rac1.  However, there are no significant activity pattern differences 
seen when the C-terminus is replaced with the K-Ras4b sequence (Figure 2.3B), but 
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localization is altered.  When K-Ras modified, virtually all Rac1 is present at the 
peripheral membrane, and the GTPase is lost from the perinuclear region and other 
internal membranes (Figure 2.3C).  Interestingly, even though the activity patterns do not 
change for Rac1 (Figure 2.3B), Rac1 activity appears biased towards higher levels and 
the K-Ras modified sensor does not respond to GDI-1 as expected (Figure 2.3D), 
suggesting that GDI-1 plays a significant role in preventing the activation of the sensor, 
particularly at the leading edge.  To confirm that these localization differences occur for 
other GTPases as well, a RhoA dual-chain sensor was C-terminally modified with the 
KRas-4b sequence.  Localization patterns again show that K-Ras modification causes loss 
of the GTPase from internal membranes and localization to the plasma membrane only 
(Figure 2.3E).  Additionally, when analyzing this RhoA dual-chain sensor for FRET by 
FLIM, the high FRET state had a FRET efficiency of 38.4%, consistent with our previous 
results showing that K-Ras modification biases the sensors toward higher activity.   
Thus, we conclude that utilizing C-terminal sequences other than the wild-type 
sequence may alter the ability of the sensor to properly sense endogenous signaling 
pathways by either modulating the placement of the GTPase (Michaelson et al. 2001; 
Prior et al. 2001; del Pozo et al. 2004; Michaelson et al. 2008; Osmani et al. 2010), or 
altering how it is regulated.   
 
Rational Development and Improvement of Intramolecular and Intermolecular GTPase 
Activity FRET Sensors: 
 
Seizing upon the issues with both single-chain and dual-chain FRET sensors, we 
sought to develop new probes and upgrade existing probes for the GTPases.  To design 
these probes, most effort has been expended determining the proper orientation and 
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positioning of the fluorophores and recognition elements through the use of linker 
sequences.  In the process of improving and upgrading our biosensor library, we found 
that the linker, or hinge region, between the two fluorophores (Figure 2.1A) greatly 
affected the ability of sensors to respond appropriately to upstream regulators.  In 
generating a single-chain Rac1 activity FRET sensor, we tested linker lengths increasing 
by 18 amino acids (1L = 18 amino acids) and found that while the Rac1 sensor could be 
activated to its maximum by GEFs at all linker lengths tested, GDI interactions were 
greatly impacted by linker length both in terms of activity (Figure 2.4A) and localization 
(Figure 2.4B), perhaps due to steric block within the sensor itself preventing GDI-1 
access.   
Next, we found that the choice of assay used for sensor validation influenced 
whether the sensor was determined to respond appropriately to regulators.  For example, 
when validating the Rac1 single-chain sensor with the GEF Tiam-1, we noted that in 
fluorometry assays using cell suspensions previously used to validate a number of FRET-
based GTPase biosensors (Pertz et al. 2006), Tiam-1 appeared to have no ability to 
activate the Rac1 sensor since no increase in FRET was seen (Figure 2.4C).  In contrast, 
if FRET responses to Tiam-1 expression were tested in adherent cells, robust activation 
of the sensor was observed (Figure 2.4C), suggesting adherence of cells may be required 
to properly localize cellular signaling components for the activation of these sensors.  As 
a consequence, construction and validation of single-chain FRET sensors can be a 
difficult process, requiring testing and consideration of a great number of factors.   
We have also explored the development and improvement of intermolecular 
(dual-chain) FRET sensor designs.  Typically in these probe formats, the target is tagged 
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with a donor fluorophore, and the affinity reagent is expressed separately, tagged with an 
acceptor fluorophore.  In the process of testing these probes, it was determined that 
fluorophore orientation was critically important for these probes (Figure 2.4D).  In testing 
a binding domain of constant length, placement of the fluorophore at one terminus versus 
the other yielded significant differences in FRET.  Similar to the single-chain sensors, the 
length of linkers also influenced the resultant FRET signal.  Using binding domains 
increasing in length by 5 amino acids, which shifts the acceptor fluorophore in space 
roughly 5 amino acids in length, we showed that there was an optimal placement of the 
acceptor fluorophore in space (Figure 2.4E).  Linkers that were too short or too long 
resulted in suboptimal FRET.  Lastly, based on recent work showing that the presence of 
two acceptor fluorophores in a FRET system results in greater than additive FRET 
transfer (Koushik et al. 2009), we tested the use of tandem acceptor constructs and their 
ability to increase FRET.  Independent of the increase in molecular brightness, we 
showed that use of tandem YPet as an acceptor for CFP nearly doubles the apparent 
FRET signal (Figure 2.4F), enhancing the dynamic range of these dual-chain FRET 
probes.   
 
Generation of Orthogonal Red-Shifted FRET Probes for Use with CFP/YFP FRET 
Probes: 
 
Particularly intriguing questions in the field of GTPase signaling involve the 
study of cross-talk between different GTPases.  Currently, no genetically encodable 
FRET probe pairs for the GTPases are available to simultaneously study two GTPases in 
the same cell at the same time.  Recent studies have either used dye-labeled probes or 
have used computational methodologies reliant upon a common fiduciary marker to 
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cross-correlate different GTPase activities in cells (Tsukada et al. 2008; Machacek et al. 
2009).  To overcome this issue, we have generated single-chain and dual-chain FRET 
probes that rely upon FRET between orange and red fluorescent proteins and that are 
spectrally distinct from currently available CFP/YFP probes.  As shown in Figure 2.5A, 
these probes are constructed using similar designs as the new probes we generated in 
Figures 2.1A and 2.1B, but using mKO and mCherry (or tandem mCherry in Figure 
2.5A) as donor and acceptor, respectively.  In constructing these probes, we noted that 
mKO possessed a different C-terminal sequence than most of the EGFP variants.  In an 
attempt to restore roughly the same orientation as that found in the original CFP/YFP 
sensors, we modified the C-terminus to contain the amino acid sequence ITLGMDELYK 
found at the C-terminus of the GFP variants.  By adding this sequence to the end of 
mKO, we were able to increase the resultant FRET significantly.  However, as shown in 
Figure 2.5B, and as reported by others (Ai et al. 2008), mCherry is a fairly poor acceptor 
and thus the FRET signal is reduced compared to donor signal in red-shifted single-chain 
sensors compared to CFP/YFP probes.  However, as we have shown that dual-chain 
sensors are more sensitive than single-chain sensors, we attempted to improve red-shifted 
FRET signal by generating a tandem mCherry acceptor which, as shown in Figure 2.5C, 
enhances the resultant FRET signal significantly, almost to levels seen for CFP/YFP 
variants as shown in Figure 2.5C. even after bleedthrough correction.  We also tested 
tandem acceptors in red-shifted single-chain sensors, but this appeared to decrease 
expression levels and increase the susceptibility of these probes to aggregation and 
degradation as was also the case for CFP/tdYFP single-chain variants (data not shown).  
A summary of new and updated probes is provided in Figure S2.3. 
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Generation of a Novel Expression Cassette for Dual-Chain FRET Sensors: 
Even though we have demonstrated that dual-chain sensors are very sensitive, two 
of the greatest hindrances to the use of dual-chain sensors have been 1) uneven 
expression and differential localization of the donor and acceptor components, and 2) 
difficulties in correctly determining FRET signal due to the need for bleedthrough 
correction because of point (1).  While bleedthrough correction will be required for all 
dual-chain sensors, we can attempt to alleviate some of the difficulty in point (1) by 
normalizing expression of the two sensor components in a population of cells.  The 
design of such a new Rac1 dual-chain sensor cassette is shown in Figure 2.6A.  Through 
the use of a short viral sequence, the A2 sequence (Das and Piccirilli 2005; Trichas et al. 
2008), that causes co-translational cleavage of a protein product, we have generated an 
auto-cleavable construct that expresses both components of the sensor at roughly equal 
levels from a single plasmid with no contaminating uncleaved product (Figure 2.6B).  As 
shown in Figure 2.6C, use of the wild-type A2 sequence yields expression of two 
separable bands that are reactive with anti-GFP antibody by western blot.  Replacement 
of the A2 sequence with a poly-GS linker of equivalent length, or mutation of the critical 
final two amino acid residues of the A2 sequence to alanine both result in a much larger 
band representing the uncleaved product (Figure 2.6C).  That there is no uncleaved 
sensor product in the WT A2 linker condition is critical since any uncleaved product 
would contaminate the signal from the actual sensor.  Further, in live cells, we can show 
that the autocleavable sensor normalizes the relative expression of the two components 
compared to manual selection of cells during imaging (Figure 2.6D).  We also show that 
in live cells, use of the WT A2 linker results in differential distribution of the sensor 
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components as expected (Figure 2.6E), whereas when the final two residues of the A2 
sequence are mutated to alanine as above, the two sensor components are both 
membrane-localized (Figure 2.6E).  Quantitation of these localization differences is 
demonstrated in the linescans for both the GTPase and binding domain fragments in 
Figure 2.6F.  Most importantly, Rac1 activity patterns appear identical between both the 
normal dual-chain and this autocleavable dual-chain, with prominent activity seen in the 
lamellipodium upon protrusion, indicating that this sensor behaves normally in adherent 
cells (Figure 2.6G).  Initial experiments to incorporate this construct into Drosophila 
melanogaster indicate that this autocleavage process remains intact in living organisms, 
and that the subcellular distribution of the two components is properly maintained.  
Further, generation of stable Drosophila lines incorporating this construct enables the 
uniform expression of the two components in contrast to insertion of the donor and 
acceptor independently into the genome (data not shown).  Thus, this novel expression 
cassette allows for the use of dual-chain sensors in a variety of experimental conditions 
by overcoming one of the major hurdles to their use: uneven expression of the donor and 
acceptor components of the sensor. 
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2.4  Discussion 
Development of New and Updated Rho GTPase Biosensors: 
Rho GTPases are molecular switches that serve as central integrators and 
regulators of a host of cellular functions downstream of extracellular receptors.  Given 
that these GTPases very specifically control certain cellular functions in response to very 
specific cellular cues, it is clear that significant spatial and temporal control is exerted on 
these GTPases to regulate their functions.  Understanding these controls has been largely 
inaccessible until the development of biosensors that could examine Rho GTPase activity 
in live cells (Kraynov et al. 2000b; Mochizuki et al. 2001; Yoshizaki et al. 2003; Nalbant 
et al. 2004a; Pertz et al. 2006b; Kitano et al. 2008).  However, despite the value of these 
probes, there has been an endless drive to improve these sensors (Seth et al. 2003; 
Yoshizaki et al. 2003), much as has been done for other sensors (Miyawaki et al. 1997; 
Miyawaki et al. 1999; Truong et al. 2001; Palmer et al. 2006) to obtain improvements in 
brightness, in dynamic range, and in sensitivity without perturbation of cellular signaling.  
Additionally, as our microscopes and computational abilities improve, researchers seek to 
study the relationship between two GTPases simultaneously in the same cell (Schultz et 
al. 2005; Ai et al. 2008; Piljic and Schultz 2008; Machacek et al. 2009). 
To this end, in the present study, we demonstrate the development of novel dual-
chain FRET biosensors for the GTPases Cdc42, RhoG, RhoA, and Rac1, along with a 
new single-chain sensor for Rac1 which maintains GDI regulation.  Through this 
development process, we illustrate some of the difficulties in building and testing 
biosensors, such as the choice of linker regions and proper positioning of binding 
domains and fluorophores, and the choice of assays performed for validation of the 
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sensors.  Additionally, we show that by use of a tandem acceptor cassette, tdYPet, we can 
further enhance the dynamic ranges of dual-chain sensors, based on the reports of 
anomalous surplus FRET energy transfer in the presence of multiple acceptors (Koushik 
et al. 2009).  Additionally, we report the conversion of these sensors to red-shifted 
varieties that can be used simultaneously with CFP/YFP FRET pairs.  Drawing upon our 
experience in the development of a tdYPet acceptor, we find that development of a 
tdmCherry acceptor similarly improves the dynamic range of dual-chain red-shifted 
FRET sensors. 
 
Artefacts Inherent to Biosensor Imaging: 
Many arguments have been made that favor the use of single-chain sensors for 
protein activity in live cells, particularly that single-chain sensors perturb intracellular 
signaling to a lesser degree, and that they exhibit higher amounts of FRET which are 
easier to detect in live-cell imaging.  However, little data that supports these points is 
available for the Rho GTPase sensor field from a comparative standpoint with dual-chain 
sensors (Pertz and Hahn 2004).  Because we consistently saw higher dynamic ranges for 
dual-chain sensors during probe development, we set out to compare the value of dual-
chain and single-chain sensors in live cell imaging. 
Through these comparative analyses, we find that dual-chain sensors indeed have 
larger dynamic ranges than single-chain sensors, and exhibit higher sensitivity, permitting 
lower expression levels of dual-chain probes compared to single-chain probes to observe 
the same intracellular signals.  Further, both sensors display imaging artefacts that must 
be understood when using them.  Single-chain sensors are prone to exhibit FRET where 
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none exists, or false positive signals.  Dual-chain sensors are prone to exhibit false 
negative signals, or lack of FRET where activation of GTPase does occur.  Thus, a 
careful understanding of these risks is required during their use. 
Additionally we demonstrate that both sensor designs perturb downstream 
signaling to the same degree, presumably from effects not only on interactions with 
effectors, but also due to effects on GDI-1 binding and saturation.  Lastly, we show that 
due to the design of the dual-chain probes, we can analyze FRET in low signal situations 
by the study of total FRET with certain caveats.   
Lastly, we examine a number of modifications used to enhance cellular signals 
during imaging, such as the use of different C-terminal modifications, and their effects on 
FRET interpretation.  As expected, loss of the C-terminal tail greatly disrupts patterns of 
activation seen in live cells.  Modification by constitutive membrane-tagging using the K-
Ras4b sequence is more subtle.  Grossly, FRET patterns are intact, but the probes localize 
very differently, with loss of cytosolic and endomembrane localization for the Rac1-
KRas4b sensor and placement of the sensor at locations different than where some of its 
regulators exist.  Additionally, we show that Rac1 activity seen in these locations with the 
wild-type sensor is lost by use of the K-Ras modified version.  Such modifications are 
useful in certain circumstances, but must be used with an understanding of their caveats.  
For example, for a number of GTPases it has been shown that vesicular trafficking is key 
to their regulation, and that in the case of Rac1, activation occurs on endosomes via the 
GEF Tiam-1 (Palamidessi et al. 2008; Osmani et al. 2010).  Indeed, use of a K-Ras 
modified sensor would fail to detect such activation events.  However, if utilized 
properly, these sensors can be targeted to specific subcellular regions to enhance the 
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contrast of FRET detected in those regions, such as on endomembranes or at focal 
adhesions. 
 
Overcoming Hurdles to the Use of Dual-Chain Sensors: 
As we have shown, dual-chain sensors have higher sensitivity and dynamic range 
than single-chain sensors, and can be extremely valuable for detecting small changes in 
intracellular signaling with low expression of the probe such that intracellular signaling is 
not perturbed.  However, the two biggest hurdles to their use, practically, are the need for 
bleedthrough correction, and the uneven control of expression of the two sensor 
components.  To circumvent the issues with uneven expression of the two sensor 
components, an autocleavable cassette has been developed which normalizes the 
expression of both components from a single plasmid, yielding roughly a 1:1 expression 
ratio for the two components.  Our hope is that this will enable broader use of these 
probes in cells in tissue culture, and eventually in organisms.  Achieving equal and even 
expression of two exogenously expressed proteins in living organisms is notoriously 
difficult, making the use of dual-chain sensors quite difficult.  However, with the ability 
to express a dual-chain sensor from a single plasmid gene, the use of these sensors could 
be eased significantly.  Thus, use of a more sensitive dual-chain sensor in live organisms 
could permit the study of much smaller changes in intracellular signaling. 
 
Concluding Remarks: 
 In closing, we have attempted to further the field of genetically encodable FRET 
sensors for Rho GTPases by performing a quantitative comparison of biosensor 
development and design with an eye to their use in the study of intracellular signaling.  
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Our findings indicate that, while infrequently used in the literature, dual-chain FRET 
probes for the Rho GTPases are of significant value.  Also, as is the case for any 
experimental setup, a solid understanding of the advantages and disadvantages to the use 
of both single-chain and dual-chain FRET probes is needed when selecting a probe to use 
in the study of intracellular signaling pathways.  Such an understanding is critical for the 
appropriate analysis and interpretation of FRET signals and Rho GTPase activation 
during cellular signaling. 
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2.5  Materials and Methods 
Materials and Reagents: 
Lipofectamine was purchased from Invitrogen (Carlsbad, CA), Fugene6 from Roche 
(Basel, Switzerland).  All other chemicals were from Sigma.  Anti-GFP antibody (Clone JL-
8) was from Clontech, Inc.  Anti-Cofilin, Anti-phospho-Cofilin (S3), anti-p42MAPK, and 
anti-phospho-p42/44MAPK antibodies were from Cell Signaling.  Anti-actin antibody was 
from Millipore.  Anti-mouse and anti-rabbit secondary antibodies were from Amersham/GE 
Health Sciences. 
 
Cell culture and Constructs: 
The Rac1 dual-chain FRET biosensor was reported previously (Kraynov et al. 
2000b; Machacek et al. 2009). The new dual-chain Cdc42 biosensor uses an 
intermolecular design as reported by several groups (Itoh et al. 2002; Seth et al. 2003; 
Tzima et al. 2003; Hoppe and Swanson 2004), but here is further optimized by the use of 
different fluorescent proteins and of a Cdc42-binding domain from Neuronal Wiskott 
Aldrich Syndrome Protein (N-WASP), a fragment shown to provide good selectivity for 
activated Cdc42 in previously developed biosensors with a different design(Nalbant et al. 
2004; Frantz et al. 2007; Koivusalo et al. 2010).  The new RhoA dual-chain sensor is 
based upon a previous RhoA dual-chain sensor (Machacek et al. 2009), but is modified to 
extend the Rho binding domain by 10 amino acids, and the acceptor construct was 
modified to generate a trandem YPet construct fused to the C-terminus of the Rho 
binding domain.  The red-shifted variants of these sensors were generated by replacing 
CFP or CyPet with mKO, and YFP or YPet with mCherry.  The autocleavable Rac1 
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sensor was generated by cloning the previously described Rac1 sensor into a pTriEx 
plasmid with the cleavable sequence described in (Das and Piccirilli 2005; Trichas et al. 
2008) sandwiched between the two sensor components. 
Each of the dual-chain biosensors was generated by first constructing plasmids 
encoding either Rac1, RhoA, or Cdc42 fused to the C terminus of CyPet, a CFP variant 
optimized for FRET (Nguyen and Daugherty 2005), and either the CRIB domain from 
p21-activated kinase (PBD) published previously (Machacek et al. 2009), the Cdc42-
binding CRIB domain from WASP (CBD), amino acids 230–314, or amino acids 7-99 
from Rhotekin (RBD) fused to the C terminus of YPet, a YFP variant optimized for 
FRET (Nguyen and Daugherty 2005) for PBD and CBD, or the N-terminus of YPet for 
RBD. The EGFP coding region from the EGFP-C1 vector (Clontech, Inc.) was replaced 
with a PCR product containing the CyPet or YPet coding regions flanked by an NcoI 
restriction site and a SGLRSELGS linker containing a BamHI restriction site. The PCR 
products of the Rac1, RhoA, Cdc42, PBD, and CBD coding sequences were inserted 
between the BamHI restriction site in the SGLRSELGS linker and an EcoRI restriction 
site in the downstream multiple cloning site of the vector.  The RBD-YPet construct were 
generated by inserting the PCR product for YPet via the EcoRI and XhoI restriction sites 
in the pTriEx-4 backbone.  Then, the PCR product for amino acids 7-99 of RBD were 
then cloned in via the restriction sites NcoI and BamHI in the pTriEx-4 backbone.  To 
generate the RBD-tandem-YPet construct, the PCR product for a second YPet was cloned 
between the BamHI and EcoRI sites in the pTriEx-4 backbone, flanked by a GSGS linker 
sequences on both sides.  To generate the red-shifted forms of these sensors, the same 
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constructs were used, except that mKO and mCherry replace CyPet and YPet, 
respectively.   
For the single-chain biosensor designs, the RhoA single-chain FRET biosensor is 
used as described previously (Pertz et al. 2006b; Machacek et al. 2009).  For the Rac1 
single-chain sensor, a similar GTPase-effector fusion design is used.  The YPet-PBD 
fragment was generated by PCR from the dual-chain acceptor DNA template and inserted 
into the pTriEx-4 backbone via the NcoI/HindIII restriction sites in the MCS.  This was 
followed by a 4x repeated linker based on the linker described previously for the RhoA 
single-chain sensor (Pertz et al. 2006) inserted between the restriction sites HindIII and 
NotI.  Monomeric Cerulean (A206K) was generated from template by PCR, as was wild-
type Rac1, and the two were fused via overlapping PCR with a GSG linker sequence 
between them.  This fragment was subsequently cloned into the pTriEx-4 vector via the 
NotI and XhoI restriction sites in the MCS.  To generate the red-shifted forms of these 
sensors, the same constructs are used, except that mKO and mCherry replace CFP and 
YFP, respectively.  For mKO, the C-terminus differs slightly from EGFP-based 
fluorophores and we found that this mattered in single-chain constructs, so the C-
terminus was extended to match the EGFP C-terminus by using the amino acid sequence 
ITLGMDELYK. 
To generate the K-Ras4b variants of the sensors, the Rac1, RhoG, and RhoA 
fragments were amplified by PCR from amino acids 1-176 for Rac1 and RhoG, and 1-
178 for RhoA with flanking BamHI or EcoRI and HindIII restriction sites, excluding the 
prenylation sequence and poly-basic region.  Primers were ordered that corresponded to 
the K-Ras4b poly-basic region and prenylation sequence containing flanking restriction 
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sites of HindIII and EcoRI or XhoI and were annealed.  This fragment was then ligated to 
the Rac1, RhoG, or RhoA fragments, with subsequent ligation into the sensor vector 
constructs (both single-chain and dual-chain) described above.  The C-terminal truncation 
variants were generated by amplifying Rac1, RhoG, and RhoA by PCR from amino acids 
1-176 for Rac1, and 1-178 for RhoA with flanking BamHI or EcoRI and EcoRI or XhoI 
restriction sites with subsequent ligation into the sensor vector constructs (both single-
chain and dual-chain) described above.   
To generate the autocleavable Rac1 dual-chain construct, YPet-PBD was 
amplified from template by PCR and ligated in to the pTriEx-4 vector via NcoI and NdeI 
restriction sites.  CyPet-Rac1 was amplified from template by PCR and ligated in to the 
pTriEx-4 vector via NheI and XhoI restriction sites found in the MCS.  Primers were 
generated corresponding to the 18 amino acid A2 viral sequence (Das and Piccirilli 2005; 
Trichas et al. 2008), annealed, and subsequently ligated in to the pTriEx-4 vector via 
NdeI and NheI restriction sites. 
For regulators tested with each sensor, the Vav2, Tim, Ect2, and Tiam-1 GEF 
DH/PH domains, Rho GDI-1, and p50RhoGAP were used as described previously (Pertz 
et al. 2006).   
Plasmids were transfected into Cos-7 cells or HeLa cells using Lipofectamine or 
Fugene6.  Cos-7 cells and HeLa cells were maintained in DMEM (Mediatech, Manassas, 
VA) supplemented with 10% FBS, penicillin/streptomycin, and 2 mM glutamine 
(Invitrogen, Carlsbad, CA). 
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Generation of Stable Cell Lines:  
For production of mouse embryonic fibroblasts (MEF) stably incorporating the 
biosensor DNA, we used the tet-OFF MEF/3T3 cells (Clontech.com). The biosensor 
components were cut out as cassettes from the pCyPet/pYPet or pTriEx cloning 
constructs at NcoI/EcoRI sites for CyPet-RhoA, and NcoI/XhoI sites for RBD-YPet.  
Digested fragments were treated with Klenow fragment of the DNA polymerase I in the 
presence of 33μM dNTP for 15 minutes at room temperature to perform the end filling 
reaction of the 5’-overhangs to produce blunt ends. The pBabe-sin-Puro-tet-CMV was cut 
at an HpaI site to produce blunt ends and ligated with the blunt-ended inserts. Bacterial 
colonies were screened using polymerase chain reaction (PCR) for the proper directional 
incorporation of the biosensor DNA.  For detection of RhoA activity using the previously 
described RhoA single-chain sensor, MEF/3T3 cells were stably transduced using a 
retroviral system with the RhoA biosensor under the control of a tet-inducible promoter 
and FAC sorted for low expressors, as described in (Pertz et al. 2006) . Cells were kept 
under 1 μg/ml Doxycycline in the culture medium to repress biosensor expression. Forty 
eight hours before experiments Doxycycline was removed from the medium. These cells 
did not exhibit migration behaviors different from non-transfected MEF/3T3 cells. 
 
Fluorometry Assays for Validation of RhoA, Rac1, and Cdc42 Biosensors: 
  To validate the various sensors constructed in this assay, 293 cells were 
transfected with low levels of each of the sensors and co-transfected with a panel of 
regulators to assess the ability of each sensor to respond appropriately to endogenous 
regulators.  In brief, 293 cells were plated on poly-L-lysine coated wells of a 6-well dish 
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36 hours before the assay was run.  The following morning, 24 hours before the assay 
was run, the 293 cells were transfected with Lipofectamine according to the 
manufacturer’s instructions.  A total of 650 ng of DNA was transfected per well, 
consisting of 100 ng of sensor donor, 100 ng of sensor acceptor, or in the case of single-
chain sensors, 100 ng of sensor, and the balance consisted of various regulators or blank 
vector DNA.  Each experimental condition was set up in triplicate.  The following 
morning, the cells were checked for appropriate brightness, washed once with DPBS, 
gently trypsinized using 400 L trypsin which was removed after 15 seconds, and then 
resuspended in 500 L cold DPBS.  400 L of cell suspension was then loaded into a 
spectrophotometer cuvette.  Using a SPEX Fluorolog sensitive spectrophotometer to 
assess CFP/YFP FRET, the cell suspension was excited at 433 nm, the excitation of 
CyPet, and the emission was monitored from 450 nm to 600 nm at 3 nm intervals to 
monitor the emission spectrum of YPet.  For each test, a sample transfected with YPet 
only and monitored for emission with CFP excitation as above to account for differences 
in brightness and thus bleedthrough by direct excitation of the acceptor fluorophore.  This 
reading was subtracted from each measurement.  For the calculation of FRET ratio, after 
bleedthrough correction, each sample was normalized such that the peak of CFP emission 
(475 nm) was set as an intensity value of 1.0.  The FRET emission peak (525 nm) was 
then divided by the CFP peak for each sample, and the samples were averaged for each 
condition.  For mKO/mCherry FRET, the cell suspension was excited at 540 nm, near the 
excitation of mKO, and the emission was monitored from 550 nm to 700 nm at 3 nm 
intervals to monitor the emission spectrum of mCherry.  For each test, a sample 
transfected with mCherry only was monitored for emission upon mKO excitation as 
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above to account for differences in brightness and thus bleedthrough by direct excitation 
of the acceptor fluorophore.  This reading was also subtracted from each measurement.  
For the red-shifted FRET ratio, each sample was normalized such that the peak of mKO 
emission (560 nm) was set as an intensity value of 1.0.  The FRET emission peak (610 
nm) was then divided by the mKO peak for each sample, and the samples were averaged 
for each condition.  FRET ratios could then be compared between each condition.  
Statistical significance between conditions was assessed by two-tailed student’s t-test 
assuming unequal variance. 
 
Rac1, RhoG, and RhoA Adherent Cell Activity Assays: 
Cos-7 cells were transfected with Rac1, RhoG, and RhoA dual-chain and single-
chain sensors, separately, with the regulators also used for the fluorometry assays 
described above using FuGene6.  The following day, the cells were transferred to 
fibronectin-coated glass coverslips, and conditioned in Ham’s F-12K without phenol red 
(Invitrogen, Carlsbad, CA) with 2% FBS and 15 mM HEPES (Mediatech, Manassas, 
VA).  The cells were then placed in a closed chamber (Warner Instruments, Hamden, CT) 
and immediately transferred to a heated stage for imaging.  Cells were chosen for 
medium expression levels so that cellular morphology did not change noticeably.  FRET 
imaging was performed as described below in “Imaging the Activity of One Rho GTPase 
per Cell.” 
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Whole-Cell FRET Analysis: 
To calculate whole-cell average FRET ratio, photobleach-corrected FRET ratio 
(FRET/CFP) time-lapse image stacks acquired and processed as described above were 
loaded into Metamorph, thresholded to generate masks for each cell, and regions were 
drawn around each cell using the mask.  From these regions, a number of parameters, 
including average pixel intensity, could be measured and recorded.  Average FRET ratio 
was calculated for three separate time points, averaged, and recorded for each cell.   
 
Imaging the Activity of One Rho GTPase per Cell: 
Activation levels of Rac1, RhoA, and Cdc42 assessed by dual-chain sensors were 
measured in living cells by monitoring the ratio of FRET (CyPet to Ypet transfer) to 
CyPet emission, and corrected for bleed-through from CyPet and YPet species as detailed 
below. Time-lapse sequences were acquired on an Olympus IX81 inverted 
epifluorescence microscope, using an Olympus 40x UPlan FLN1.3 N/A DIC lens, 
CoolsnapES2 CCD camera (Roper Scientific) and Metamorph software (Universal 
Imaging).  For emission ratio imaging, the following filter sets were used (Chroma): 
CFP: D436/20, D470/40; FRET: D436/20, HQ535/30; YFP: HQ500/20, HQ535/30.  A 
dichroic mirror (“Quad-Custom” Lot# 511112038) was custom manufactured by Chroma 
Technology Corporation for compatibility with all of these filter sets. Cells were 
illuminated with a 100 W Hg arc lamp through an ND 1.0 neutral density filter. At each 
time point, three images were recorded with the following exposure times: CFP (1.2 s), 
FRET (excitation of donor, observation of acceptor emission) (1.2 s), YPet (0.4 s) at 
binning 2x2. We routinely changed the order of acquisition for all experiments, varying 
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between the order CyPet, FRET, YPet, or FRET, CyPet, YPet. The image sets were taken 
at 10s intervals. Ratio calculations to generate activity images were performed following 
bleed-through correction methods described previously. Briefly, Metamorph software 
was used for image alignment and ratiometric calculation of activation signals. All 
images were shading-corrected and background-subtracted. Binary masks with values 
equal to 1 inside the cell and 0 elsewhere were extracted by applying a threshold to the 
CyPet image, because it had the largest signal-to-noise ratio. Control cells expressing 
either CyPet alone or YPet alone were used to obtain bleed-through coefficients, α and β 
in the following equation: 
 (Eq. 1) 
where R is the Ratio, FRET  is the total FRET intensity as measured, α is the bleed-
through of CyPet into the FRET  signal, β is the bleed-through of YPet into the FRET 
signal and CyPet and YPet are the total CyPet and YPet intensities as measured through 
the CyPet and YPet filter sets, respectively. The bleed-through parameter α is given by 
the slope of the linear relationship between FRET and CyPet intensities upon CyPet 
excitation of cells expressing only CyPet. Similarly, the bleed-through parameter β is 
given by the slope of the linear relationship between FRET and mYPet intensities of cells 
expressing only the mYPet. The α parameter was found to be 0.4~0.5 and the β parameter 
was ~0.2. Both were dependent on the particular optical configuration of the microscope 
used. With these parameters, the ratio of corrected FRET over CyPet was calculated and 
used as a measure of Rac1 and RhoG activation. In time-lapse experiments, CyPet and 
YPet typically bleach at different rates. Therefore, the ratio was corrected for 
photobleaching as described in (Nalbant et al. 2004; Hodgson et al. 2006).   
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For Rac1 and RhoA activites assessed by single-chain sensors, since both donor 
and acceptor fluorophores are present on the same molecule, no bleedthrough correction 
was required.  At each time point for RhoA, two images were recorded with the 
following exposure times: CFP (1.2 s) and FRET (0.6 s) using illumination from a 100 W 
Hg arc lamp through an ND 1.0 neutral density filter.  The FRET ratio was calculated as 
the ratio of FRET/CFP after image processing as described above. 
For visual representations of ratio images, a linear pseudocolor lookup table was 
applied to all ratio images and the ratio values were normalized to the lower scale value, 
which was chosen to exclude the bottom 5% of the total histogram distribution, avoiding 
spurious low intensity pixels. In each experiment, all images were carefully inspected to 
verify that all portions used to create the ratio image had a sufficiently high signal/noise 
ratio. We targeted at least 300 gray level values (12 bit dynamic range) above 
background in the lowest intensity regions within the cell (S/N > 3). This was especially 
important in thin parts of the cell where fluorescence was low and where beads typically 
adhered. Furthermore, we routinely reversed the order of image acquisition to confirm 
that the effects of motion artifacts associated with sequential image acquisition were not 
significant. We have used this approach previously to show that the order of data 
acquisition did not affect the measured ratio (Nalbant et al. 2004; Pertz et al. 2006).  
 
Confocal Imaging: 
To obtain images of the distributions of wild-type Rac1 and K-Ras-4b-modified 
Rac1, live cell imaging was performed on an Olympus Fluoview FV1000MPE 
Multiphoton laser scanning confocal microscope outfitted with a zero-drift compensation 
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(ZDC) device for active focal plane maintenance.  The cells were kept in Ham’s F12K 
medium supplemented with 10% FBS and 15 mM HEPEs buffer (to create CO2-
independent medium at 37° C by means of a Prior on-stage incubation chamber.  
Automated image acquisition was performed using Olympus Fluoview software.  Z-
stacks were acquired for single cells at sufficient intervals to satisfy Nyquist sampling 
requirements.  
 
Biochemical Measurement of Biosensor Perturbation of Downstream Signaling: 
To measure cofilin phosphorylation as a readout of downstream signaling 
perturbation due to expression of low or high levels of dual-chain and single-chain 
sensors, we performed western blotting. Briefly, HeLa cells were starved for 6 hours in 
DMEM supplemented with glutamine (Gibco), and then one set of each treatment 
condition was stimulated using 20% serum in DMEM for 20 minutes at 37C.  Cells were 
then washed twice with Dulbecco’s phosphate buffered saline (Mediatech) and then lysed 
in lysis buffer (50 mM Tris, pH 7.4, 10 mM MgCl2, 150 mM NaCl, 1% Triton X-100, 1 
mM PMSF, and 10 μg/ml each of aprotinin and leupeptin). Lysates were cleared by 
centrifugation at 14,000 g for 5 min.  Lysates were then immunoblotted for total cofilin, 
S3-phospho-cofilin, p42MAPK, phospho-p42/44MAPK, biosensor expression (GFP), 
and actin. 
 102
2.6  Acknowledgments 
We thank R. Tsien (University of California San Diego) for the generous gift of 
the mCherry expression plasmid.  This project was supported by grants from the NIGMS 
to K.M.H. (GM057464).  C.W. is supported by fellowships from the NIH (T32 
GM008719, and F30 F30HL094020-02).  We particularly thank Evan Trudeau and Marie 
Rougie for their assistance in cloning and imaging experiments, respectively. 
 103
2.7  Figures and Legends 
Figure 2.1:  Comparison of FRET Signal Measurement in Intramolecular and 
Intermolecular GTPase Activity FRET Sensors. 
 
(A) Single-chain probe design: a schematic representation of the intramolecular FRET 
activity biosensor. GTP: guanosine triphosphate, GDP: guanosine diphosphate, CFP: 
cyan fluorescent protein, YFP: yellow fluorescent protein.  
(B) Dual-chain probe design: a schematic representation of the intermolecular FRET 
activity biosensor. GTP: guanosine triphosphate, GDP: guanosine diphosphate, CFP: 
cyan fluorescent protein, YFP: yellow fluorescent protein.  
(C and D) Representative images and quantitation of effects of binding domain truncation 
on the FRET/CFP emission ratio (RhoA activity) in both single-chain and dual-chain 
sensors. Red outline in panel at far right indicates location of cell.  Heat map indicating 
dynamic range scaling is shown for each cell. Data are represented as means  95% 
confidence intervals at α = 0.05.  
(E) Representative images of the FRET ratio, total bleedthrough corrected FRET signal, 
and CyPet-Rac1 or CyPet-Rac1/K-Ras4b modified as acquired by widefield 
epifluorescence or total internal reflection microscopy.  Red lines indicate linescans used 
for analysis in panel (F).   
(F) Representative linescans of the normalized intensities for FRET ratio, total 
bleedthrough corrected FRET signal, and CyPet-Rac1 or CyPet-Rac1 (K-Ras4b 
modified) as acquired by widefield epifluorescence or total internal reflection 
microscopy.   
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Figure 2.2:  Comparison of Sensitivity of Intramolecular and Intermolecular 
GTPase Activity FRET Sensors. 
 
(A) Quantitation of raw FRET emission intensity in dual-chain versus single-chain RhoA 
sensors as assessed in adherent mouse embryonic fibroblasts at equivalent expression 
levels.  
(B) Quantitation of detection of a 20% increase in RhoA FRET signal at the leading edge 
of protrusions compared to cell center in migratory mouse embryonic fibroblasts 
expressing varying concentrations (as assessed by CFP Intensity) of a dual-chain or 
single-chain RhoA sensor. Black data points indicate presence of a 20% increase, red 
data points indicate absence of a 20% increase. Solid red lines indicate means of CFP 
intensity where there was absence of a 20% increase, with dashed red lines indicating 
confidence intervals at α = 0.05.  
(C) Quantitation of FRET efficiency as determined by fluorescence lifetime microscopy 
(FLIM) in Cos-7 cells expressing either a dual-chain Rac1 sensor or a single-chain RhoA 
sensor in either non-stimulated (“Free”) or stimulated (“Bound”) states. Data are 
represented as means. 
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Figure 2.3:  Comparison of C-terminal Modifications in GTPase Activity FRET 
Sensors. 
 
(A) Alignment of C-termini of Rac1 components used to generate wild-type, no-tail, and 
K-Ras-modified dual chain probes.  K-Ras sequence appended to Rac1 is highlighted in 
red. 
(B) Representative images of effects of C-terminal tail modification in Rac1 dual-chain 
sensors on FRET/CFP emission ratio (Rac1 activity, left panel) and localization (right 
panel). Heat map indicating dynamic range scaling is shown for each cell.  
(C) Representative images of effects of C-terminal tail modification of a Rac1 dual-chain 
sensor on localization to membranes (a), with quantitation of relative intensity of internal 
membranes and cytosol (cell center) versus the plasma membrane (b). Data are 
represented as means  95% confidence intervals at α = 0.05. 
(D) Effects of C-terminal tail modification of a Rac1 dual-chain sensor on normalized 
FRET/CFP emission ratios representing Rac1 activity. Biosensor responses were assessed 
with wild type and K-Ras modified dual-chain Rac1 biosensors in 293 cell suspension 
assays in the presence of the GEF Vav2, control DNA, or RhoGDI-1. Data are 
represented as means  95% confidence intervals at α = 0.05. 
(E)  Representative images of effects of C-terminal tail modification of a RhoA dual-
chain sensor on localization to membranes and the golgi (indicated by the red arrow in 
the wild-type condition). 
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Figure 2.4:  Rational Development and Improvement of Intramolecular and 
Intermolecular GTPase Activity FRET Sensors. 
 
(A) Effects of linker length on normalized FRET/CFP emission ratios representing Rac1 
activity. Biosensor responses were assessed with a wild type single-chain Rac1 biosensor 
in 293 cell suspension assays. Biosensor response was assessed in the presence or 
absence of the GEF Vav2 or RhoGDI-1. Data are represented as means  95% 
confidence intervals at α = 0.05.  
(B) Representative images of effects of linker length on Rac1 single-chain sensor 
localization. Left panel illustrates continued membrane localization in the presence of 
GDI with a 1L linker, but increasing to a 4L linker causes all Rac1 to be cytosolic in the 
presence of GDI (middle panel). Right panel illustrates membrane localization of sensor 
in the presence of the GEF Vav2.  
(C) Effects of assay type on normalized FRET/CFP emission ratios representing Rac1 
activity. Biosensor responses were assessed with a wild type single-chain Rac1 biosensor 
in 293 cell suspension assays and in adherent Cos-7 cells in the presence or absence of 
constitutively active Tiam-1. Data are represented as means  95% confidence intervals 
at α = 0.05.  
(D) Effects of fluorophore positioning on normalized FRET/CFP emission ratios 
representing RhoA activity. Biosensor responses were assessed with a wild type dual-
chain RhoA biosensor in 293 cell suspension assays in the presence of a RhoA binding 
domain from Rhotekin tagged at either the N- or C-terminus with YPet. Data are 
represented as means  95% confidence intervals at α = 0.05.  
(E) Effects of binding domain length on normalized FRET/CFP emission ratios 
representing RhoA activity. Biosensor responses were assessed with a wild type dual-
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chain RhoA biosensor in 293 cell suspension assays in the presence of RhoA binding 
domains from Rhotekin of increasing length tagged at the C-terminus with YPet. Data are 
represented as means  95% confidence intervals at α = 0.05.  
(F) Effects of increasing the number of acceptor fluorophores on normalized FRET/CFP 
emission ratios representing RhoA activity. Biosensor responses were assessed with a 
wild type dual-chain RhoA biosensor in 293 cell suspension assays in the presence of 
RhoA binding domains from Rhotekin tagged at the C-terminus with either one or two 
YPet acceptors. Data are represented as means  95% confidence intervals at α = 0.05. 
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Figure 2.5:  Generation of Orthogonal Red-Shifted FRET Probes for use with 
CFP/YFP FRET Probes. 
 
(A) Dual-chain probe design: a schematic representation of the intermolecular FRET 
activity biosensor. GTP: guanosine triphosphate, GDP: guanosine diphosphate, mKO: 
monomeric Kusabira orange fluorescent protein, mCherry: red fluorescent protein.  
(B) Emission intensity scans from 293 cell suspension assays with cells expressing a 
CFP/YFP RhoA single-chain sensor or a red-shifted single-chain RhoA sensor in the 
presence of either the catalytic DH/PH domain of the GEF Tim (active) or RhoGDI-1 
(inactive). Emission intensities are normalized to the CFP or mKO peak at a value of 1.0 
for comparison. FRET quantity is indicated by the second, right-most peak in each scan 
(~525 nm for CFP/YFP and ~ 610 nm for mKO/mCherry). Data are represented as an 
average of three experiments.  
(C) Emission intensity scans from 293 cell suspension assays with cells expressing either 
a CFP/YFP dual-chain Rac1 sensor or a red-shifted tandem-mCherry acceptor dual-chain 
Rac1 sensor in the presence of either the catalytic DH/PH domain of the GEF Vav2 
(active) or RhoGDI-1 (inactive). Emission intensities are normalized to the CFP or mKO 
peaks at a value of 1.0 for comparison. FRET quantity is indicated by the second, right-
most peak in each scan at ~ 525 for CFP/YFP and ~610 nm for mKO/mCherry). Data are 
represented as an average of three separate experiments.  
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Figure 2.6:  Generation of a Novel Expression Cassette for Dual-Chain FRET 
Sensors. 
 
(A) Dual-chain probe design: a schematic representation of the intermolecular FRET 
Rac1 activity biosensor. GTP: guanosine triphosphate, GDP: guanosine diphosphate, 
CyPet: cyan fluorescent protein, YPet: yellow fluorescent protein.  
(B) Dual-chain autocleavable probe design: a schematic representation of the 
intermolecular FRET Rac1 autocleavable activity biosensor. GTP: guanosine 
triphosphate, GDP: guanosine diphosphate, CyPet: cyan fluorescent protein, YPet: yellow 
fluorescent protein, A2 sequence: autocleavable motif.  
(C) Representative western blot illustrating appropriate cleavage and expression of dual-
chain autocleavable Rac1 activity biosensor. Wild-type or mutated versions of the A2 
sequence lacking autocleavable function are shown demonstrating that lack of a 
functional A2 sequence leads to expression of a single higher molecular weight band 
corresponding to uncleaved product.  
(D) Quantitation of CFP:YFP expression level ratio in adherent Cos-7 cells expressing 
the autocleavable Rac1 dual-chain sensor or selected manually for imaging from a 
population of Cos-7 cells transfected with both components of the dual-chain sensor. 
Solid black lines represent means, and dashed black lines indicate 95% confidence 
intervals at α = 0.05.  
(E) Representative pseudocolored images of differential localization of the CFP and YFP 
components (CyPet-Rac1, YPet-PBD) of the Rac1 dual-chain autocleavable sensor 
(mutant, left panel and wild-type, right panel) demonstrating differential localization.  
(F) Representative linescans across the cell body demonstrating the localization of the 
CFP and YFP components (CyPet-Rac1, Ypet-PBD) of the Rac1 dual-chain 
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autocleavable sensor taken from the images in panel (E) with either the wild-type P2A 
sequence, or the AA mutant. 
(G) Representative images of FRET/CFP emission ratio from wild-type and 
autocleavable dual-chain Rac1 activity sensors. Images are scaled so that regions of 
intense GTPase activity are shown in white. Heat map indicating dynamic range scaling 
is shown for each cell. 
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Supplemental Figure 2.1, Related to Figure 2.1: Comparison of FRET Signal and 
Measurement in Intramolecular and Intermolecular Rho GTPase Activity Sensors. 
 
(A) Response of RhoA.SC RBD truncation mutant sensor to regulation by GEFs, GAPs, 
and GDI-1 as assessed by changes in normalized FRET/CFP emission ratios representing 
RhoA activity. Biosensor responses were assessed with an RBD-truncated and wild-type 
single-chain RhoA biosensor in 293 cell suspension assays in the presence or absence of 
regulators of RhoA. Data are represented as means  95% confidence intervals at α = 
0.05.  Asterisks indicate p < 0.05 compared to wild-type (RhoA.SC RBD truncation) or 
GEF (Wild-type RhoA.SC). 
(B)  Representative images of RhoA activity in mouse embryonic fibroblasts and HeLa 
cells acquired using RhoA.SC and RhoA.DC sensors illustrating differences in resultant 
FRET signal from both probes in different cell lines. 
(C)  Representative images of Cdc42 activity (left panel) and Cdc42 protein localization 
(right panel) using a constitutively active Cdc42 (Q61L) illustrating areas of non-uniform 
FRET activity (black arrows) in the cytoplasm. 
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Supplemental Figure 2.2, Related to Figure 2.2: Analysis of Perturbation of 
Downstream Signaling by Overexpression of Intramolecular and Intermolecular 
Rho GTPase FRET Biosensors.  
 
Representative western blot illustrating the effects of overexpression of Rac1 and RhoA dual-
chain and single-chain sensors on cofilin phosphorylation in the presence or absence of 
serum stimulation after 20 minutes. Top-most cofilin and phospho-cofilin bands correspond 
to experiments performed with the Rac1 dual-chain and single-chain sensors. Lower cofilin 
and phospho-cofilin bands correspond to experiments performed with the RhoA dual-chain 
and single-chain sensors. Phospho-MAPK and total MAPK levels are given to show that 
serum stimulation was effective. Short and long exposures for GFP indicate the expression of 
RhoA dual-chain and single-chain sensors at low and high levels. Actin expression levels are 
given as a loading control. 
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Supplemental Figure 2.3, Related to Figure 2.4: Validation of Updated or Newly 
Generated GTPase FRET Probes. 
 
Validation of various dual-chain and single-chain GTPase sensors, as indicated, by 
assessing normalized FRET/CFP emission ratios representing activity in the presence or 
absence of regulatory molecules, as indicated.  Biosensor responses were assessed in 293 
cell suspension assays in the presence of GEFs, GAPs, and GDIs, as indicated.  Data are 
represented as means. 
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Supplemental Figure 2.3 
 
  
CHAPTER THREE:  RHOA, RAC1, AND CDC42 GTPASE DYNAMICS AT THE 
CELLULAR LEADING EDGE 
 
3.1  Abstract 
Rho family GTPases work together to regulate cytoskeleton dynamics during cell 
migration (Ridley et al. 2003; Burridge and Wennerberg 2004; Jaffe and Hall 2005). 
Although much has been learned from biochemical and imaging studies regarding the 
morphogenic pathways they control, the rapidity and tight localization required for 
motility signaling has precluded a clear understanding of their interactions.  Recent 
biosensor analyses have reported that all three proteins are activated in cell protrusions 
(Kraynov et al. 2000; Nalbant et al. 2004; Kurokawa and Matsuda 2005; Pertz et al. 
2006). Biochemical data suggests that Cdc42 can activate Rac1 (Nobes and Hall 1995),  
and that Rac1 and RhoA are mutually inhibitory  (Rottner et al. 1999; Arthur and 
Burridge 2001; Nimnual et al. 2003; Ohta et al. 2006).  In addition, a variety of signaling 
inputs regulate these individual GTPases.  These synergistic and antagonistic relations 
may play important roles in the regulation of cell protrusion events. Testing this 
hypothesis requires measurement of the activation and deactivation kinetics of the three 
Rho GTPases at single microns and seconds resolution, the typical dimensions of 
protrusion events in motile cells.  
Our analyses show that RhoA is activated at the cell edge synchronous with edge 
advancement, whereas Cdc42 and Rac1 are activated 2m behind the cell edge with a 
delay of 40 s relative to initiation of protrusion. Thus, Rac1 and RhoA operate at the 
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leading edge antagonistically through spatial separation and precise relative timing. 
RhoA plays a role in the initial events of protrusion, while Rac1 and Cdc42 signals 
activate pathways implicated in reinforcement and stabilization of newly expanded 
protrusions.  
 To further advance our understanding of the GTPases and their functions at the 
cell edge, we have studied two regulators of the GTPases, a GEF for RhoA, TEM4, and a 
GAP for Cdc42, MILO, and their effects on GTPase behaviors at the cell edge.   
First, I and my collaborator examined focal adhesion disassembly which is 
required for optimal cell migration.  From imaging studies a model has emerged where 
microtubules target focal adhesion (FAs) and undergo depolymerization to deliver a 
factor that promotes FA disassembly.  The molecular mechanism of FA disassembly is 
unknown but entails the suppression of RhoA and actomyosin contractility.  Here, it is 
shown that the Rho-specific exchange factor TEM4 restricts activation of RhoA at the 
leading edge and thus potentially suppress actomyosin contractility. 
 Second, another collaborator has identified a GTPase activating protein (GAP) for 
Cdc42 that binds specifically to mDia2 at the leading edge of cells and is involved in the 
induction of filopodia.  Here, it is demonstrated that a tip complex that contains active 
Cdc42 exists during the initiation, but not retraction, of filopodia.  Further, the GAP 
regulates Cdc42 activity at a whole-cell level and in these tip complexes during the 
formation of filopodia, The mechanism by which this GAP controls Cdc42 activity and 
thus filopodia formation is via its phosphorylation by a kinase, specifically Src kinase.  
This regulatory mechanism inactivates the GAP to permit increased Cdc42 activation and 
filopodia formation. 
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3.2  Introduction 
 During cell migration, cells respond to environmental cues with a variety of 
morphological changes, including leading edge, or lamellipodial, extension, and 
retraction of the rear of the cell.  To coordinate these behaviors in time and space, many 
signaling pathways are engaged, principal among them the Rho GTPases, which regulate 
the actin cytoskeleton, vesicular trafficking, and cellular polarity, among other functions 
(Burridge and Wennerberg 2004; Jaffe and Hall 2005; Ridley 2006).  Biochemical 
assays, loss-of-function assays, and gain-of-function assays have all contributed to our 
understanding of the functions of these Rho GTPases, particularly the major family 
members RhoA, Rac1, and Cdc42.  Each of these GTPases interacts with unique 
downstream effectors to alter cellular behaviors (Jaffe and Hall 2005), but how they are 
coordinated in both space and time to yield productive cellular movement has remained 
difficult to assess, except at a gross biochemical level.  This difficulty arises in part 
because these GTPases must become active to initiate downstream signaling, and perhaps 
only 5% of any GTPase is active at any time within the cell.  Further, the subcellular 
location of the GTPase alone does not reflect the location of the activity (Kraynov et al. 
2000; Pertz et al. 2006).  Since it is known that the location of the active form of these 
GTPases is critical for the resultant cellular behavior, it is important to correlate GTPase 
activation levels with cellular behaviors.   
However, high-resolution measurements of multiple signaling activities 
simultaneously have been impaired by the spectral constraints of currently available 
biosensors, limiting imaging to one sensor per experiment.  Through collaboration with 
the Danuser laboratory at Harvard, we developed two new approaches that allowed us to 
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resolve the coordination of the three Rho GTPases, RhoA, Rac1, and Cdc42, with 
submicron and seconds resolution. First, our collaborators developed a “computational 
multiplexing” technique, where the activities of individual Rho GTPases, determined in 
separate experiments, are related locally to cell morphological activities as a common 
reference. Using this methodology, we were able to show that despite the complexity and 
heterogeneity of protrusion behavior from cell to cell, the relationships between the 
GTPases were remarkably consistent and could be inferred indirectly by correlation 
analysis of multiple separate imaging experiments.  
Our analyses show that RhoA is activated at the cell edge synchronous with edge 
advancement, whereas Cdc42 and Rac1 are activated 2m behind the cell edge with a 
delay of 40 s relative to initiation of protrusion. Thus, Rac1 and RhoA operate at the 
leading edge antagonistically through spatial separation and precise relative timing. 
RhoA plays a role in the initial events of protrusion, while Rac1 and Cdc42 signals 
activate pathways implicated in reinforcement and stabilization of newly expanded 
protrusions.  
 N.B.: For the journal article describing this part of the work, there were three co-
first-authors, including myself.  Thus, the data represented herein are a collaboration of 
our efforts which are not easily dissected.  Dr. Louis Hodgson and I generated the 
imaging data, while all the computational work was performed on that data by Dr. 
Matthias Machacek.  Where possible, I have used my own examples and data, but many 
of the graphics are compilations of data from our joint efforts.  I have attempted to 
indicate specifically my contributions to this work rather than claim ownership of all 
data and data analysis in the following sections.  Additionally, I generated an 
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intermolecular Cdc42 sensor for this paper, though the data I generated was not 
incorporated for technical reasons.  As a consequence, none of the Cdc42 data herein is 
my work. 
 We also focus on a little known but widely expressed protein called TEM4.  
TEM4 (tumor endothelial marker 4) was identified as a gene whose expression was 
upregulated in endothelial cells during tumor-induced angiogenesis (St Croix et al. 2000) 
and is a member of the Dbl family of Rho guanine nucleotide exchange factors 
(RhoGEFs) (Rossman et al. 2005).  Our collaborators have shown that TEM4 associates 
with microtubules and promotes microtubule-dependent FA disassembly by engaging the 
RhoC/mDia1 signaling pathway.  TEM4 also regulates protrusion dynamics of the 
leading edge and directionality of cellular migration upstream of RhoC/mDia1.  Here, we 
focus on a particular aspect of TEM4 regulation of RhoA activity.  Curiously, even 
though TEM4 has catalytic activity toward all three Rho isoforms in vitro, knockdown of 
TEM4 expression results in an elevation of RhoA activity.  To determine the nature of 
this RhoA activation, we visualized RhoA activity in live cells with or without TEM4, 
demonstrating that upon TEM4 knockdown, RhoA becomes active all along the cell 
periphery, rather than solely in protrusions, suggesting that TEM4, through its regulation 
of RhoC, suppresses RhoA activation at non-protruding regions of the cellular edge and 
contributes to microtubule mediated focal adhesion disassembly.  Thus, we expand the 
role for RhoA at the leading edge by examining one of its regulators, TEM4. 
 Lastly, we examine the role of Cdc42 in the formation of another type of leading 
edge protrusional structure: filopodia.  As has been stated above, actin-based structures 
are responsible for the majority of cytoskeletal changes observed in cells, including the 
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formation of filopodia, which contain tightly bundled parallel actin filaments (Davenport 
et al. 1993).  These structures perform many functions, including a sensing function in 
neurons (Lendvai et al. 2000; Sabatini and Svoboda 2000), but their formation is not well 
understood.  The bundled nature of the filopodia has given rise to a number of hypotheses 
about how these structures might form, and which proteins might be involved, such as the 
VASP family, formins, and N-WASP/Arp2/3, each of which is controversial (Svitkina et 
al. 2003; Lebrand et al. 2004; Steffen et al. 2006; Korobova and Svitkina 2008).  From 
these data, two models have been proposed: the convergent elongation and de novo 
nucleation models, but no good methods exist to resolve these models.  Recent work by 
Kirschner et al. (Lee et al. 2010b) used a reconstituted lipid bilayer system to propose a 
new model, the clustering-outgrowth model, wherein molecules are locally recruited to 
initiate linear outgrowth of filopodia from those sites.  Here, in a cellular system, we 
attempt to discern how Cdc42 regulates filpodia formation, and whether its functions are 
consistent with any of these three models.  Our results demonstrate that Cdc42 is 
activated locally at the sites of filopodia formation and is maintained in an active form 
during the course of filopodia elongation.  The activity of Cdc42 is regulated by a novel 
GAP whose activity is modulated by Src activity at these filopodia. 
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3.3 Results and Discussion 
Computational Multiplexing of Rho GTPase Activities at the Leading Edge: 
Our computational multiplexing approach makes the critical assumption that the 
relationship between GTPase activation and the movements of the cell edge during 
constitutive protrusion and retraction cycles is preserved within a cell, and among cells. 
Thus, the initiation of protrusion and retraction can be used as a timing reference to 
indirectly determine the activation dynamics of multiple Rho GTPases: First, for each 
GTPase, the timing of activation relative to protrusion/retraction events is determined in 
separate experiments. Then, the activation timings of different GTPases are aligned, 
using protrusion/retraction events as a common reference. GTPase activities were imaged 
in Mouse Embryo Fibroblasts (MEF) using biosensors for Rac1, Cdc42, or RhoA 
(Figures 3.1A-C). The Rac1 biosensor was improved over the previously published 
version, using a fluorescent protein rather than a covalently attached dye. Images were 
captured at 10 s intervals, sufficient to sample the protrusion-retraction cycles below 
Nyquist frequency.   
As reported previously, all GTPases, including RhoA, were maximally activated 
proximal to the leading edge. Visual inspection of time lapse sequences indicated 
substantial fluctuations in GTPase activity as the cell edges protruded and retracted. To 
quantify the magnitude and location of the fluctuations we extracted time courses of 
GTPase activity at multiple distances from the cell edge and quantified the extent of 
signal modulation (Figure 3.1D). For all three GTPases the modulation was highest at the 
cell edge, decreased monotonically within ∼2 – 4 μm, and then reached a plateau of 
baseline activity (Figures 3.1E-G). Rac1 displayed the least significant decay, mainly 
 130
because of cell-to-cell variations in the extent of the region with high activation. RhoA, 
on the other hand, decayed tightly over 2 μm. Thus, GTPase activities are regulated most 
prominently within a few micrometers from the leading edge, supporting our hypothesis 
that these fluctuations are linked to cell edge movements. 
To investigate how GTPase activation relates to edge movement spatially and 
temporally, we tracked the position of the cell edge and compared edge velocities with 
the biosensor signal in forty to eighty sampling windows moving with the leading edge 
(Figure 3.1H). The window width was set to 1.8 - 3 μm, the distance over which edge 
movements were correlated along the cell boundary, and 0.9 μm in depth, the distance 
over which signaling molecules bound to the plasma membrane would be expected to 
diffuse between consecutive movie frames.  Edge velocities were sampled every 400 nm, 
so that 5 - 7 velocity measurements would fall within a window (Figure 3.1I). Thus each 
window yielded time courses of both edge velocity and GTPase activation level (Figure 
3.1J), with independent measurements in each adjacent window. Changes in edge 
velocity appeared to parallel changes in GTPase activity (shown for the example of a 
Cdc42 data set), but with a time lag. 
We were concerned that the observed Cdc42, Rho and Rac1 activation dynamics 
might be attributed to the different biosensor designs used for each protein.   Since the 
measurements of Rho, Rac1 and Cdc42 activity were carried out using biosensors of 
different designs (Figure 3.2A-D). It was conceivable that these design differences 
contributed to the differences in Rho, Rac and Cdc42 activation kinetics that we 
observed. Most importantly, the portion of the biosensor that bound to the activated 
GTPase in each biosensor was in one case attached to the GTPase (RhoA biosensor) and 
 131
in the other two cases underwent intermolecular interaction with the GTPase (Rac1 and 
Cdc42 biosensors) (Figure 3.2: CBD for Cdc42, RBD for RhoA, and PBD for Rac1).  It 
was conceivable that endogenous GTPase ligands could compete more effectively for 
the affinity reagent binding site on the GTPase in the case of the intermolecular sensors, 
or that response to activation would be faster in the case of the intramolecular RhoA 
biosensor. Two types of controls were carried out to address these concerns.  First, for 
the intermolecular Cdc42 and Rac1 biosensors, we titrated the intracellular 
concentrations of the affinity reagent and the fluorescently labeled target to examine 
how this affected the activation-protrusion correlations that we were measuring. The 
cell’s average intensity/exposure time at fixed illumination intensity was used as a 
measure of intracellular concentration, a reasonable approximation given the linearity of 
CCD camera response. For the Rac1 biosensor, both the affinity reagent and the 
fluorescently tagged Rac were titrated. For Cdc42, only the affinity reagent was titrated, 
as this biosensor responds to endogenous Cdc42.  For the Rac1 biosensor, no systematic 
effects on the activation-protrusion correlation were observed when either the affinity 
reagent or the fluorescently labeled Rac1 were varied (Figure 3.3A-D). The affinity 
reagent:Rac1 ratio was varied over a > 3-fold  range, encompassing a > 4 fold variation 
in affinity reagent concentration and > 3-fold variation in Rac1 concentration.  For the 
Cdc42 biosensor, variation over a > 14-fold range also produced no systematic effect on 
the correlation. Most importantly, when this data, spanning a broad range of biosensor 
and target concentrations, was used to recalculate protrusion-activation correlations, 
results were in excellent agreement with those found using the optimal biosensor 
concentrations as shown in Figure 3.5. 
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Second, a new intermolecular biosensor of RhoA activation was produced for 
comparison with the intramolecular biosensor. The existing single chain RhoA biosensor 
was modified by eliminating the chain connecting the affinity reagent to RhoA, 
producing a new intermolecular biosensor (Figure 3.2D). Use of this biosensor produced 
the same correlation between protrusion and RhoA activation (Figures 3.4B-D) as did the 
single chain biosensor (Figure 3.5). With this new biosensor in hand, all three GTPases 
had now been measured using intermolecular biosensors. The new intermolecular 
biosensor showed superior dynamic range (Figure 3.4A), likely because FRET was 
completely eliminated when the biosensor was in the ‘off’ state.  These data clearly 
demonstrated that differences in biosensor design did not affect the relative timing of 
activation determined in our studies, and statistically defined the extent of potential 
variation produced by design changes.   
To investigate how GTPase activation relates to edge movement spatially and 
temporally, we tracked the position of the cell edge (Machacek and Danuser 2006),  
comparing local protrusion and retraction velocities with the  biosensor signal in the 
vicinity. Forty to sixty sampling windows were set to track leading edge velocity and the 
corresponding Rho GTPase activation within each window. The windows were set at 2-3 
m in width, the maximum distances over which edge movements were correlated along 
the cell boundary, and 0.9 m in depth, the maximum distance over which signaling 
molecules bound to the plasma membrane would be expected to diffuse between 
consecutive movie frames (Marguet et al. 2006). Edge velocities were sampled along the 
cell edge at an interval of 400 nm so that 5 to 7 velocity measurements would fall within 
each window. Thus each window yielded a time series of both edge velocity and GTPase 
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activity level, with measurements in each window independent of those measured in 
adjacent windows. Visual inspection of GTPase activation and edge velocity time series 
indicated potential similarity between local signaling and edge dynamics. Salient features 
of the edge velocity time series resembled similar features in the Cdc42 activity series, 
but with a time lag. This suggested that Cdc42 activation was delayed relative to the 
dynamics of edge movement.  
To study the potential relationships between edge morphological dynamics and 
GTPase activation dynamics more systematically the data from the individual sampling 
windows along the entire cell boundary was assembled, and pasted these into activity 
maps (Machacek and Danuser 2006). This data analysis revealed tight control and 
correlation of morphological dynamics and GTPase activation. Protrusion and retraction 
occurred in a quasi-cyclic fashion with a periodicity of ~100 s. Transitions between 
active and quiescent portions of the cell edge occurred over distances as short as the 
width of one sampling window (2 – 3 m) and were accompanied by an equally sharp 
gradient in GTPase activity. Thus, this data supports the notion of an immediate coupling 
of GTPase activation and cell morphological dynamics, in both time and space.  
To quantify the relationship between GTPase activation and morphological 
dynamics we computed Pearson’s correlation coefficient between edge velocity and the 
GTPase activity for every sampling window. We examined how the correlation 
coefficient depended on the time lag between the edge velocity and GTPase activity. This 
allowed us to assess firstly the degree of correlation between GTPase fluctuations and 
constitutive edge movements. High correlation coefficients would indicate a tight 
coupling of GTPase activation and cell protrusion/retraction events, whereas low 
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correlation coefficients would suggest a more remote relationship between the two 
processes. Secondly, if the maximum correlation coefficient was obtained with a time 
shift between dynamics and GTPase activation, we could identify the relative timing of 
the two processes. For actively protruding regions, we observed significant correlation 
coefficient maxima for all three GTPases. For either Cdc42 or Rac1, the correlation 
maxima occurred with a negative time-shift, i.e. the maximal activation of these two 
GTPases was delayed relative to the forward movement of the cell edge. In contrast, for 
RhoA the correlation maxima had no apparent time lag. RhoA activation was 
synchronous with protrusion. These results showed that GTPase activation occurs at a 
fixed time interval relative to the dynamics of the proximal leading edge segment. By 
analyzing the relationships between the biosensor signal and protrusion activities at a 
local scale it is possible to accumulate statistical evidence for the precise coupling of the 
two activities, even for random edge movements along the cell boundary. To obtain a 
robust estimate of the relationship between GTPase activation and protrusion and 
retraction events, we averaged the correlation coefficient functions over all sampling 
windows.    
We speculated that the GTPases at the leading edge might not only be organized 
by a tight temporal coordination but also spatially, within the narrow band of highly 
modulated signaling activity. A visual inspection of the biosensor images did not allow us 
to infer in what way the GTPases are spatially modulated. Therefore, we repeated the 
correlation analysis between morphodynamic activity at the cell edge and activation of 
Rac1, Cdc42, and RhoA in sampling windows of 0.9 m depth at distances D = 0, 0.6, 
1.3, 2.5, 4.4 and 6.3 m from the cell edge. Maxima of the correlation coefficients and 
 135
the corresponding time lags t were determined for each distance D. The data was fitted 
with a smoothing spline and 95%-confidence bands were estimated by bootstrap 
sampling of the residual distributions for at least n = 4 cells (Efron and Tibshirani 1994), 
dashed lines on both sides of the splines). For RhoA the correlation coefficient was 
highest at the leading edge and monotonically decreased at larger distances from the 
edge. At D > 2 m the correlation coefficient was smaller than 0.2, which is the 95% 
confidence level for correlation coefficients. Thus, beyond 2 m RhoA activity is no 
longer related to protrusion and retraction events. In contrast, Rac1 and Cdc42 activities 
were correlated with edge movements over a wider region (4.5 m and 3.2 m, 
respectively). Interestingly, the highest correlation coefficients were found at a distance 
D = 1.8 0.7 μm for Rac1 and at D =1.3 0.7 μm for Cdc42.  The spatial location and 
time lags of the maxima, and the shapes of the correlation functions suggested that both 
Rac1 and Cdc42 are activated at D = 1.8 m and that the signals then propagate at equal 
rates in anterior and posterior directions. Together this data directly confirmed that only 
the GTPase activity within a narrow band at the leading edge is functionally related to 
edge protrusion. Whereas RhoA is activated at the leading edge, Rac1 and Cdc42 are 
activated in a region 1-2 m behind the edge. 
We estimated the variability of the cross-correlation time-lag between different 
cells (Figure 3.5A). The time-lags were consistently negative for all three-GTPases, i.e. 
the peak in their activation was delayed relative to the protrusion of the cell edge (time 
lag to protrusion for Rac1: -41 [-61 -13]; Cdc42: -46 [-51 -39]; RhoA -6 [-8 -4] s; mean, 
± 95% confidence interval, as determined by bootstrapping 2000 samples from the 
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residual distribution of the spline fit). Together these results show that Rac1, Cdc42 and 
RhoA each have a different timing of activation, which is well conserved between cells.  
Additional work by a previous postdoctoral fellow in the lab confirmed the 
validity of this computational system by using two biosensors, with orthogonal 
wavelengths, to visualize the activities of two GTPases in the same cell. The 
simultaneous measurements of Cdc42 and RhoA confirmed the computational analyses 
of the timing relationships between these signaling molecules performed in separate 
experiments (Figure 3.5B). 
Together, these data indicate the following dynamics of Rho family GTPase 
activation during one random protrusion–retraction cycle (Figure 3.5C): RhoA activation 
increases and decreases in synchrony with protrusion and retraction.  RhoA activation 
that is correlated with leading edge dynamics is confined to a narrow band 2 m from the 
leading edge. In contrast, Cdc42 and Rac1 are activated with a 40 s delay relative to 
protrusion, and their activation is initiated 1.8 m from the leading edge. Rac1 and Cdc42 
are temporally as well as spatially less closely coupled to protrusion. Rac1 and Cdc42 
maintain significant levels of activity during the retraction phase, such that low level 
Rac1 activation overlaps the onset of the next protrusion cycle. Rac1 and Cdc42 signals 
propagate both in anterograde and retrograde directions via as yet unidentified 
mechanisms.  
The delayed activation of Rac1 and Cdc42 suggests that their primary role may 
not be in initiating protrusion, as is currently supposed. While the early, low activation of 
Rac1 we observe may still be sufficient for this role, the peak activities for Rac1 and 
Cdc42 are localized closer to the sites of maturing adhesions (located ~1.8 m behind the 
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protruding leading edge (Zaidel-Bar et al. 2003). Rac1 and Cdc42 appear to be affecting 
the actin network at least in part through adhesion dynamics, potentially reinforcing the 
extended lamellipodial network at sites required to balance the increasing protrusive 
forces at the leading edge. Indeed, Rac1 and Cdc42 have been associated with newly 
formed focal adhesion sites (Del Pozo et al. 2002; Nayal et al. 2006; ten Klooster et al. 
2006) after initial protrusion. In addition, our data supports the notion that Rac1 operates 
as an antagonist to RhoA (Ohta et al. 2006). RhoA activity is rapidly suppressed after 
protrusion, as Rac1 reaches its maximum activation. Since our measurements have shown 
that RhoA was activated during protrusion, and that activity was declining during 
retraction, RhoA activation at the leading edge may not be linked to contraction, the most 
commonly proposed role for RhoA in migration. Rather, the synchronized activation of 
RhoA with protrusion likely relates to a function of RhoA as an initiator of actin 
polymerization at the onset of the protrusion-retraction cycle, possibly via its ability to 
activate members of the formin family such as mDia (Narumiya et al. 1997; Yamana et 
al. 2006). In addition, the RhoA – mDia pathway is known to stabilize microtubules 
specifically in leading edge adhesions (Palazzo et al. 2001). This may contribute to the 
delayed activation of Rac1 we measured in adhesion sites; for example, via the localized 
initiation of a positive feedback between microtubule growth and Rac1 activation 
(Rodriguez et al. 2003) and/or via the engagement of integrins that regulate the coupling 
of Rac1 to its effector Pak1 (Del Pozo et al. 2000), which are also known to operate in a 
mutually positive feedback (Nayal et al. 2006).  
These results present a broadly applicable approach to in situ analysis of cellular 
pathways. “Computational multiplexing” makes use of the spontaneous activation of 
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pathways by random local changes in signaling molecules due to low level stochastic 
stimulation of receptors, variations in concentration, and other factors. Thus it is 
potentially less perturbing than methods that rely on acute cell stimulation to initiate a 
signaling cascade. Further, while the activity levels of pathway components and hence 
the pathway outputs may vary between cellular locations and between cells, the hierarchy 
and timing between pathway components are conserved. The robustness of this 
computational technique permits pathways to be reconstructed despite significant cell-to-
cell heterogeneity.  The statistical approaches described here will be useful to integrate 
the heterogeneous and complex responses made visible by simultaneous imaging of 
cellular signaling via different biosensor combinations into a consistent pathway model.  
The ultimate goal here is to harness the constitutive random fluctuations of cell 
morphological and signaling activities to establish spatial and temporal relationships 
between signals. Such constitutive fluctuations are induced via random activation of cell 
surface receptors by relatively low concentrations of growth factors and chemokines in 
the medium. The fluctuations are propagated through mechanochemical pathways to 
induce constitutive morphodynamic responses.  In contrast, many studies of GTPase 
signaling in migration have relied on acute stimulation with growth factors such as EGF.  
There are two major limitations to an acute stimulation approach, even though it might 
yield more robust signal: first, acute stimulation may drive the pathways outside the 
normal range of operation and thus potentially distort the fine balance between the three 
Rho GTPases characteristic of homeostasis and cell signaling in more physiological 
settings. For example, PDGF stimulation of MEFs is known to enhance Rac1 and 
suppress RhoA activity. However, under normal serum conditions RhoA has been shown 
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to be a key factor in modulating protrusion/retraction events (Arthur et al. 2000; Del Pozo 
et al. 2002; Pertz et al. 2006).  Second, acute stimulation generates a single broad 
activation signal. Its propagation through signaling intermediates to produce cell 
morphodynamic behaviors could be followed using correlation analyses similar to those 
presented in this paper. However, studying constitutive fluctuations is preferable because 
these contain multiple cycles of activation and deactivation. Despite the lower dynamic 
range of constitutive fluctuation signals, capturing multiple cycles results in a more 
accurate definition of timing. 
 
Role of RhoA Regulation by TEM4 at the Leading Edge: 
TEM4 depletion elevated levels of active RhoA in cells with intact microtubules 
(Figures 3.6A and 3.6B).  To further investigate the nature of this increase, we employed 
FRET analysis to visualize spatial activation of RhoA in migrating HUVECs (Figure 
3.6C).  As reported previously for other cell types, RhoA activity was high in protrusive 
areas of the leading edge, and low in the areas of local retraction (Figure 3.6D) (Pertz et 
al. 2006).  However, active RhoA in cells depleted of TEM4 revealed a different spatial 
profile.  While activation of RhoA remained high during protrusion, active RhoA was 
found along the entire leading edge, including the retracting areas, in a ribbon-like pattern 
(Figure 3.6E).  These data suggest that TEM4 extinguishes active RhoA in retracting 
areas of the leading edge thus promoting the discontinuous pattern of RhoA activation 
seen in the lamellipodium of control cells.  The inability of TEM4-depleted cells to 
down-regulate RhoA activity and the RhoA-induced contractility along the leading edge 
likely explains the dampened protrusion dynamics in these cells observed by our 
collaborators. 
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Expanding our understanding of RhoA at the leading edge, we focused on a GEF 
for RhoA, TEM4, that appears to be involved in the microtubule-dependent trafficking of 
vesicles to the leading edge and can activate RhoA.  Despite the fact that TEM4 has 
catalytic activity towards all three Rho isoforms in vitro, our collaborator’s data suggest 
that it engages RhoC specifically to promote FA disassembly and to regulate cell 
migration.  However, the link between TEM4 and RhoA is most puzzling.  Whereas the 
finding that TEM4 does not mediate microtubule polymerization-dependent activation of 
RhoA was not surprising as it is a well-described function of another Rho GEF GEF-H1 
(Chang et al. 2008), the finding that depletion of TEM4 leads to an increase in RhoA-
GTP levels in cells with intact microtubules was completely unexpected.  Furthermore, 
analysis of RhoA activation by FRET demonstrates that depletion of TEM4 does not 
cause a localized hyperactivation of RhoA at discrete protrusive areas as seen in control 
cells but rather a continuous activation of RhoA across the entire leading edge.  These 
data suggest that TEM signaling is antagonistic to RhoA activity.  This observation is of 
significance as antagonistic roles for RhoA and RhoC in cancer cell migration and 
invasion have been described (Simpson et al. 2004; Bellovin et al. 2006).  How does 
TEM4 suppress activation of RhoA?  The most likely mechanism involves Src kinase and 
a phosphorylation-mediated activation of a RhoGAP.  This mechanism is used by 
integrin β1 to restrict RhoA activity at the leading edge during cell spreading (Arthur et 
al. 2000; Arthur and Burridge 2001).  The RhoC effector mDia1 has been shown to 
recruit active Src to FAs (Yamana et al. 2006) and Src can phosphorylate and activate 
p190RhoGAP (Moran et al. 1991; Settleman et al. 1992; Dumenil et al. 2000), thus 
decreasing RhoA activity.  We would like to note that the lack of protrusive activity seen 
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upon TEM4 depletion may be due to the lack of activation of mDia and actin 
polymerization, but a competing hypothesis is that it could also be due to the local 
hyperactivation of RhoA and inability to decrease contractility in the protrusive region.   
 
Role of Cdc42 Regulation by the GAP MILO at the Leading Edge: 
Lastly, we sought to better understand the role of Cdc42 at the leading edge given 
its unique ability to both enable lamellipodial protrusion, and filopodium formation.  The 
discovery of a GTPase activating protein for Cdc42 that binds mDia2 by our collaborator 
prompted us to investigate whether Cdc42 is present and active within filopodia. 
Although several studies have implicated Cdc42 as essential for the initial formation of 
filopodia (Nobes and Hall 1995; Rohatgi et al. 1999; Anton et al. 2003; Peng et al. 2003; 
Ho et al. 2004; Lee et al. 2010b), the localization and activity of Cdc42 in the filopodia 
ments  PAGEREF _Toc299910291 \h 
challenge of signal detection in fine cellular structures.  Previously, activation of Cdc42 
in filopodia was not observed using the MeroCBD probe (Nalbant et al. 2004). We could 
not rule out the possibility that active endogenous Cdc42 in the filopodia was below the 
threshold of detection or inaccessible to the probe. To address this question we used a 
newly-designed Cdc42 biosensor. This probe is genetically-encoded and utilizes 
intermolecular FRET between ECFP and YPet fused to Cdc42 and the GTPase-binding 
domain of N-WASP, respectively (Figure 3.7A). The resulting FRET-based biosensor 
exhibits up to an 8-fold difference between the “on” and “off” states compared with a 2.8 
fold maximum for MeroCBD. Although the initial activation of mDia2 by an active GTPase through relief of 
autoinhibition is widely accepted (Wallar et al. 2006), the exact role of the GTPase in 
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maintaining the mDia2 active state is unknown. For filopodia, Cdc42 could detach from 
mDia2 after relief of inhibition at the base, leading to subsequent formation of an mDia2 
complex with profilin and IRSp53.  Alternatively, Cdc42 could remain bound to mDia2 
where it would be transported into the newly formed filopodium. 
To distinguish between these possibilities, we imaged live cells treated with TNF-
 to induce filopodia formation (Gadea et al. 2004). HeLa cells were transfected with the 
Cdc42 intermolecular FRET sensor and subsequently plated on fibronectin-coated glass 
coverslips.  The cells were then starved in serum-free DMEM for 6 hrs and transferred to 
the microscope for imaging.  Cells were typically imaged for 5 minutes prior to 
stimulation with TNFα at 10 ng/mL with subsequent imaging for 15 minutes post-
stimulation.  Filopodium induction was rapid and immediate after TNFα treatment (~ 30 
s). Consistent with previous reports, we observed activation of Cdc42 at the leading edge 
of migrating cells (Machacek et al. 2009), with an increase in signal at the base of 
filopodia (Fig 3.7B) (Nalbant et al. 2004). In addition, however, we were also able to 
detect active Cdc42 within the filopodia shaft (Figure 3.7B).  
If active Cdc42 is associated with activated mDia2, then we should expect to see 
an increase in Cdc42 activity at the filopodia tips where mDia2 is enriched (Mellor 
2009).  To determine this, we performed 2 μm wide linescans along the long axis of 
filopodia on the FRET ratio image and determined the location of local FRET maxima 
along the line.  We consistently observed a higher signal within 3 pixels of the distal tip 
of each filopodium compared to controls where local maxima were more randomly 
distributed along the length of the filopodium (Figure 3.7C). For controls, we performed 
a ratio of the acceptor divided by the donor images for the same filopodia above, which 
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accounts for non-meaningful increases in the probe signal at the tip which could be due to 
differential filopodium thicknesses, bleedthrough artefacts, possible edge artefacts, and 
non-specific binding to membranes at the filopodia tips which can be club-like in 
appearance when mDia2 is active.  By performing the same linescan analysis on this 
YFP/CFP ratio as described above for the FRET ratio image, we found that the local 
maxima were fairly evenly distributed along the length of the filopodium in these images 
(Figure 3.7D).   
If Cdc42 must remain bound to mDia2 for it to remain active, it follows that 
Cdc42 detachment from mDia2 would inactivate the complex. Since mDia2 controls 
filopodia growth, the activation of Cdc42 should be comparatively higher in extending 
filopodia and lower when filopodia are retracting or collapsing. To test this we analyzed 
filopodia where we could observe the entire extension/retraction cycle of the filopodia. 
To accomplish this, cells expressing the Cdc42 sensor were imaged at 10 s intervals and 
treated with TNFα to induce filopodium formation.  After image processing to yield the 
FRET ratio, filopodial extension/retraction cycles were simple to discern based on either 
elongation or shortening of the filopodium.  Filopodia in each state were isolated using 
the region drawing tool in Metamorph in the accompanying DIC image, and the regions 
were transferred to the ratio image to quantify filopodial activity within that region. 
Consistent with our model, Cdc42 showed an average of 25.3% higher FRET signal 
when filopodia were in the extension phase versus retraction phase (n = 18 filopodia in 
each state) (Figures 3.7E and 3.7F). 
In regions of the cell where the formation of a single filopodium was discernable, 
the activation of Cdc42 was spatially restricted on the plasma membrane to an area that 
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marked the formation of the filopodium shaft (Figure 3.7G). To determine this, at 
membrane regions where single filopodia formed, FRET ratio intensity in a region 
incorporating the base of the filopodium was measured and compared, pair-wise, with 
FRET ratio intensity in a nearby region of plasma membrane of similar size (n = 67 
filopodia). This observation is consistent with a model where initiation of a filopodium 
occurs at a discrete focus containing toca-1 and activated N-WASP prior to mDia2 
recruitment and de novo polymerization (Ho et al. 2004). 
 
Role of MILO in Regulating Cdc42 Activation Status: 
Since MILO is a GTPase-activating protein for Cdc42, we next sought to 
investigate the role of MILO on activation of Cdc42 in live cells using the biosensor 
combined with an RNAi-based loss of function approach.  HeLa cells were treated with 
control or MILO siRNA, and then transfected with the Cdc42 biosensor and imaged as 
described above.  Consistent with our collaborator’s observation that loss of MILO 
results in an increase in whole-cell activation of Cdc42 in whole-cell extracts, we see a 
15% increase in Cdc42 activation in MILO siRNA-treated cells (Figures 3.8A and 3.8B). 
Because MILO can localize to filopodia by binding to active mDia2, we next sought to 
determine the effect of MILO depletion on Cdc42 activation at the leading edge in 
migrating cells where filopodia emerge.  To determine this, at membrane regions where 
single filopodia formed in control cells, FRET ratio intensity in a region incorporating the 
base of the filopodium was measured and compared to similar regions in MILO siRNA-
treated cells (n = 30 control filopodia, n = 82 MILO KD filopodia).  The average level of 
Cdc42 signal at the base of filopodia increased by 18.6% in MILO-depleted cells (Figure 
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3.8C). Since we detect active Cdc42 within the filopodia shaft we compared wild-type 
levels to levels in cells treated with MILO siRNA. Filopodia in each state were isolated 
using the region drawing tool in Metamorph in the accompanying DIC image, and the 
regions were transferred to the FRET ratio image to quantify filopodial activity within 
that region.  We see an increase of Cdc42 activation of 22.3% in MILO-deficient cells 
(Figures 3.8E and 3.8F).   
As discussed in the introduction, there are three models for filopodial assembly: 
convergent elongation (Svitkina et al. 2003), de novo nucleation (Faix et al. 2009), and 
clustering-outgrowth (Lee et al. 2010b). Each model proposes a role for Arp2/3 
polyermization of actin filaments, and for bundling proteins, in addition to a tip complex 
in the case of the latter two models.  Our results fit well with the model proposed by (Lee 
et al. 2010b) , as we demonstrate that Cdc42 is activated early in the process of 
filopodium formation, and is maintained in an active form at the tip in a tip complex 
where the recruitment of actin polymerizers (Arp2/3, formins, VASP) and bundling 
proteins (fascin) occurs to allow for further elongation of the filopodium shaft.  
Additionally, we demonstrate that a novel mDia-associated GAP, MILO, regulates the 
the activity of Cdc42 at these filopodium initiation sites.  This GAP is regulated by its 
phosphorylation by Src, leading to its inactivation, an increase in Cdc42 activity, and 
subsequent formation of filopodia in response to TNF treatment. 
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3.4  Materials and Methods 
Expression Constructs and Reagents:  
A full length TEM4/ARHGEF17 (Genbank accession NM_014786) clone was obtained 
by subcloning the first exon (PCR amplified from human genomic DNA) encoding the 
first 456 aa into the KIAA1337 clone (Kazusa DNA Research Institute, Japan) using the 
internal SalI restriction site.  cDNAs encoding full length TEM4/ARHGEF17 were 
subsequently cloned into pEGFP (Clontech) and pcDNA3-HA vectors.  Point mutations 
(R1215A, N1252A) in the DH domain of TEM4 were introduced by site-directed 
mutagenesis.  Constructs containing wild-type MILO, in addition to the YA and YE 
mutant MILO constructs, were fluorescently tagged at the N-terminus with mCherry to 
allow for monitoring of MILO expression in single cells in parallel to the biosensor 
imaging.  To generate these constructs, genomic clone KIAA1688 was amplified by PCR 
and ligated into the original source vector.  The full-length cDNA encoding MILO was 
subsequently amplified by PCR and then ligated into a pTriEx-4 vector via the HindIII 
restriction site within the multiple cloning site.  Proper orientation was verified first by 
PCR screening with subsequent sequencing.  The mCherry fluorescent protein was 
amplified by PCR from template and ligated into these vectors via the BamHI site 
upstream of HindIII within the multiple cloning site.  Again, proper orientation was 
verified first by PCR screening with subsequent sequencing.  The Vav2 DH/PH domain 
plus C-terminal regulatory domain (amino acids 184-878) was a gift from Keith 
Burridge, as was full-length RhoGDI-1. 
Human recombinant TNFα was obtained from R&D Systems.  All growth factors 
were used at a final concentration of 20 ng/ml unless otherwise indicated. 
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Cell Culture, Transient Transfections, and siRNA Transfection: 
Human umbilical vein endothelial cells (HUVECs; Clonetics) were maintained in 
EGM-2 medium supplemented with 10% fetal bovine serum (FBS; HyClone) on gelatin-
coated dishes.  HUVECs were electroporated with expression constructs or siRNAs using 
Amaxa Nucleofection technology according to manufacturer’s instructions.  All 
experiments were carried out in cells between passages 4 and 5. 
 HeLa cells and 293T cells were obtained from the Lineberger Comprehensive 
Cancer Center tissue culture facility (UNC Chapel Hill), and tet-off mouse embryonic 
fibroblasts (MEFs) were acquired from Clontech, Inc. (Takara Biosciences), and were 
cultured in DMEM (high glucose, with glutamine, Mediatech) supplemented with 10% 
fetal bovine serum (HyClone) and antibiotics (Mediatech).   
DNA plasmids were transfected into HeLa cells using Fugene6 according to the 
manufacturer’s instructions. For transfection of siRNAs into HeLa cells Oligofectamine 
reagent (Invitrogen) was used according to the manufacturer’s instructions. Briefly, HeLa 
cells were seeded on coverslips at 175,000-250,000 cells per 35mm dish.  The next day, 
the cells were transfected with siRNA as follows: 11 μl Opti-MEM was combined with 4 
μl Oligofectamine.  In another tube, 175 μl Optimem was combined with 10 μL of siRNA 
stock to yield a final concentration of 20 nM.  After 5 minutes, the two samples were 
combined and allowed to complex for 30 minutes, whereupon the solution was added 
dropwise to the cells, growing in 1 mL Opti-MEM.  The cells were incubated with the 
siRNA for 5 hours at 37 °C, and then supplemented with 1 mL of Opti-MEM with 20% 
FBS.  Cells were used for experiments between 48 and 72 hours post-transfection.   
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Lentivirus Production and Cellular Transduction: 
293T cells (ATCC) were maintained in high glucose Dulbecco's modified Eagle's 
medium (DMEM) supplemented with 10% FBS and antibiotics.  For virus production, 
293T cells (plated at 5 x 106 cells per T75 flask) were transfected using a standard 
calcium phosphate DNA precipitation method with a target vector and the ViraPower 
lentiviral packaging system (Invitrogen).  Supernatant containing the virus was collected 
48 h post transfection and the titer was determined by infecting fresh 293T cells.  
HUVECs were transduced for 4-5 h in EGM-2 medium in the absence of serum.  The 
transduction efficiency was close to 100% as determined by observing GFP or mCherry 
fluorescence marker expression.  HUVECs were split 24 h after transduction and used for 
experiments 24-48 h later. 
 
TEM4 RNA Interference: 
Short hairpin (shRNA) oligos were cloned into pLL 5.0 GFP (Cai et al. 2007) or 
pLL 5.0 mCherry vector.  Target sequences were as following: TEM4 #3 5’-
GCACCACTCTGAAGCGAA-3’, TEM4 #5 5’-GGAAATGACATGAGGAAA-3’, The 
control shRNA (NS; GATCGACTTACGACGTTAT) has no exact match in the human, 
mouse or rat genomes (Cai et al. 2007).  TEM4 shRNA #5 consistently showed a higher 
degree of knockdown of TEM4 protein expression (about 50%) but caused cell death 
(same was observed for shRNA #4 and 6).  TEM4 shRNA #3 decreased TEM4 
expression by about 30% and did not cause cell death and therefore was used 
predominantly in this study.   
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Biosensor Designs: 
Our analyses of the relationships between Rho GTPase activation and 
protrusion/retraction relied on three previously published and extensively evaluated 
biosensors, for Rac1, Cdc42, and RhoA. The designs of these sensors are summarized in 
Figure 3.2A-D.  To facilitate the experimental procedures, the original FLAIR biosensor 
reporting Rac1 activity, which requires microinjection of cells, was modified as follows: 
The EGFP was replaced by CyPet and the Alexa-546 on the p21-binding domain of p21-
Activated Kinase 1 (PBD) was replaced by YPet. Hence, biosensor constructs could be 
retrovirally co-transduced into MEF/3T3. A stable cell line was produced following 
selection with puromycin (10 μg/ml). We were concerned that restricting experiments to 
a fixed, optimized donor/acceptor ratio could result in a particular localization pattern of 
Rac1 activation and/or a particular timing behavior with respect to the protrusion cycle. 
Therefore, unlike the single-chain RhoA biosensor discussed below, we did not FAC sort 
the cell population for specific expression profiles of acceptor and donor components, but 
maximized the concentration variability of the two components. We then performed 
control experiments, described above, to examine how the reported Rac1 activation 
depended on the concentration and ratio of donor and acceptor constructs. For detection 
of Cdc42 activity, cells were microinjected with the meroCBD biosensor. Before 
imaging, cells were allowed to recover for 30 minutes. As with the Rac1 sensor, we were 
concerned that variable amounts of microinjected meroCBD could affect the observed 
spatiotemporal relationships between Cdc42 activation and protrusion/retraction. To test 
the potential influence of biosensor concentration we examined the Cdc42 activities at 
meroCBD concentrations deliberately varied 15-fold. For detection of RhoA activity, 
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MEF/3T3 cells were stably transduced using a retroviral system with the RhoA FRET 
biosensor under the control of a tet-inducible promoter and FAC sorted for 
lowexpressors, as described in(Pertz et al. 2006). Cells were kept under 1 μg/ml 
Doxycycline in the culture medium to repress biosensor expression. Forty-eight hours 
before experiments doxycycline was removed from the medium. These cells did not 
exhibit migration behaviors different from non-transfected MEF/3T3 cells. 
 
Production of the Intermolecular FRET RhoA and Cdc42 Biosensors: 
For controls a new intermolecular FRET RhoA biosensor was produced. mCyPet 
(Nguyen and Daugherty 2005) was subcloned upstream of full length RhoA, followed by 
a SGLRSELGS linker which contained a restriction site for BamHI. Full length RhoA 
was subcloned at the BamHI site within this linker sequence and the EcoRI site within 
the multiple cloning site (MCS) of pEGFP-C1 (Clontech, Inc.) using primer pairs 5’-
GGATCCTCTATGGCTGCCATCCGGAAGAAAC-3’ and 5’-
GCGAATTCAGTTTCACAAGACAAGGCACCCAG-3’. The upstream restriction site 
for mCyPet was NcoI within the pEGFP MCS. For the binding domain portion and hence 
the FRET acceptor, the Rho binding domain (RBD; amino acids 7 to 89) from Rhotekin 
was used (Nalbant et al. 2004; Pertz et al. 2006). The binding domains were subcloned 
into the pTriEx backbone at the NcoI / BamHI sites within the MCS using the primer 
pairs 5’-GGATCCTGTCTTCTCCAGCACCTG-3’. mYPet (Nguyen and Daugherty 
2005) was subcloned following the binding domain at BamHI and XhoI sites within the 
pTriEX MCS using the primer pair 5’-
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ATATGGATCCGGAATGGTGAGCAAGGGCGAAGAGC-3’ and 5’-
TTCTCGAGTCATTACTTGTACAGCTCGTCCATGC-3’.  
For production of mouse embryonic fibroblasts (MEF) stably incorporating the 
biosensor DNA, we used the tet-OFF MEF/3T3 cells (Clontech). The biosensor 
components were cut out as cassettes from the pEGFP or pTriEx cloning constructs at 
NcoI/EcoRI sites for mCyPet-RhoA, and NcoI/XhoI sites for RBD-mYPet. Digested 
fragments were treated with Klenow fragment of the DNA polymerase I in the presence 
of 33μM dNTP for 15 minutes at room temperature to perform the end filling reaction of 
the 5’-overhangs to produce blunt ends. The pBabe-sin-Puro-tet-CMV was cut at an HpaI 
site to produce blunt ends and ligated with the blunt-ended inserts. Bacterial colonies 
were screened using polymerase chain reaction (PCR) for the proper directional 
incorporation of the biosensor DNA.  Retroviral transduction was used to stably 
incorporate the biosensor DNA in MEF/3T3 under a tetracycline-repressible promoter 
and expression was inhibited via doxycycline at 1 μg/ml until induction for imaging 
experiments. 
The new dual-chain Cdc42 biosensor uses an intermolecular design as reported by 
several groups (Itoh et al. 2002; Seth et al. 2003; Tzima et al. 2003; Hoppe and Swanson 
2004), but here is further optimized by the use of different fluorescent proteins and of a 
Cdc42-binding domain from Neuronal Wiskott Aldrich Syndrome Protein (N-WASP), a 
fragment shown to provide good selectivity for activated Cdc42 in previously developed 
biosensors with a different design (Nalbant et al. 2004; Frantz et al. 2007; Koivusalo et 
al. 2010).  The biosensor was generated by first constructing plasmids encoding either 
Cdc42 fused to the C terminus of CyPet, a CFP variant optimized for FRET (Nguyen and 
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Daugherty 2005), or the Cdc42-binding CRIB domain from WASP (CBD), amino acids 
230–314, fused to the C terminus of YPet, a YFP variant optimized for FRET (Nguyen 
and Daugherty 2005). The EGFP coding region from the EGFP-C1 vector (Clontech, 
Inc.) was replaced with a PCR product containing the CyPet or YPet coding regions 
flanked by an NcoI restriction site and a SGLRSELGS linker containing a BamHI 
restriction site. The PCR products of the Cdc42 and CBD coding sequences were inserted 
between the BamHI restriction site in the SGLRSELGS linker and an EcoRI restriction 
site in the downstream multiple cloning site of the vector.   
 
Fluorometry Assays of GAP Activity on Cdc42 Activation: 
  To determine the ability of wild-type MILO and either phosphomimetic (YE) 
or non-phosphorylatable (YA) MILO mutants to affect Cdc42 activity, we performed 
FRET measurements in a spectrophotometer in a bulk cellular suspension assay in which 
293 cells were expressing the Cdc42 activity FRET biosensor.  In brief, 293 cells were 
plated on poly-L-lysine coated wells of a 6-well dish 36 hours before the assay was run.  
The following morning, 24 hours before the assay was run, the 293 cells were transfected 
with Lipofectamine according to the manufacturer’s instructions.  A total of 650 ng of 
DNA was transfected per well, consisting of 100 ng of CyPet-Cdc42, 100 ng of YPet-
CBD, and the balance consisted of mCherry-tagged MILO, MILO mutants, known 
regulators of Cdc42, or blank vector DNA.  Each experimental condition was set up in 
triplicate.  The following morning, the cells were checked for appropriate brightness, 
washed once with DPBS, gently trypsinized using 400 L trypsin which was removed 
after 15 seconds, and then resuspended in 500 L cold DPBS.  400 L of cell suspension 
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was then loaded into a spectrophotometer cuvette.  Using a SPEX Fluorolog sensitive 
spectrophotometer, the cell suspension was excited at 433 nm, the excitation of CyPet, 
and the emission was monitored from 450 nm to 600 nm at 3 nm intervals to monitor the 
emission spectrum of YPet.  For each test, a sample transfected with YPet-CBD only and 
monitored for FRET as above was monitored to account for differences in brightness and 
thus bleedthrough into the FRET channel by direct excitation of the acceptor fluorophore.  
This reading was subtracted from each measurement.  For the calculation of FRET ratio, 
after bleedthrough correction, each sample was normalized such that the peak of CFP 
emission (475 nm) was set as an intensity value of 1.0.  The FRET emission peak (525 
nm) was then divided by the CFP peak for each sample, and the samples were averaged 
for each condition.  FRET ratios could then be compared between each condition.  
Positive and negative controls consisted of the Cdc42 sensor transfected with the catalytic 
DH/PH domain from Vav2, or GDI-1, respectively, to determine the maximum possible 
range of Cdc42 activation in the assay.  Statistical significance between conditions was 
assessed by two-tailed students’ t-test assuming unequal variance. 
 
Induction of Filopodia During Imaging: 
  To study filopodia growth, retraction, and dynamics, cells were transfected with 
control or MILO siRNA 48 hours prior to imaging, and then subsequently transfected 
with the Cdc42 biosensor with or without mutant GAP constructs 36 hours prior to 
imaging  (Gadea et al. 2004).  Cells were then plated on fibronectin-coated coverslips 24 
hours prior to imaging.  Six hours before imaging, cells were starved in Ham’s F12K 
medium containing 0.5% delipidated BSA plus glutamine.  Cells were transferred to a 
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heated open chamber apparatus to allow for addition of TNFα and allowed to return to 
37 C for 30 minutes before imaging.  Cells were imaged for 5 minutes at 20 second 
intervals prior to the addition of 20 ng/mL TNFα and imaged for a subsequent 15 minutes 
post-stimulation to observe filopodia formation and retraction. 
 
Imaging a Single Rho GTPase Activity in Cells: 
Mouse embryonic fibroblasts (MEF/3T3, BD Biosciences, Clontech, # C3018-1) 
were maintained in Dulbecco’s modified Eagle’s medium (Gibco, Carlsbad, CA) with 
10% FBS.  Rac1 activity was imaged using a modified version of the FLAIR biosensor 
(Kraynov et al. 2000), described above.  Forty-eight hours post-induction of expression, 
cells were plated on fibronectin-coated glass coverslips for 3-4 hours prior to imaging. 
Imaging was performed in imaging medium (see below) with 2% fetal bovine serum. For 
emission ratio imaging, the following filter sets were used (Chroma): ECFP: D436/20, 
D470/40; FRET: D436/20, HQ535/30; EYFP: HQ500/20, HQ535/30. A dichroic mirror 
(“Quad-Custom” Lot# 511112038) was custom manufactured by Chroma Technology 
Corp. for compatibility with all of these filter sets. Cells were illuminated with a 200 W 
Hg arc lamp through a 10% transmittance neutral density filter. At each time point, three 
images were recorded with the following exposure times: CyPet (1.2 s), FRET (excitation 
of donor, observation of acceptor emission) (1.2 s), YPet (0.4 s) at binning 2x2. The 
image sets were taken at 10 s intervals.  Ratio calculations to generate activity images 
were performed following bleed-through correction methods described previously 
(Kraynov et al. 2000).  Briefly, Metamorph software (Universal Imaging) was used for 
image alignment and ratiometric calculation of activation signals. All images were 
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shading-corrected and background-subtracted. Binary masks with values equal to 1 inside 
the cell and 0 elsewhere were extracted by applying a threshold to the CyPet image, 
because it had the largest signal-to-noise ratio. Control cells expressing either CyPet 
alone or YPet alone were used to obtain bleed-through coefficients α and β in the 
following equation: 
CyPet
YPetCyPetFRETR t    (Eq. 1) 
where R is the Ratio, FRETt is the total FRET intensity as measured, α is the bleed-
through of CyPet into FRET channel, β is the bleed-through of YPet into the FRET 
channel and CyPet is the total CyPet intensity as measured. By calculating the linear 
slope of the relationship between FRET and CyPet intensities upon CyPet excitation of 
cells expressing only the CyPet, the bleed-through parameter α can be determined. 
Similarly, by determining bleed-through into the FRET channel upon CyPet excitation of 
cells expressing only the YPet, the bleed-through contribution of YPet excitation by 
CyPet into the FRET channel β can be determined. The α parameter was found to be 
within 0.4-0.5 and the β parameter was typically ~0.2 Both were dependent on the 
particular optical configuration of the microscope used. With these parameters, the ratio 
of corrected FRET over CyPet was calculated and used as a measure of Rac1 activation. 
In time-lapse experiments, CyPet and YPet typically bleach at different rates. Therefore, 
the ratio was corrected for photobleaching as described elsewhere (Hodgson et al. 2005).  
Briefly, by algebraic manipulation, (Eq.1) can be rearranged to: 
  
CyPet
YPet
CyPet
FRETR t  (Eq.2) 
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where Γ is the fraction of FRET intensity over CyPet intensity, and Ψ is the fraction of 
YPet intensity over CyPet intensity, and α and β are the bleed-through constants 
described above. By taking double exponential fits of the decays of both Γ and Ψ, the 
correction function, 1R , can be calculated following the methods outlined in (Hodgson 
et al. 2005).  
 For detection of Cdc42 activity, cells were seeded on fibronectin-coated glass 
coverslips (10 g/ml fibronectin) for two to four hours. Endogenous Cdc42 activity was 
visualized using either the fluorescent biosensor MeroCBD (Nalbant et al. 2004; 
Hodgson et al. 2006) or the genetically encoded probe described above. After 
microinjection with MeroCBD biosensor, cells were allowed to recover for 30 minutes 
before imaging, otherwise for the genetically encoded probe, cells were treated just as for 
the Rac1 probe above. Cells were imaged in imaging medium (Ham’s F-12K without 
phenol red (Biosource), 10 mM HEPEs and 10 g/ml Oxyfluor reagent (Oxyrase Inc.) 
with 2 % fetal bovine serum in a heated closed chamber. Images were obtained using a 
Zeiss Axiovert 100TV microscope, a Zeiss 40 1.3 N/A EC-Plan NeoFluar DIC lens, a 
CoolSnapES CCD camera (Roper Scientific), and Metamorph software (Universal 
Imaging). The exposure times were ~900 ms for the ISO-dye and ~300 ms for EGFP at 
binning 2x2, with a 10% transmittance neutral density filter for MeroCBD, and for the 
genetically encoded probe, three images were recorded with the following exposure 
times: CyPet (1.2 s), FRET (excitation of donor, observation of acceptor emission) (1.2 
s), YPet (0.4 s) at binning 2x2. The image sets were taken at 10 – 20 s intervals. For ratio 
imaging of MeroCBD, the following filter sets were used (Chroma): EGFP: HQ470/40, 
HQ525/50; ISO: HQ580/30, HQ630/40 for MeroCBD, or. The dichroic mirror (“Scripps 
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Custom” Lot#511111886) was custom manufactured by Chroma Technology Corp. for 
compatibility with EGFP and ISO fluorescence wavelengths. For emission ratio imaging 
of the genetically encoded Cdc42 probe, the following filter sets were used (Chroma): 
ECFP: D436/20, D470/40; FRET: D436/20, HQ535/30; EYFP: HQ500/20, HQ535/30. A 
dichroic mirror (“Quad-Custom” Lot# 511112038) was custom manufactured by Chroma 
Technology Corp. for compatibility with all of these filter sets. Image alignment, ratio 
calculations and correction for photobleaching were performed as described in (Nalbant 
et al. 2004). 
 RhoA activation imaging in MEF/3T3 cells was performed by expressing the 
previously described RhoA FRET biosensor (Pertz et al. 2006) under the control of a tet-
inducible promoter. Cells were plated on fibronectin-coated glass coverslips for 3-4 hours 
prior to imaging. Imaging was performed in imaging medium with 2% fetal bovine 
serum. The filter sets and the dichroic mirror used for ratiometric imaging were identical 
to the sets used to image Rac1 above. Cells were illuminated with a 200 W Hg arc lamp 
through a 10% neutral density filter. At each time point, three images were recorded with 
the following exposure times: ECFP (1.2 s), FRET (0.6 s) at binning 2x2. The image sets 
were taken at 10 s intervals.  Metamorph software (Universal Imaging) was used for 
image alignment, ratiometric calculation of activation signals, and photobleaching 
corrections, as described above for Rac1 imaging. In contrast to Rac1 above, RhoA ratios 
did not require bleed-through corrections (Pertz et al. 2006) because the ECFP and EYFP 
are equimolar in any given pixel for this single-chain biosensor (Pertz et al. 2006).   For 
RhoA imaging in HUVECs, cells were infected with a lentivirus-based TEM4 shRNA 
construct co-expressing an mCherry fluorescent protein marker.  Next day, cells were 
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split onto gelatin-coated 25-mm glass slides at 25,000 cells/slide in EGM-2 medium with 
10% FBS (HyClone).  Five hours after plating, cells were infected overnight with an 
adenoviral vector-based single chain RhoA FRET construct (Pertz et al. 2006; Machacek 
et al. 2009).  The next morning, the virus was removed and cells were transitioned to 
imaging medium (phenol red free M199 medium (Gibco) supplemented with 2% FBS, 2 
mM glutamine (Glutamax, Invitrogen), 15 mM HEPES buffer, and endothelial cell 
growth media supplements (Lonza).  Cells were then imaged as described above for 
RhoA MEFs, except image sets were taken at 60 s intervals to avoid cellular 
photodamage and toxicity.   The mCherry channel was monitored initially to determine 
whether the cells had been infected with the TEM4 shRNA lentivirus.   
 RhoA intermolecular FRET activity was imaged using the protocols described for 
the Rac1 GTPase above (Kraynov et al. 2000). 48 hours post-induction of the stable 
biosensor MEF cells, cells were plated on fibronectin-coated glass coverslips for 3~4 
hours prior to imaging. Imaging was performed in imaging medium with 2% fetal bovine 
serum. For emission ratio imaging, the following filter sets were used (Chroma): ECFP: 
D436/20, D470/40; FRET: D436/20, HQ535/30; EYFP: HQ500/20, HQ535/30. The 
dichroic mirror (“Quad-Custom” Lot# 511112038) was custom manufactured by Chroma 
Technology Corp. for compatibility with all of the filter sets. Cells were illuminated with 
a 200 W Hg lamp through a 10% transmittance neutral density filter. At each time point, 
three images were recorded with the following exposure times: mCyPet (1.2 s), FRET 
(excitation of donor, observation of acceptor emission) (1.2 s), mYPet (0.4 s) at binning 
2x2. The image sets were taken at 10s intervals.  Ratio calculations to generate activity 
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images were performed following the bleed-through correction methods outlined above 
for the Rac1 biosensor.  
 For visual representations of ratiometric images, a linear pseudocolor lookup table 
was applied to all ratio images and the ratio values were normalized to the lower scale 
value, which was chosen to exclude the bottom 5% of the total histogram distribution, 
avoiding spurious low intensity pixels. In each experiment, CFP, YFP, and FRET images 
were carefully inspected to verify that all portions used to create the ratio image had a 
sufficiently high signal/noise ratio. We routinely target at least 300 gray level values (12 
bit dynamic range) above background in the lowest intensity regions within the cell.  This 
was especially important in thin parts of the cell where fluorescence was low.  
 
Cell Edge Tracking: 
Rates of protrusion and retraction where obtained from biosensor images by 
computational edge tracking using a custom-built software package written in Matlab 
(Mathworks). Cell edges were segmented via an intensity-based criterion and cell edge 
displacements were tracked by applying the  mechanical model described in (Machacek 
and Danuser 2006) for morphing the edge between consecutive time points.  
 
Tracking of Sampling Windows at Constant Distance to the Cell Edge:  
To construct the sampling windows at a constant distance from the cell edge we 
computed a distance map (Matlab function: bwdist) to the segmented cell edge 
(Machacek and Danuser 2006). The distance map readily yielded lines of constant 
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distance which were offset by the window depth and equally subdivided to obtain the 
sampling windows.   
 
Cross-Correlation Analysis:  
Pearson’s correlation coefficient between two time series of a sampling window at 
different time lags was computed using the Matlab function xcorr. To obtain the 
correlation for the entire leading edge of a migrating cell we averaged the correlation 
coefficient over all sampling windows for each time lag regardless of the protrusive state 
of an edge section. Significance levels of cross-correlation functions at the 95% 
confidence level were estimated by N(-0.5) * 1.96, where N is the time series length.  
 To investigate the cell-to-cell heterogeneity of the time-lag we pooled the average 
correlation data from different cells and estimated the common cross-correlation by 
computing a smoothing spline. Importantly, morphological variations among cells do not 
affect this analysis because averaging is performed at the level of the cross-correlation 
coefficient. The central assumption underlying these calculations is that the states of Rho 
GTPase activity and cell edge movement are locally coupled and that the pathways from 
regulatory signals to downstream morphology are equal for all cells observed under equal 
conditions. Therefore, variations in global cell morphology have no influence on the 
cross-correlation coefficients which are acquired strictly locally.    
 To estimate the variance of the smoothing spline approximation and hence of the 
time lag we employed a non-parametric bootstrapping method (Efron and Tibshirani 
1994). From the residuals of the spline approximation 2000 bootstrap samples were taken 
to calculate local variation of the spline about the mean. The 95% confidence interval, 
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bands between dashed parallels to splines, was then obtained in each location as the 
interval containing 95% of the spline samples.  
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3.6  Figures and Legends 
Figure 3.1:  Activation of Rho GTPases in Migrating Mouse Embryonic Fibroblasts.   
(A) Rac1, (B) Cdc42, and (C) RhoA activation reported by biosensors. White rectangle: 
Region of interest selected for analysis. Scale bar: 20 m.  
(D) Time course (blue line) of Rac1 activation within 0.6 m from the cell edge, 
averaged over a 5 m long portion of the cell edge. Red line: filtered time-course 
(Gaussian filter, = 5 frames). Green triangles: local maxima and minima of filtered 
time-course.  
(E-G) Modulation of GTPase activation (mean absolute difference between consecutive 
local extrema of the time-course) as a function of the distance D from the leading edge. 
Values are normalized to the modulation at the cell edge. Error bars: s.e.m. of n = 6 
(Rac1); n = 4 (Cdc42); n = 4 (RhoA) cells.  
(H) Sampling windows of 0.9 m depth placed at the cell edge and at D = 1.8 m from 
the cell edge.  
(I) Parameters to define the position and size of a sampling window. In each window, the 
time course of GTPase activation was recorded (average of ~10 pixels). For a sampling 
window at D = 0, a time course of edge velocity was recorded (mean of 6 – 8 
measurements).  
(J) Time courses of edge velocity (green) and GTPase activation (Cdc42, red) recorded in 
one sampling window. 
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Figure 3.1 
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Figure 3.2:  Designs of the Biosensors Used. 
In each biosensor an “affinity reagent”, derived from a downstream effector, is used in 
the biosensor to bind specifically to the active form of the GTPase. The affinity reagents 
are a fragment of WASP (CBD in panel A, for Cdc42), a fragment of Pak (PBD in panel 
B, for Rac1) and a fragment of Rhotekin (RBD in panels C and D, for RhoA. The 
published sensors used in the paper are shown in the left hand column, in panels A, B, 
and C. Biosensor C differs from the others in that the affinity reagent is covalently linked 
to the target GTPase. For controls examining the effects of biosensor design, an 
additional biosensor was produced, the biosensor of panel D. With this biosensor in hand, 
each GTPase could be examined using an intermolecular design. Biosensors B, C and D 
use FRET as a proxy for GTPase binding. In design A, an environmentally sensitive dye 
reports binding to endogenous Cdc42. Titration of affinity reagent concentration, titration 
of  fluorescent GTPase concentration, and comparison of the intermolecular and 
intramolecular RhoA biosensors C and D all demonstrated that our conclusions were not 
attributable to differences in biosensor design. 
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Figure 3.2 
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Figure 3.3:  Effect of Biosensor Component Concentrations on the Measured Rac1-
Protrusion Correlation. 
 
(A) The ratio of acceptor (YFP) to donor (CFP) concentrations and corresponding 
correlation maxima time lags for each of the cells assessed. A dynamic range of 3:1 was 
achieved.  
(B) Cross-correlation functions for individual cells (color-coded to match A). No trend in 
the timing as a function of probe concentration was observed.  
(C and D) Donor and acceptor concentrations of individual cells, indicating that higher 
and lower concentration ratios in (A) were associated with high and low acceptor and low 
and high donor, respectively. Cells were background subtracted and intensities were 
corrected for channel cross talk. Concentrations were computed as intensity/exposure 
time, at fixed illumination intensity.  
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Figure 3.3 
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Figure 3.4:  Relationship Between RhoA and Protrusion/Retraction Determined by 
an Intermolecular Biosensor. 
 
(A) Activation of RhoA. Notice the increased dynamic range of the intermolecular sensor 
as compared to the intramolecular sensor in Figure 3.5. Areas of dynamic activity 
correspond to regions of rapid protrusion and retraction (shown with white arrows). Scale 
bar in the 14'00" time point: 20 microns.  
(B) Comparing the correlation functions of the intramolecular RhoA biosensor (black) 
and the intermolecular RhoA biosensor (red). 95%-confidence bands (dashed lines) were 
calculated by bootstrap analysis of n = 14 cells (intramolecular) and n = 5 cells 
(intermolecular). The timings of the two probe activations relative to protrusion were 
statistically indistinguishable: -6 [-8 -4] s (intramolecular) and -10 [-15 -5] s 
(intermolecular); mean +/- 95% confidence interval.  
(C) Correlation of the intermolecular RhoA probe as a function of the distance from the 
cell edge. Consistent with the results obtained with the intramolecular probe (see Figure  
3.5), RhoA activation reported by the intermolecular probe decreases in correlation as the 
probing windows are placed at increasing distances from the cell edge. In addition, the 
correlation peaks indicate increasing delay in maximal activation at increasing distance 
from the cell edge.  
(D) Summary of spatial and temporal relationships reported by the intermolecular probe. 
Blue line: magnitude of the cross-correlation maximum as a function of the distance. Red 
line: time lag of cross-correlation maxima as a function of the distance. Dashed lines: 
95% confidence interval computed by bootstrap analysis. Dots: Values for individual cell 
shown in B.
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Figure 3.4 
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Figure 3.5:  Spatiotemporal Coordination of Rac1, Cdc42, and RhoA Activation.  
(A) Timing of Rho GTPase activation relative to edge velocity, as determined by 
temporal cross-correlation functions. The variable ‘edge movement’ is being used as the 
reference signal. Thus, correlation maxima in the sector labeled “After” indicate that the 
GTPase reaches the activation maximum after the protrusion event (time point of fastest 
edge advancement). Dashed lines: 95% confidence intervals. Data originate from n = 11 
cells (Rac1), n = 12 cells (Cdc42), and n=12 cells (RhoA). Confidence intervals were 
computed by bootstrap sampling of 2000 residuals to the spline fits.  
(B) Timing of RhoA activity relative to Cdc42 activity, both monitored in the same cell, 
as determined by the temporal crosscorrelation function. The variable Cdc42 is being 
used as the reference signal. Thus, the correlation maximum in the sector labeled 
“Before” indicates that RhoA reaches the activation maximum before Cdc42 (n = 7 cells). 
(C) Model of GTPase activation during protrusion and retraction. Green: Rac1 activation. 
Black: RhoA activation. Blue: Cdc42 activation. 
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Figure 3.5 
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Figure 3.6: TEM4 Activates RhoC during Microtubular Depolymerization. 
(A)  Levels of activated (GTP-loaded) RhoA and RhoC were measured by affinity 
precipitation assay in control or TEM4-depleted HUVECs that were left untreated, 
treated with nocodazole, or treated with nocodazole and then incubated with serum for 5 
min.  The activation levels of RhoA and RhoC and expression levels of RhoA, RhoC and 
TEM4 in whole cell lysates were determined by immunoblotting.  Numbers below the 
gels indicate band intensities relative to the untreated NS control group as determined by 
densitometry.  Similar results were obtained in four independent experiments. 
(B)  Quantitation of active RhoA (open bars) or RhoC (grey bars).  Ratio between Rho 
activation levels in TEM4 sh vs NS group was determined for each experimental 
condition for each experiment and then averaged.  A horizontal line indicates a baseline 
where TEM4 depletion has no effect on Rho activation levels. 
(C) Spatial RhoA activation patterns assessed by FRET analysis.  RhoA activity was 
monitored via FRET analysis of a genetically-encoded biosensor in HUVECs as detailed 
in Methods, with and without TEM4 knockdown.  Images are representative of NS 
shRNA (n = 9) and TEM4 shRNA treatment conditions (n = 11).   
Dynamic courses of RhoA activity during protrusive behaviors assessed by FRET 
imaging of a genetically-encoded biosensor in HUVECs treated with NS shRNA (D) or 
TEM4 shRNA (E).  Arrowheads indicate high RhoA activity associated with areas of 
active protrusion.  Arrows highlight membrane patches with minimal RhoA activity that 
correlated with areas of local retraction or protrusion arrest within the leading edge.  A 
longer time course is presented for TEM4-depleted cells as they showed slower rate of 
protrusion.  Time course is representative of protrusions in NS shRNA treated cells (n = 
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9) and TEM4 shRNA treated cells (n = 11).  Scale bar = 10 μm.  Elapsed time is 
indicated in minutes, and warmer colors correspond to higher ratio values per the 
representative heat maps, indicating greater RhoA activity. 
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 Figure 3.6 
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Figure 3.7:  Cdc42 Dynamics in TNF-Stimulated Filopodium Formation. 
(A) Schematic of the dual-chain Cdc42 biosensor design and regulation.  
(B) Cdc42 activation in TNF-induced filopodia, demonstrating the ability to detect 
Cdc42 activity within these structures using this sensor.   
(C) Sample images demonstrating Cdc42 activation at the tips of protruding filopodia, 
schematized in (D) with quantitation of the frequency of these local maxima along the 
length of the filopodium, comparing the FRET signal versus a simple ratio of YFP/CFP 
in the same filopodia as an internal control.   
(E and F) Sample images and quantitation of Cdc42 activation levels within the 
filopodium shaft during protrusion or retraction.  Values are mean Cdc42 FRET ratio 
intensities averaged along the filopodium length.  Error bars indicate S.E.M.  Asterisks 
indicate p < 0.05.  
(G and H) Sample images and quantitation of Cdc42 activation levels at the site of 
filopodium formation compared to the whole-cell Cdc42 activity average, and to the 
Cdc42 activity in a nearby region of interest that did not form filopodia.  Values are mean 
Cdc42 FRET ratio intensities averaged along the filopodium length.  Error bars indicate 
S.E.M. Asterisks indicate p < 0.05. 
 
 177
Figure 3.7 
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Figure 3.8:  Effects of MILO GAP Activity on Cdc42 Activation Globally and within 
Filopodia. 
 
(A) Cdc42 activity in control vs. MILO knock-down cells.  Activity is represented by the 
heat map in the upper right corner, and scaling is roughly equivalent.  
(B) Quantitation of whole-cell Cdc42 activity in control vs. MILO knock-down cells.  
Values are mean Cdc42 FRET ratio intensities averaged along the filopodium length.  
Error bars indicate S.E.M.  Asterisks indicate p < 0.05.  
(C) Cdc42 activity in control vs. MILO knock-down cells at the base of filopodia.  
Activity is represented by the heat map in the upper right corner, and scaling is roughly 
equivalent.   
(D) Quantitation of Cdc42 activity in control vs. MILO knock-down cells at the base of 
filopodia.  Values are mean Cdc42 FRET ratio intensities averaged along the filopodium 
length.  Error bars indicate S.E.M.  Asterisks indicate p < 0.05.  
(E)  Cdc42 activity in control vs. MILO knock-down cells within the filopodium shaft.  
Activity is represented by the heat map in the upper right corner, and scaling is roughly 
equivalent.   
(F) Quantitation of Cdc42 activity in control vs. MILO knock-down cells within the 
filopodium shaft.  Values are mean Cdc42 FRET ratio intensities averaged along the 
filopodium length.  Error bars indicate S.E.M.  Asterisks indicate p < 0.05. 
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CHAPTER FOUR:  ROLE OF RHOG IN CELL MIGRATION 
4.1  Abstract 
 Spatiotemporal control of Rho GTPase activity is required for optimal cell 
migration through the proper coordination of a variety of cellular behaviors.  RhoG, a 
GTPase, has been shown to act upstream of Rac1, but its role in cell migration is poorly 
understood.  Here we develop a novel FRET activity biosensor for RhoG and show that 
RhoG is activated coincident with the leading edge of lamellipodial protrusion.  Further, 
RhoG activates a subpopulation of Rac1 at the leading edge of migrating cells via the 
ELMO/DOCK180 complex, and activation of Rac1 by RhoG is dependent on the 
endocytic recycling of RhoG to the leading edge as regulated by RhoGDI-3.  
Dysregulation of RhoG and its endocytic recycling leads to alteration in the recruitment 
and activation of Rac1 at the leading edge, changes in focal adhesion and actin dynamics, 
and ultimately the dysregulation of cell migration in both 2D and 3D matrices. 
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4.2  Introduction 
 Cell migration is important in a variety of physiological and pathological 
processes such as embryogenesis, angiogenesis, leukocyte transendothelial migration, 
wound healing, and tumor invasion and metastasis.  The Rho family GTPases are key 
regulators of cell migration, with RhoA promoting actomyosin contractility, and Rac1 
and Cdc42 regulating actin polymerization and membrane protrusion (Burridge and 
Wennerberg 2004).  These roles have been clarified further in cellular protrusion, 
demonstrating that all three GTPases are activated at the leading edge of cells to enable 
protrusion and cell migration with precise spatial and temporal activation patterns for 
each of these GTPases (Machacek et al. 2009).   
The functions of these GTPases depend critically on their proper activation and 
coordination in response to extracellular cues.  Cells have developed a large number of 
regulatory mechanisms that accomplish the spatial and temporal coordination of their 
activation, often through tight regulation of upstream regulators, and through localized 
activation of downstream signaling molecules in response to extracellular cues.  Cell 
motility in particular relies on these spatially restricted regulatory processes that 
coordinate localized Rho GTPase signaling, particularly near the plasma membrane 
where interaction with extracellular signals occurs.  In response to extracellular stimuli, 
these processes promote polarization and the remodeling of actin at the leading edge of 
cells for the formation of lamellipodia, one of the first steps in cell migration (Ridley et 
al. 2003).  The mechanisms of how these GTPase signals are locally coordinated and 
constrained remain an area of active study. 
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Studies have revealed a number of mechanisms used to achieve this signal 
restriction and polarization.  Among these mechanisms, upstream regulatory molecules 
may be selectively positioned to engage cell migration machinery, particularly the 
GTPases, in response to extracellular cues.  As an example, integrins are a major class of 
signaling proteins that are positioned at the leading edge to respond to extracellular cues, 
often by endocytic recycling, and thus to coordinate GTPase activation.  In 3-dimensional 
matrices, Rab25-coated vesicles associate with β1 integrins and recycle predominantly to 
the tips of leading edge protrusions, helping to activate GTPases, and regulate directed 
cell migration (Caswell et al. 2007).  Further, the activity of the GTPases may be spatially 
restricted to generate localized downstream responses.  Rac1 is one of the GTPases that is 
tightly controlled by both of these mechanisms.  Rac1 activity has been shown to be high 
at the leading edge during cell migration (Kraynov et al. 2000; Machacek et al. 2009) at 
odds with what the broadly uniform localization of Rac1 alone would suggest.  Further, 
the positioning of Rac1 determines its activity.  The control of Rac1 activity is thought to 
depend in part on endosomal recycling (Palamidessi et al. 2008) to the leading edge, and 
by its recruitment and activation by GEFs at the leading edge of cells. Ultimately the 
levels and location of Rac1 activity determine cellular behaviors: high and low levels of 
Rac1 activity, which often correlate with delocalized Rac1 activity, both lead to minimal 
cell migration, but at intermediate levels of Rac1 activity, productive cell migration 
occurs (Pankov et al. 2005; Petrie et al. 2009).  Much remains to be learned about how 
Rac1 is spatiotemporally restricted in its activation and how the positioning and 
regulation of activators and inactivators is controlled. 
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Among the Rac subfamily of GTPases, three Rac isoforms exist, along with the 
closely related RhoG, which is 72% identical to Rac1 by sequence identity.  Of these, 
Rac1 and RhoG are ubiquitously expressed and have a unique relationship where RhoG 
is capable of activating Rac1 through an ELMO/DOCK180 GEF complex (Katoh et al. 
2000; Katoh and Negishi 2003; Katoh et al. 2006).  This relationship between RhoG and 
Rac1 is critical in a number of cell behaviors, including phagocytosis and the engulfment 
of apoptotic cells, where RhoG is required for Rac1-dependent actin reorganization 
(deBakker et al. 2004; Park et al. 2007).  RhoG is unique in that it has been implicated 
both in lamellipodia formation (Katoh et al. 2006) required for 2-dimensional migration, 
and in dorsal ruffle (or “wave”) formation also implicated in 2-dimensional and 3-
dimensional cell migration (Wennerberg et al. 2002; Buccione et al. 2004; van Buul et al. 
2007a; Gu et al. 2011).  However, the mechanism and precise role of RhoG in regulating 
Rac1 in these cell migratory processes remains unclear.  Since RhoG is upstream of 
Rac1, this raises a number of questions with regard to the role of RhoG in cell migration.  
How is RhoG itself regulated?  When and where is RhoG active in migrating cells?  Is 
RhoG-dependent activation of Rac1 important during cell migration, or do RhoG and 
Rac1 have separable functions? Previous work indicates both scenarios are at work, 
namely that RhoG and Rac1 can signal in parallel and in tandem (Wennerberg et al. 
2002; Ellerbroek et al. 2004).   Since Rac1 activity is known to be spatiotemporally 
restricted to the leading edge, does RhoG play a role in this process?  Thus, 
understanding the spatial and temporal dynamics of RhoG activity in relationship to Rac1 
will be critical in revealing the roles of these proteins in cell migration.   
 184
Here, through the development and use of a novel FRET activity sensor for 
RhoG, we show first that RhoG is activated coincident with lamellipodial protrusion and 
tightly associated with the leading edge.  Further, RhoG activates a subpopulation of 
Rac1 at the leading edge of migrating cells via the ELMO/DOCK180 complex, and 
activation of Rac1 by RhoG is dependent on the endocytic recycling of RhoG to the 
leading edge as regulated by RhoGDI-3.  Dysregulation of RhoG activity and/or 
trafficking leads to alterations in the recruitment and activation of Rac1 at the leading 
edge and at focal adhesions and changes in focal adhesion and actin dynamics.  
Ultimately, we define a role for RhoG in enabling cells to change the direction of their 
migration during random cell migration due to the ability of RhoG to initiate sites of 
Rac1 activation at the cell periphery.   
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4.3  Results 
Spatio-temporal Dynamics of RhoG and Rac1 Activity at the Leading Edge of Motile 
Cells: 
In order to study the dynamics of RhoG “activation” (GTP loading) we produced 
a RhoG  biosensor based on intermolecular FRET between RhoG fused to the fluorescent 
protein CyPet (Nguyen and Daugherty 2005), and an ELMO1 fragment fused to the 
fluorescent protein YPet (Nguyen and Daugherty 2005) (Figure 4.1A). In this biosensor, 
when RhoG adopted the activated conformation, the ELMO fragment bound to  RhoG,  
leading to FRET between the two fluorescent proteins. To optimize the brightness and 
dynamic range of the biosensor, we examined ELMO fragments of different size (85 
amino acids to full length ELMO1), in all cases with CyPet on the N terminus of RhoG 
and YPet at either the C or N terminus of the ELMO fragment. This configuration 
preserved normal regulation of RhoG by guanosine dissociation inhibitors. We also tested 
biosensors in which the ELMO fragment and RhoG were linked in a single chain, but the 
dual chain design provided enhanced sensitivity because it effectively eliminated any 
FRET in the biosensor ‘off’ state (optimization of the single chain biosensor led to an 
approximately 25% FRET increase upon activation - data not shown). The two biosensor 
chains were co-expressed in adherent Cos-7 cells, and cell populations were examined for 
the ratio of FRET/CFP fluorescence. We first compared  a dominant negative CyPet-
RhoG (T17N) and a constitutively active CyPet-RhoG (Q61L) (Figure 4.1B). The 
expression levels of the two chains were maintained at roughly equal levels by 
monitoring the intensities in the CFP and YFP channels. Optimum response was obtained 
using a fragment containing ELMO1 residues 1-95, with YPet at its C terminus.   
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We examined whether the biosensor responded to upstream stimuli as did 
unmodified RhoG.  Cos-7 cells were co-transfected with wild-type biosensor and 
different known regulators of RhoG (Figure 4.1B). Cellular concentrations (roughly 
estimated as fluorescence per unit area) were maintained below levels generating obvious 
cellular phenotypes, such as dorsal ruffling or effects on activation kinetics relative to 
protrusion velocity.  The limits on maximal concentration defined here were used during 
the biological studies described below. Biosensor co-transfected with the activating 
guanosine exchange factors (GEFs) Vav2 and PLEKHG6 displayed FRET similar to that 
of the constitutively active RhoG.  In contrast, minimal FRET was observed with the 
dominant negative form of RhoG (T17N) or for wild-type RhoG co-transfected with 
p50RhoGAP or RhoGDI-1.  Notably, p50RhoGAP has not been previously identified as a 
GAP for RhoG; pull-down assays of GTPase activity identified this GAP as a negative 
regulator (Figure S4.1A).  The negative regulators reduced FRET to  levels below those 
seen for wild-type biosensor alone, indicating that the wild-type biosensor reflected 
constitutive activity and that negative regulators could in fact active reduce RhoG 
activity=. To test the specificity of the biosensor for RhoG activation, we co-transfected 
GTPase regulators specific for GTPases other than RhoG. The catalytic domains from the 
GEFs Tiam-1 (Rac1-specific), Tim (Rho-specific) and Rap1GAP (Rap-specific) 
produced no effect on FRET.  Finally, we modulated endogenous RhoG regulators.  
Stimulation of cells with EGF, which is known to activate RhoG (Samson et al. 2010), 
increased FRET  (Figure S4.1B).  A recent report showed that the scaffold protein 
synectin prevents RhoG activation by serving as a scaffold for RhoGDI-1, which 
sequesters RhoG (Elfenbein et al. 2009). As expected, synectin knockdown led to a 
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significant increase (2.52-fold) in the biosensor FRET/CFP ratio (Figure S4.1C-E).  In 
summary, these data demonstrate that we constructed a RhoG biosensor capable of 
correctly reporting RhoG activation in living cells, at expression levels that did not 
perturb normal cell motility or morphology. 
The biosensor was first used to examine the kinetics and localization of RhoG 
activation at the leading edge of motile cells, and to compare these dynamics to those of 
Rac1 and RhoA, in both mouse embryonic fibroblasts (MEFs) and HeLa cells (Figure 
4.1C). Despite the fact that RhoG is much closer in sequence to Rac1 than to RhoA,  
RhoG dynamics strongly resembled those of RhoA, and not Rac1, in both cell types. 
RhoG activation was observed in a narrow band proximal to the leading edge of 
migratory cells, as previously reported for RhoA (Itoh et al. 2005; Pertz et al. 2006). In 
contrast, Rac1 was activated in a broader band more distal to the leading edge, also 
consistent with previous reports (Kraynov et al. 2000; Itoh et al. 2002; Machacek et al. 
2009) (Figure 4.1C).   Automated line scan analysis of  > 388,000  lines drawn parallel to 
the leading edge of motile cells indicated that RhoG was active during protrusion but not 
retraction, and that activity peaked within the first 2 microns from the edge (Figures 
4.1D, 4.1E, and 4.1G). To determine whether RhoG activity was correlated with 
protrusion or retraction speed, edge movements from migrating cells were binned into 
groups based on their peak velocities, and these protrusional velocities were correlated 
with the respective RhoG activity levels.  RhoG activity increased proportionately with 
protrusion speed (Figure 4.1D), but showed no correlation with retraction, regardless of 
the velocity.  These line scans  confirmed that RhoA and RhoG peak within 1 micron of 
the cell edge, while Rac1 activation peaks at approximately 2 microns. (Figure 4.1G). 
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Using previously described methods we also examined the relative timing of changes in 
edge velocity and RhoG activation.  RhoG activity correlated maximally with edge 
velocity 6 ± 1.4 seconds after a velocity change (Figure 4.1F and S4.1F), similar to the 
correlation previously reported for RhoA (-6 seconds) and unlike that reported for Rac1 
(-40 seconds) (Machacek et al. 2009). Together, these data indicate that RhoG is 
activated during cell protrusion, prior to Rac 1 and at a region closer to the cell edge, 
more closely resembling the dynamics of RhoA than of Rac1. 
 
RhoG is Targeted to the Leading Edge by Endosomal Recycling and Regulated by 
RhoGDI-3: 
 
Previous studies have shown that RhoG is recruited to both microtubules (Vignal 
et al. 2001) and to caveolin-positive vesicles (Prieto-Sanchez et al. 2006), so we 
hypothesized that trafficking of RhoG might contribute to its tight regulation at the 
leading edge. CFP-RhoG fusion protein was visualized in living HeLa, MEF, and Cos-7 
cells.  In addition to the membrane and perinuclear localizations commonly seen for 
GTPases, we observed RhoG in rapidly moving vesicular structures (Figure 4.2A). Co-
expression of CFP-RhoG together with mCherry-tubulin showed the RhoG vesicles to be 
associated with microtubules (Figure 4.2B), as previously described in fixed specimens 
(Zalcman et al. 1996; Brunet et al. 2002; Dransart et al. 2005; Prieto-Sanchez et al. 2006).  
By tracking both microtubules and vesicles in living cells, we observed that most of the 
RhoG-positive vesicles (94.7% of 75 vesicles tracked) moved along microtubules (Figure 
4.2B), and moved in both retrograde and anterograde directions (Figure 4.2C). To 
determine the identity of the vesicles, we imaged CFP-RhoG together with different 
mCherry-labeled Rab GTPase constructs used to mark specific components of the 
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endosomal network, particularly Rab4, Rab5, and Rab11 of the rapid endosomal 
recycling compartments, and Rab7 of the lysosomal degradation pathway.   RhoG-
positive vesicles were associated with  Rab4, Rab5, and Rab11 fluorescence  (n = 10-15 
cells per condition, > 60% colocalization), but rarely co-localized with  Rab7 (n= 10 
cells, colocalization 3.5% ± 2.2%) (Figures 4.2C and S4.2A-D). 
Time-lapse movies of RhoG biosensor activity showed that RhoG was inactive 
(70%) or unchanged in activity (24%) at the vesicles (Figure 4.2D) in 178 vesicles 
examined.We sought to determine how RhoG was maintained there in its inactive form.. 
Previous studies showed that both RhoGDI-1 and RhoGDI-3 (also known as RhoGDI-γ) 
bind and sequester RhoG in its inactive form; we pursued RhoGDI-3 because it is known 
to localize to vesicles and the Golgi apparatus (Figure 4.2E) (Brunet et al. 2002).   CFP-
RhoG and mCherry-RhoGDI-3 co-localized at vesicles and at a perinuclear accumulation 
morphologically consistent with the Golgi apparatus (n= 20 cells) (Figure 4.2E). 
Overexpression of RhoGDI-3 greatly reduced the egress of  RhoG vesicles from the 
perinuclear region to vesicles, and reduced the amout of RhoG at the cell edge (Figures 
4.2F and 4.2G).  Importantly, although  RhoGDI-3 overexpression reduced the number of 
RhoG vesicles, endosomal trafficking remained intact, as assessed by time-lapse imaging 
of fluorescent Rab proteins.  This data indicated that RhoGDI-3 controls the egress 
specifically of RhoG from a perinuclear compartment, and maintains RhoG in an inactive 
state on vesicles. This not only shed light on RhoGDI-3 regulation of RhoG, but provided 
a powerful tool for further studies: in RhoGDI-3 knockdown cells, the RhoG biosensor 
showed RhoG to be more activated both globally and diffusely (Figures 4.2H, 4.2I, and 
S4.2E). Overexpression of RhoGDI-3 led to a decrease in RhoG activity (Figure 4.2I), 
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with more uniform activation not localized to the leading edge  (Figure 4.2I compared to 
controls in Figure 4.1C).  
To examine our hypothesis that RhoG trafficking contributes to the tight 
localization of RhoG activity at the leading edge, and to examine a potential role for 
RhoG in cell polarization, we tested whether the RhoG vesicles are targeted to actively 
protruding regions of  polarized, moving HeLa cells. Examining the locations traversed 
by all RhoG vesicles over a 120 minute time interval clearly showed that RhoG vesicles 
were largely restricted to the region between the nucleus and the leading edge of moving 
cells (Figure 4.2J).  The vesicles appeared to target areas of the cell that were actively 
protruding, with numerous vesicles tracking both towards and away from the leading 
edge. Again here, overexpression of RhoGDI-3 blocked transit of vesicles from the 
perinuclear region to the edge (Figure 4.2J).  Together, these data indicate that inactive 
RhoG is dynamically trafficked to and from the membrane through the endosomal 
recycling pathway, targeting regions of active protrusion, and that this process is 
regulated by RhoGDI-3.  In the following sections, RhoGDI-3 is used as a tool to 
modulate the positioning and level of RhoG activity in living cells. 
 
RhoG  Regulates the Spatio-temporal Dynamics of Rac1 Activity in Protrusions: 
We sought next to examine whether RhoG regulates Rac activity at the leading 
edge. Biochemical studies have indicated that RhoG can affect Rac1 by activating the 
bipartite ELMO/DOCK180 GEF complex that activates Rac1 (Katoh and Negishi 2003; 
Hiramoto et al. 2006; Katoh et al. 2006). We found that knockdown of RhoG using 
previously characterized RhoG siRNA (Figure S4.3A) (Samson et al. 2010) did indeed 
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reduce Rac1 activation in HeLa cells by 50%, as measured by GST-CRIB pull-down 
assays (Figure 4.3A) . Using our published biosensor of Rac1 activity (Kraynov et al. 
2000; Machacek et al. 2009), we examined whether RhoG affects the dynamics of Rac1 
activity in cell protrusions, potentially to control cell motility.   RhoG knockdown 
affected both the level and localization of Rac1 activity.  Rac1 activity at the cell edge 
was substantially reduced and peak Rac1 activity was shifted towards the center of the 
cell (Figures 4.3B-D). In control cells, peak activity was 1.8 μm from the edge, as 
opposed to 6.4 μm after RhoG knockdown. 
We tested whether the ELMO/DOCK180 complex was involved in these effects 
of RhoG on Rac1.  Expression of an ELMO truncation mutant (ELMOΔT625), 
previously shown to block this pathway (Brugnera et al. 2002; deBakker et al. 2004),  
reduced Rac1 activation and caused the peak activation to shift inwards.  Co-transfection 
of wild type DOCK180 had no impact on Rac1 activity, but a catalytically inactive 
dominant negative form (denoted as DOCK180 DN carrying mutations in the residues 
1487–1489, Ile-Ser-Pro Ala-Ala-Ala) (Brugnera et al. 2002) also reduced Rac1 activity 
and shifted its peak away from the edge. This was quantitatively substantiated with 
linescan analysis and measurements of peak activation (Figures 4.3D, 4.3E, S4.3B and 
S4.3C).  We also asked whether the RhoGDI-3 regulation of RhoG elucidated in the 
previous section could impact Rac1 at the cell edge. Consistent with the above results, 
knockdown of RhoGDI-3 increased Rac1 activation, shifting it closer to the cell edge 
(Figures 4.3D, 4.3E, and S4.3D).  Overexpression of RhoGDI-3 reduced Rac1 activity 
(Figure 4.3F).  Together these results demonstrate that RhoG regulates both the position 
and level of Rac1 activity in cell protrusions, that these effects are mediated by the 
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bipartite DOCK180/ELMO GEF complex, and that this pathway is subject to RhoGDI-3 
regulation of RhoG.  
 
RhoG Regulates Adhesion and Actin Dynamics at the Leading Edge: 
We could now both activate and inactivate RhoG via RhoGDI-3 or RhoG 
knockdown, enabling us to more precisely define the role of RhoG in regulating Rac and 
various components of the motile machinery. Because Rac1 activation in cell protrusions 
is known to be controlled by numerous interactions at adhesion complexes (Ridley et al. 
1992; del Pozo et al. 2004; ten Klooster et al. 2006; Chang et al. 2007) we first examined 
whether RhoG was affecting Rac1 localization at adhesions, or adhesion dynamics. Time 
lapse imaging of CyPet-Rac1 together with mCherry-Paxillin showed accumulation of 
Rac1 at leading edge adhesion complexes. This accumulation was strongly reduced by 
RhoG knockdown, expression of RhoGDI-3, or expression of the ELMOT625 construct 
(Figures 4.4A and 4.4B), indicating that the signaling pathway elucidated above controls 
Rac1-adhesion interactions. These effects correlated with changes in Rac1 activity seen 
by TIRF FRET that match those illustrated in Figure 4.3 (Figure S4.4A and S4.4B).  We 
observed that DOCK180 was also localized at adhesions, while RhoG and ELMO were 
diffusely localized. These localization patterns were not affected by the  molecular 
manipulations that disrupted Rac adhesion localization. 
 (Figures S4.4C-E).  
RhoG signaling affected not only accumulation of Rac1 at adhesions, but also the 
adhesions themselves. Analysis of GFP-Paxillin within 6 μm of the edge of extending 
protrusions showed that RhoG knockdown, and overexpression of the ELMOΔT625 
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truncation mutant and RhoGDI-3 overexpression all affected adhesion size and number 
(Figures 4.4F-H).  The number of adhesions was decreased by RhoG knockdown, 
dominant negative RhoG (T17N), RhoGDI-3 or ELMOT625, while a constitutively 
active RhoG (Q61L) increased adhesion number.  The average adhesion area was also 
sensitive to RhoG, increased by  RhoG knockdown and decreased by RhoGDI-3 
knockdown, as revealed by automated image analysis. It is clear that RhoG affects the 
dynamics of adhesions, and this data supports involvement of the RhoG to 
ELMO/DOCK180 pathway discussed above. Interestingly, the increased adhesion size 
produced by RhoG knockdown resembles effects of increased RhoA or Rho kinase 
activity on adhesion size.  We hypothesized that RhoG knockdown might affect RhoA 
activation in these cells, but GST-RBD pull-down assay showed no effect on RhoA 
activation (Figure S4.4F).  
We also tested for effects of RhoG on protrusion/retraction dynamics. Kymograph 
analysis showed that control HeLa cells showed regular constitutive cycles of protrusion 
and retraction. Activation of RhoG through knockdown of RhoGDI-3 increased the rate 
of these cycles, while RhoG knockdown decreased the rate and led to more erratic timing 
(Figures 4.5A and 4.5B).  Consistent with the data presented in Figure 1D, RhoG 
knockdown decreased protrusion velocity and overactivation of RhoG via RhoGDI-3 
knockdown increased protrusion velocity (Figure 4.5C). Surprisingly, perturbation of 
RhoG activity also led to alterations in retraction velocity, possibly due to de-coupling of 
Rac1-RhoA feedback signaling at the leading edge (Figure S4.5).  Despite changes in 
velocity, the average protrusion length was relatively unaffected (control = 3.44 microns 
per protrusion, RhoG knockdown = 2.98, RhoGDI-3 knockdown = 2.98, none 
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significant) (Figure 4.5D).  To more directly assess actin polymerization atlamellipodial 
protrusions, we performed an actin filament barbed end assay to determine the 
distribution of polymerization-competent actin.  RhoG knockdown significantly shifted 
the peak barbed end density away from the cell edge (Figures 4.5E and 4.5F).   
Collectively, these data show that the differences in Rac1 activity and function 
observed upon manipulation of RhoG signaling translate to alterations in adhesion and 
lamellipodial dynamics.  Further, we show effects on the initiation of protrusion and the 
timing of protrusion/retraction cycles, rather than the distance traveled by each 
protrusion, which may be governed by a different mechanism. 
 
RhoG Plays a Role in Protrusion Formation and Determining the Frequency and 
Direction of Cell Turning: 
Our finding that RhoG is selectively targeted to the leading edge via vesicle 
trafficking suggested that it may play an important role in determining the direction of 
cell movement. We set out to test this hypothesis by studying the movement tracks of 
HeLa cells traveling on fibronectin. To quantify the movement of these cells we 
computed the average cell speed and persistence of movement.  We defined cell speed as 
the magnitude of distance, |d|, traveled by the cell centroid between successive time 
frames divided by the time interval, t, and persistence as the cosine of the 
difference,,  between the direction of movement of centroid between successive time 
frames.  We found extraordinarily strong effects of both RhoG knockdown and of 
RhoGDI-3 knockdown on both velocity and persistence (Figures 4.6A and 4.6B).  The 
effects on velocity were consistent with the effects of RhoG on Rac1, as multiple lines of 
evidence have previously shown that velocity is reduced when Rac1 is either inhibited or 
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overstimulated (Pankov et al. 2005; Petrie et al. 2009). The effects on persistence were, 
however, unexpected and showed that persistence increased when RhoG activity was 
increased or inhibited.  
To further characterize the role of RhoG on cell movement we developed a 
mathematical model that describes the motion of the cells as a random walk with 
persistence.  The simplest version of the model treats the distance moved by the centroid, 
d, and direction of movement, , as normally distributed random variables (Figure 4.6C). 
The distribution for d is characterized by its mean d and variance d. The distribution for 
is characterized by its variance  and is assumed to have a mean value given by the 
previous direction of movement. Note that as  becomes large this model becomes 
equivalent to two-dimensional diffusive motion and that small values of   signify 
highly persistent motion.  We used a Monte Carlo method to estimate the three model 
parameters (d ,d  and ) directly from the experimentally measured  cell tracks.  
Interestingly, our analysis revealed that a good fit between the model behavior and 
experimental data could not be achieved. Therefore we expanded the model to include the 
possibility that each cell could exist in two states. In each state the motion of the cell is 
again characterized by the three parameters (d i,d i and i), where the subscript i 
denotes state 1 or 2, and the final parameter denotes the fraction of time spent in state 
1.   Therefore, this version of the model contains 7 free parameters. The Monte Carlo 
method was again used to fit the expanded model to experimental data. In this case, 
excellent agreement between the model behavior and experimental data for all conditions 
tested was observed.  For the case of control cells, the model predicts the existence of a 
state in which the cell moves with high speed and persistent motion (‘fast’state)  and a 
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second state in which the speed and persistence of the cells are significantly reduced 
(‘slow’ state) (Figure 4.6D).  
 We next used the model to asses the effects of RhoG and RhoGDI-3 knockdown 
(Figures 4.6E and 4.6F). Despite the overall reduction in velocity, there were still two 
states with clearly different velocities. In contrast, the difference in persistence between 
the two states was abolished or greatly reduced, and all states became much more 
persistent. This indicated that RhoG was not necessary to generate the two states, but 
played an important role in generating the differences in persistence between them.  
Because differences in velocity remained throughout our treatments, the two states were 
denoted the ‘fast state’ and the ‘slow state’. 
 The model enabled us to predict which specific portions of cell tracks 
corresponded to the fast or slow states. Using the Rac1 and RhoG biosensors we 
examined the distribution of Rac1 and RhoG activity in the two states, and determined 
the effects of RhoG and RhoGDI-3 knockdown on the distributions (Figures 4.6H and 
4.6I). In the fast state of control cells, Rac1 activation localized to a single, defined 
leading edge, as would be expected for persistently moving cells. In contrast, control cells 
in the slow state showed multiple spots of Rac1 activation distributed around the cell 
periphery. Movies showed these states to be associated with protrusive activity extending  
from all sides of the cells. RhoG distributions (Figure 4.6I) paralleled those of Rac1, but 
RhoG activation was seen along the edge of the cell. 
 We asked whether RhoG was playing a role in generating the multiple foci of 
Rac1 by counting the foci in individual cells and examining effects of RhoG and 
RhoGDI-3 knockdown. Foci were defined as spots where activity at the cell edge was at 
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least 1.5x greater than that in the perinuclear region.  Control cells in the fast state 
averaged one spot of Rac1 activity per cell, while in the fast state they averaged 2-3 
spots.   RhoG knockdown cells showed a significant reduction in Rac1 activity at the 
edge (consistent with Figure 4.3) and reduced polarity (Figure 4.6J) but retained a single 
focus of Rac1 activity in the  fast state. In the slow state, these cells showed reduced 
Rac1 activity distributed all around their perimeters, without clear foci of activity. In 
contrast, when RhoGDI-3 was knocked down, Rac1 activity was increased in both states 
(consistent with Figure 4.3), decreased in polarity (Figure 4.6J) and the number of foci in 
both states increased. All this data is consistent with RhoG playing an important role in 
generating multiple foci of Rac1-mediated protrusion. 
 It was surprising that the increased number of foci in the fast state of RhoGDI-3 
knockdown cells was associated with increased persistence.  We hypothesize that the 
cell’s ability to turn depends on responding to the changes at the cell edge revealed in our 
studies of foci of Rac activation, perhaps by picking a new leading edge there.  In the 
RhoGDI-3 knockdown case, foci are generated over a much higher background of 
activated RhoG and Rac1,  as demonstrated by quantitative analysis of  activity 
distributions (Figure  4.6K). This could inhibit the cell’s ability to discriminate new 
regions of polarization. 
 Finally, we examined whether the ability of RhoG to produce multiple foci of 
Rac1 activity played a role in three dimensional migration. HeLa cells were embedded 
within a matrigel plug and allowed to migrate for 18-24 hours before imaging on a two 
photon laser scanning confocal microscope. As described in previous studies, wild type 
cells moved by extending several rounded pseudopods in multiple directions (Sahai and 
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Marshall 2003; Sanz-Moreno et al. 2008).    Consistent with the results above, depletion 
of RhoG activity through RhoG knockdown redued the number of these pseudopods, and 
overactivation of RhoG through RhoGDI-3 knockdown substantially increased the 
number of pseudopods (Figures 4.6L and 4.6M).  
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4.4  Discussion and Ongoing Studies 
RhoG is Activated at the Leading Edge during Protrusion: 
 In this paper we demonstrate the construction and validation of a novel FRET-
based biosensor for RhoG activity that sensitively detects RhoG activation in living cells.  
A previous sensor for RhoG exists (Mohammadi and Isberg 2009), but was only used to 
assess host-pathogen signaling at the dorsal surface of cells.  Our new sensitive sensor 
reveals that RhoG is activated coincident with cellular protrusion, as had been previously 
reported for RhoA, but contrasting with the measures previously reported for Rac1 
(Machacek et al. 2009).  This was unexpected, given that the similarity of RhoG to Rac1 
has led many to propose that RhoG and Rac1 have redundant and overlapping functions 
in the cell.  Thus it appears that RhoG activation is temporally separable from Rac1 
activation.  There is evidence that RhoG can signal both independently of Rac1, and in 
parallel (Wennerberg et al. 2002; Katoh and Negishi 2003; Ellerbroek et al. 2004).  Thus, 
it is conceivable that the activation of RhoG prior to Rac1 accomplishes two goals: 1) to 
prime the locations of Rac1 activity, perhaps by initiating actin polymerization, and then 
2) to activate Rac1 through the ELMO/DOCK180 complex, whereby Rac1 continues to 
polymerize actin during lamellipodial protrusion, and where Rac1 can also contribute to 
the turnover of focal adhesions at the leading edge. 
While the role of RhoG has clearly been delineated in engulfment behaviors 
where it activates Rac1 through ELMO/DOCK180, its role has been difficult to discern in 
cell migratory behaviors.  Early studies of RhoG indicated that it could signal both in 
tandem and in parallel with both Rac1 and Cdc42.  Most subsequent studies have focused 
predominantly on its activation of Rac1, and no mechanism has yet been elucidated for 
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its ability to activate Cdc42.  How RhoG is regulated has also remained unclear.  For 
example, the molecule(s) that activate RhoG are largely unknown.  As was reported 
recently, RhoG can also be held in its inactive form on the scaffolding protein synectin at 
the leading edge (Elfenbein et al. 2009), but the GEF(s) responsible for activating RhoG 
in this system was not identified.  We do know that upon EGF stimulation the GEFs 
Vav2/3 are capable of activating RhoG (Samson et al. 2010).  With the recent discovery 
of a protein complex found in vesicles consisting of the sorting nexins (SNX 1 and 2), 
Trio, and RhoG (Prosser et al. 2010), it is tempting to speculate that Trio may be the GEF 
that is responsible for activating RhoG upon release from vesicles.  Indeed, we have 
evidence that Trio regulates a large percentage of RhoG activation in the cell systems 
described in this study (unpublished data).  Further, given the results in this paper 
identifying RhoG activity as being closely correlated with protrusional velocity, its 
similarity to RhoA in these same measurements (Machacek et al. 2009), and the presence 
of GEF domains in Trio that activate both RhoG/Rac1 and RhoA (Debant et al. 1996), 
Trio could conceivably coordinate the activation of both GTPases in response to 
environmental cues.   
  
RhoG Activity is Regulated by Trafficking and RhoGDI-3: 
We also demonstrate that RhoG localization and activity are dependent on 
endocytic recycling as regulated by RhoGDI-3, as shown in the model in Figure 7.  RhoG 
has been shown to associate with protein components involved in cellular trafficking, 
including microtubules via kinectin, caveolin-1 and clathrin (Prieto-Sanchez et al. 2006; 
Samson et al. 2010), and with GDI-3 (Brunet et al. 2002) which has a vesicular 
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localization pattern.  However, the importance of these subcellular localization patterns 
had not been elucidated.  Here, we present evidence that RhoG is actively trafficked to 
and from the leading edge in vesicular structures, and that this pathway regulates its 
membrane targeting and presence at the leading edge of migrating cells.  However, 
several questions remain about this RhoG/Rac1 signaling axis.  First, how does the cell 
regulate the recycling of RhoG: does this occur through regulation of RhoGDI-3 itself, or 
through some other mechanism that targets RhoG to the plasma membrane, and RhoGDI-
3 only serves to prevent the activation of RhoG?  Much still remains to be discerned 
about the regulation of RhoGDI-3 and its precise cellular function.   
 
RhoG Activity Coordinates the Local Activation of Lamellipodial Rac1: 
We also define that RhoG regulates the recruitment and activation of 
lamellipodial Rac1, leading to changes in focal adhesion dynamics, actin rearrangement, 
and productive polarized cell migration in the system tested herein.  This is largely due to 
the ability of active RhoG at the leading edge to recruit Rac1 through ELMO/DOCK180 
and orchestrate its local activation.  Dysregulation of RhoG and its trafficking results in 
either indiscriminate activation of Rac1, or loss of activation of Rac1 in the 
lamellipodium.  Thus, RhoG represents an upstream signaling molecule that serves as a 
local coordinator of Rac1 activation, both preventing indiscriminate activation of Rac1, 
and priming Rac1 for appropriate localized activation.  Given the rapid recycling of 
RhoG, this provides a mechanism by which the cell can rapidly shuttle an activating 
factor to the appropriate site along the leading edge to activate a downstream molecule, in 
this case Rac1, and thus initiate cellular behaviors.   
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Many questions remain, however, about how these molecules are regulated in the 
lamellipodium.  For example, what are the cues that terminate both RhoG and Rac1 
signaling?  Traditionally, GAPs and GDIs have been identified as major inactivators of 
the GTPases, so these are certainly possibilities in this signaling pathway.  Also, since 
RhoG and Rac1 have both been shown to be endocytosed (Prieto-Sanchez et al. 2006; 
Palamidessi et al. 2008; Samson et al. 2010), and since endocytosis is a commonly used 
strategy to terminate or alter intracellular signaling, perhaps endocytosis of the GTPases 
themselves from the membrane leads to association with proteins that terminate their 
signaling, or sequestration away from GEFs preventing their activation.     
Such signaling pathways are highly conserved throughout evolution: RhoG signal 
transduction, and endocytic recycling for the coordination of cell signaling.  Rac1 appears 
to be at the confluence of these mechanisms which precisely position and regulate its 
localized activation, and thus Rac1’s ability to orchestrate the actin dynamics required for 
lamellipodial protrusion and productive cell migration. 
 
RhoG Regulates the Ability of Cells to Turn during Random Migration: 
The role of RhoG in cell migration has been difficult to discern, in large part due 
to its ability to directly activate Rac1, its closest homolog.  Divergent results have been 
obtained, with some work suggesting RhoG is dispensible for cell spreading (Meller et al. 
2008), others suggesting it is important for cell migration in a wound-healing assay 
(Katoh et al. 2006), and other studies demonstrating that downstream targets of RhoG are 
present at the leading edge of cells (Ho et al. 2009).  A RhoG knockout mouse was even 
generated (Vigorito et al. 2004), which was viable and showed few, if any, defects.  
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However, it is clear that RhoG does indeed respond to growth factors such as EGF and 
FGF2 (Elfenbein et al. 2009; Samson et al. 2010), but these growth factors are often 
applied at concentrations that also activate Rac1 independently of RhoG, hindering an 
analysis of RhoG function in such a chemotactic system. 
We demonstrate that RhoG signaling is important for cell migration, since 
dysregulation of RhoG alters migratory behaviors in a random migration assay due to the 
altered activation patterns of Rac1.  By using random, non-stimulated motility in this 
study, we believe that we have overcome prior difficulties in assessing the independent 
role of RhoG in migration.  In such an assay, the cell responds to cues in a shallow 
gradient, and thus is continually changing directions as new “dominant” cues or cell-
intrinsic mechanisms drive the motility of the cell in a new direction.  The precise defects 
we observe with perturbation of RhoG activity are a decrease in velocity, consistent with 
previous studies (Monypenny et al. 2009), and an increase in persistence.  The decrease 
in velocity is not unexpected, as most of the GTPases, when perturbed, lead to reductions 
in cellular velocity, but are still capable of motility.  Indeed, even in cells where Rac1 has 
been genetically ablated, the cells are still motile and respond to growth factors such as 
PDGF (Vidali et al. 2006).  However, the alterations in persistence are quite striking and 
are present in both the low and high activity states of RhoG, indicating that proper 
regulation of RhoG signaling is required for the ability of cells to turn in a random 
migration assay.  We find that this ability to turn is dependent on the cell’s ability to 
generate a distinguishable high activity “focus” of Rac1 activity.  With loss of RhoG, 
cells have difficulty in initiating new sites of Rac1 activation and thus there are fewer 
foci with which to turn.  Curiously, even though Rac1 is increasingly activated in the 
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high RhoG activity condition, the cell is prevented from distinguishing these high activity 
foci due to the high baseline activity.  Thus, in both cases, cells remain persistent, albeit 
slower. 
 
Small GTPase Signaling in the Regulation of Directed Cell Migration: 
We have described a signaling pathway that uses a number of mechanisms to 
properly orchestrate the amount, timing, and positioning of Rac1 activation to guide cell 
migration.  This study also clarifies the role of RhoG in cell migration, which has 
previously been difficult to elucidate (Katoh et al. 2006; Meller et al. 2008), using 
complementary biochemical and live-cell imaging techniques.   It also elucidates the role 
of RhoGDI-3 in regulating RhoG, and its importance for the regulation of Rac1 activity, 
demonstrating the complex mechanisms by which cells define the spatial and temporal 
parameters of GTPase activities to permit coordination of productive cell migration.  The 
mechanisms reported here resemble in some ways previous work (Palamidessi et al. 
2008) examining the endocytic recycling of Rac1 and its activation on endosomes by 
Tiam-1 in that the activity of Rac1 is controlled by endocytic recycling.  However, there 
are significant differences in that the subpopulation of lamellipodial Rac1 here does not 
appear to be “pre-activated” before delivery to the edge, but rather is recruited and 
activated by RhoG-dependent signaling for the regulation of cell migration.  Similarly, 
RhoG remains inactive in vesicles as well until delivered to the edge for activation, and 
simply happens to use the endocytic machinery to target specific regions of the cell to 
regulate Rac1.  In this study, and in previous studies (Hasegawa et al. 1996; Kiyokawa 
and Matsuda 2009; Tachibana et al. 2009), it has been shown that DOCK180 localizes to 
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focal adhesions independent of RhoG, and is known to activate Rac1 there via a number 
of signaling pathways (Cote and Vuori 2007).  Since we show that RhoG regulates the 
recruitment of Rac1 to focal adhesions, the question emerges whether RhoG signaling 
and integrin function converge on these high-affinity Rac1 binding sites to localize and 
anchor Rac1 to the leading edge for the promotion of lamellipodial protrusion (del Pozo 
et al. 2004; Del Pozo and Schwartz 2007).  Integrins have been shown to be critical for 
lamellipodial protrusion, and indeed redistribution of these integrins to the leading edge 
can even promote protrusion.  Curiously, these integrins often prevent the internalization 
of caveolin-rich lipid rafts, which are sites of high affinity for Rac1 (Del Pozo and 
Schwartz 2007), and these are also sites where focal adhesions form (ten Klooster et al. 
2006; Nethe et al. 2010).  Since RhoG is also known to associate with caveolin-positive 
vesicles and traffic along microtubules, focal adhesions and the nearby membrane at the 
leading edge may be the target for endosomally recycled RhoG.  The common thread is 
that these strategies are used by the cell to define the spatial and temporal constraints on 
Rac1 activity required for appropriate function.   
 
Spatiotemporal Coordination of Signaling in Physiological Migration:  
Lastly, since we show that RhoG has significant impacts on the migratory 
behaviors of cells in both 2- and 3-dimensional matrices, this has implications for cellular 
behaviors in vivo.  Given that RhoG is known to promote both lamellipodium and dorsal 
wave formation (Ellerbroek et al. 2004; van Buul et al. 2007a), and that both actin-rich 
structures have been proposed to be important for 3-dimensional motility (Buccione et al. 
2004; Gu et al. 2011), it would be reasonable to expect RhoG to have more profound 
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effects in 3-dimensional matrices as we have shown.  Thus one might expect RhoG to 
influence physiological migration behaviors, such as cell migration during development, 
or cancer cell metastasis.  Indeed, in parallel to studies that show that RhoA levels 
decrease and RhoC levels increase in highly aggressive metastatic breast cancers and that 
this was associated with decreased patient survival (Clark et al. 2000), a study showed 
that RhoG and RhoGDI-3 protein levels were increased and decreased, respectively, in 
tandem, also associated with decreased patient survival (Jiang et al. 2003).  As we have 
shown in this study, such a molecular change would serve to alter the spatial and 
temporal constraints on signaling by increasing and broadening the activation of RhoG, 
and consequently increasing and broadening Rac1 activity.  In vivo, this would likely 
translate to increased protrusion formation and potentially increased cell migration.  
Further, one of the scaffolds known to regulate RhoG signaling, synectin, is highly 
expressed in a number of malignancies and promotes tumor growth (Lee et al. 2009; 
Muders et al. 2009; Choi et al. 2010; Wang et al. 2010).  Thus, our findings suggest that 
RhoG may be a key regulatory node for the precise regulation of Rac1 localization and 
activity.  Further, since RhoG only regulates a subpopulation of Rac1 and manipulation 
of RhoG does not appear to directly interfere with the behavior or expression levels of 
any of the other major GTPases, RhoG and its regulators could be potential targets of 
pharmacological intervention to control migration-related disease processes, such as in 
cancer or inflammation.  Such a strategy could have potentially fewer side effects than 
inhibiting the major GTPases themselves.  Understanding these signaling processes, 
particularly those upstream of this RhoG/Rac1 signaling axis, will be important in further 
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understanding how cells properly orchestrate cellular signaling to permit normal function 
and behavior. 
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4.5  Materials and Methods 
Expression Constructs and Antibodies:  
Expression constructs:  To generate CyPet-RhoG, the full-length cDNA for RhoG 
was amplified by PCR using the primers: and subcloned into the pCyPet vector 
previously described via BamHI and EcoRI restriction sites.  The Q61L and T17N point 
mutants in RhoG were generated by site-directed mutagenesis.  To generate mCherry-
RhoG, the full-length cDNA for mCherry was amplified by PCR and subcloned into the 
pTriEx-4-6x-His vector via BamHI and EcoRI restriction sites (creating pTriEx-
mCherry-C1), followed by subcloning of full-length RhoG cDNA into EcoRI and XhoI 
restriction sites with a GSGS linker between mCherry and RhoG.  An identical strategy 
was used to generate mCherry-Rac1.  The GST-ELMO1, GST-PBD, CyPet-Rac1, Rac1 
biosensor, RhoA.SC biosensor, Vav2, Tim, Tiam-1, p50RhoGAP, Rap1GAP, GDI-1 
(Pertz et al. 2006) and mCherry-PLEKHG6 constructs (Samson et al. 2010) have all been 
described previously.  Full-length cDNA for RhoGDI-3 was acquired from Open 
Biosystems.  To generate RhoGDI-3-mCherry, the full-length cDNA for mCherry was 
amplified by PCR and subcloned into the pTriEx-4-6x-His vector via NotI and XhoI 
restriction sites (creating pTriEx-mCherry-N1), with subsequent amplification and 
subcloning of full-length RhoGDI-3 into NcoI and HindIII restriction sites, Full-length 
cDNAs for DOCK180 and DOCK180 dominant negative (ISP to AAA mutant) were 
generous gifts from the Ravichandran laboratory (University of Virginia), and were 
amplified by PCR, with subcloning into the pTriEx-mCherry-C1 vector described above 
via NotI and XhoI restriction sites. To generate mCherry-ELMO1, full-length ELMO1 
was amplified by PCR and subcloned into the pTriEx-mCherry-C1 vector described 
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above via NotI and XhoI restriction sites.  To generate mCherry-ELMO1ΔT625, a stop 
codon was generated after amino acid 625 in the mCherry-ELMO1 construct by site-
directed mutagenesis.  EGFP-Paxillin, mCherry-Paxillin, EGFP-Vinculin, and mCherry-
Vinculin were gifts from the Burridge laboratory. The constructs for EGFP-Rab4, EGFP-
Rab5, EGFP-Rab7, EGFP-Rab11 were generous gifts from the Ehlers laboratory (Duke 
University).  To generate the mCherry-Rab4, mCherry-Rab5, mCherry-Rab7, and 
mCherry-Rab11 constructs, the full-length cDNA from each Rab was amplified by PCR 
and cloned into the pTriEx-mCherry-C1 vector above via NotI and XhoI restriction sites.   
For western blotting, the anti-RhoG antibody was acquired from Millipore (mouse 
monoclonal antibody, clone 1F3B3E5), the anti-Rac1 antibody was acquired from BD 
Transduction Laboratories (mouse monoclonal antibody, #610651), the anti-ELMO1 was 
acquired from abcam (goat polyclonal antibody, #ab2239), and the anti-synectin antibody 
was acquired from Santa Cruz Biotechnology (goat polyclonal antibody, #sc-9648).   
 
Cell Culture and Transient Transfections: 
Cos-7, HeLa, and Mouse Embryonic Fibroblast (MEF) cells were maintained in 
Dulbecco’s modified Eagle’s Medium (DMEM) (Cellgro) supplemented with 10% fetal 
bovine serum (FBS) (HyClone), 100 U/mL penicillin and 100 μg/mL streptomycin 
(Cellgro) and 2 mM L-glutamine (Invitrogen) at 37 °C and 5% CO2.  All cDNA 
constructs were transfected into cells using FuGene6 (Roche) according to the 
manufacturer’s instructions.  siRNA was transfected into HeLa cells using the TransIt 
siRNA transfection reagent (Mirus) according to the manufacturer’s instructions.  Briefly, 
1.5 ml serum-free media was mixed with 18 µl siQuest reagent and 11.25 μl of a 20 μM 
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siRNA stock solution. After 20 min incubation at room temperature the complexes were 
added to a 10 cm tissue culture dish (cell confluency ~ 50%) with 7.5 ml fresh media 
containing serum. After 24 hours, the cells were re-transfected by the same method. 48 h 
after the first transfection the cells were split 1:3 and used for experiments between 72 to 
96 h post transfection where knock-down efficiency was found to be maximal.  
 
siRNA Sequences: 
Target sequences were as follows: RhoG anti-sense: 
GCAACAGGAUGGUGUCAAGUU, sense: CUUGACACCAUCCUGUUGCUU; 
RhoGDI-3 anti-sense: UCUGUAAUCAACACCUUCCdTdT,, sense: 
GGAAGGUGUUGAUUACAGAdTdT.  The control siRNA (anti-sense: 
UCACUCGUGCCGCAUUUCCdTdT, sense: GAAAUGCGGCACGAGUGAdTdT) has 
been used previously (Cai et al. 2007). 
 
RT-PCR: 
To test effective knock-down of GDI-3 we performed RT-PCR. Total RNA was 
isolated from transfected HeLa cells using Trizol reagent (Invitrogen). For reverse 
transcription ‘iScript cDNA Synthesis Kit’ (Biorad) was used according to the 
manufacture’s protocol. For semi-quantitative RT-PCR, an aliquot of the RT-reaction 
was amplified using Taq polymerase. Primers: GDI-3: fwd: 5’- 
ATGCTGGGCCTGGACGCGTGCGAGCTG-3’; rev: 5’-
TCAGGGGAGACACGGACTGGG-3’, β2-microgobulin: fwd: 5’-
CTCGCGCTACTCTCTCTTTCTGG-3’; rev : 5’-
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GCTTACATCTCTCAATCCCACTTAA-3’. PCR conditions: 28 cycles: 15 sec 94 °C, 
30 sec 55° C, 60 sec 72° C. 
 
Biochemical Measurement of RhoG and Rac1 Activity: 
To measure endogenous levels of GTP-loaded RhoG and Rac1, we used pull-
down assays as previously described. Briefly, cells were washed twice with ice cold TBS 
(50 mM Tris, pH 7.4, 5 mM MgCl2, 150 mM NaCl) and then lysed in lysis buffer (50 
mM Tris, pH 7.4, 10 mM MgCl2, 150 mM NaCl, 1% Triton X-100, 1 mM PMSF, and 10 
μg/ml each of aprotinin and leupeptin). After clearing the lysates by centrifugation at 
14,000 g for 5 min, protein concentrations of the supernatants were determined and equal 
amounts of total protein were used to measure RhoG.GTP and Rac1.GTP. The 
supernatants were rotated for 30 min with glutathione-sepharose beads (GE Healthcare) 
which were loaded with 60–90 μg of either GST-ELMO (GST fusion protein containing 
the full-length RhoG effector ELMO) or GST-PBD (GST fusion protein containing the 
Pak1-binding domain). Subsequently the beads were washed four times in lysis buffer. 
Pull-downs and lysates were then immunoblotted for RhoG or Rac1, respectively. 
 
Actin Barbed End Assay: 
The density of free F-actin barbed ends was measured as previously described 
(Bryce et al. 2005), but with slight modifications: HeLa cells were plated at subconfluent 
density on fibronection (10 ug/ml) coated cover slips in DMEM / 2% FBS. After 4 hours, 
the cells were briefly washed with prewarmed PBS. Barbed end labeling was done for 
180 seconds in Permeabilization Buffer: 20 mM HEPES, 138 mM KCl, 4 mM MgCl2, 3 
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mM EGTA, 0.2 mg/ml saponin, 1 % BSA, 1 mM ATP, 3 µM phalloidin, 0.4 µM 
Rhodamine-Actin (Cytoskeleton). Subsequently the cells were quickly washed with PBS 
and then fixed for 10 min in 4% paraformaldehyde in Krebs Buffer (20 mM HEPES pH 
7.4, 145 mM NaCl, 5 mM KCl, 1.2 mM CaCl2, 1.3 mM MgCl2, 1.2 mM NaH2PO4, 10 
mM glucose, 0.4 M sucrose). Epifluorescence images of randomly chosen isolated cells 
were taken. Binary image masks were generated from median filtered images (20x20 
matrix) and applied on the original image. Line scans (line width 20 pixels, perpendicular 
to the cell edge) were placed at randomly selected positions which appeared to be 
actively protruding cell areas at the moment of cell fixation. Counted from the cell edge, 
the distance of the point with maximum fluorescence value on this line scan was 
determined within a distance range of 8 m from the cell edge. 
 
Rho GTPase Activity Biosensors: 
The RhoA and Rac1 biosensors were used as originally described and validated 
(Pertz et al. 2006; Machacek et al. 2009).  The RhoG biosensor consists of two plasmids: 
for the first plasmid, the fluorescent protein YPet (Nguyen and Daugherty 2005) was 
fused to the C-terminus of amino acids 1-95 of full-length ELMO1 with an intervening 
linker coding for the amino acid sequence: SGLRSELGS, while for the second plasmid, 
CyPet (Nguyen and Daugherty 2005) was fused with the N-terminus of full-length RhoG 
with an intervening linker coding for the amino acid sequence: SGLRSELGS, leaving the 
C-terminus free for appropriate lipid modification and interaction with guanine 
dissociation inhibitors (GDIs).   
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TIRF Microscopy: 
For TIRF imaging, cells were plated on fibronectin-coated coverslips (10 mg/l 
fibronectin) 4 h before imaging, then transferred to Ham’s F12-K imaging medium 
(described above) supplemented with 2% FBS and 15 mM HEPES. Live cell imaging 
was performed in a closed heated chamber (20/20 Bionomic Controller) using an 
Olympus IX-81 microscope equipped with an objective-based total internal reflection 
fluorescence (TIRF) system and a PlanApo N 60× TIRFM objective (NA 1.45). All 
images were collected using a Photometrics CoolSnap ES2 CCD camera controlled by 
Metamorph software. The 440 nm line from a Kimmon IK Series HeCd laser, the 468 nm 
and 568 nm lines from an omnichrome series 43 Ar/Kr laser, and the 594 nm line from a 
Cobolt Mambo laser were used for TIRF imaging.  Epifluorescence images were taken 
using a 100 W Hg arc lamp light source. Cells expressing the various fluorescent 
constructs used throughout the paper were selected using epifluorescence imaging. Time-
lapse movies were taken at anywhere from 20 second to 1 minute time intervals as noted 
elsewhere. TIRF image analysis was performed using Metamorph software.  TIRF FRET 
image analysis was performed as described below for FRET acquisition and FRET 
Ratiometric image analysis. 
 
Live Cell Imaging for FRET Acquisition and FRET Ratiometric Corrections: 
For live cell imaging, cells were plated on fibronectin-coated coverslips (10 mg/l 
fibronectin) 4 h before imaging, then transferred to Ham’s F12-K imaging medium 
(described above) supplemented with 2% FBS and 15 mM HEPES. Live cell imaging 
was performed in a closed heated chamber (20/20 Bionomic Controller).  Biosensors 
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were imaged as previously described (Pertz et al. 2006; Machacek et al. 2009).  Briefly, 
cells observed by widefield microscopy for cross-correlation analysis and the analysis of 
Rac1 activity were filmed at 10-20 second intervals using a 40X/1.3 NA objective and 
2X2 binning, a CCD camera (CoolsnapES2; Photometrics), and MetaMorph software 
(Universal Imaging).  Cells observed by TIRF microscopy for FRET were filmed at 30 
second intervals using a 60X/1.45 NA objective and 2X2 binning, a CCD camera 
(CoolsnapES2; Photometrics), and MetaMorph software (Universal Imaging).  For 
emission ratio imaging by widefield microscopy, the following filter sets were used 
(Chroma Technology Corp.): CFP: D436/20, D470/40; FRET: D436/20, ET535/30; YFP: 
D500/20, ET535/30.  mCherry was imaged using an D580/30, HQ630/40 filter where 
indicated, and EGFP was imaged using D470/40, HQ525/50 where indicated.  Cells were 
illuminated with a 100 W Hg arc lamp through an ND 1.0 neutral density filter.  For 
emission ratio imaging by TIRF, the same filtersets were used as above, but instead of 
illumination with a Hg lamp, the 440 nm line from a Kimmon IK Series HeCd laser, the 
468 nm and 568 nm lines from an omnichrome series 43 Ar/Kr laser, and the 594 nm line 
from a Cobolt Mambo solid-state laser were used.   Dichroic mirrors were custom-
manufactured by Chroma for compatibility with all of these filters.  At each time point, 
three images were typically recorded with the following exposure times for ratio imaging: 
CFP (1.2 s), FRET (1.2 s), and YFP (0.4 s).  These exposure times were more variable for 
TIRF but typically reflected the same ratio of times.  Raw images were sub-pixel aligned 
and background subtracted to allow ratiometric correction of volume effects and variation 
in sensor concentration.  Ratio calculations to generate activity images were performed 
following bleedthrough and photobleaching correction methods described previously 
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(Hodgson 2009), since each component of the dual-chain biosensor is not distributed 
equally throughout the cell.  For bleedthrough correction, cells expressing the CFP 
fluorophore or YFP fluorophore alone were imaged using the same imaging medium, 
exposure times, and intensities as those for the actual experiment. These measurements 
were used to determine the amount of bleedthrough of each fluorescent protein’s direct 
emission into the FRET channel.  Images from each channel were shade corrected and 
background subtracted. Plotting FRET intensity as the dependent variable versus CFP or 
YFP intensity as the independent variable yielded a linear relationship where the slope of 
the line defined the bleedthrough coefficient for that fluorescent protein and condition.  
Using these parameters, the ratio was derived using equation (1): 
     (1) 
This equation corrects the raw FRET signal for bleedthrough from both CFP and YFP 
into the FRET channel, with subsequent calculation of the ratio.  For visual 
representations, a linear pseudocolor look-up table was applied to all ratio images and the 
ratio values were normalized to the lower scale value, which was chosen to exclude the 
bottom 5% of the total histogram distribution, thereby avoiding spurious low intensity 
pixels.  In each experiment, all images were carefully inspected to verify that all portions 
used to create the ratio image had a sufficiently high signal to noise ratio.  We targeted at 
least 400 gray level values (12-bit dynamic range) above background in the lowest 
intensity regions within the cell (S/N > 4).  This was especially important in thin parts of 
the cell where fluorescence was low.  
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Dual-Camera FRET Imaging: 
Dual-camera FRET imaging of vesicles was performed to minimize between-
acquisition movement of vesicles and improperly aligned resultant images.  Experimental 
design followed the protocols above for live-cell imaging, except for the filtersets used 
and order of image acquisition.  For these experiments, an Olympus IX-81 body was 
outfitted with a side-port dual-camera splitter (Photometrics DC2) with an HQ470/24 
emission filter placed before one CoolSnap ES2 camera and a long-pass 505 nm emission 
filter placed before the second CoolSnap ES2 camera.  With excitation from a 100 W Hg 
arc lamp through an HQ436/20 excitation filter, CFP and FRET emission can be acquired 
simultaneously. Subsequent YFP emission is acquired using excitation through a 
D500/20 excitation filter and emission through the long-pass 505 nm emission filter.  A 
custom dichroic (Chroma) was manufactured for compatibility with each fluorophore.  
Image acquisition considerations and processing was performed as described above.   
 
Whole-Cell FRET Analysis: 
To calculate whole-cell average FRET ratio, photobleach-corrected FRET ratio 
(FRET/CFP) time-lapse  image stacks acquired and processed as described above were 
loaded into Metamorph, thresholded to generate masks for each cell, and regions were 
drawn around each cell using the mask.  From these regions, a number of parameters, 
including average pixel intensity, could be measured and recorded.  Average FRET ratio 
was calculated for three separate time points, averaged, and recorded for each cell.   
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Single Cell Tracking and Kymography Analysis: 
HeLa cells treated as described were sparsely plated on fibronectin-coated 
coverslips in growth medium (DMEM (Mediatech) supplemented with 10% FBS 
(HyClone)) and allowed to attach for 6 hours.  10× phase time-lapse movies were 
recorded for 18 h with frames taken every 5 minutes on an Olympus IX-81 inverted 
microscope.  In each experiment 20-25 fields (containing 10-15 cells per field) were 
simultaneously recorded using an automated stage.  For the analysis, every cell in each 
movie that met the tracking criteria (was completely within the field of view for the entire 
experiment, did not divide, and did not touch another cell for more than three frames) 
was tracked using the Track Objects plug-in for Metamorph.  Data were exported into 
Microsoft Excel for analysis.  The velocity was calculated as an average of distance 
traveled between each time point (μm)/time between each time point (h) for each time 
segment.  The persistence of migration was calculated as an average net angular 
displacement from origin (radians) relative to an assumption of no net angular 
displacement from origin for each time segment.   
For kymography, 60X DIC time-lapse movies that contained 120 images were 
captured at 30 s or 1 minute intervals on an Olympus IX-81 inverted microscope and 
processed using Metamorph for each individual cell.  Kymographs were generated from 
3-5 protrusive areas of at least 12 cells per experimental group and lamellipodial 
parameters were calculated as follows: a line was traced along the cell border for each 
kymograph and the x-y coordinates along the line over time were extracted and recorded.  
From these x-y coordinates, positive net x displacement with increasing y values was 
defined as a protrusion, and negative net x displacement with increasing y values was 
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defined as a retraction.  A protrusion/retraction cycle was defined as the first positive net 
x displacement to the last negative net x displacement before positive net x displacement 
began again.  The number of these cycles per time length of the movie (hours) 
determined the retraction/protrusion cycles per hour.  Average protrusion or retraction 
distance was calculated by determining the net positive or negative x displacement.  
Average protrusion or retraction velocity was calculated by taking the average protrusion 
or retraction distance and dividing by the time frame encompassing the protrusion or 
retraction (displacement/time). 
 
Imaging and Quantitation of Focal Adhesion Dynamics: 
For time-lapse microscopy, HeLa cells were transiently transfected with EGFP- or 
mCherry-Paxillin-β, or mCherry-Vinculin, and plated on fibronectin-coated glass 
coverslips (Warner Instruments) in growth medium (DMEM with supplemented with 
10% FBS, Pen/Strep, and L-glutamine as above) the next day.  Cells were transferred to 
imaging medium (Ham’s F12K supplemented with 2% FBS, Pen/Strep, and L-glutamine) 
and imaged using an inverted Olympus IX-81 with a 60x 1.45 NA TIRFM objective.  
Cells were recorded for at least 60 minutes with frames taken every 1 min.  In 12-15 cells 
over three experiments, at least 15 focal adhesions that localized within 8 m of the 
leading edge per cell were analyzed with Metamorph software.  Only cells with a single 
nucleus were used for the analysis to avoid variations in relative area comprising the 
lamellipodium, and the total number of focal adhesions, due to cell size.  Number of focal 
adhesions per area was measured from thresholded images of at least 15 cells using 
Metamorph. To calculate adhesion size, Matlab code for automated image processing and 
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calculation of adhesion parameters was used (manuscript in submission).  In brief, the 
code was designed to accept time-lapse image sequences of cells expressing a focal 
adhesion marker such as Paxillin-β or Vinculin.  The program first creates a mask around 
each cell to exclude any background noise.  Next, the images are high-pass filtered and 
thresholded to isolate individual adhesions from the background.  Further, “connected” or 
adhesions in close proximity to one another are identified and isolated as individual 
adhesions.  Last, each individual adhesion is sequentially numbered and outlined by a 
region trace.  These regions are then analyzed for their properties, and in this case, 
particularly for the size in pixels.  Pixel number is then converted to size in square 
microns based on the size of a single pixel for a given lens and camera as measured by a 
micrometer standard.   
 
Linescan Analysis of Protrusional Rac1 Activity: 
To calculate protrusional Rac1 activity, photobleach-corrected Rac1 FRET ratio 
time-lapse (FRET/CFP) image stacks acquired and processed as described above were 
loaded into Metamorph.  Cells were visually inspected for cell health (defined as non-
retracting, non-blebbing cells) and regions of active protrusion to identify cells for 
analysis.  Once a protrusion was identified, the mid-protrusion frame was determined and 
analyzed for Rac1 activity.  Briefly, a line was drawn perpendicular to the direction of 
protrusion at mid-protrusion.  The line was then expanded to a width of 10-25 pixels (3.2 
µm to 8 µm) depending on the width of the protrusion, at least sufficient to encompass 
the entire protrusion, and a depth of at least 15 µm to prevent bias by user placement of 
the linescan.  The average Rac1 activity along the entire width and length of the line was 
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then recorded.  By inspecting the values measured along the line, the position of peak 
Rac1 activity could be determined and recorded for each cell measured.  In cases where 
co-transfection of an additional plasmid was needed, expression of that construct was 
monitored by fluorescence in the red channel for mCherry (D580/30, HQ630/40 emission 
filter as above). 
 
Rac1 Activity “Spot” Analysis: 
 To calculate the number of high Rac1 activity “spots” or regions, long (~18 hours, 
5 minute intervals) photobleach-corrected Rac1 FRET ratio time-lapse (FRET/CFP) 
image stacks acquired and processed as described above were loaded into Metamorph.  
Cells were visually inspected for cell health (defined as non-retracting, non-blebbing 
cells) and regions of high activity were observed (~20% over cell center) and quantified 
for cells treated with control, RhoG, and RhoGDI-3 siRNAs throughout the duration of 
the movie.  If two regions protruded in divergent directions, but were not separable by a 
20% difference in activity between the regions, they were still separated into two regions 
of high activity, but such occasions were infrequent. 
 
RhoGTPase Activity Correlation Analysis: 
Correlation analysis was performed as previously reported (Machacek et al. 
2009).  Briefly, corrected biosensor images were segmented and cell edge displacements 
tracked as in (Machacek and Danuser 2006). Sampling windows of 0.9 mm depth and 
1.8–3 mm width were constructed to follow morphological changes at a fixed distance 
from the cell edge. For each window, biosensor activation time courses were recorded.  
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For windows placed at the cell edge, additionally, a time course of protrusion/retraction 
velocity was recorded. Coupling of two activity time courses was analyzed per window 
by Pearson’s cross-correlation function. Subsequently, for a cell the per-window 
correlation functions between edge velocity and biosensor activation were averaged over 
all windows following the edge at a specific distance.  Per-cell correlation functions were 
averaged over multiple cells and statistically analyzed by bootstrap sampling to 
determine the significance and time lag of the coupling between two activities.  These 
procedures have been described previously in (Machacek and Danuser 2006; Machacek 
et al. 2009). 
 
3-D Migration Assay: 
To create 3-dimensional matrices, 3D gels were assembled in ¼” diameter 
polypropylene gas tubing cut and firmly secured to glass-bottom 35-mm dishes using 
epoxy resin.  The tubing was punctured in several sites to allow diffusion with medium in 
the rest of the dish.  HeLa cells transfected with mCherry, were resuspended and then 
mixed with 2X 3D gel master mix and added to the tubing.  The gel master mix, at final 
concentration (1x), consisted of 0.6 mg/mL LDEV-free, growth-factor reduced, phenol-
red free Matrigel (BD Biosciences), 0.6 mg/mL type I collagen (BD Biosciences), and 10 
ug/mL fibronectin (Sigma) in DMEM supplemented with 10% FBS containing 300,000 
cells.  The 3D gel-cell mixture was allowed to solidify for 20 min at room temperature, 
and DMEM supplemented with 10% FBS was subsequently added to the tubing and the 
remainder of the dish surrounding the tube.  Live cell imaging was then performed on an 
Olympus Fluoview FV1000MPE Multiphoton laser scanning microscope outfitted with a 
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zero-drift compensation (ZDC) device for active focal plane maintenance.  The matrix 
was kept in Ham’s F12K medium supplemented with 10% FBS and 15 mM HEPEs 
buffer (to create CO2-independent medium at 37° C by means of a Prior on-stage 
incubation chamber.  Automated image acquisition was performed using Olympus 
Fluoview software.  Z-stacks were acquired for single cells at sufficient intervals to 
satisfy Nyquist sampling requirements.   
 
Cell-Tracking and Cell-Track Modeling: 
Cell tracks were generated by 20x phase contrast imaging of HeLa cells plated on 
fibronectin-coated coverslips, imaged in Ham’s F12K medium supplemented with 2% 
FBS for 18-24 hours at 5 minute intervals in a closed heated chamber.  Movies were 
captured of  ~200 frames, 5 minutes apart.  Our approach here is to extract parameters 
that describe migration by fitting of a mathematical model to experimental data. 
Specifically, by fitting our model to data from the experimental cell tracks we derive 
parameters describing speed and persistence of migration. Furthermore, we fit standard 
deviations for these values for a given time interval. 
We model migration as a stochastic sequence of steps, Figure 4.6C. Since the 
speed  is generated independently from the angle  the probability density function for 
the position at  is 
 Equation (2) 
where  is the pdf for the normal distribution  and   is the pdf for 
the normal distribution , where  is the orientation from the previous 
step and . Note that inherent in the model (due to the linearity of the 
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normal distribution) the standard deviations (of speed and persistence) scale proportional 
to the square root of time – so our findings are independent of the frequency of time 
points in the cell tracks. Although, the higher the frequency of time points the less 
degeneracy there will be in our model fitting. In this paper we have normalized so that 
. 
To fit the model we compare the pdf to a histogram representing the cell data. In 
principle, we could generate histograms for  and  by measuring these directly from 
the data. However, consider   and . Since it is likely that in some cases cells 
take a backward step while maintaining their orientation (as part of the protrusion, 
retraction cycle), we note  this case is degenerate (in the sense of leading to the same 
Cartesian co-ordinates) with   and . To take account of this 
degeneracy we analyze our model in Cartesian co-ordinates. 
This histogram is generated from the cell tracks as follows. For all pairs of steps 
in a cell track, defined by , we rotate the pair as a rigid 
body about  by   then analyze the step . 
The result of this is that all steps are pre-orientated in an easterly direction and initiated at 
, and can be plotted as a histogram of step distance in the  or  direction.   By a 
change of variables, into Cartesian coordinates, equation (3) Error! Reference source 
not found. is fitted to a histogram of step distance in the  direction.  In Cartesian 
coordinates the pdf is  
 Equation (3) 
where , and, 
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Equation (4) 
 
The final histograms for both the control and KD case were amalgamated from 
multiple cells (n = 17 in the RhoG KD case, n = 74 in the RhoGDI3 KD and n = 40 in the 
control case). 
We fitted model parameters by simulated annealing. However, initially we found 
that the model could not satisfactorily fit the data (not shown). To improve this we 
introduced the possibility for multiple states of behavior, so that our model is now a 
mixture model. So in the case of two states, the fitted pdf is  
 
where  is the weight between pdfs  and  which are parmeterized by 
 and  respectively.  
Note that the one state solution was still permitted by the simulated annealing 
(initially parameters are set such that , with ). However, we found 
consistent convergence towards multiple states, and indeed the multiple state solutions 
were ~20% better (as quantified by sum of square deviations from the experimental data).  
Given that we have identified that in the data sets as a whole there exists two 
states of migration, we next asked how these states partitioned the data-sets. For example, 
a priori  there was no reason to suspect that the case where some of the cells were 
entirely in one state versus, the more interesting observation, where over the course of the 
experiment, cells switch between states. To identify what state a cell is in at a given time-
point we used Bayes’ theorem to invert the problem. That is we calculate the probability 
that a cell is in  given the experimental data. Note that in calculating this probability we 
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also get the false positive rate, or p-value.  In order to make a reliable prediction of  we 
found that we had to consider a 5-step window, . Then: 
 
where  is calculated from the model, and we take . 
 
Rac1 and RhoG Activity Polarity Analysis: 
We assessed polarity using a measure (polarity index –   previously 
developed: 
 
  Equation (5) 
where  is the geometric center,   the activity center (a weighted average of position, 
with pixels in the cell having the weight of the intensity ratio, and zero otherwise),  and 
 is the effective radius of the cell (  , where the area of the cell is ).  The 
partition of the data into multiple subsets (for each state) allowed us to calculate the mean 
polarity index for each state. To test if the difference between the mean polarity index, 
, for each state was significant we used a boot-strapping method: by sorting the data in 
to subsets at random, and repeating this multiple times, we built a distribution of the test 
statistic . 
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Statistical Analysis: 
Microsoft Excel was used for statistical analysis.  In each case, p-values were 
calculated using a two-tailed unpaired t-test assuming unequal variance.  Significance for 
all tests was assumed at p<0.05 (α 0.05). 
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4.7  Figures and Legends 
Figure 4.1:  Localization and Timing of RhoG Activation at the Leading Edge of 
Motile Cells. 
 
(A)  Probe design: a schematic representation of the intermolecular FRET RhoG activity 
biosensor.  GTP:  guanosine triphosphate, GDP: guanosine diphosphate, CyPet: cyan 
fluorescent protein, YPet: yellow fluorescent protein. 
(B) Normalized FRET/CFP emission ratios representing RhoG activity.  Biosensor 
responses were assessed with mutant and wild type RhoG biosensors in adherent Cos-7 
cells.  Biosensor response to GEFs was assessed in the presence of the catalytic DH-PH 
domains of Vav2 and Tim, C-terminally truncated Tiam-1 (C1199), or full-length 
PLEKHG6.  Response to GAPs and GDI was assessed in the presence of full-length 
p50RhoGAP, Rap1GAP, and RhoGDI-1.  Asterisks indicate p < 0.001 for signal from all 
conditions compared to WT (t-test), and data are represented as means  95% confidence 
intervals at α = 0.05.  
(C)  Representative images of RhoG, Rac1, and RhoA activity in randomly migrating 
mouse embryonic fibroblasts (left panels) and HeLa cells (right panels).  Scale bar, 20 
µm.  Images are scaled so that regions of intense GTPase activity are shown in white.  
Heat map indicating dynamic range scaling is shown for each cell.   
(D) Correlation of RhoG activity level in migrating mouse embryonic fibroblasts 
migrating on fibronectin with protrusion or retraction velocity and distance from the edge 
as assessed by automated linescan analysis.  Correlation is derived from 388,000 
measurements from 9 cells. 
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(E)  Timelapse images of RhoG activity in a mouse embryonic fibroblast migrating on 
fibronectin.  First panel illustrates the whole cell and subsequent panels are magnified 
images of the region outlined in white at noted time steps.  Scale bar, 20 µm.   
(F)  Cross-correlation analysis of RhoG activity with protrusional velocity as assessed by 
Pearson’s correlation coefficient.  Cross-correlation is significant above 0.42, represented 
by the dashed black horizontal line and indicating strong correlation.  Peak time lag 
between peak RhoG activity and protrusional velocity is indicated by the dashed red 
vertical line at t = -6 seconds ± 1.4 seconds.  Each line represents correlation of RhoG 
activity with protrusional velocity in regions 1 (red line), 2 (yellow line), 3 (blue line), 4 
(green line), 5 (orange line), or 6 µm (black line) from the leading edge of the cell.  Data 
is derived from 320 measurements from 9 cells across 3 separate experiments. 
(G) Ten pixel-wide linescans of RhoG, Rac1, and RhoA activity in protrusive regions of 
migrating cells were normalized and averaged for 12 cells for each GTPase activity.  
Average normalized activity along the length of protrusions is given for RhoG (blue 
trace), Rac1 (red trace), and RhoA (green trace).  Dashed lines indicate 95% confidence 
intervals for each trace.  See also Supplemental Figure S4.1. 
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Figure 4.2: RhoG is Targeted to the Leading Edge by Endosomal Recycling and is 
Regulated by RhoGDI-3. 
 
(A)  Cos-7 cell expressing mCherry-RhoG showing localization to vesicles.  
(B) Disk-spinning confocal images of a HeLa cell co-expressing CyPet-RhoG and 
mCherry-tubulin showing colocalization of motile vesicles (arrows) on microtubules 
(yellow trace). 
(C) Quantitation of colocalization of RhoG-positive vesicles with Rab-GTPase positive 
vesicles. Colocalization is represented as a percent of RhoG-positive vesicles co-stained 
with Rab-positive vesicles.  Data are represented as means  95% confidence intervals at 
α = 0.05.  N > 270 vesicles for each condition for at least 10 cells per condition. 
(D) Quantitation of RhoG activity in vesicles as assessed by live-cell dual-camera 
epifluorescence imaging.  CyPet-RhoG image shows RhoG-positive vesicle (red arrow), 
and corresponds with the middle RhoG activity image.  Right panel shows a trace of 
activity corresponds to white line in RhoG activity image showing peak activity at the 
edge and minimum activity within the vesicle (black arrows). 
(E) Epifluorescence images (inverted) of live cells expressing mCherry-tagged RhoGDI-
3 (left panel) showing predominantly perinuclear localization but also presence in 
vesicles that colocalize with CyPet-RhoG.    
(F) Epifluorescence images of live cells expressing mCherry-tagged RhoGDI-3 (right 
panel) in one of two cells (second cell outlined in red) and CyPet-RhoG (left panel) in 
both cells illustrating effects of RhoGDI-3 on RhoG localization.  RhoG remains 
predominantly perinuclear in the presence of RhoGDI-3, but is lamellipodial and 
membrane-bound in the absence of ectopic RhoGDI-3 expression.   
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(G) Quantitation of RhoG fluorescence intensity ratio of the lamellipodium to the 
perinuclear region in cells expressing CyPet-RhoG and transfected with mCherry-
RhoGDI-3, a control siRNA, or RhoGDI-3 siRNA.   
(H) Quantitation of RhoG activity in the presence or absence of RhoGDI-3 as assessed by 
FRET in adherent HeLa cells.  Data are represented as means  95% confidence intervals 
at α = 0.05.  Asterisks indicate p < 0.05 by t-test.  
(I) Representative images of RhoG activity in HeLa cells expressing a RhoG activity 
sensor and transfected with either mCherry-RhoGDI-3 or RhoGDI-3 siRNA.  Images are 
scaled so that regions of intense GTPase activity are shown in white, and both cells are 
scaled identically to allow visual comparison.  Heat map indicating dynamic range 
scaling is shown for each cell.   
(J) Timelapse image integrated over 120 minutes of a HeLa cell expressing either CyPet-
RhoG, or CyPet-RhoG and mCherry-RhoGDI-3 illustrating the preference of RhoG-
positive vesicles for the perinuclear region and the leading edge in the direction of 
cellular movement in the wild-type condition (left panel).  With RhoGDI-3 
overexpression, transit of vesicles to the leading edge is blocked (right panel).  Cells were 
thresholded to isolate vesicles, and integrated time spent by vesicles in a given pixel is 
indicated by white coloration on a blue background.  Cell outline is indicated in red, and 
direction of movement is indicated by large white arrow.  See also Supplemental Figure 
S4.2. 
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Figure 4.3: RhoG Regulates the Spatio-temporal Dynamics of Rac1 Activity in 
Protrusions. 
 
(A) Representative western blot of endogenous Rac1 activity in HeLa cells migrating on 
fibronectin with or without RhoG knockdown as assessed by GST-CRIB pulldown.  
Bands were quantified and normalized with intensities expressed in arbitrary units 
relative to control (assumed as 1).  Values are means ± SEM (n = 6).  Asterisk indicates p 
< 0.05 by t-test. 
(B and C) Representative Rac1 activity spatial patterns in control siRNA-treated (B) and 
RhoG siRNA-treated HeLa cells migrating on fibronectin.  Right-most panels correspond 
to regions outlined with red boxes.  Scale bar, 20 µm.  Activity scale is indicated by heat 
map in upper left corner of each figure. 
(D) Representative linescans from panels (B) and (C) and Figure S3.B-D indicated by the 
dashed white lines quantifying Rac1 activation along the protrusion.  Control siRNA (red 
line), RhoG siRNA (black line), ELMOT625 (blue line), DOCK180 DN (yellow line), 
and RhoGDI-3 siRNA (green line) are represented. 
(E) Quantitation of distance from leading edge of maximal Rac1 activity during 
protrusion and migration of HeLa cells on fibronectin for individual cells treated with 
control siRNA (n =25), RhoG siRNA (n=24), ELMO1/2 siRNA (n=15), ELMOT625 
(n=12), DOCK180 WT (n=15), DOCK180 DN (n=15), RhoGDI-3 siRNA (n = 12) as 
assessed by linescan analysis.  Solid black lines indicate average peak of Rac1 activity; 
dashed red lines represent SEM.  Asterisks indicate p < 0.05 by student’s t-test compared 
to control siRNA. 
(F) Quantitation of RhoGDI-3 effects on Rac1 activity by FRET as measured by whole-
cell average of FRET ratio with n > 10 cells per condition.  Data are represented as means 
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 95% confidence intervals at α = 0.05.  Asterisks indicate p < 0.05 by t-test.  See also 
Supplemental Figure S4.3. 
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 Figure 4.4: RhoG Regulates Adhesion Dynamics at the Leading Edge. 
(A) Migrating cells expressing mCherry-Paxillin-β and CyPet- Rac1 as assessed by total 
internal reflectance microscopy (TIRFM).  Lower panel inset from regions outlined in 
black.  Arrows indicate areas of Paxillin-β and Rac1 colocalization.  Images inverted.  
Scale bar, 20 µm. 
(B) Rac1 activity as assessed by TIRFM in control siRNA-treated migrating cells 
expressing mCherry- Paxillin-β and a Rac1 FRET biosensor.  Yellow arrows indicate 
regions of adhesion formation.  Red arrows indicate regions of adhesion stabilization.  
Scale bar, 20 µm.  Heat map for Rac1 activity is shown at lower right. 
(C) Rac1 activity and Rac1 localization to adhesions as assessed by TIRFM in RhoG 
siRNA-treated migrating cells expressing mCherry-Paxillin-β and a Rac1 FRET 
biosensor.  Lower panels magnified from inset of regions in black or white in top panels.  
Arrows indicate location of adhesion identified in mCherry-Paxillin-β inset in subsequent 
images.  Scale bar, 20 µm. Heat map for Rac1 activity is shown at lower right. 
(D) Quantitation of Rac1 recruitment to adhesions as percentage intensity increase over 
background as assessed by TIRFM in cells expressing mCherry-Paxillin-β and CyPet- 
Rac1 and treated with control or RhoG siRNA, or expressing Rac1 Q61L, Rac1 T17N, 
ELMOT625, or RhoGDI-3.  Data are represented as means  95% confidence intervals 
at α = 0.05.  Asterisks indicate p < 0.05 as assessed by t-test.   
(E) Assessment of DOCK180 recruitment to adhesions by TIRFM in migrating cells 
expressing EGFP- Paxillin-β and mCherry-DOCK180.  Arrows indicate the same 
adhesions in each inset for DOCK180.  Scale bar, 20 µm. 
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(F) Migrating cells expressing mCherry-tagged Paxillin-β as assessed by total internal 
reflectance microscopy (TIRFM) and treated with control siRNA, RhoG siRNA, or 
expressing CFP-RhoG Q61L.  Images inverted.  Direction of protrusion indicated by 
black arrow.  Scale bar, 20 µm.   
(G) Quantitation of leading edge adhesion number per 100µm2 in cells treated with 
control siRNA, RhoG siRNA, or expressing RhoG Q61L, RhoG T17N, ELMOT625, or 
RhoGDI-3 as assessed by TIRFM.  Data are represented as means  95% confidence 
intervals at α = 0.05.  Asterisks indicate p < 0.05.   
(H) Quantitation of leading edge adhesion size in cells treated with control, RhoG, or 
RhoGDI-3 siRNA as assessed by TIRFM.  Data are represented as means  95% 
confidence intervals at α = 0.05.  Asterisks indicate p < 0.05 by t-test.  See also 
Supplemental Figure S4.4. 
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Figure 4.5: RhoG Regulates Actin and Protrusion Dynamics at the Leading Edge. 
(A) Representative kymographs of protrusions from migrating cells treated with control 
or RhoG siRNA as assessed by DIC.  Direction of protrusion, distance traveled, and time 
are all indicated for each image. The cell edge is traced in black outline.   
(B) Quantitation of protrusion/retraction cycle frequency from kymographs of migrating 
cells treated with control, RhoG, or RhoGDI-3 siRNA as assessed by DIC.  Data are 
represented as means  95% confidence intervals at α = 0.05.  Asterisks indicate p < 0.05 
by t-test.  
(C) Quantitation of average distance traveled by a protrusion from kymographs of 
migrating cells treated with control, RhoG, or RhoGDI-3 siRNA as assessed by DIC.  
Data are represented as means  95% confidence intervals at α = 0.05.  Asterisks indicate 
p < 0.05 by t-test.  
(D) Representative pseudocolored actin barbed end density images as assessed by 
epifluorescence in fixed control and RhoG siRNA-treated cells.  Lower panel is 
magnified inset in region highlighted in white in top panel.  Arrows indicate potential 
regions of protrusion.  Barbed end density corresponds to the heat map in upper right 
corner.  Scale bar, 20µm.  Heat map at upper right indicates density scaling. 
(E) Quantitation of actin barbed end density as assessed by linescans from the entire cell 
edge in epifluorescence images of fixed control, RhoG, and RhoGDI-3 siRNA-treated 
cells.    Data are represented as means  95% confidence intervals at α = 0.05.  Asterisks 
indicate p < 0.05 by t-test.  See also Supplemental Figure S4.5. 
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Figure 4.6: RhoG Regulates Cell Migration Behaviors on 2-D and 3-D Substrates. 
(A) Quantitation of cell migration velocity from tracks in control, RhoG, or RhoGDI-3 
siRNA-treated cells.  Data are represented as means  95% confidence intervals at α = 
0.05.  Asterisks indicate p < 0.05 by t-test. 
(B) Quantitation of cell migration persistence from tracks in control, RhoG, or RhoGDI-3 
siRNA-treated cells.  Data are represented as means  95% confidence intervals at α = 
0.05.  Asterisks indicate p < 0.05 by t-test. 
(C)  Illustration of the parameter space and methods of measurement of cellular behaviors 
during cell migration tracks that give rise to State 1 and State 2.  Parameters measured 
include velocity (μr), change in directional angle (σθ), and deviation in velocity (σr). 
(D) Representative traces of cell migration tracks for control and RhoG siRNA-treated 
cells with color shading indicating the behavior state of the cell.  Scale bar, 10 µm.  Time 
frames indicated for each cell.   
(E) Quantitation of cell migration velocity from tracks in control, RhoG, or RhoGDI-3 
siRNA-treated cells and separated by behavior state.  Data are represented as means  
95% confidence intervals at α = 0.05.  Asterisks indicate p < 0.05 by t-test. 
(F) Quantitation of cell migration persistence from tracks in control, RhoG, or RhoGDI-3 
siRNA-treated cells and separated by behavior state.  Data are represented as means  
95% confidence intervals at α = 0.05.  Asterisks indicate p < 0.05 by t-test. 
(G) Quantitation of foci of Rac1 activation (> 1.5x increase in Rac1 activation compared 
to cell center) for control, RhoG, and RhoGDI-3 siRNA-treated cells separated by 
behavior state.  Data are represented as means  95% confidence intervals at α = 0.05.  
Asterisks indicate p < 0.05 by t-test.  
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(H and I) Representative examples of RhoG and Rac1 activity in cell migration as 
assessed by FRET in State 1 or State 2 for control, RhoG, or RhoGDI-3 siRNA-treated 
cells, and used for the analysis in Figure 5G.     
(J) Quantitation of polarity of Rac1 and RhoG activation in migration tracks from cells 
expressing a RhoG or Rac1 activity sensor and separated by behavior state.  Data are 
represented as means  S.E.M. at α = 0.05.  Asterisks indicate p < 0.05 by t-test. 
(K)  Quantitation of average maximum peak Rac1 and RhoG activity as a proportional 
increase relative to average baseline Rac1 and RhoG activity for states 1 and 2.  Black 
bars represent normalized baseline Rac1 and RhoG activity for each state, with the white 
bars representating the additional amount of Rac1 and RhoG activity found at peak in 
protrusions, or “spots.”  Data are represented as means  S.E.M. at α = 0.05.  Asterisks 
indicate p < 0.05 by t-test. 
(L) Representative images of cell morphology of control, RhoG, and RhoGDI-3 siRNA-
treated cells embedded in 3-D matrices expressing mCherry alone. 
(M) Quantitation of protrusional number in control, RhoG, and RhoGDI-3 siRNA-treated 
cells embedded in 3-D matrices as assessed by laser scanning microscopy.  Data are 
represented as means  95% confidence intervals at α = 0.05.  Asterisks indicate p < 0.05 
by t-test.  See also Supplemental Figure S4.6. 
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Figure 4.7:  Model for the Regulation of Lamellipodial Rac1 Activity by RhoG. 
Model of cellular signaling depicting the regulation of RhoG and its trafficking by 
RhoGDI-3, and RhoG regulation of Rac1 in the lamellipodium and proposed model of 
RhoG mediation of cellular turning during random migration. 
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Supplemental Figure S4.1, Related to Figure 4.1: Validation of a RhoG Activity 
Biosensor and Observed Activity at the Leading Edge.  
 
(A) Analysis of RhoG-GTP and Rac1-GTP levels by GST-ELMO or GST-CRIB 
pulldown assay in cells treated with empty vector or p50RhoGAP.  Total RhoG and Rac1 
levels are shown as loading controls.   
(B) Normalized FRET/CFP emission ratios representing RhoG activity in response to 
EGF stimulation, Synectin siRNA-treatment, and RhoGDI-3 overexpression versus 
controls as assessed in imaging of adherent HeLa cells.  EGF was used at a concentration 
of  20 ng/mL and activation of RhoG peaked within 30 seconds of stimulation as 
previously described (Samson et al. 2010).  Asterisks indicate p < 0.001 for signal from 
all conditions compared to WT (t-test), and data are represented as means  95% 
confidence intervals at α = 0.05. N of at least 15 cells per condition.  
(C) HeLa cells were transfected with control siRNA or synectin siRNA and assessed for 
endogenous synectin protein levels by Western blot.  Tubulin levels are given as a 
loading control.   
(D)  Representative images of RhoG and Rac1 activities in HeLa cells transfected with 
either control or synectin siRNA and expressing either a RhoG or Rac1 activity sensor.  
Images are scaled so that regions of intense GTPase activity are shown in white.  Heat 
map indicating dynamic range scaling is shown for each cell.   
(E) Quantitation of RhoG and Rac1 activity (FRET intensity) in cells transfected with 
either control or synectin siRNA and expressing either a RhoG or Rac1 activity sensor.  
Asterisks indicate p < 0.05 for signal for each synectin knockdown condition compared to 
control (t-test), and data are represented as means  95% confidence intervals at α = 0.05.  
N of at least 10 cells per condition. 
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(F) Cross-correlation analysis of timing of peak RhoG activity with change in velocity 
versus distance from leading edge where RhoG activity is assessed (red line) or the cross-
correlation coefficient as assessed with increasing distance from the leading edge (blue 
line).  A cross-correlation coefficient above 0.42 is considered statistically significant at p 
< 0.05.   
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Supplemental Figure S4.1 
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Supplemental Figure S4.2, Related to Figure 4.2: Vesicular RhoG Localization and 
Trafficking and its Regulation by RhoGDI-3. 
 
(A, B, C, and D) As indicated, coexpression of CyPet-RhoG with mCherry-tagged Rab4, 
Rab5, Rab7, or Rab11 in vesicles as assessed by epifluorescence in live Cos-7 cells.  
Arrows indicate the same vesicle in both images, or in the case of Rab7, absence of the 
associated vesicle.  Rightmost panels are magnified insets of the regions outlined in black 
for each image pair.   
(E) Endogenous mRNA levels of RhoGDI-3 in HeLa cells treated with control or 
RhoGDI-3 siRNA as assessed by RT-PCR.  β2-microglobulin levels are given as a 
control.   
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Supplemental Figure S4.2 
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Supplemental Figure S4.3, Related to Figure 4.3: Effects of RhoG Activity on 
Lamellipodial Rac1 Activity. 
 
(A) Endogenous RhoG and Rac1 expression in cells treated with control or RhoG siRNA 
as assessed by western blot.  Tubulin levels are given as a loading control.   
(B) Representative Rac1 activity spatial patterns in HeLa cell migrating on fibronectin 
expressing mCherry-ELMOT625.  Bottom panel corresponds to region outlined with 
red box.  Activity is indicated by heat map in upper left corner of each panel. 
(C) Representative Rac1 activity spatial patterns in HeLa cell migrating on fibronectin 
expressing mCherry-DOCK180 DN.  Bottom panel corresponds to region outlined with 
red box.  Activity is indicated by heat map in upper left corner of each panel. 
(D) Representative Rac1 activity spatial patterns in HeLa cell migrating on fibronectin 
transfected with RhoGDI-3 siRNA.  Bottom panel corresponds to region outlined with 
red box.  Activity is indicated by heat map in upper left corner of each panel. 
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Supplemental Figure S4.3 
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Supplemental Figure S4.4, Related to Figure 4.4: Effects of RhoG Manipulation on 
Rac1 Activity at the Ventral Cellular Surface and Adhesion Dynamics. 
 
(A) Representative Rac1 activity spatial patterns in control siRNA-treated (B) and RhoG 
siRNA-treated HeLa cells migrating on fibronectin as observed via TIRF microscopy.  
Bottom panels are enlarged from the area of the leading edge outlined with white box.  
White arrows indicate direction of cellular movement.  Activity scale is indicated by heat 
map in each figure. 
(B) HeLa cell plated on fibronectin treated with control siRNA expressing mCherry-
DOCK180 and EGFP-Paxillin-β as assessed by TIRFM.  DOCK180 colocalizes with 
focal adhesions in both conditions.   
(C) HeLa cell plated on fibronectin expressing CyPet-RhoG and mCherry-Paxillin-β as 
assessed by TIRFM.  RhoG is diffusely localized within the membrane in the TIRF plane 
with no apparent colocalization with adhesions.   
(D)  HeLa cell plated on fibronectin treated with control or RhoG siRNA expressing 
mCherry-ELMO1 and EGFP-Paxillin-β as assessed by TIRFM.  ELMO1 is diffusely 
localized within the membrane in the TIRF plane with no apparent changes in 
localization compared to control siRNA treated cells.   
(E) Representative western blot of endogenous RhoA activity in HeLa cells migrating on 
fibronectin with or without RhoG knockdown as assessed by GST-RBD pulldown in two 
separate experiments (from four total experiments).  Total RhoG levels are shown to 
indicate the effectiveness of RhoG knockdown.  Total RhoA levels are shown to 
demonstrate that RhoG knockdown did not influence the levels of RhoA protein.  Tubulin 
levels are given as a loading control.   
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Supplemental Figure 4.4 
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Supplemental Figure S4.5, Related to Figure 4.5: RhoG Regulates Retraction 
Velocities in Migrating Cells. 
 
Quantitation of retraction velocities from kymographs of migrating cells treated with 
control, RhoG, or RhoGDI-3 siRNA as assessed by DIC.  Asterisks indicate p < 0.05 as 
assessed by t-test.  Data are represented as means  95% confidence intervals at α = 0.05. 
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Supplemental Figure 4.5 
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Supplemental Figure S4.6, Related to Figure 4.6: RhoG Modulation of Rac1 Activity 
Regulates Random Cell Migration Patterns. 
 
(A, B, and C) Representative traces of cell migration tracks acquired over 18 hours for 
control, RhoG, and RhoGDI-3 siRNA-treated cells.  Scale bar, 20 µm. 
(D) Quantitation of cell migration velocity variance from tracks in control, RhoG, or 
RhoGDI-3 siRNA-treated cells and separated by behavior state.  Data are represented as 
means  95% confidence intervals at α = 0.05.   
(E) Representative image of Rac1 activity with RhoGDI-3 knockdown.  Red arrows in 
lower panel indicate areas of protrusion and high Rac1 activity.  Activity level 
corresponds to heat map in upper right corner of image.   
(F) Quantitation of Rac1 activation foci for HeLa cells migrating on fibronectin treated 
with control, RhoG, or RhoGDI-3 siRNA in short time frames. 
(E)  Quantitation of migration velocity based on the presumed levels of Rac1 activity and 
total Rac1 levels for HeLa cells migrating on fibronectin transfected with Rac1 T17N, 
RhoG siRNA, control siRNA, RhoG Q61L, or Rac1 Q61L, or combinations of RhoG 
siRNA with wild-type Rac1 or control siRNA with wild-type Rac1. 
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Supplemental Figure 4.6 
 
 
  
CHAPTER FIVE:  ACTIVATION OF RHO GTPASES BY GROWTH FACTORS 
5.1  Abstract 
 RhoG is a member of the Rac-like subgroup of Rho GTPases and has been linked 
to a variety of different cellular functions. Nevertheless, many aspects of RhoG upstream 
and downstream signaling remain unclear; in particular extracellular stimuli which 
modulate RhoG activity. Here we describe that stimulation of epithelial cells with 
epidermal growth factor leads to the induction of macropinocytosis and strong and rapid 
activation of RhoG. The kinetics of RhoG activation after EGF stimulation parallels the 
previously described Rac1 activation. By using nucleotide-free RhoG pull down assays 
and siRNA mediated knock-down studies we further show that GEFs of the Vav-family 
mediate EGF-induced rapid activation of RhoG. In addition, we found that in certain cell 
types the recently described RhoG GEF PLEKHG6 can also contribute to the rapid 
activation of RhoG after EGF stimulation.  
In addition to these findings, we noted that EGF-induced macropinocytosis is 
differentiated from other types of endocytosis by its unique susceptibility to inhibitors of 
Na+/H+ exchange.  Yet, the functional relationship between Na+/H+ exchange and 
macropinosome formation remains obscure.  In A431 cells, stimulation by EGF 
simultaneously activated macropinocytosis and Na+/H+ exchange, elevating cytosolic pH 
and stimulating Na+ influx.  Our collaborators have been able to show that, using novel 
probes of submembranous pH, metabolically-generated acid at sites of macropinocytosis 
 261
accumulates, an effect counteracted by Na+/H+ exchange.  The acidification observed in 
the presence of the inhibitors significantly altered the activation of the GTPases that 
promote actin remodelling and this sensitivity confers to macropinocytosis its unique 
susceptibility to inhibitors of Na+/H+ exchange. 
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5.2  Introduction 
 The family of Rho GTPases comprises 20 members which are divided into five 
subgroups based on amino acid sequence similarity (Wherlock and Mellor 2002; 
Burridge and Wennerberg 2004). The discovery of their role in regulating actin 
organization and focal adhesion dynamics was a seminal moment in understanding the 
importance of these molecules (Ridley and Hall 1992; Ridley et al. 1992) in cellular 
signaling. Rho GTPases are now known to control a diverse set of cellular functions, 
including cell migration, gene expression, endocytosis, cell cycle progression and 
differentiation (Jaffe and Hall 2005). 
 
Regulation of RhoG Signaling: 
RhoG is an evolutionarily conserved member of the Rac-like subgroup of Rho 
GTPases, with homologues identified in mammals, Drosophila, and C. elegans (Hakeda-
Suzuki et al. 2002; Kishore and Sundaram 2002; Vigorito et al. 2004), as described in 
Chapter 4.  However, RhoG upstream and downstream signaling pathways are to date 
poorly characterized. Only a few RhoG downstream effectors have been identified, such 
as the ELMO protein family, PI3K, and kinectin (Vignal et al. 2001; Katoh and Negishi 
2003; Yamaki et al. 2007).  Further, only a few GEFs for RhoG have been described and 
no cellular RhoG GAPs are currently known. Until recently, ICAM-1 and syndecan-4 
were the only cell surface receptors shown to modulate RhoG activity after their 
engagement (van Buul et al. 2007a; Elfenbein et al. 2009) by ligands. However, given the 
high degree of conservation of RhoG, its broad expression pattern, and the diversity of 
RhoG functions, other receptors are also likely involved in modulating RhoG activation. 
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Epidermal growth factor (EGF) receptor signaling involves a complex network of 
pathways (Oda et al. 2005). Upon ligand binding, the dimerized EGF receptor (EGFR) 
undergoes a conformational shift which stimulates its intrinsic kinase activity (Ferguson 
2008; Landau and Ben-Tal 2008), resulting in autophosphorylation of the receptor.  This 
autophosphorylation facilitates binding of numerous proteins to phosphorylated residues 
on the receptor, thereby initiating downstream signaling pathways. Additionally, direct 
phosphorylation of target proteins by the EGFR also contributes to signaling. Major 
signaling targets activated by EGFR signaling are src-family kinases (Osherov and 
Levitzki 1994), phosphatidylinositol 3-kinase (PI3K) (Rodrigues et al. 2000) and the 
mitogen-activated protein kinase (MAPK) (Sasaoka et al. 1994; Jones et al. 1999). 
Additionally, several Rho GTPases are regulated by EGF.  For instance, several different 
mechanisms have been described for the activation of Rac1 and Cdc42 after EGF 
stimulation (Scita et al. 1999; Marcoux and Vuori 2003; Ray et al. 2007; Itoh et al. 2008). 
In the first part of this study we looked for extracellular factors which stimulate 
RhoG activity and the signaling pathways involved. We identified EGF as a strong and 
rapid activator of RhoG, whereas other growth factors were not. We focused our studies 
on the immediate activation of RhoG and its close homologue Rac1 within 30 s after 
EGF stimulation. This early time point suggested that activation occurs by direct 
signaling from the activated EGFR to RhoG GEF(s) that could rapidly activate the 
GTPase. We found different GEFs to be involved in EGF-induced RhoG activation in a 
cell type-specific manner, including members of the Vav family and PLEKHG6, 
suggesting that the composition of GEFs in a given cell type dictates the morphological 
change induced by EGF stimulation (dorsal ruffling versus cell spreading). 
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Unique Properties of Signaling during Macropinocytosis: 
The macropinocytosis induced by EGF stimulation in this study is the most 
effective way for cells to ingest large amounts of extracellular fluid.  In some cell types 
macropinocytosis is a constitutive process: immature dendritic cells use it to sample 
soluble antigens (Sallusto et al. 1995) and Dictyostelium amoeba for nutrient uptake 
(Cardelli 2001).  Constitutive macropinocytosis is also observed in fibroblasts 
transformed with oncogenic v-Src or K-Ras (Amyere et al. 2000; Amyere et al. 2002). 
Alternatively, macropinocytosis can be transiently induced by growth factors, such as 
epidermal growth factor (EGF) or macrophage colony-stimulating factor (Racoosin and 
Swanson 1989; West et al. 1989).  
The remodelling of the cytoskeleton that leads to macropinocytosis requires 
phosphatidylinositol-3-kinase (PI3K) activity at the plasma membrane (Araki et al. 1996; 
Rupper et al. 2001; Lindmo and Stenmark 2006).  While the entire signaling sequence is 
incompletely understood, the GTPases Rac1 (West et al. 2000) and Cdc42 (Garrett et al. 
2000) as well as p21-activated kinase-1 (PAK1)  (Dharmawardhane et al. 1997; 
Dharmawardhane et al. 2000) are involved in actin polymerization, and CtBP1/BARS is 
required for macropinosome closure (Liberali et al. 2008).  The activation of PI3K and 
the engagement of Rho-family GTPases are common to a variety of actin-dependent 
processes such as phagocytosis and chemotaxis.  Thus, treatment with inhibitors like 
wortmannin and Clostridium difficile toxin B effectively block most actin-based 
processes, as well as macropinocytosis.  In contrast, macropinosome formation appears to 
be uniquely susceptible to inhibition by amiloride and its analogues, and this property has 
been extensively used as an identifying feature of macropinocytosis (West et al. 1989; 
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Veithen et al. 1996; Meier et al. 2002).  Amiloride, a guanidinium-containing pyrazine 
derivative, has been used extensively as an inhibitor of Na+/H+ exchangers (NHEs) 
(Grinstein et al. 1989; Orlowski and Grinstein 2004).  However, amiloride is not a 
universal, nor a specific inhibitor of NHE: the affinity of the different NHE isoforms for 
amiloride varies greatly and, importantly, the drug also inhibits conductive Na+-channels 
and Na+/Ca2+ exchangers (Alvarez de la Rosa et al. 2000; Masereel et al. 2003).  To 
increase the potency and selectivity of NHE inhibitors several amiloride analogs have 
been synthesized, including ethylisopropylamiloride (EIPA) (Masereel et al. 2003) and 
(3-methylsulphonyl-4-piperidinobenzoyl)guanidine methanesulphonate (HOE-694), 
which is specific for the NHE1 isoform (Counillon et al. 1993).  
How amiloride inhibits macropinocytosis remains unknown.  To the extent that 
EIPA also blocks macropinocytosis, NHEs are likely to play a role in the process (Cosson 
et al. 1989; West et al. 1989), but the mechanism linking ion exchange and vacuole 
formation is not apparent.  Three possible mechanisms can be contemplated: 1) uptake of 
Na+ by the exchangers may increase the intracellular solute concentration, driving 
osmotically obliged water and causing swelling that would favor the protrusion of 
macropinocytic pseudopods.  Though the stoichiometric exchange of Na+ for H+ is 
osmotically neutral, extruded H+ are replaced from intracellular buffers, resulting in a net 
osmotic gain; 2) NHE could be acting indirectly by altering the cytosolic concentration of 
calcium, which has been suggested to regulate macropinocytosis (Falcone et al. 2006).  
Na+ delivered intracellularly in exchange for H+ can promote the uptake of calcium via 
Na+/Ca2+ exchange; 3) the effect of NHE on macropinocytosis may be mediated by 
changes in cytosolic pH.  Stimulation of NHE by hormones or growth promoters has 
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been shown to alkalinize the cytosol (Rothenberg et al. 1983; L'Allemain et al. 1984; 
Grinstein et al. 1985; Pouyssegur et al. 1985; Van Obberghen-Schilling et al. 1985).  
Conversely, inhibition of the antiporters impairs the ability of cells to eliminate H+ 
generated metabolically and can cause acidification (L'Allemain et al. 1984; Grinstein et 
al. 1985; L'Allemain et al. 1985; Liaw et al. 1998).  The changes in pH resulting from 
modulation of NHE activity could conceivably alter the signaling and/or cytoskeletal 
rearrangements required for macropinocytosis. 
 
Functional Relationship between Macropinocytosis and Na+/H+ Exchange: 
In addition to the studies delineating a novel signaling pathway to RhoG 
downstream of EGF stimulation, and the GEFs involved, we investigated the functional 
relationship between macropinocytosis and Na+/H+ exchange. Macropinocytosis was 
induced in A431 cells by EGF, and NHE activity was modulated pharmacologically and 
by ion substitution.  Our results indicate that NHE1 activity is required to attain a critical 
H+ concentration in the immediate vicinity of the plasma membrane that promotes actin 
polymerization during macropinocytosis. 
Our collaborators were able to demonstrate that the prototypical NHE inhibitor 
amiloride effectively inhibited EGF-induced fluid phase uptake and actin polymerization, 
as did HOE-694, a more selective NHE antagonist that also blocks Na+/H+ exchange. 
Together, their work confirms the burst of metabolic acid generation downstream of EGF 
stimulation and demonstrates that its effects are more pronounced in the immediate 
vicinity of the membrane, where macropinocytic lamellipodia extend. These and previous 
data (Cosson et al. 1989; West et al. 1989), however, cannot define whether entry of Na+ 
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or extrusion of H+ is the critical event. By omitting Na+ from the medium, they were able 
to effectively neutralize the metabolic acidification triggered by EGF via an K+/H+ ion 
exchange ionophore. Importantly, the ability of EGF to induce TMR-dextran uptake was 
restored by nigericin, implying that extrusion of H+, and not the entry of Na+, per se, is 
the key requirement for macropinosome formation.  Their work also showed that the 
alkalinization mediated by NHE1 that normally accompanies stimulation by EGF through 
the extrusion of H+ ions is not absolutely required for macropinocytosis because the latter 
persists when pHc is clamped with nigericin/K+. Instead, it is more likely that NHE 
activity is required to prevent the development of a membrane-localized acidification that 
may be deleterious to macropinocytosis. To evaluate this possibility, they measured the 
intracellular pH dependence of macropinocytosis.  The uptake of TMR-dextran in 
response to EGF was quantified in cells where pHc was clamped at the desired level using 
nigericin/K+.  Maintaining pH at a level comparable to that attained when cells are 
stimulated in physiological media enabled the cells to respond to EGF with robust 
macropinocytosis, despite the absence of Na+.  Normal macropinocytosis was also 
observed when pHc was clamped near the resting level recorded in unstimulated cells 
(7.5-7.6).  However, even modest reduction in pH produced marked, highly significant 
decreases in macropinocytic efficiency and virtually complete inhibition was noted at pH 
6.8.  They further were able to show that in contrast to the exquisite sensitivity of 
macropinocytosis to acidification, clathrin-mediated endocytosis was virtually unaffected 
by modest changes in pHc and was inhibited only after marked cytosolic acidification.   
Next, they attempted to ascertain the pH sensitivity of the signals leading to 
macropinocytosis. Dynamic assessment of the behavior of pHc-clamped cells by DIC 
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microscopy revealed that the extension of membrane ruffles, rather than their closure to 
form macropinosomes, was affected by moderate acidification.  This suggested that an 
early step in the signalling cascade was impaired by pH.  However, phosphorylation of 
the EGF receptor was robustly stimulated by EGF and this effect persisted in the presence 
of HOE-694 or in the absence of Na+.  This implies that downstream signalling events 
must be responsible for most of the pH dependence of macropinocytosis. Through 
sequential analysis of the signaling components, neither adaptors that bind the EGF 
receptor to transduce downstream signals, nor recruitment and activation of PI3K were 
affected by clamping the pHc at either pH 7.8 or 6.8.  Of interest, however, PIP3 
generated by PI3K serves to target to the membrane and to stimulate guanine nucleotide 
exchange factors (GEFs) that activate Rho-family GTPases (Lemmon et al. 2002; 
Lindmo and Stenmark 2006).  GEFs like Vav2 and Tiam1 transduce the signals of the 
PI3K to Rac1 and Cdc42, contributing to membrane ruffling and macropinocytosis (West 
et al. 2000; Marcoux and Vuori 2003; Ridley 2006; Garrett et al. 2007; Ray et al. 2007).  
Of note, initial imaging studies suggested that EGF-induced redistribution of Rac1/Cdc42 
binding partners to the membrane was eliminated when cells were stimulated in Na+-free, 
NMG+-rich buffer, implying that Rac1/Cdc42 activation is impaired by decreased 
cytosolic pH.   
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5.3  Results and Discussion 
EGF Induces Rapid Activation of RhoG: 
In order to identify physiologic stimuli which regulate RhoG signaling, our 
collaborator tested a panel of growth factors and measured the activity status of RhoG. 
Interestingly, when starved HeLa cells were treated with media containing physiologic 
concentrations of EGF (20 ng/ml) (Sigismund et al. 2005), a strong increase in active 
RhoG levels compared to cells treated with media lacking EGF was noted. Levels of 
active Rac1 also increased after EGF treatment, as described previously (Dise et al. 
2008).   
To understand the kinetics of RhoG activation after EGF stimulation we measured 
levels of active RhoG in HeLa cells at time points from 30 seconds to 10 minutes after 
EGF treatment. Interestingly, RhoG peak activation was observed as early as 30 seconds 
after EGF treatment, whereupon its activity began to decrease between 5 and 10 minutes. 
Rac1 activity followed the same kinetic as also reported by others in a different cell type 
(Patel et al. 2007). Equivalent activation kinetics of RhoG and Rac1 occurred in 
experiments using higher concentrations of EGF (data not shown). We also observed 
RhoG activation after 30 seconds of EGF treatment in a different cell line (A431), which 
showed that EGF-induced RhoG activation at 30 seconds is not limited to HeLa cells.  
Using our previously developed biosensor for RhoG activity (Chapter 4), we showed that 
in single cells, these kinetics were consistent, with rapid activation of RhoG initiating at 
10 seconds, peaking 30-40 seconds after stimulation, and trailing off at 5 to 10 minutes.  
This activation was diffuse, with stronger activation within the lamellipodium where it 
has been shown previously that more EGF receptor exists (Assaker et al. 2010).  A 
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striking difference between our results with EGF-induced RhoG activation compared to 
the recently reported FGF-induced RhoG activation (Elfenbein et al. 2009) is the time 
course with which this occurs. RhoG activation in response to FGF treatment peaks after 
10 minutes, whereas the peak activation of RhoG is already reached 30 seconds after 
treating cells with EGF and has returned almost to baseline levels by 10 minutes. EGF-
induced RhoG activation also differs mechanistically from FGF-induced RhoG 
activation. Syndecan-4 engagement by FGF induces the release of RhoG from GDI-1 by 
PKCα-mediated phosphorylation of GDI-1 (Elfenbein et al. 2009). In contrast, EGF 
stimulation leads to rapid RhoG activation by activating GEFs and does not require PKC 
activity. 
Because of the fast activation of RhoG and Rac1 by EGF treatment (30 seconds) 
and in order to separate these events from later (potentially secondary or autocrine loop) 
activation events of these GTPases, we refer from here on to their activation at 30 
seconds as the ‘rapid activation’. 
 
Identification of GEFs Mediating the Rapid Activation of RhoG: 
Next we aimed to identify GEFs involved in the rapid activation of RhoG after 
EGF stimulation. Only a limited number of GEFs have been described which stimulate 
nucleotide exchange of RhoG. We first sought to test the involvement of the RhoG GEF 
SGEF (Ellerbroek et al. 2004) and our collaborators’ results suggested that SGEF does 
not play a role in the rapid activation of RhoG after EGF treatment. 
Given their strong link with EGF signaling, GEFs of the Vav family appeared to 
be other likely candidates for the rapid activation, (Pandey et al. 2000; Zeng et al. 2000), 
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since Vav2 and Vav3 are expressed in many different cell types (Turner 2002) and they 
are known GEFs implicated in Rac1 activation after EGF stimulation. Interestingly, our 
collaborator found that Vav2 and Vav3 activation increased after 30 seconds of EGF 
stimulation. This result strongly suggested that Vav2 and Vav3 are mediating the rapid 
activation of RhoG. Thus, he tested whether Vav2 and Vav3 were essential for RhoG 
activation by EGF.  When Vav2 or Vav3 were knocked down simultaneously the rapid 
activation of RhoG after EGF treatment was completely abolished.  
Therefore, we conclude that Vav2 and Vav3 jointly mediate the rapid activation 
of both RhoG and Rac1 by their direct phosphorylation by the EGFR kinase.   A possible 
explanation for the EGF-specific activation of RhoG is the involvement of a receptor-
specific scaffold which promotes coupling of Vav GEFs to RhoG. It was previously 
shown that after EGF and PDGF stimulation 90% of the activated signaling proteins are 
identical, but 10% are unique (Kratchmarova et al. 2005). It will be interesting to look for 
the critical component(s) mediating EGF signaling to RhoG activation. Our results do not 
exclude that other tyrosine kinase receptors exist which activate RhoG. The TrkA 
receptor is a potential candidate for this, as NGF was shown to stimulate neurite 
outgrowth through RhoG (Katoh et al. 2000). 
 
Involvement of PLEKHG6 in Rapid Activation of RhoG in A431 Cells: 
Recently, another GEF, PLEKHG6, was implicated in RhoG activation in the 
epidermoid carcinoma cell line A431 (D'Angelo et al. 2007). It has also been shown that 
EGF-induced macropinocytosis in A431 cells depends on PLEKHG6. As 
macropinocytosis is a known RhoG-mediated function, we wondered if PLEKHG6 also 
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contributes to RhoG activation in A431 cells in a cell type specific manner. First we 
wanted to confirm that PLEKHG6 has in vivo GEF specificity for RhoG. In agreement 
with results from D’Angelo and coworkers, endogenous RhoG activity was increased 
when myc-PLEKHG6 was expressed in Cos-7 cells. PLEKHG6 does not appear to be 
ubiquitously expressed in all tissues and cell lines (D'Angelo et al. 2007). We therefore 
considered that PLEKHG6 might be an additional GEF mediating the rapid activation of 
RhoG after EGF stimulation in those cells in which it is expressed. siRNAs targeting 
PLEKHG6 were transfected into HeLa and A431 cells.  Strikingly, our collaborator 
observed decreased RhoG activity after EGF stimulation in A431 cells, but not in HeLa 
cells. Our collaborator also tested the influence of knock-down of Vav-GEFs in A431 
cells and found that Vav2 knock-down led to the same decrease of rapid activation of 
RhoG and Rac1 as did the double knock-down of Vav2/Vav3. In summary, the 
composition of GEFs in A431 cells is different from HeLa cells (PLEKHG6 and Vav2 
versus Vav2/Vav3) in terms of GEFs that regulate the rapid activation of RhoG and 
Rac1. 
A431 cells are well known for the rapid formation of dorsal ruffles after EGF 
application (Araki et al. 2007). Furthermore, PLEKHG6 was previously shown to induce 
dorsal ruffle formation when over-expressed in different mammalian cells (D'Angelo et 
al. 2007). We therefore tested if RhoG and PLEKHG6 regulate EGF-induced dorsal 
ruffle formation of A431 cells. siRNA-transfected A431 cells were plated at sub-
confluent densities and serum-starved before being stimulated with 20 ng/ml EGF. 
Differential interference contrast (DIC) microscopy movies of isolated cells were taken 
and later categorized for cells that form dorsal ruffles (dorsal-ruffle phenotype; Figure 
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5.1A, upper row) versus cells that spread a large lamellipodium in multiple directions 
(Rac1-like phenotype; Figure 5.1A, bottom row). We found that the majority of control 
siRNA-transfected cells (78%; ±3.5% SEM) responded to EGF treatment with the 
formation of dorsal ruffles (Figure 5.1B). Interestingly, when we knocked down RhoG or 
PLEKHG6, the fraction of dorsal ruffling cells significantly decreased and increased 
numbers of cells showed the Rac1-like phenotype (RhoG siRNA: 39% dorsal ruffling and 
61% Rac1-like phenotype (each ±10.2% SEM); PLEKHG6 siRNA: 52% dorsal ruffling, 
48% Rac1-like phenotype (each ±4.7% SEM)). These results show that RhoG and 
PLEKHG6 are necessary for dorsal ruffle formation in A431 cells after EGF stimulation. 
Furthermore, when we analyzed A431 cells transfected with siRNA targeting Vav2 / 
Vav3, we observed significantly fewer cells with a Rac1-induced phenotype, with more 
cells forming dorsal ruffles (95% dorsal ruffling, 5% Rac1-like phenotype (each ±2.7% 
SEM). Of note, the dorsal ruffles formed by cells transfected with Vav2 / Vav3 siRNA 
had an overall different morphology compared to control cells, in that the dorsal 
protrusions appeared to be extended further out of the dorsal surface of the cell (data not 
shown). Overall, these results indicate that PLEKHG6 is the critical component which 
dictates the different EGF-induced morphological response of HeLa cells compared to 
A431 cells. PLEKHG6 was previously shown to induce spontaneous dorsal ruffle 
formation when overexpressed in HeLa cells. To test, if PLEKHG6 is indeed the 
component which leads to EGF induced ruffle formation in A431 cells, we expressed 
very low levels of PLEKHG6 in HeLa cells. At this expression level the cells did not 
form spontaneous ruffles (Figure 5.1C), but after stimulating the cells with EGF, we 
observed formation of dorsal ruffles, which could not be observed in cells transfected 
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with mCherry empty vector (Figure 5.1D).  In conclusion, multiple GEFs (Vav-GEFs and 
PLEKHG6) are involved in EGF induced RhoG activation in a cell type specific manner 
and dictates the resulting cellular response.    Our results with HeLa cells and A431 cells 
demonstrate that the composition of GEFs involved in EGF-induced signaling varies 
between different epithelial cell types. Furthermore, the timing of activation of a Rho 
GTPase downstream from EGF is likely another critical parameter that determines which 
kinases, GEFs, and GAPs are involved.  
At the outset of this work, we did not anticipate finding a role for the GEF 
PLEKHG6 in the rapid activation of RhoG in response to EGF stimulation. PLEKHG6 
was previously described as a GEF for RhoG, and to a lesser extent also for Rac1 
(D'Angelo et al. 2007). Furthermore, PLEKHG6 appears to be a critical factor which 
controls cellular morphological responses after EGF treatment, since we could convert 
non-ruffling HeLa cells expressing very low levels of PLEKHG6 to ruffling HeLa cells 
after stimulating with EGF. Interestingly, D’Angelo and coworkers found that PLEKHG6 
can act as a scaffold and forms a ternary complex consisting of Ezrin, PLEKHG6, and 
RhoG (D'Angelo et al. 2007). Thus, it is possible that in addition to its function as a 
RhoG GEF, PLEKHG6 might also serve to localize RhoG to the plasma membrane, 
placing it into close proximity with the EGFR. Experiments with PLEKHG6 mutants 
which do not bind to Ezrin, but retain GEF activity could further clarify the role of 
PLEKHG6 in rapid activation of RhoG. 
Thus, we demonstrate here that RhoG is rapidly activated by EGF through GEFs 
of the Vav-family and, depending on the cell type, through the GEF PLEKHG6. We 
found that this rapid activation regulates dorsal membrane dynamics, including ruffling 
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and EGFR internalization. Our future work will focus on RhoG activation after longer 
periods of EGF stimulation and the functional consequences of this activation.  
 
Role of pH in the Regulation of Rho GTPases during Macropinocytosis: 
It has been known for some time that cellular pH strongly regulates both cell 
migration (Heuser 1989; Heuser and Anderson 1989) and macropinocytosis.  Based on 
our collaborator’s work, we ruled out pH sensitivity of most signaling proteins upstream 
of the Rho GTPases.  To assess whether decreased pHc affects preferentially Rac1 or 
Cdc42, we used two different methods.  We initially performed a biochemical assay, 
sedimenting the active form of the GTPases using immobilized PBD-GST, followed by 
immunoblotting with Rac1 or Cdc42-specific antibodies.  In cells clamped at pH 7.8, 
both Rac1 and Cdc42 were stimulated by EGF, as found earlier (Kurokawa et al. 2004). 
At pHc 6.8, however, the activation of both GTPases was depressed.  The effect was more 
apparent for Rac1, which is stimulated more robustly at pH 7.8 (Figures 5.2A and 5.2B). 
We analyzed the spatio-temporal dynamics of Rac1 and Cdc42 activation using 
FRET biosensors (Figures 5.2C and 5.2D).  A clone of A431 cells that is more amenable 
to transfection was used for these experiments, which require simultaneous expression of 
two constructs.  This clone responded to EGF with ruffling and macropinocytosis and the 
response was largely suppressed at pH 6.6.  As shown in Figure 5.2C, treatment with 
EGF induced localized activation of Rac1 at the ruffles and similar, though less robust 
responses were recorded for Cdc42.  When the cytosol was acidified, however, the 
responses of both GTPases were largely obliterated (Figures 5.2C and 5.2D).  Thus, the 
FRET analysis is consistent with the biochemical data, indicating that Rac1 and to a 
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lesser extent Cdc42 are activated by EGF and that both GTPases are sensitive to 
moderate cytosolic acidification.  These data are consistent with our previous results 
showing that EGF-induced dorsal ruffling leading to macropinocytosis is greatly 
impaired by the loss of the GEFs Vav2/Vav3 in HeLa cells and Vav2/PLEKHG6 in A431 
cells, suggesting that the GTPases are the critical mediators of macropinosome formation. 
The preceding results indicate that Rac1 and Cdc42 are stimulated by EGF, but do 
not directly link their activity to ruffling and macropinocytosis.  A causal relationship 
was established taking advantage of the ability of the PBD domain of PAK and the CRIB 
domain of WASP to bind to active Rac1 and Cdc42, respectively.  When expressed at 
low levels, these domains serve as reliable probes of GTPase activation, but when 
overexpressed they can scavenge away a major fraction of Rac1 or Cdc42 and thereby 
induce functional inhibition (Figures 5.2E and 5.2F).  Thus, involvement of both Rac1 
and Cdc42 is required for optimal macropinocytosis.   
EGF is a potent activator of macropinocytosis.  Concomitantly, EGF also 
stimulates Na+/H+ exchange via NHE1.  Stimulation of NHE1 by growth promoters, 
including EGF, has been repeatedly found to induce cytosolic alkalinization, particularly 
when bicarbonate is omitted (Rothenberg et al. 1983; L'Allemain et al. 1984; Ganz et al. 
1989; Sardet et al. 1991; Yanaka et al. 2002).  These observations prompted the widely 
held view that the stimulatory effects of the growth factors were mediated by, or at least 
required, an increase of pHc above its resting value.  In support of this notion, amiloride 
and its analogues were reported to preclude the alkalinization and in parallel inhibit 
cellular proliferation (L'Allemain et al. 1984; L'Allemain et al. 1985; Van Obberghen-
Schilling et al. 1985).  
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Amiloride and HOE-694 also effectively inhibit macropinocytosis (West et al. 
1989; Sallusto et al. 1995; Veithen et al. 1996; Meier et al. 2002).  Extending the 
rationale applied to cellular proliferation, it can be postulated that cytosolic alkalosis 
signals, or is permissive to macropinosome formation.  An alternative possibility is that 
the net osmotic gain associated with Na+/H+ exchange drives water influx and swelling of 
the advancing lamellipodia.  While appealing, these possibilities are not consistent with 
our data: EGF activated macropinocytosis under conditions where pHc was maintained at 
or even slightly below the resting (unstimulated) level.  Moreover, macropinocytosis 
persisted in the absence of Na+, e.g. when nigericin/K+ were used to clamp pHc.  
These observations can be reconciled when considering the changes in pHc 
induced by EGF.  The growth factor stimulates metabolic generation of H+ equivalents, 
but these are effectively extruded by NHE1, which is activated concomitantly.  Indeed, in 
the presence of physiological [Na+] the stimulation of the antiporter outstrips the rate of 
H+ generation, resulting in a net alkalinization.  The occurrence of a metabolic burst is 
only unmasked when Na+/H+ exchange is prevented.  We therefore propose that 
macropinocytosis is not directly sensitive to amiloride or even to inhibition of NHE1, but 
is instead impaired by the acidification that results when excess H+ production is 
uncompensated by the regulatory action of the Na+/H+ antiporter.  
If macropinocytosis is merely responding to the cytosolic acidification, what 
makes it uniquely sensitive to amiloride and its analogues?   Other endocytic processes, 
including uptake of transferrin through clathrin-coated pits, are also affected by low pHc 
(Davoust et al. 1987; Sandvig et al. 1987; Cosson et al. 1989).  However, individual 
endocytic pathways display differential sensitivity to changes is pHc: a modest 
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acidification (pHc ≈6.8) virtually eliminated macropinosome formation, while inhibition 
of clathrin-mediated endocytosis requires a more profound acidification (pHc ≤6.0) 
(Davoust et al. 1987; Sandvig et al. 1987).   Moreover, geometrical considerations may 
accentuate the drop in pH experienced during macropinocytosis.  When Na+/H+ exchange 
is impaired, the H+ generated metabolically during signalling and actin polymerization is 
likely to accumulate in the thin lamellipodia, where diffusional exchange with the bulk 
cytosolic buffers is restricted.  Accordingly, our probes of submembranous pH revealed 
that during macropinocytosis the acidification is more profound in the immediate vicinity 
of the receptors than in the cytosol overall.  Cell motility, another process dependent on 
extension of lamellipodia, is similarly sensitive to the pHc and requires NHE1 for optimal 
function (Lagana et al. 2000; Denker and Barber 2002; Stock et al. 2005; Frantz et al. 
2007; Frantz et al. 2008). 
The nature of the pH-sensitive step(s) in macropinocytosis was analyzed by 
measuring individual events in the signaling cascade while clamping pHc.  We found that 
the activation of Rac1/Cdc42 and their effectors was profoundly inhibited (Figure 5.2). 
This conclusion is consistent with earlier observations of Frantz et al. (Frantz et al. 2007), 
who noted the pH dependence of Cdc42 activation at the leading edge of migrating cells.  
We therefore conclude that the exchange factors that activate Rac1/Cdc42 and/or the 
GTPases themselves are highly sensitive to pHc.  Tiam1, Vav2, and Dock180 have been 
implicated in EGF-R mediated activation of Rac1 and Cdc42 (Marcoux and Vuori 2003; 
Tamas et al. 2003; Makino et al. 2006; Ray et al. 2007).  However, initial attempts to 
discern which GEFs were involved in this process were unsuccessful. 
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Irrespective of the exact mechanism whereby decreased cytosolic pH affects small 
GTPase activation and actin assembly, our results indicate that amiloride and related 
compounds generate their inhibitory effects as a consequence of submembranous 
acidification caused by metabolic H+ generation, unopposed by the regulatory extrusion 
across the membrane.  The unique sensitivity of macropinocytosis, compared to other 
endocytic processes, results from a complex convergence of circumstances: a large and 
sustained metabolic burst that occurs within a diffusionally constrained compartment, the 
thin lamellipod.   
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5.4  Materials and Methods 
Materials and Reagents: 
Nigericin and EGF were from Molecular Probes (Carlsbad, CA).  Lipofectamine 
LTX was from Invitrogen (Carlsbad, CA), Fugene6 from Roche (Basel, Switzerland), 
mouse monoclonal anti-Rac1 and anti-Cdc42 were from BD Biosciences (Franklin 
Lakes, NJ).  All other chemicals were from Sigma.   
Isotonic Na+-rich buffer contained 140 mM NaCl, 3 mM KCl, 1 mM MgCl2, 1 
mM CaCl2, 5 mM glucose and 20 mM HEPES (pH 7.4).  In NMG+-rich buffer NaCl and 
KCl were replaced by 143 mM NMG-chloride, and in K+-rich buffer NaCl was replaced 
by 100 mM K-glutamate and 43 mM KCl.   
 
Cells, Media, Transfection and Growth Factor Stimulation: 
HeLa and A431 cells were obtained from the LCCC tissue culture facility (UNC 
Chapel Hill). HeLa and A431 cells were cultured in DMEM (high glucose, with 
glutamine, Gibco) supplemented with 10% fetal bovine serum (Sigma) and antibiotics 
(Gibco). For transfection of plasmid DNA, FuGene6 (Roche) was used according to the 
manufacturer’s protocol. For transfection of siRNAs into HeLa cells siQuest reagent 
(Mirus) was used according to the manufacturer’s instructions. Briefly, 1.5 ml serum-free 
media was mixed with 18 µl siQuest reagent and 11.25 μl of a 20 μM siRNA stock 
solution. After 20 min incubation at room temperature the complexes were added to a 10 
cm tissue culture dish (cell confluency ~ 50%) with 7.5 ml fresh media containing serum. 
24 h after transfection the media was changed and 48 h after transfection the cells were 
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split 1:2. The cells were used for subsequent experiments between 72 to 96 h post 
transfection. 
For growth factor stimulation experiments, cells were initially starved in 
DMEM/0.5% delipidated BSA or Ham’s F12K without phenol red (Invitrogen, CA, 
delipidated BSA, Sigma) for 4 h. Subsequently, the media was replaced by DMEM/0.5% 
delipidated BSA or Ham’s F12K without phenol red supplemented with the 
corresponding growth factor at the indicated concentration. Human recombinant EGF 
was obtained from R&D Systems.  All growth factors were used at a final concentration 
of 20 ng/ml unless otherwise indicated. 
 
Plasmids and Expression Constructs: 
The Rac1 FRET biosensor was reported previously (Kraynov et al. 2000; Machacek et al. 
2009), and here includes modifications to improve FRET efficiency reported in 
(Machacek et al. 2009). The Cdc42 biosensor uses an intermolecular design as reported 
by several groups (Itoh et al. 2002; Seth et al. 2003; Tzima et al. 2003; Hoppe and 
Swanson 2004), but here is further optimized by the use of different fluorescent proteins 
and of a Cdc42-binding domain from WASP, a fragment shown to provide good 
selectivity for activated Cdc42 in a previously developed biosensor with a different 
design (Nalbant et al. 2004; Frantz et al. 2007; Machacek et al. 2009). Both biosensors 
were generated by first constructing plasmids encoding either Rac1 or Cdc42 fused to the 
C terminus of CyPet, a CFP variant optimized for FRET (Nguyen and Daugherty 2005), 
and either the CRIB domain from p21-activated kinase (PBD) published previously 
(Machacek et al. 2009) or the Cdc42-binding CRIB domain from WASP (CBD), amino 
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acids 230–314, fused to the C terminus of YPet, a YFP variant optimized for FRET 
(Nguyen and Daugherty 2005). The EGFP coding region from the EGFP-C1 vector 
(Clontech, Inc.) was replaced with a PCR product containing the CyPet or YPet coding 
regions flanked by an NcoI restriction site and a SGLASELGS linker containing a 
BamHI restriction site. The PCR products of the Rac1, Cdc42, PBD, and CBD coding 
sequences were inserted between the BamHI restriction site in the SGLASELGS linker 
and an EcoRI restriction site in the downstream multiple cloning site of the vector.  The 
潨 慥㱥䄯瑵 㹲夼 㹲〲   教牡㰾transfected into A431 cells using Lipofectamine LTX, 
Amaxa Nucleofection kit according to the manufacturer’s instructions.  
 
Rac1 and Cdc42 Activity Assays 
FRET biosensor imaging cell culture conditions: A431 cells were maintained in 
Dulbecco’s modified Eagle’s medium (Mediatech, Manassas, VA) with 10 % FBS. For 
all imaging experiments, cells were plated on fibronectin-coated (5 g/ml) glass 
coverslips 12 hours prior to imaging. Cells were initially starved in Ham’s F-12K without 
phenol red (Invitrogen, Carlsbad, CA) with 0.01% delipidated BSA (Sigma) and 15 mM 
HEPES (Mediatech, Manassas, VA) for 4 hours.  The cells were then incubated in an 
open chamber (Warner Instruments, Hamden, CT) in the K+-rich/nigericin isotonic buffer 
described above for 10 minutes, then transferred to a heated stage for imaging.  After 
imaging for 3 minutes, 200 ng/mL EGF (Sigma, St. Louis, MO) was added to the open 
chamber, and imaging was continued for an additional 10 minutes.  Cells were chosen for 
low expression levels so that neither YPet-PBD nor YPet-CBD inhibited 
macropinocytosis. 
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Imaging the Activity of One Rho GTPase per Cell: 
Activation levels of both Rac1 and Cdc42 were measured in living cells by 
monitoring the ratio of FRET (CyPet to YPet) to CyPet emission, and corrected for 
bleed-through from CyPet and YPet as detailed below. Time-lapse sequences were 
acquired on an Olympus IX81 inverted epifluorescence microscope, using an Olympus 
40x UPlan FLN1.3 N/A DIC lens, CoolsnapES2 CCD camera (Roper Scientific) and 
Metamorph software (Universal Imaging).  For emission ratio imaging, the following 
filter sets were used (Chroma): CyPet: D436/20, D470/40; FRET: D436/20, HQ535/30; 
YPet: HQ500/20, HQ535/30.  A dichroic mirror (“Quad-Custom” Lot# 511112038) was 
custom manufactured by Chroma Technology Corporation for compatibility with all of 
these filter sets. Cells were illuminated with a 100 W Hg arc lamp through an ND 1.0 
neutral density filter. At each time point, three images were recorded with the following 
exposure times: CyPet (1.2 s), FRET (excitation of donor, observation of acceptor 
emission) (1.2 s), YPet (0.4 s) at binning 2x2. We routinely changed the order of 
acquisition for all experiments, varying between the order CyPet, FRET, YPet, or FRET, 
CyPet, YPet. The image sets were taken at 10s intervals. Ratio calculations to generate 
activity images were performed following bleed-through correction methods described 
previously. Briefly, Metamorph software was used for image alignment and ratiometric 
calculation of activation signals. All images were shading-corrected and background-
subtracted. Binary masks with values equal to 1 inside the cell and 0 elsewhere were 
extracted by applying a threshold to the CyPet image, because it had the largest signal-to-
noise ratio. Control cells expressing either CyPet alone or YPet alone were used to obtain 
bleed-through coefficients, α and βin the following equation: 
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 (Equation 1) 
where R is the Ratio, FRETt  is the total FRET intensity as measured, α is the bleed-
through of CyPet into the FRETt  signal, β is the bleed-through of YPet into the FRETt 
signal and CyPet and YPet are the total CyPet and YPet intensities as measured through 
the CyPet and YPet filter sets, respectively. The bleed-through parameter α is given by 
the slope of the linear relationship between FRET and CyPet intensities upon CyPet 
excitation of cells expressing only CyPet. Similarly, the bleed-through parameter β is 
given by the slope of the linear relationship between FRET and mYPet intensities of cells 
expressing only the mYPet. The α parameter was found to be 0.4~0.5 and the β parameter 
was ~0.2. Both were dependent on the particular optical configuration of the microscope 
used. With these parameters, the ratio of corrected FRET over CyPet was calculated and 
used as a measure of Rac1 and Cdc42 activation. In time-lapse experiments, CyPet and 
YPet typically bleach at different rates. Therefore, the ratio was corrected for 
photobleaching as described in {Hodgson, 2006 #648; Nalbant, 2004 #190}.   
For visual representations of ratio images, a linear pseudocolor lookup table was 
applied to all ratio images and the ratio values were normalized to the lower scale value, 
which was chosen to exclude the bottom 5% of the total histogram distribution, avoiding 
spurious low intensity pixels. In each experiment, all images were carefully inspected to 
verify that all portions used to create the ratio image had a sufficiently high signal/noise 
ratio. We targeted at least 300 gray level values (12 bit dynamic range) above 
background in the lowest intensity regions within the cell (S/N > 3). This was especially 
important in thin parts of the cell where fluorescence was low. Furthermore, we routinely 
reversed the order of image acquisition to confirm that the effects of motion artefacts 
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associated with sequential image acquisition were not significant. We have used this 
approach previously to show that the order of data acquisition did not affect the measured 
ratio (Nalbant et al. 2004; Pertz et al. 2006).  
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5.6  Figures and Legends 
Table 5.1:  siRNA Sequences Used in this Study  
A list of siRNA sequences used and their targets.  
Protein Anti-sense Sense 
PLEKHG6 
(#1) 
UAGCAGAUCAGUCAUGAUCdTdT GAUCAUGACUGAUCUGCUAdTdT 
PLEKHG6 
(#2) 
UUAGUUUCUUGCUGUUCUCdTdT GAGAACAGCAAGAAACUAAdTdT
RhoG GCAACAGGAUGGUGUCAAGUU CUUGACACCAUCCUGUUGCUU 
Vav2 UCACAGAGGCCAAGAAAUUdTdT AAUUUCUUGGCCUCUGUGAdTdT 
Vav3 UUUCAGAACUUAAUGCUCCTGdT
dT 
GGAGCAUUAAGUUCUGAAAdTdT
Control UCACUCGUGCCGCAUUUCCdTdT GGAAAUGCGGCACGAGUGAdTdT
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Figure 5.1:  RhoG and PLEKHG6 are Required for Dorsal Ruffle Formation in 
A431 cells after EGF Stimulation. 
 
(A) A431 cells were transfected with the control, RhoG or PLEKHG6-specific siRNAs. 
After 72 hours the cells were plated on fibronectin-coated coverslips (20 µg/ml). After 4 
hour serum starvation, the cells were treated with 20 ng/ml EGF and DIC microscopy 
movies of individual cells were taken (10 seconds per frame, 480 seconds total). Cellular 
ruffling response showed either a ‘dorsal ruffling phenotype’ (upper row, arrowheads 
indicate dorsal ruffles, also shown enlarged in the inset) or a ‘Rac-like ruffling 
phenotype’ (bottom row). Bar: 20 µm.  
(B) Quantification of the occurrence of dorsal-ruffle phenotype versus Rac1-like 
phenotype after transfecting the different siRNAs. Shown are averaged results from three 
independently performed experiments. Asterisk indicate significant difference compared 
to control siRNA transfected cells (according to ttest, p<0.05 and p<0.01, respectively). 
(C) HeLa cells were transfected with low amounts of expression constructs for mCherry 
or mCherry-PLEKHG6 and analyzed for dorsal ruffle formation after EGF treatment.  
(D) Quantification of the frequency of EGF induced dorsal ruffle formation of HeLa cells 
transfected with the indicated expression constructs. 
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Figure 5.1 
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Figure 5.2:  Effect of pH on Activation of Rac1 and Cdc42. 
(A) Analysis of activated Rac1 and Cdc42 before and after treatment for 5 min with EGF, 
while clamping pHc at the indicated values. Active Rac1 and Cdc42 were pulled down 
using GST-PBD–coated beads.  
(B) Quantification of the effect of pHc-clamping on EGF-induced Rac1 and Cdc42 
activation analyzed by GST-PBD pull-down. Data are means ± SE of three experiments. 
Data were compared between pHc 7.8 and pHc 6.8; *, P < 0.05.  
(C) Assessment of Rac1 activation by FRET imaging of genetically encoded biosensors. 
Activation of Rac1 was measured by FRET as detailed in Materials and methods before 
and after treatment with EGF, while clamping pH at pHc 6.6 or pHc 7.8. Dashed lines in 
whole-cell images (middle) align with the direction of protrusion and indicate the area 
selected for kymography and line-scan analysis (right). Bar, 10 µm.  
(D) Quantification of Rac1 and Cdc42 activation analyzed by FRET using line-scan 
analysis of the regions studied by kymography as in A. Data are means ± SE of three 
experiments analyzing 6–8 cells in each; ***, P < 0.001.   
(E) Effect of overexpression or PBD-YPet or CBD-YPet on macropinocytosis. Confocal 
images of cells transfected with PBD-YPet or CBD-YPet (left) incubated with EGF and 
TMR-Dextran (right) for 10 min in Na+-rich medium to assess macropinocytosis. Dashed 
lines indicate outlines of cells. Bar, 10 µm.  
(F) Quantification of macropinocytosis in untransfected or in highly transfected cells by 
measuring TMR-Dextran fluorescence intensity (right). Data are means ± SE of three 
experiments. Data were compared between untransfected and transfected cells; ***, P < 
0.001. 
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Figure 5.2 
 
 
 
 
  
CHAPTER SIX:  ROLE OF RHO GTPASES IN TRANSENDOTHELIAL 
MIGRATION 
 
6.1  Abstract 
 Blood leukocytes play a critical role in immune surveillance and the host response 
to foreign antigens.  In inflammation, an inflammatory stimulus or antigen causes the 
extravasation of leukocytes to the site of the stimulus or antigen.  Extravasation of these 
leukocytes into tissues is the critical process of transendothelial migration (TEM), and 
excessive TEM is seen in a variety of inflammatory disorders, including ischemia-
reperfusion injury after heart attack, atherosclerosis, and asthma (Jones et al. 2000; 
Worthylake and Burridge 2001; Hordijk 2006; Galkina and Ley 2007; van Buul et al. 
2007b), among others.  Interestingly, mouse models predisposed to atherosclerosis 
demonstrate that disruption of endothelial cell adhesion molecule interactions reduces the 
development of atherosclerotic plaques (Lichtman et al. 1996; Lutters et al. 2004; 
Galkina and Ley 2007).  One of these adhesion molecules, intracellular adhesion 
molecule 1 (ICAM-1), is critical for leukocyte adhesion in TEM, and is upregulated by 
inflammatory stimuli (Ross 1999; Cybulsky et al. 2001).  It is unclear how engagement 
and clustering of ICAM-1 by leukocyte integrins induces cytoskeletal changes necessary 
to produce TCs and the directional TEM of leukocytes.  However, given their 
prominence in signaling leading to cytoskeletal rearrangement and previous studies in 
this field, the Rho GTPases are known to be key coordinators of this process.  In this 
study, we attempt to better understand the roles of the Rho GTPases in TEM, with the 
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goal of identifying novel signaling targets for reducing the pathological inflammation 
seen in the development and consequences of CVD and other inflammatory diseases. 
   
 
 294
6.2  Introduction 
 Blood leukocytes play a critical role in immune surveillance and the host response 
to foreign antigens.  In inflammation, an inflammatory stimulus or antigen causes the 
extravasation of leukocytes to the site of the stimulus or antigen via the critical process of 
transendothelial migration (TEM).  Excessive TEM is seen in a variety of inflammatory 
disorders.  In an effort to modulate inflammatory signals and leukocyte recruitment, TEM 
has been studied intensively.  The paradigm of leukocyte TEM signaling divides the 
process into three steps: rolling adhesion, firm adhesion, and TEM.  In rolling adhesion, 
selectins on the leukocyte bind weakly to carbohydrate ligands on the endothelial surface.  
Next, leukocytes encounter endothelial-bound chemokines which in turn activate 
leukocyte integrins, facilitating firm adhesion through binding and clustering of the 
leukocyte integrins 41 and L/M2 to the endothelial ligands VCAM-1 and ICAM-1, 
respectively (Springer 1994).  At this point, it is thought that engagement and clustering 
of VCAM-1 and ICAM-1 stimulates endothelial cell signaling which permits leukocytes 
to pass through or between cells to reach the inflammatory stimulus.  How the 
endothelium responds still remains a subject of controversy. 
 
Transmigratory Cup Composition: 
 Current knowledge of transcellular TEM signaling suggests that leukocyte 
adhesion to the endothelium clusters endothelial ICAM-1 via the integrins L/M2, 
inducing the formation of microvillous cup-like structures that embrace the migrating 
leukocytes within minutes.  The leukocytes also probe the endothelial cells via 
podosomes during TC formation (Carman et al. 2007).  ICAM-1 signaling is clearly 
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important in TEM since the cytoplasmic tail is required for TC formation and leukocyte 
TEM across the endothelium (Greenwood et al. 2003).  The signals downstream of 
ICAM-1 are poorly defined in TC formation, but recent studies have delineated a number 
of molecules that co-localize to TCs.  TCs are thought to be caveolar compartments 
containing clustered ICAM-1 (Millan et al. 2006), closely linked to the actin cytoskeleton 
by filamin (Gauthier-Rouviere et al. 1998; Bellanger et al. 2000), to the cortical 
cytoskeleton by the modulators ezrin and moesin (Barreiro et al. 2002), to the 
intermediate filament cytoskeleton by vimentin (Nieminen et al. 2006), and to the 
microtubule cytoskeleton (Carman and Springer 2004).  Morphological alteration of the 
cytoskeleton to form TCs also depends critically on Ca2+, intact microtubules, and actin, 
since Ca2+-chelators, microtubule polymerization inhibitors, and actin polymerization 
inhibitors all impair TC formation and leukocyte TEM (Carman et al. 2003).  Once 
formed, TCs also present chemokines apically to adhered leukocytes (Middleton et al. 
1997), guiding leukocytes through the endothelium.    
 
Transmigratory Cup and TEM Signaling Pathways: 
 It is unclear how engagement and clustering of ICAM-1 by leukocyte integrins 
induces cytoskeletal changes necessary to produce TCs and the directional TEM of 
leukocytes.  TCs are thought to be similar to phagocytic cups found in other cell types 
(Millan et al. 2006), and it is possible that similar molecules are involved in their 
formation.  One signaling molecule involved is RhoG, a Rho GTPase 72% identical to 
Rac1 and 62% identical to Cdc42 in sequence, which has been shown to be activated in 
the phagocytosis of apoptotic cells (deBakker et al. 2004; Henson 2005).  Upon 
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stimulation, RhoG activates effector proteins while also activating Rac1 via the 
ELMO/DOCK180 complex in parallel (Wennerberg et al. 2002; Prieto-Sanchez and 
Bustelo 2003), but the in vivo significance of this RhoG-mediated Rac1 activation 
remains unknown.  RhoG has also been localized to the plasma membrane with 
microtubules and filamin (Gauthier-Rouviere et al. 1998), as well as with ICAM-1 in TCs 
(van Buul et al. 2007a), and can modulate the actin cytoskeleton similar to Rac1 
(Wennerberg et al. 2002).  RhoA has also been proposed to play a role in TC formation 
but its role is controversial as different labs have obtained different results regarding its 
importance (Etienne et al. 1998; Barreiro et al. 2002; Thompson et al. 2002; Carman et 
al. 2003; Carman and Springer 2004; Millan et al. 2006; van Buul et al. 2007a).  Since 
TC formation is rapid and highly dynamic, the signaling activity producing TCs must be 
spatio-temporally orchestrated, making traditional biochemical and fixed cell approaches 
ineffective in resolving the signaling kinetics of the Rho GTPases (Pertz et al. 2006), but 
the approach in this study overcomes many of these problems.   
To study the Rho GTPases involved in this process, we have used our previously 
developed sensors for RhoA, Rac1, and RhoG to study their activation downstream of 
ICAM-1 ligation by anti-ICAM-1-antibody-coated beads.  By analysis of RhoA, Rac1, 
and RhoG activity, we have been able to establish a sequence of timing events for the 
activation of these GTPases downstream of ICAM-1 ligation.   
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6.3  Results 
Establishment of a Model System for Studying ICAM-1 Ligation and Downstream 
Signaling: 
 
Previous work has established the use of anti-ICAM-1-antibody coated beads as a 
method for ligating ICAM-1 and activating endothelial Rho GTPases (Thompson et al. 
2002; Millan et al. 2006; van Buul et al. 2007a).  Using this information as a starting 
point, we attempted to establish a model cell system in which to study ICAM-1 ligation 
and activation of downstream pathways.  First, 3 μm latex beads were conjugated with 
anti-ICAM-1 antibody or a control anti-IgG antibody to ascertain whether the beads 
would bind to Cos-7 cells, the choice model cell system, given their lack of endogenous 
ICAM-1 expression.  When both the anti-ICAM-1 and control beads were added to Cos-7 
cells, or to mouse embryonic fibroblasts, a parallel control, neither bead type bound the 
cells.  However, if ICAM-1-mCherry was overexpressed in either cell line, only the anti-
ICAM-1 beads were demonstrated to bind tightly (Figure 6.1A) and only to the cells 
expressing ICAM-1, and generally tracked along with retrograde actin flow toward the 
center of the cell (Figure 6.1B).  Further, bead binding led to clustering of ICAM-1 
around the beads, as expected (Figure 6.1C).  Interestingly, 8μm and 10 μm beads, while 
closer to the size of leukocytes, had some significant disadvantages.  One, they were 
much more autofluorescent, and compared to the 3μm beads which demonstrated a 
directional flow over the cells due to convective heating within the imaging chamber, 
they simply fell onto cells and adhered non-selectively preventing a specific analysis of 
ICAM-1 ligation.   
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Examining Rac1 Activity Downstream of ICAM-1 Ligation: 
Once established that ICAM-1 could be selectively bound and ligated by 3μm 
anti-ICAM-1 beads, we attempted to study the activation of Rac1 in this system.  Cos-7 
cells expressing both a dual-chain Rac1 activity FRET sensor and ICAM-1-mCherry 
were treated with the anti-ICAM-1 beads and examined for changes in Rac1 activation 
under or surrounding the beads (Figure 6.2A).  Addition of beads and binding to the 
ICAM-1-mCherry expressing cells led to an initial decrease in Rac1 activation directly 
beneath the bead, which was persistent over time.  However, these bead binding events 
ultimately led to transient, robust activation of Rac1 downstream of the ligation of 
ICAM-1 (Figure 6.2B).  This was in contrast to initial observations that showed 
immediate recruitment of Rac1 protein to these bead-binding sites.  Thus, protein 
recruitment did not correlate with the observed activity.  These bursts of Rac1 activation 
were short in duration (~10 minutes maximal duration) but of high intensity, reaching 
between 5 and 10-fold higher than baseline Rac1 activity.  To confirm that this activation 
was not an artefact of the sensor itself, or of optical alterations due to the refraction of 
light by beads on the surface of the cell, a Rac1 dominant negative sensor (T17N) was 
tested, in addition to replacing components of the sensor with fluorophore only.  None of 
these conditions led to the transient, high-level Rac1 activation events seen in the wild-
type condition.  Quantitation of bead binding events that led to Rac1 activation showed 
that Rac1 was activated by over 40% of bead binding events, whereas sensor controls 
(fluorophore only donor or acceptor constructs) and the Rac1 T17N dominant negative 
sensor showed virtually no transient Rac1 activation events.  Further, when the C-
terminus of ICAM-1, which is responsible for binding signaling partners, was truncated, 
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transient Rac1 activation events were reduced dramatically, suggesting that the ligation of 
ICAM-1 specifically activates Rac1 in a transient manner downstream (Figure 6.2C).  We 
again noted the recruitment of ICAM-1-mCherry to sites of bead adhesion with the wild-
type ICAM-1 construct, but not when the C-terminus was truncated (Figure 6.2D).   
Further, upon bead recruitment of ICAM-1, we attempted to discern as previously 
reported whether a transmigratory “cup” or docking structure was formed.  By 
performing imaging on a disk-spinning confocal microscope, we were able to assess the 
structure of the membrane around the bead.  After deconvolution and 3-D reconstruction 
of the image, it was noted that ICAM-1-mCherry formed finger-like projections that 
surround the attached bead (Figure 6.2E), consistent with previous reports in the 
literature.  These finger-like projections seemed to form before the initiation of Rac1 
activity, as they were present on the majority of attached beads (but not all).  These 
behaviors have also been confirmed in human umbilical vein endothelial cells (HUVECs) 
and primary microvascular cells (data not shown) pre-treated with TNFα to induce 
ICAM-1 surface expression. 
 
Examining RhoA Activity Downstream of ICAM-1 Ligation: 
Previous biochemical work has shown that both RhoA and Rac1 are activated 
downstream of ICAM-1 in endothelial cells (Adamson et al. 1999; Thompson et al. 2002; 
van Buul et al. 2007a; Fernandez-Borja et al. 2010).  Since Rac1 activation was 
visualized as described above, we wanted to establish a spatiotemporal relationship 
between RhoA and Rac1 signaling downstream of ICAM-1 ligation.  Thus, we attempted 
to perform the same experiments as done above for Rac1.  At this point, we shifted most 
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of our experimentation to primary microvascular endothelial cells as it had been 
established that bead-binding and Rho GTPase activation were detectable in the model 
system.  Microvascular cells express low levels of ICAM-1 at the cell surface at baseline 
(Wertheimer et al. 1992), and therefore should not bind anti-ICAM-1 or control beads, 
and indeed this was found to be the case.  After treatment with TNFα to induce ICAM-1 
expression at the surface of cells, we found that the anti-ICAM-1 beads did bind 
selectively to the endothelial cells.  A single-chain RhoA activation FRET biosensor was 
expressed in these cells via adenoviral transduction, and the cells were treated first with 
TNFα, then with anti-ICAM-1 beads.   
Surprisingly, consistent depression of RhoA activity around the site of the bead 
was observed.  This depression was immediate and sustained (Figure 6.3A).  This result 
was at odds with previous biochemical data demonstrating activation of RhoA (Adamson 
et al. 1999; Thompson et al. 2002).  Thus, there were two possibilities: 1) RhoA was 
being activated focally at another site that was not previously appreciated, or 2) RhoA 
was being activated globally in response to local ligation of ICAM-1 (with evidence 
being the formation of stress fibers (Adamson et al. 1999; Thompson et al. 2002)).  To 
address this, we examined cells more closely.  First, it was noted that in DIC images, 
cells did seem to contract almost immediately upon bead adherence, especially at 
junctional regions between cells.  Examination of RhoA activity at these sites 
demonstrated activation of RhoA at junctional regions, perhaps indicating a contractile 
response mediated by actomyosin contractility (Figure 6.3B).  Further, examining global, 
rather than local (around the bead) RhoA activity demonstrated a small increase in 
diffuse RhoA activation of approximately 2.5% compared to controls at 0.5% (data not 
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shown) in a limited data set.  Thus, it is possible that the activation seen biochemically is 
a diffuse activation of RhoA coupled to the actomyosin network.  Further experiments 
would need to be performed to address this possibility, such as blocking actomyosin 
contractility downstream of RhoA and observing whether cell junctions were separated 
upon bead binding as seen previously.  Further, if stress fiber formation in these cells was 
examined, an increase upon bead binding would be likely, and should happen rapidly if 
RhoA activation is diffuse rapid.  Additionally, blockade of actomyosin contractility 
would abrogate the stress fiber response if this hypothesis were true.   
 
Examining RhoA Activity Downstream of Applied Mechanical Force: 
To attempt to answer the previous question about whether RhoA activation is 
global, focal, or possibly both, we examined RhoA activation in a well-characterized 
system, namely mechanical force application, to determine whether RhoA activation 
could be detected.  Previous work has repeatedly demonstrated that the application of 
mechanical force to cells causes cellular stiffening via RhoA activation leading to 
actomyosin contractile forces (Choquet et al. 1997; Matthews et al. 2006) .  Thus, it was 
anticipated that this would be an excellent system in which to address whether a focal 
application of force to cells would activate RhoA locally or globally, and whether it could 
be detected.  To address this, bovine aortic endothelial cells (BAECs) were used as a 
model system, as they have many of the cell surface receptors that the endothelial cells 
used previously do.  To treat these cells, 3 μm magnetic beads were conjugated with anti-
PECAM-1 antibody specific for PECAM-1 on the surface of the endothelial cells, since 
PECAM-1 is known to transduce force in endothelial cells (Tzima et al. 2005).  The cells 
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were plated, allowed to spread, and subsequently treated with the beads.  The beads were 
then subjected to mechanical force application of 2 nN and observed at 0, 2, 5, or 30 
minutes post-force, in addition to the same experiments performed with control IgG 
beads that would not bind the cells.  When the endothelial cells were plated on 
fibronectin, biochemical pull-down assays for GTP-loaded RhoA showed RhoA 
activation at 2, 5, and 30 minutes post-force application.  In contrast, when endothelial 
cells were plated on collagen, the same experimental setup showed that RhoA activation 
was seen very prominently at 5 minutes post-force application but less at other time 
points, suggesting that cellular stiffening responses vary depending on the substrate upon 
which the cells are plated.   
Next, we attempted to discern the nature of these changes in RhoA activation, 
spatiotemporally.  These same cells were transfected with the RhoA activity FRET sensor 
and the same experiments were performed.  Our data (Figure 6.4A) illustrate that the 
biochemical findings can be recapitulated using the RhoA activity FRET sensor with 
slightly more variance than is seen biochemically (Matthews et al. 2006).  Indeed, in cells 
plated on fibronectin, we see activation at 2 and 5 minutes, but not at 30 minutes.  
However, an examination of the individual cellular values at the 30 minute time point 
suggest that some of the cells are responding with higher than average activity values, 
and some have returned to baseline by this point, suggesting that the blots were only 
detecting a portion of the cell population.  Similarly, on collagen, we found activation of 
RhoA to be significant only at the 5 minute time point, consistent with the biochemical 
data.  When we examined these cells for spatial and temporal patterns associated with 
RhoA, we saw no consistent pattern with the cells plated on fibronectin.  In each case, 
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RhoA activation increased globally (Figure 6.4B), as indicated by taking region 
measurements in different areas of the cell.  There was no local increase in RhoA 
activation surrounding the beads through which force was applied (though this may have 
been masked by significant autofluorescence from the beads).   
With cells plated on collagen, global RhoA activation also increased as with the 
cells plated on fibronectin (Figure 6.4C), but we also noted a specific increase at the 
edges of cells, suggesting an increase in cellular ruffling and protrusion, which was not 
observed in the cells plated on fibronectin.  Thus, this provides evidence that RhoA can 
be activated or inactivated both globally and locally by different stimuli and that these 
processes may be separable.  Thus, this data is consistent with the possibility that RhoA 
is depressed locally upon ICAM-1 ligation, yet activated globally, as seen in biochemical 
assays, stress fiber formation assays, and by biosensor studies.  Additionally, it is 
consistent with the hypothesis and data that cells move faster when presented with a 
stiffer environment, such as a fibronectin-coated glass coverslip (Peyton and Putnam 
2005).  Thus, if a leukocyte were to move across the surface of cells, it would likely gain 
greater speed from a stiffer substrate, such as an endothelium exhibiting contractile 
properties due to RhoA activation, rather than a pliable endothelial surface.  Such an idea 
would be very interesting to test and demonstrate in vivo. 
 
Examining RhoG Activity Downstream of ICAM-1 Ligation: 
Given that we have established a relationship between RhoA and Rac1 in 
endothelial cells upon ICAM-1 ligation, we sought to address an additional relationship.  
It is well known from the literature that the small GTPase RhoG, covered in Chapter 4, 
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can activate Rac1 directly via the ELMO/DOCK180 complex.  This relationship has been 
shown to play a role in leukocyte transmigration downstream of ICAM-1 ligation, but the 
dynamics of this process have remained poorly understood (van Buul et al. 2007a).  Is 
RhoG activated first?  Are Rac1 and RhoG activated in parallel?  To address this 
question, we sought to examine RhoG activation downstream of ICAM-1 ligation as 
described for Rac1 and RhoA above.  Endothelial cells were infected with adenovirus 
carrying the RhoG sensor, stimulated with TNFα, and treated with anti-ICAM-1 beads.  
Initial observations showed that both RhoG and the ELMO binding domain components 
of the biosensor were immediately and rapidly recruited to adhering beads (Figure 6.5A).  
In contrast with what we observed for Rac1, RhoG was also immediately activated at the 
site of the bead and gradually increased over the first 10 minutes of bead binding (Figure 
6.5B).  To confirm the specificity of this RhoG activation, and since we were unable to 
manipulate the endogenous ICAM-1 as we did in our previous model system, we turned 
to endothelial cells derived from mice missing the RhoG-selective GEF, SGEF, 
previously shown to be involved in the leukocyte transendothelial migration process (van 
Buul et al. 2007a).  By performing this same assay in aortic endothelial cells derived 
from comparable wild-type (SGEF+/+) and knock-out (SGEF-/-) mice, stimulated with 
TNFα and treated with anti-ICAM-1 beads, the recruitment of RhoG and ELMO binding 
domain to beads is abrogated, as is the observed activation of RhoG (Figure 6.5C) in 
SGEF-/- cells compared to wild-type cells.  This strongly suggests that the ligation of 
ICAM-1 leads to activation of SGEF, which in turn activates RhoG selectively 
downstream of ICAM-1.  The rapidity of this activation further places it upstream of 
Rac1 given the results in Figure 6.1 where Rac1 is transiently activated with a delay, but 
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no causal link between RhoG and Rac1 has yet been demonstrated.  We hope to address 
this by manipulating the ELMO/DOCK180 pathway and showing that the transient 
activation of Rac1 we see downstream of ICAM-1 ligation is altered or absent when the 
ELMO/DOCK180 complex is disrupted.   
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6.4  Discussion and Ongoing Studies 
In the present study, we demonstrate differing spatiotemporal dynamics of RhoA, 
Rac1, and RhoG activation after ligation of ICAM-1 by anti-ICAM-1-antibody 
conjugated beads.  Consistent with the literature (Wennerberg et al. 2002; Katoh and 
Negishi 2003; van Buul et al. 2007a), RhoG is typically activated before Rac1, and is 
more constant in nature, suggesting that RhoG is the among the first GTPases activated at 
these sites of bead binding.  Subsequently, Rac1 is transiently activated and the cells 
attempt to engulf the bead, suggesting that Rac1 may be critical for the closure and 
internalization of the bead, or in vivo, the leukocyte.  However, this remains to be 
elucidated.  Further, the temporal delay between RhoG and Rac1 also warrants further 
investigation.  While it is not surprising that Rac1 would be activated after RhoG, given 
the robust literature indicating that in phagocytic behaviors, and that Rac1 is activated by 
RhoG via the ELMO/DOCK180 pathway (deBakker et al. 2004), the constant nature of 
RhoG activity compared to the highly transient Rac1 activation indicates other factors are 
at play.  Is RhoG activation mediated independent of phosphoinositide production and 
accumulation after ICAM-1 ligation?  In contrast, is the delay to Rac1 activation due to 
the necessary accumulation of phosphoinositides (Chung et al. 2001; Huang et al. 2003; 
Merlot and Firtel 2003; Welch et al. 2003), or the organization of the ELMO/DOCK180 
complex?  The literature suggests that indeed, RhoG activation is mediated rapidly, either 
by the GEFs Trio (deBakker et al. 2004; Park et al. 2007), or SGEF (Ellerbroek et al. 
2004; van Buul et al. 2007a), or perhaps both.  These questions remain to be investigated, 
and a variety of tools can be used to address them, such as siRNA against the GEFs, or 
probes that are available for detecting phosphoinositide accumulation. 
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We have attempted to address one of these questions, whether RhoG activation is 
mediated rapidly and immediately downstream of ICAM-1 ligation and clustering.  
Through the use of SGEF knockout mice, we could quantify RhoG recruitment and 
activation at sites of anti-ICAM-1-antibody coated bead binding in cells with or without 
SGEF.  These results indicate that SGEF is critical for the immediate, strong activation of 
RhoG downstream of ICAM-1.  However, it remains to be determined how SGEF is 
activated, and what other signaling partners might be involved in this process.   
RhoA, on the other hand, is a stark contrast to RhoG and Rac1.  Our findings that 
RhoA is inactivated locally at the sites of bead binding conflict directly with the literature 
(Adamson et al. 1999; Wojciak-Stothard et al. 1999; Etienne-Manneville et al. 2000; 
Thompson et al. 2002; van Buul et al. 2007a).  At the moment, I still remain uncertain of 
the reason for this discrepancy, but believe that the biochemical data do not accurately 
reflect the possibility that RhoA could be differentially regulated at different locations in 
the cell at the same time.  For example, whole-cell increases in RhoA activation 
downstream of ICAM-1 ligation are observed, in addition to junctional separation with 
high RhoA activity.  This may be more consistent with the literature, given that ICAM-1 
ligation leads to immediate formation of stress fibers (Adamson et al. 1999; Wojciak-
Stothard et al. 1999; Etienne-Manneville et al. 2000; Thompson et al. 2002; van Buul et 
al. 2007a) suggesting global RhoA activation.  However, Rac1 is known to antagonize 
RhoA activation (Arthur et al. 2000; Nimnual et al. 2003; Noren et al. 2003) and thus if 
activation of Rac1 at bead recruitment sites is observed, this may lead to RhoA 
inactivation locally.  Ongoing studies are attempting to address this issue. 
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One method used to address this issue indirectly is through the study of RhoA 
activation by a separate stimulus, magnetic bead-applied mechanical force.  Mechanical 
force, when applied to adherent cells, is well known to activate RhoA (Wang et al. 2005; 
Matthews et al. 2006).  Indeed, these findings were reproduced using a RhoA activity 
FRET sensor, and it was noted that the activation induced by force application was 
global, at least on fibronectin, in that activity over the entire cell increased, rather than 
being due to local increases in activity, which were observed on collagen (Figure 6.4).  
These findings give credence to the idea that ICAM-1 ligation by beads may lead to 
global changes in RhoA activation independent of local changes in RhoA activation at 
the sites of the beads.  Certainly more study is warranted in deciphering the mechanisms 
of RhoA regulation downstream of ICAM-1 ligation.   
Once the spatial and temporal relationships between Rac1, RhoA, and RhoG are 
established, many additional studies can be performed.  For example, through genetic 
manipulation, does loss of any of these GTPases cause blockade of cup formation, and if 
so, at what stage of formation is the process disrupted?  Second, what are the upstream 
regulators that control this cup formation process?  SGEF has been fairly well 
characterized as one of the GEFs for RhoG in this process, but what are the GEFs for 
RhoA and Rac1?  Does Rac1 become activated due to RhoG and the ELMO/DOCK180 
pathway alone?  What other signaling partners are required for this process?  Are the 
phases of cup formation, such as ruffle extension versus cup closure distinguishable at a 
molecular level?  Do any new targets for therapeutic intervention in inflammatory disease 
emerge from these studies?  All these answers, and many more experiments await future 
efforts. 
 309
6.5  Materials and Methods 
Materials and Reagents: 
Lipofectamine was purchased from Invitrogen (Carlsbad, CA), Fugene6 from Roche 
(Basel, Switzerland).  Mouse monoclonal anti-human ICAM-1 and anti-mouse ICAM-1 
antibodies were purchased from BD Biosciences (Franklin Lakes, NJ).  All other chemicals 
were from Sigma.  Adenoviral plasmids were generated using the Virapower system from 
Invitrogen (Carlsbad, CA).     
 
Cell Culture and Constructs: 
The Rac1 FRET biosensor was reported previously (Kraynov et al. 2000; 
Machacek et al. 2009), and here includes modifications to improve FRET efficiency 
reported in (Machacek et al. 2009), and the RhoG sensor is described in detail in Chapter 
4.  The Rac1 and RhoG biosensors were generated by first constructing plasmids 
encoding Rac1 or RhoG fused to the C terminus of CyPet, a CFP variant optimized for 
FRET (Nguyen and Daugherty 2005), and the CRIB domain from p21-activated kinase 
(PBD) published previously (Machacek et al. 2009) or the first 95 amino acids of 
ELMO1 fused to the C terminus or N-terminus, respectively, of YPet, a YFP variant 
optimized for FRET (Nguyen and Daugherty 2005). The EGFP coding region from the 
EGFP-C1 vector (Clontech, Inc.) was replaced with a PCR product containing the CyPet 
or YPet coding regions flanked by an NcoI restriction site and a SGLASELGS linker 
containing a BamHI restriction site. The PCR products of the Rac1 and PBD coding 
sequences were inserted between the BamHI restriction site in the SGLASELGS linker 
and an EcoRI restriction site in the downstream multiple cloning site of the vector.    
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CyPet-Rac1 T17N was generated by site-directed mutagenesis to generate a point 
mutation at residue 17 of Rac1.  The ELMO-YPet construct was generated by inserting 
the PCR product for YPet via the EcoRI and XhoI restriction sites in the pTriEx-4 
backbone.  Then, the PCR product for amino acids 1-95 of ELMO was then cloned in via 
the restriction sites NcoI and BamHI in the pTriEx-4 backbone.  The RhoA FRET 
biosensor is used as described previously (Pertz et al. 2006).  Each of these sensors was 
then subsequently cloned into the D-Topo pENTR entry vector and then pAd-DEST-
CMV-V5 destination vector according to the manufacturer’s instructions for the 
ViraPower adenoviral cloning system (Invitrogen).  ICAM-1-mCherry was generated by 
amplifying ICAM-1 from a template and ligating the PCR product into the EcoRI and 
BamHI restriction sites within the multiple cloning site of the pEGFP-N1 vector.  EGFP 
was replaced with mCherry in this plasmid by amplifying mCherry from template by 
PCR and ligating it into the vector via NotI and XhoI restriction sites within the plasmid.  
To generate the ICAM-1-mCherry C-terminal truncation mutant, a shortened version of 
ICAM-1 corresponding to amino acids 1-1512 was amplified by PCR and ligated into the 
EcoRI and BamHI restriction sites within the multiple cloning site of the vector above. 
The plasmids were transfected into Cos-7 cells or Bovine Aortic Endothelial cells 
(BAECs) using Lipofectamine, Fugene6, or the Amaxa Nucleofection kit according to 
the manufacturer’s instructions.  For Human Umbilical Vein Endothelial Cells 
(HUVECs) or primary microvascular endothelial cells, adenovirus containing the coding 
sequences for the RhoG and RhoA sensors was added to cells to obtain uniform 
expression at a level appropriate for imaging. 
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 Cos-7 cells were maintained in DMEM supplemented with 10% FBS, 
penicillin/streptomycin, and 2 mM glutamine.  All endothelial cells were maintained in 
EBM-2 basal growth medium supplemented with endothelial Bullet Kit containing all 
appropriate growth factors and serum (Lonza Biosciences). 
 For imaging studies with BAECs, cells were plated on glass coverslips either on 
fibronectin or collagen, then treated and fixed at the referenced time points in 3.7% 
paraformaldehyde in Dulbecco’s Phosphate Buffered Saline.  The coverslips were then 
mounted on glass microscopy slides for imaging on an inverted Olympus IX81 
epifluorescence system set up for FRET imaging as described below. 
 
Antibody Conjugation to Beads: 
Three m amino-functionalized polystyrene beads were acquired from 
Polysciences, Inc. and coupled with control IgG or anti-ICAM-1 anti-human or anti-
mouse antibody according to the manufacturer’s instructions.  In brief, a 2.5% solution of 
beads was washed three times with PBS and then reacted with 8% glutaraldehyde at room 
temperature for 6 hours with agitation.  The beads were then washed twice with DPBS, 
and 200-400 g of protein per 0.5 mL of 2.5% bead solution was reacted overnight at 4 
C with agitation.  The beads were then sequentially blocked with 0.2 M ethanolamine 
and BSA solution for 30 minutes each at room temperature and resuspended in storage 
buffer for use.  Beads were washed three times in imaging medium before addition to 
imaging chambers.  Magnetic beads were conjugated with control IgG antibody or anti-
PECAM-1 antibody and washed in a similar fashion before addition to BAECs.   
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Magnetic Bead Force Application: 
Application of force through control or anti-PECAM-1 antibodies was performed 
by Caitlin Collins of Dr. Ellie Tzima’s lab in collaboration with Dr. Richard Superfine’s 
laboratory using pre-specified protocols.   
 
Rac1, RhoG, and RhoA Activity Assays: 
Cos-7 cells were imaged in Ham’s F-12K without phenol red (Invitrogen, Carlsbad, 
CA) with 2% FBS and 15 mM HEPES (Mediatech, Manassas, VA) while endothelial 
cells were imaged in the same medium they were grown in, EBM-2 supplemented with 
2% FBS and endothelial growth factor supplements (Lonza, Inc.).  The cells were then 
incubated in a closed chamber (Warner Instruments, Hamden, CT) with beads added, and 
immediately transferred to a heated stage for imaging.  Cells were chosen for medium 
expression levels so that in the case of primary endothelial cells junctions remained intact 
and cellular morphology did not change noticeably.  Mouse aortic endothelial cells were 
isolated by another laboratory and cultured using previously established protocols for the 
isolation of primary endothelial cells from vasculature. 
 
Imaging the Activity of One Rho GTPase per Cell: 
Activation levels of both Rac1 and RhoG were measured in living cells by monitoring 
the ratio of FRET (CyPet to YPet) to CyPet emission, and corrected for bleed-through 
from CyPet and YPet as detailed below. Time-lapse sequences were acquired on an 
Olympus IX81 inverted epifluorescence microscope, using an Olympus 40x UPlan 
FLN1.3 N/A DIC lens, CoolsnapES2 CCD camera (Photometrics) and Metamorph 
software (Universal Imaging).  For emission ratio imaging, the following filter sets were 
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used (Chroma): CyPet: D436/20, D470/40; FRET: D436/20, HQ535/30; YPet: 
HQ500/20, HQ535/30.  A dichroic mirror (“Quad-Custom” Lot# 511112038) was custom 
manufactured by Chroma Technology Corporation for compatibility with all of these 
filter sets. Cells were illuminated with a 100 W Hg arc lamp through an ND 1.0 neutral 
density filter. At each time point, three images were recorded with the following 
exposure times: CyPet (1.2 s), FRET (excitation of donor, observation of acceptor 
emission) (1.2 s), YPet (0.4 s) at binning 2x2. We routinely changed the order of 
acquisition for all experiments, varying between the order CyPet, FRET, YPet, or FRET, 
CyPet, YPet. The image sets were taken at 10s intervals. Ratio calculations to generate 
activity images were performed following bleed-through correction methods described 
previously. Briefly, Metamorph software was used for image alignment and ratiometric 
calculation of activation signals. All images were shading-corrected and background-
subtracted. Binary masks with values equal to 1 inside the cell and 0 elsewhere were 
extracted by applying a threshold to the CyPet image, because it had the largest signal-to-
noise ratio. Control cells expressing either CyPet alone or YPet alone were used to obtain 
bleed-through coefficients, α and β in the following equation: 
 (Eq. 1) 
where R is the Ratio, FRET  is the total FRET intensity as measured, α is the bleed-
through of CyPet into the FRET  signal, β is the bleed-through of YPet into the FRET 
signal and CyPet and YPet are the total CyPet and YPet intensities as measured through 
the CyPet and YPet filter sets, respectively. The bleed-through parameter α is given by 
the slope of the linear relationship between FRET and CyPet intensities upon CyPet 
excitation of cells expressing only CyPet. Similarly, the bleed-through parameter β is 
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given by the slope of the linear relationship between FRET and mYPet intensities of cells 
expressing only the mYPet. The α parameter was found to be 0.4~0.5 and the β parameter 
was ~0.2. Both were dependent on the particular optical configuration of the microscope 
used. With these parameters, the ratio of corrected FRET over CyPet was calculated and 
used as a measure of Rac1 and RhoG activation. In time-lapse experiments, CyPet and 
YPet typically bleach at different rates. Therefore, the ratio was corrected for 
photobleaching as described in (Nalbant et al. 2004; Hodgson et al. 2006) (Nalbant 2004, 
Hodgson 2006).  For RhoA activity, since both donor and acceptor fluorophores are 
present on the same molecule, no bleedthrough correction was required.  At each time 
point for RhoA, two images were recorded with the following exposure times: CFP 
(1.2 s) and FRET (0.6 s) using illumination from a 100 W Hg arc lamp through an ND 
1.0 neutral density filter.  The FRET ratio was calculated as the ratio of FRET/CFP after 
image processing as described above. 
For visual representations of ratio images, a linear pseudocolor lookup table was 
applied to all ratio images and the ratio values were normalized to the lower scale value, 
which was chosen to exclude the bottom 5% of the total histogram distribution, avoiding 
spurious low intensity pixels. In each experiment, all images were carefully inspected to 
verify that all portions used to create the ratio image had a sufficiently high signal/noise 
ratio. We targeted at least 300 gray level values (12 bit dynamic range) above 
background in the lowest intensity regions within the cell (S/N > 3). This was especially 
important in thin parts of the cell where fluorescence was low and where beads typically 
adhered. Furthermore, we routinely reversed the order of image acquisition to confirm 
that the effects of motion artefacts associated with sequential image acquisition were not 
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significant. We have used this approach previously to show that the order of data 
acquisition did not affect the measured ratio (Nalbant et al. 2004; Pertz et al. 2006). 
Further, for the Cos-7 cells where ICAM-1-mCherry and mutants were exogenously 
expressed, expression was monitored via the red fluorescence channel using the 
following filter set: D580/30; HQ630/40.   
 
Disk-spinning Confocal Imaging and 3-D Deconvolution: 
 To obtain three-dimensional images of transmigratory cup formation and ICAM-1 
clustering, we utilized an Olympus IX81 inverted epifluorescence microscope, using an 
Olympus 60x UPlan FLN1.3 N/A DIC lens, CoolsnapES2 CCD camera (Photometrics) 
and Metamorph software (Universal Imaging) outfitted with a Nipkow-type disk-
spinning confocal unit.  Sequential images were acquired for the entire depth of the cell at 
50 nm intervals at single time points after the addition of 3m anti-ICAM-1 beads using 
100% illumination from a 100 W Hg arc lamp with a filter set for mCherry: D580/30; 
HQ630/40 through the custom dichroic described above.  Deconvolution and 
reconstruction of the acquired 3-dimensional image stacks was performed using 
AutoQuant deconvolution software (Media Cybernetics, Bethesda, MD). 
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6.7  Figures and Legends 
Figure 6.1:  Establishment of a Model System for Studying ICAM-1 Ligation and 
Downstream Signaling. 
 
(A) Cos-7 cells with or without expression of ICAM-1 showing selective adherence of 
ICAM-1 beads to mCherry-ICAM-1 expressing cells only (red arrow).   
(B) Actin retrograde flow-based movement of beads from the cell edge to cell interior 
after bead adherence.  Time points shown are at 0 and 200 minutes, and the right-most 
panel illustrates the bead track over time.  
(C) Cos-7 cell expressing mCherry-ICAM-1 shows that bead adherence leads to 
recruitment of ICAM-1 around the beads (red arrows). 
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Figure 6.2:  Rac1 Activation Downstream of ICAM-1 Ligation. 
(A) Cos-7 cell expressing both a Rac1 dual-chain sensor and mCherry-ICAM-1 showing 
that FRET can be detected in the presence of anti-ICAM-1-antibody coated beads.  
Activity heat map is indicated in the upper right corner of the lower panel. 
(B) Time course of Rac1 activation after bead binding to a Cos-7 cell expressing both a 
Rac1 dual-chain sensor and mCherry-ICAM-1.  Rac1 activity is indicated by the heat 
map in the upper left corner.  DIC image is shown to provide bead location.   
(C) Quantitation of transient Rac1 activation events in the context of wild-type ICAM-1, 
C-terminally truncated ICAM-1, Rac1 T17N, or an optical biosensor control.  Rac1 
activation events were defined as a 5x increase in Rac1 activation over a nearby region of 
interest.  
(D) Comparison of bead-induced clustering of ICAM-1 in cells expressing wild-type 
mCherry-ICAM-1 or C-terminally truncated mCherry-ICAM-1.   
(E) Deconvoluted disk-spinning confocal image of beads adhered to Cos-7 cell 
expressing mCherry-ICAM-1.  Top panel illustrates recruitment in the x-y plane.  Bottom 
panel illustrates recruitment to cup-like structures in the x-z plane.   
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Figure 6.3:  RhoA Inactivation Downstream of ICAM-1 Ligation. 
(A) Human umbilical vein endothelial cell (HUVEC) expressing a RhoA single-chain 
sensor after TNFα treatment shows bead binding.  RhoA is locally depressed at the site of 
bead adherence (red arrows).  Activity heat map is indicated in the upper left corner.  A 
quantitative illustrative trace of RhoA activity along a linescan through the bead is 
illustrated at left.   
(B) Human umbilical vein endothelial cell (HUVEC) expressing a RhoA single-chain 
sensor after TNFα treatment shows bead binding.  RhoA appears to be activated at 
regions where cell-cell junctions separate (red arrows).  Activity heat map is indicated in 
the upper right corner.   
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Figure 6.4:  RhoA Activation Downstream of Applied Mechanical Force. 
(A) Quantitation of whole-cell RhoA activity in fixed Bovine Aortic Endothelial Cells 
(BAECs) expressing a RhoA single-chain activity sensor, treated with force and fixed at 
the indicated time points.  
(B) Example images of whole-cell RhoA activity in fixed Bovine Aortic Endothelial 
Cells plated on fibronectin expressing a RhoA single-chain activity sensor, treated with 
force, and fixed at the indicated time points.  RhoA activity is indicated by the heat map 
in the upper panel center.  
(C) Example images of whole-cell RhoA activity in fixed Bovine Aortic Endothelial 
Cells plated on collagen expressing a RhoA single-chain activity sensor, treated with 
force, and fixed at the indicated time points.  RhoA activity is indicated by the heat map 
in the upper left panel.  Red arrows indicate sites of increased peripheral membrane 
ruffling after force application. 
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Figure 6.5:  RhoG Activation Downstream of ICAM-1 Ligation. 
(A) Quantitation of recruitment of CFP-RhoG and YPet-ELMO, components of a RhoG 
dual-chain biosensor, to adherent beads on mouse aortic endothelial cells isolated from 
SGEF WT or SGEF-/- mice expressing a RhoG dual-chain biosensor after treatment with 
TNFα.  Right-most panels are examples of increased CFP-RhoG and YPet-ELMO 
recruitment to an adhered bead on an SGEF WT mouse aortic endothelial cell.   
(B) HUVEC expressing a RhoG dual-chain biosensor after treatment with TNFα 
demonstrating adherence of a bead with subsequent rapid and increasing activation at the 
site of the bead within 15 minutes of bead adherence.  Relative RhoG activity is indicated 
by the heat map at left.  
(C) Mouse aortic endothelial cells isolated from SGEF-/- mice expressing a RhoG dual-
chain biosensor after treatment with TNFα demonstrating reduced RhoG activity at the 
site of bead adherence compared to (B).  Right-most panels are examples of the reduced 
recruitment of CFP-RhoG and YPet-ELMO to adhered beads in SGEF-/- mouse aortic 
endothelial cells.  
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CHAPTER SEVEN:  DISCUSSION, CLINICAL RELEVANCE, AND FUTURE 
DIRECTIONS 
 
7.1  Summary of Findings 
 Cell migration is a highly complex process that requires the coordination of 
multiple signaling pathways in both time and space to orchestrate the myriad functional 
and morphological changes in a cell that lead to polarization, protrusion, and retraction of 
the rear of the cell.  Clearly, the activities of these pathways coordinating migration 
operate within a fairly tight window of control to properly respond to environmental cues 
in either an attractive or repulsive fashion.  These pathways are also differentially 
regulated depending on the cells studied:  for example, the cues that cause a neuronal cell 
process to be extended, or that cause dendrites to form on the neuron may be entirely 
unimportant for the movement and migration of leukocytes to sites of inflammation 
(Franz et al. 2002; Ridley 2006; Ley et al. 2007).  Remarkably, however, the myriad cues 
that tell cells what to do and how to behave often engage the same core cellular 
machinery regardless of the cell type, namely the Rho GTPases (Burridge and 
Wennerberg 2004).  The commonality of these molecules to the whole of cell migration 
makes them excellent targets for study of how cells respond to environmental cues and 
translate those cues into functional behaviors.   
 Biochemical studies have provided a great deal of evidence about the roles and 
functions of the GTPases, identifying 20 Rho GTPases to date and categorizing many of 
their functions.  Many of these GTPases are cell-type specific or function-specific and 
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play less important roles (Jaffe and Hall 2005).  Further, biochemical evidence has often 
taken advantage of growth factor stimulation to exaggerate the differences between 
conditions of study, often pushing cellular signaling outside the boundaries of normal 
cellular controls.  Thus, we lose sight of many of the intrinsic regulatory mechanisms 
found in cells that operate predominantly in the non-stimulated state (Machacek et al. 
2009).  Further, it is quite apparent that the location and timing of the signals from these 
patterns matters greatly in determining their functions.  For example, RhoA is capable of 
both polymerizing actin through mDia1 (Lammers et al. 2008), and causing cellular 
contractility through myosin activation (Burridge and Chrzanowska-Wodnicka 1996).  It 
would be unproductive for the cell to perform both functions in the same place at the 
same time, so RhoA is likely segregated with different signaling partners or scaffolds 
which respond to different cues to orchestrate specific behaviors in specific locations of 
the cell, such as with IQGAP (White et al. 2009).  Through the use of a combination of 
biochemistry, imaging techniques, and FRET-based probes for GTPase activity I have 
begun to characterize and elucidate the mechanisms by which cells control the spatial and 
temporal dynamics of the Rho GTPases both during constitutive cell migration 
movements, and in response to specific cellular cues.  In the process of this work, I have 
developed significant new tools for the study of Rho GTPase activation in living cells.  
The main findings of this work are summarized below: 
 
Rational Design and Development of Rho GTPase Biosensors for Live Cell Imaging: 
1. Two major GTPase activity FRET probe designs have been further improved and 
optimized, specifically generating a new single-chain Rac1 sensor, and generating 
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new, enhanced sensitivity versions of dual-chain sensors for RhoA, Rac1, Cdc42, 
and RhoG. 
2. Single-chain and dual-chain sensor designs, along with their modifications, both 
present unique advantages and disadvantages in terms of ease of use, simplicity of 
signal analysis, and resultant false positive and false negative results.  Further, 
dual-chain sensors are amenable to a different format of analysis, permitting a 
better recognition of total activity within a region of a cell, and permitting study 
of activity in low signal situations.  Choice of sensor will strongly depend on the 
experimental conditions. 
3. Rho GTPase sensors have been generated and optimized with wavelengths 
orthogonal to the CFP/YFP pairs currently in use by using mKO/mCherry as 
donor and acceptor fluors.   
4. A novel system to control the expression of the two components of the dual-chain 
sensor has been developed and utilized to express dual-chain sensors at 
appropriate concentrations. 
 
Coordination of the Spatiotemporal Dynamics of Rho GTPases during Cell Migration: 
1. Rac1, RhoA, and Cdc42 activities can be directly correlated to constitutive cell 
edge movements. 
2. Using cell edge movements as a common reference point, we can infer the 
relationships between Rac1, RhoA, and Cdc42 activities in both time and space. 
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3. Computational modeling provides a powerful tool with which to correlate 
multiple signaling protein activities derived from imaging data from single 
experiments in both time and space. 
4. RhoA is activated coincident with cell protrusion and is active at the very cell 
edge.  Rac1 and Cdc42 are both activated with a time delay of 40 seconds relative 
to cell protrusion, and are found to attain maximal activity approximately 1.3 to 
1.8 m from the cell edge. 
5. Leading edge RhoA activity is modulated by the GEF TEM4, likely indirectly 
through RhoC.  Loss of TEM4 leads to increased RhoA activity at the whole-cell 
level.  Spatially, we see uniform activation of RhoA along the entire cellular 
periphery, rather than activity in protruding regions alone. 
6. Cdc42 is activated during filopodium formation, in addition to cellular protrusion. 
7. Cdc42 is found to be active at the base of filopodium, in the shaft of the 
filopodium, and at the filopodium tip during filopodium extension.  Cdc42 
activity drops sharply upon filopodial retraction.   
8. Filopodial Cdc42 activity is regulated by a novel mDia2-associated GAP, MILO.  
Knockdown of the GAP leads to increased Cdc42 activity at the whole-cell level 
and in filopodia.  Overexpression of the “active” GAP decreases Cdc42 activity. 
9. Src kinase increases filopodial Cdc42 activity by phosphorylating and inactivating 
MILO.   
10. Not only can it be discerned how the Rho GTPases are coordinated in space and 
time through biosensor imaging, but it can also be discerned how they are 
regulated by upstream regulators. 
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Role of RhoG in Cell Migration: 
1. RhoG is activated coincident with cell protrusion and is active at the very cell 
edge.   
2. The leading edge activation pattern of RhoG is tightly regulated by the vesicular 
trafficking of RhoG along microtubules, which in turn is regulated by RhoGDI-3, 
a unique cellular GDI that only interacts with RhoG.  RhoG activity can be 
modulated by overexpression or knockdown of RhoGDI-3. 
3. RhoG precisely positions Rac1 activation within the lamellipodium via the 
ELMO/DOCK180 pathway as described for other RhoG behaviors. 
4. RhoG appears to control Rac1 activation within the lamellipodium due to its 
ability to recruit and activate Rac1 at focal adhesions via DOCK180, which is a 
focal adhesion anchor point. 
5. Due to the control of a small subpopulation of Rac1 activity by RhoG, we find 
that cell edge dynamics, in particular protrusion/retraction periodicity and 
velocity, and actin polymerization are all affected. 
6. RhoG is critical for long-term random cell migration, controlling the ability of 
cells to polarize Rac1 activity in response to environmental cues, and to turn in 
response to generation of new foci of Rac1 activity. 
 
Regulation of Rho GTPase Dynamics in Response to Growth Factors: 
1. RhoG, Rac1, and Cdc42 are all activated rapidly by EGF stimulation. 
2. Rac1 and Cdc42 activation by EGF is regulated by submembranous pH: low pH 
(< pH 6.6) prevents activation of Rac1 and Cdc42 in response to EGF stimulation.   
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3. RhoG activation in specifically mediated by Vav2/Vav3 GEFs in HeLa cells and 
Vav2/PLEKHG6 in A431 cells. 
4. PLEKHG6 is a GEF that activates RhoG and defines the morphological response 
of cells to EGF stimulation.  In A431 cells, PLEKHG6 is responsible for dorsal 
ruffling of cells, while Vav2 controls the peripheral spreading response. 
 
Role of Rho GTPases in Transendothelial Migration: 
1. Cos-7 cells, lacking endogenous ICAM-1, make an excellent model system to 
study ICAM-1 ligation and clustering, and subsequent downstream signaling as a 
proxy for leukocyte transendothelial migration. 
2. Rac1 is activated locally, transiently, and in a delayed fashion in response to 
ICAM-1 ligation and clustering. 
3. RhoG is activated locally and immediately in response to ICAM-1 ligation and 
clustering.  RhoG activation is mediated in large part by the RhoG-selective GEF, 
SGEF. 
4. RhoA is locally and immediately inactivated in response to ICAM-1 ligation and 
clustering, but is activated globally. 
5. Global RhoA activation was confirmed in a model of mechanical force 
transduction by endothelial cells.  This mechanical force transduction is strongly 
dependent on the substrate on which the cells are growing. 
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7.2  Clinical Relevance 
Role of Rho GTPases in Cancer: 
Given that the Rho GTPases are at the core of a variety of normal and 
pathological processes, such as embryonic development, neuronal development, 
inflammatory signaling, and cancer development and metastasis, among a whole host of 
other cellular behaviors (Burridge and Wennerberg 2004; Jaffe and Hall 2005), immense 
effort has been expended trying to understand their roles in these processes.   
To date, many cancer-promoting genes, or oncogenes, have been shown to exert 
their effects because of specific mutations causing unchecked downstream signaling with 
dramatic consequences on cellular behaviors.  Curiously, there have been very few 
mutations identified in the Rho GTPases themselves that cause disease, with the 
exception of RhoH (Hiraga et al. 2007; Sanchez-Aguilera et al. 2009).  The Rho GTPases 
appear to affect cancer progression predominantly through increased expression or 
increased activation.  For example, in a seminal study on Rho GTPases and cancer 
metastasis, RhoC was consistently identified as a molecule whose overexpression was 
correlated strongly with increased metastatic potential and poor survival outcomes (Clark 
et al. 2000).  In contrast, a variety of GEFs responsible for activating Rho GTPases and 
GAPs responsible for inactivating Rho GTPases have been identified as either mutated, 
amplified, or deleted in a number of cancers.  For example, Tiam-1, Vav2, LARG, and 
Dbl are all GEFs that were identified as oncogenes in the study of cancer mutations 
(Ridley 2004; Vega and Ridley 2008).  Similarly, DLC1 and DLC2 have been identified 
in liver cancer samples as GAPs that have been lost (Yuan et al. 2003), permitting 
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increased Rho GTPase activation.  What each of these changes in gene expression or 
these mutations have in common is that they cause hyperactivation of the GTPases.   
Hyperactivation of each of the GTPases has even been correlated to the different 
modes of movement and metastatic migration of cancer cells.  These studies have 
identified three major types of metastatic migration strategies: 1) single-cell amoeboid 
movement, 2) single-cell mesenchymal movement, and 3) multicellular sheet-like 
movement, each associated with activation of different Rho GTPases.  For single-cell 
amoeboid movement, cells tend to have much higher Rho activation and actomyosin 
contractility and move slowly via a propulsive mechanism (leukemia, lymphoma, small-
cell lung cancer).  For single-cell mesenchymal movement, cells have higher Rac1 
activation at the leading edge with Rho contractility at the rear to enable a more 
protrusive movement (fibrosarcomas, glioblastomas, anaplastic cancers).  For collective 
migration of cellular sheets, Rho and Rac activation are both increased and work in 
parallel to permit the entire cluster of cells to migrate (epithelial-derived cancers, 
melanoma, vascular tumors) (Sahai and Marshall 2003; Wolf and Friedl 2006; Gaggioli 
et al. 2007; Sanz-Moreno et al. 2008; Friedl and Wolf 2009; Ilina and Friedl 2009; Wolf 
et al. 2009).   
Thus, it is interesting to note that groups have attempted to examine the 
prognostic values of all these Rho GTPases in breast cancer progression and found an 
interesting pair of proteins that were increased and decreased respectively: RhoG and 
RhoGDI-3 (Jiang et al. 2003).  Coupled with another study identifying overexpression of 
both DOCK180 and ELMO1 in gliomas (Jarzynka et al. 2007), there is fairly strong 
evidence that RhoG is overactivated in cancers.  Whether these proteins play a causative 
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role in cancer progression is unknown, but given their role in cell migration, it is highly 
likely that RhoG is overactivated, resulting in Rac1 overactivation and downstream 
signaling.  Thus, RhoG may help to drive mesenchymal and collective sheet migration 
during metastasis, which would be an interesting hypothesis to test.  Further, these studies 
would also seem to indicate that the Rho GTPases would be excellent targets for anti-
cancer therapy, but due to the myriad functions they regulate, side effects are likely to be 
a significant issue.   
Cell migration has been an extremely difficult target to tackle in cancer metastasis 
because the cellular signaling components are common to so many non-pathological 
behaviors, particularly the GTPases, and because cancer cells have an amazing capacity 
to adapt and avoid what would seemingly be blockade of critical signaling pathways.  For 
example, if matrix metalloproteases necessary for invasion of tissues are inhibited, cancer 
cells can still invade (Coussens et al. 2002).  Similarly, if RhoA pathways are inhibited in 
cells demonstrating amoeboid migration, they often switch to a mesenchymal mode of 
migration, and vice-versa when Rac1 pathways are inhibited, confounding therapeutic 
intervention (Friedl and Wolf 2009).  Thus, it is becoming clear that combinatorial 
therapy may be the most viable treatment strategy in the future, attempting to inhibit 
multiple critical pathways required for cancer progression and metastasis, such as cell 
cycle progression, angiogenesis, and migration.   
Where RhoG may play a unique role in cancer therapy is by virtue of the 
uniqueness of RhoG signaling and its upstream regulators.  If it is identified that RhoG-
specific GEFs such as SGEF play a significant role in cancer cell migration, or if 
RhoGDI-3 is found to play a significant role in cancer cell migration, these might be 
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viable targets for therapeutic intervention because they would impact other important 
signaling pathways to a significantly lesser degree than targeting the other major 
GTPases.  When combined with other therapeutic agents, inhibition of RhoG signaling in 
cancer types where RhoG signaling has been found to be elevated (Jiang et al. 2003; 
Jarzynka et al. 2007) may help slow or stop metastatic progression. 
 
Role of Rho GTPases in Inflammatory Signaling: 
As delineated above for cancer development and metastasis, Rho GTPases also 
play a significant role in inflammatory diseases because both the immune cell and the 
vasculature have to change their cytoskeletal structure to permit leukocyte extravasation 
into tissues.  However, because of the narrow therapeutic window between blocking 
abnormal inflammatory cell recruitment and blocking normal immune surveillance 
behaviors which would cause immune suppression, viable therapies have been slow in 
development.  From the development process, it seems that most successful therapeutic 
agents have targeted leukocyte-endothelial interactions or the endothelium itself.  For 
example, one of the more successful drugs for multiple sclerosis and Crohn’s disease, 
Tysabri (natalizumab), blocks 41 integrins on leukocytes that interact with VCAM-1 on 
the endothelium (Miller et al. 2003; Sandborn and Yednock 2003; Dalton et al. 2004).  
Another example, Fasudil, a Rho kinase inhibitor, has been used in Japan for a number of 
years to treat cerebral cavernous malformation which causes vascular leakiness (Olson 
2008), and is also being tested in clinical trials for pro-inflammatory diseases since 
vascular leakiness is also a hallmark of inflammation and leukocyte extravasation (Olson 
2008).  Thus, a better understanding of the mechanisms behind leukocyte-endothelial 
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interactions and the resultant leaky endothelium would likely lead to better therapeutic 
agents.  Many of the anti-inflammatory agents currently in the clinical trial pipeline 
impinge upon cell migration and the Rho GTPases, including chemokine receptor 
inhibitors, adhesion molecule inhibitors, complement receptor inhibitors, and others 
(Norman and Kubes 2005; Kelly et al. 2007).  In principle, targeting the Rho GTPases 
would be a desirable approach, but again specificity and side effects are issues.  In 
addition to the role of Rho kinase mentioned above, it has also been reported that cAMP-
dependent Rac1 activation is important for the stabilization of the endothelial barrier 
function and thus could be used to block inflammation (Waschke et al. 2004; Schlegel et 
al. 2008; Baumer et al. 2009).  In support of this hypothesis, cAMP-increasing agents had 
protective effects on the microvasculature during sepsis (Trager et al. 2003), further 
validating indirect targeting of the Rho GTPases as a viable method for controlling 
inflammation and vascular leakiness. 
Where RhoG may play a unique role in the study of inflammation and leukocyte 
recruitment is illustrated in Chapter 6 in bead-binding studies and in the works of others 
(van Buul et al. 2007a).  It is known that a docking structure or “transmigratory cup” 
forms around adhering leukocytes as they bind to the endothelium.  SGEF, one of the key 
upstream GEFs for RhoG, appears to mediate this process, as loss of RhoG or SGEF 
abrogates transmigratory cup formation during leukocyte adhesion and reduces 
transendothelial migration.  By identifying the mechanistic pathways leading to RhoG 
activation downstream of ICAM-1, we may identify unique targets, such as SGEF, that 
may be amenable to inhibition without disrupting many other signaling pathways in the 
body and thus successfully reduce transendothelial migration in areas of high 
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inflammation.  It is particularly important to note that ICAM-1, the main focus of our 
work on transendothelial migration, is a highly inducible inflammatory marker.  For 
example, in atherosclerosis, ICAM-1 is markedly upregulated at sites of plaque formation 
and inflammation (Nakashima et al. 1998; Rohlena et al. 2009).  Further, associated 
molecules such as the tetraspanins which help regulate ICAM-1 and VCAM-1 signaling, 
are also upregulated, suggesting that ICAM-1, VCAM-1, and their downstream signaling 
partners may be excellent targets for the disruption of inflammatory diseases (Fernandez-
Borja et al. 2010).  Indeed, some of the best successes in targeting transendothelial 
migration during inflammation have come from inhibitors of ICAM-1 and VCAM-1-
mediated signaling, natalizumab and efalizumab, which has been shown to be useful for 
treating severe multiple sclerosis and Crohn’s disease (Miller et al. 2003; Sandborn and 
Yednock 2003; Dalton et al. 2004; Jullien et al. 2004).  
 
Imaging Probes for in vivo Detection of Aberrant Signaling: 
Additionally, the development of novel probes for the study of cellular signaling 
has clinical relevance.  Currently, most imaging probes are used in cells plated in 2-
dimensional cultures.  While this provides us a great deal of information about how 
signals are propagated in single cells, it does not tell us how signaling pathways behave 
in more complex models such as 3-dimensional cell cultures or in animals.  To this end, 
the development of novel biosensors that are much more sensitive to endogenous signals 
will allow the introduction of even smaller amounts of probe into cells and tissues for 
imaging without perturbing downstream signaling, particularly if new FRET analysis 
techniques are applied.  Second, with the use of orange/red FRET pairs, light can 
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penetrate tissues more deeply (Shaner et al. 2005; Shaner et al. 2008), permitting 
visualization of FRET from within deeper structures, perhaps even from live animals.  
Lastly, the conversion of our novel sensitive dual-chain probes to autocleavable forms 
allows for the introduction of these probes into animals at a single gene locus, rather than 
optimizing the expression of two separate loci within an animal which has been 
extremely difficult due to heterogeneity in expression levels (Trichas et al. 2008).  Thus, 
these advances bring us closer to understanding signaling pathways and their 
spatiotemporal constraints in vivo, where we might be able to see aberrant activation of 
Rho GTPases in response to genetic or exogenous insults.  Perhaps at some point in the 
future, tracer probes will be used in clinical studies to detect aberrant cellular signaling 
and pinpoint the sources of those aberrant signals, such as cancer stem cells or actively 
proliferating cancer cells. 
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7.3  Long-term Directions 
Large-scale Analysis of GTPase Regulators During Random Cell Migration: 
 Now that we have developed a spatial and temporal relationship map among the 
Rho GTPases during constitutive cell movement behaviors, precisely mapping when and 
where these GTPases are active, myriad hypotheses present themselves for testing.  
Given that computational analysis discussed in Chapter 3 can account for fairly broad 
cell-to-cell heterogeneity, it seems it would be of great value to begin by perturbing 
molecules involved in regulating Rac1, RhoG, RhoA, or Cdc42, or the GTPases 
themselves, and observing how the timing and positioning patterns change for each of the 
GTPases. It is also possible, given the consistency of the data, that this methodology 
could be applied to a high-throughput analysis.  For example, the Cell Migration 
Consortium has sponsored high-throughput siRNA screens intended to identify whether 
cell migration was perturbed by knockdown of specific cellular proteins (Kamath et al. 
2003; Cram et al. 2006; Simpson et al. 2008), generally in simple assays such as wound 
healing assays or presence/absence of migration.  These results, however, do not tell us 
how migration is perturbed: whether directionality, response to growth factors, turning 
ability, or a variety of other parameters is perturbed.  Through the analysis of single-cells 
in a high-throughput manner, GTPase activity sensors could be introduced into cells and 
imaged in a 96-well format to cover a variety of parameters, including but not limited to 
directionality, persistence, velocity, polarity, GTPase activation level, and edge 
dynamics.  By application of siRNA libraries enriched for siRNAs already known to 
affect cellular morphology or migration (genome-wide could be done but would likely be 
very burdensome in terms of imaging data and analysis), the effects of these siRNAs on 
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the timing and positioning of the GTPases due to knockdown of the target proteins could 
be determined.  Ultimately, through confirmation and validation of the siRNA targets, 
this could lead to the development of spatiotemporal maps of cellular signaling pathways 
that more accurately describe the roles of the Rho GTPases and their regulators in cellular 
behaviors.   
 I am particularly interested in such an analysis that would target three classes of 
proteins: 1) GEFs, 2) GDIs, and 3) scaffolding proteins.  Clearly, with the very precise 
positioning and activation of the GTPases found during cell protrusion, there must be 
molecules that determine their positioning and activation.  The three classes of proteins I 
mention above seem to hold the most promise in determining GTPase positioning and 
activation.  First, it is known that for Rac1, GEFs play a prominent role in recruitment 
and activation, such as -Pix and its ability to recruit and activate Rac1 at focal adhesions 
(Koh et al. 2001; ten Klooster et al. 2006; Chang et al. 2007; Lee et al. 2010a).  Loss of 
this GEF would alter the Rac1 dynamics that we see in our cellular protrusion system and 
could thus be quantified spatially and temporally.  It would be very interesting to test this 
for a number of GEFs and determine whether very specific subsets of GTPase activity are 
regulated by each GEF, or whether there is redundancy and overlap in the ability to 
position and activate the GTPases.  Second, GDIs are extremely interesting as well, as 
they have the ability to hold GTPases in the inactive form until the GDI is released, 
permitting activation of the GTPase.  For example, both PKA and PKC are capable of 
phosphorylating GDI on specific residues, leading to the release of RhoA or RhoG 
(Elfenbein et al. 2009; Tkachenko et al. 2011), respectively, from GDI and thus 
activation of those GTPases.  Through modulation of GDI by replacement with 
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phosphorylation mimics (rather than knockdown of GDI which has been shown to have 
more broad-scale effects) we could ascertain how each of the GTPases is governed by 
GDI and how GDI influences the positioning and activation of the GTPases.  A recent 
study has done precisely this, demonstrating that PKA acts as a master regulator of the 
protrusion-retraction cycle through RhoA (Tkachenko et al. 2011).  Lastly, it has long 
been known for the mitogen-activated protein kinase (MAPK) signaling pathways that 
scaffolds play an enormous role in bringing together specific signaling components to 
activate specific downstream signaling pathways in response to extracellular cues 
(Dhanasekaran et al. 2007).  These scaffold proteins provide much of the specificity for 
these kinases, preventing inappropriate interactions within the cell.  The same design also 
appears to play a part in Rho GTPase signaling as well.  For example, the protein 
synectin was recently identified as a component of a complex that tied fibroblast growth 
factor (FGF) signaling to RhoG activation by serving as a scaffold for both RhoG and 
GDI, holding RhoG in its inactive state.  This molecular complex prevents RhoG 
activation until FGF stimulation activates protein kinase C (PKC) which in turn 
phosphorylates RhoGDI-1, releasing RhoG and permitting its activation (Elfenbein et al. 
2009).  Thus, inappropriate interactions with other molecules could be prevented and 
specific downstream signaling cascades through RhoG could be initiated.  In independent 
studies, synectin has been shown to be a critical player in cell migration, due to its role as 
a scaffold for a variety of signaling proteins (Muders et al. 2009; Wang et al. 2010).  By 
knockdown of various scaffold proteins, their effects on both the timing and positioning 
of GTPase activation could also be determined.  Further work could then elucidate the 
specific molecules that bound to the scaffold with the GTPase and which extracellular 
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cues were responsible for activating the pathway.  Analysis of how each of these sets of 
molecules contribute to Rho GTPase regulation would greatly enhance our understanding 
of how these molecules operate in living cells.   
 
Regulation of RhoG in Cell Migration: 
 The work in Chapter 4 detailing the role of RhoG in cell migration in some ways 
raises more questions than it answers.  RhoG and its regulation still remains poorly 
understood.  We and others have identified the role of RhoG in cell migration 
(Wennerberg et al. 2002; Katoh and Negishi 2003; Hiramoto et al. 2006; Katoh et al. 
2006; Hiramoto-Yamaki et al. 2010), in particular its regulation via vesicular trafficking 
by RhoGDI-3 and its ability to regulate the lamellipodial subpopulation of Rac1 activity.  
We also show that it appears to be critical for the ability of cells to reorient and polarize 
Rac1 activity during the turning process in random cell migration.  However, we do not 
fully understand the cues that are responsible for activating RhoG at the leading edge.  
Our preliminary experimentation suggests that Trio may be the critical GEF that activates 
RhoG at the leading edge of cells, but there may also be others such as Ephexin4, 
Vav2/3, and PLEKHG6 (Ellerbroek et al. 2004; D'Angelo et al. 2007; Hiramoto-Yamaki 
et al. 2010; Samson et al. 2010).   
The next steps in this study would be to identify the GEFs that regulate RhoG 
during cell migration, and the specific extracellular cues that activate those GEFs.  For 
example, we have shown that in HeLa cells, the Vav2/Vav3 GEFs are critical for EGF 
response, and in A431 cells, Vav2 and PLEKHG6 are responsible for EGF response 
(Samson et al. 2010).  Other groups have identified that fibroblast growth factor (FGF) 
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activates RhoG via the FGF2 receptor coupled with Syndecan-4, but no GEF was 
identified in that study that might subsequently activate RhoG; the authors simply stated 
that FGF stimulation prepared RhoG for activation by releasing GDI (Elfenbein et al. 
2009).  Thus, there appears to be fertile ground for identifying and characterizing the 
GEFs that activate RhoG.   
While many of the growth factors have been tested for their ability to activate 
RhoG, and their roles vary from cell type to cell type, other signals have been less well 
characterized.  Since Syndecan-4 was previously identified as part of a scaffold that can 
regulate RhoG activity (Elfenbein et al. 2009), it is interesting to note that Syndecan-4 is 
also a receptor for fibronectin (Bass et al. 2007), suggesting that multiple signal inputs 
could use the Syndecan-4 pathway to activate RhoG.  It has not yet been tested whether 
fibronectin can also activate RhoG through the Syndecan-4 co-receptor.   
By examining these pathways, I not only wish to identify what activates RhoG, 
but what the activation of RhoG causes cells to do, i.e. the functional consequences of 
that pathway.  Does RhoG activation guide directionality or environmental cue-finding, 
and are these behaviors linked to specific extracellular cues?  In Chapter 4, I show that 
RhoG helps cells to change direction, but I do not identify the specific cue that activates 
RhoG in this process.  Through these studies I would hope to identify the cue(s) 
responsible for these cellular behaviors. 
The ultimate goal of such a study would be to identify novel, specific regulators 
for RhoG in cellular behaviors that could be targeted for therapeutic effect in a number of 
different diseases where RhoG plays a role.  Given that many of the molecules so far 
identified that activate RhoG are fairly specific to RhoG (Ellerbroek et al. 2004; 
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D'Angelo et al. 2007; Hiramoto-Yamaki et al. 2010), we could potentially identify unique 
cellular targets whose inhibition would have little to no effect on other GTPases, which 
has been a problem to date with many strategies attempting to inhibit the Rho GTPases. 
 
Rho GTPases in Leukocyte Transendothelial Migration: 
Lastly, much work remains to be done in understanding endothelial Rho GTPase 
activation during leukocyte transendothelial migration.  Again, from biochemical studies 
(Barreiro et al. 2002; Thompson et al. 2002; Carman et al. 2003; Carman and Springer 
2004; Millan et al. 2006; van Buul et al. 2007a; Carman 2009), we know some of the 
molecules involved in this process, such as Rac1, RhoG, RhoA, vimentin, and ICAM-1, 
among others.  I have also been able to show that Rac1, RhoG, and RhoA are activated 
downstream of ICAM-1 with different kinetics, and that for RhoG, SGEF appears to be 
one of the GEFs involved in this process.  However, we still poorly understand the role 
each of these GTPases has in the morphological changes that occur for cup formation and 
leukocyte transmigration, either through the cell or between cells (Dejana 2006; Ley et al. 
2007; Fernandez-Borja et al. 2010).  For the next steps, we would want to knock out each 
of the GTPases to observe the effects both on cup formation and on the dynamics of the 
Rho GTPases during ICAM-1 ligation and clustering, and the subsequent cup formation 
response.  For example, which is the first step in cup formation:  RhoA, RhoG, or Rac1 
activation?  By perturbing each of the GTPases individually, I could attempt to determine 
which GTPase(s) were the most critical for cup formation.  If this first step is lost, is cup 
formation lost entirely?  If later steps in cup formation are disrupted, is GTPase activation 
altered, or is the ability of the cup to close and engulf the bead or white blood cell 
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altered?  These answers are currently unknown and would represent the next steps in our 
understanding of leukocyte TEM.  Ultimately, I will shift away from using beads to using 
leukocytes for these studies.  Neutrophils and lymphocytes would likely be the cells of 
choice as both readily undergo transendothelial migration, both engage ICAM-1 
effectively, and both are capable of undergoing both transcellular and paracellular 
transendothelial migration (Dejana 2006).  I would then determine whether white blood 
cells cause endothelial Rho GTPases to become activated in the same patterns as we saw 
with our bead studies, and whether perturbation of those GTPases caused the same 
changes in cup formation.  There is some concern that signaling via VCAM-1, which has 
also been shown to be important for transendothelial migration, may activate a number of 
pathways in parallel to ICAM-1 (van Wetering et al. 2003; van Buul et al. 2007b; 
Fernandez-Borja et al. 2010).  By blocking VCAM-1 with specific antibodies or ICAM-1 
with specific antibodies, we could then isolate the effects of leukocytes on either 
signaling pathway and thus elucidate GTPase activation downstream more effectively.   
 Many attempts have been made to more effectively block inflammatory processes 
that are mediated by aberrant leukocyte TEM.  However, most of the drugs targeting 
TEM pathways have had the consequence of immune suppression due to affecting normal 
TEM needed for immune surveillance (Norman and Kubes 2005; Kelly et al. 2007).  We 
hope that through our studies we could identify novel signaling components such as 
GEFs that are aberrantly activated in these inflammatory disease processes, and thus 
target those molecules for therapeutic intervention without significantly affecting normal 
TEM pathways.   
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7.4  Concluding Remarks 
The work described above has made strides toward providing better tools for the 
imaging of GTPase activity in living cells, while at the same time providing a better 
understanding of potential analysis methods for these tools.  Additionally, this work is 
among the first to extend the use of Rho GTPase biosensors beyond descriptive analyses 
of GTPase activation patterns, to being able to quantify causal relationships among the 
GTPases and their regulators.  These analyses have helped us better understand the role 
of Rho GTPases in cellular protrusion, and in particular the role of RhoG in cell 
migration and its regulation of Rac1.  Additionally, we have gained a better 
understanding of the regulation of Rho GTPases in response to extracellular cues.   
Lastly, these studies have helped to develop a framework for the better 
understanding of leukocyte TEM by development of a system wherein we can observe 
GTPase activation in response to ICAM-1 clustering and activation.  This system should 
be translatable to studies of primary leukocytes migrating through an endothelium, a 
much more complex system closely resembling in vivo behaviors.  Each of these studies 
described above provides the framework for much larger-scale analyses of the proteins 
that regulate the Rho GTPases in each of these processes, and the Rho GTPases 
themselves.   
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